1	The	DT	O	the	det	4	SENT_1	[p1l957t81r1002b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l1021t83r1106b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l1125t83r1313b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l1332t83r1512b109],
5	of	IN	O	of	_	0	SENT_1	[p1l1531t81r1560b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l1572t83r1771b102],

1	I	PRP	O	I	nsubj	2	SENT_2	[p1l664t186r666b303],
2	ORIGINAL	VBP	O	original	_	0	SENT_2	[p1l1153t234r1376b260],
3	ARTICLE	NN	O	article	nsubj	4	SENT_2	[p1l1389t234r1575b260],
4	I	PRP	O	I	xcomp	2	SENT_2	[p1l2062t186r2064b303],

1	Screening	VBG	O	screen	_	0	SENT_3	[p1l752t379r1051b449],
2	for	IN	O	for	_	0	SENT_3	[p1l1077t378r1165b433],
3	Epidermal	NNP	O	Epidermal	nn	5	SENT_3	[p1l1191t379r1503b448],
4	Growth	NNP	O	Growth	nn	5	SENT_3	[p1l1532t379r1762b434],
5	Factor	NN	O	factor	prep_for	1	SENT_3	[p1l1790t384r1980b433],

1	Receptor	NN	O	receptor	nn	2	SENT_4	[p1l810t466r1081b531],
2	Mutations	NNS	O	mutation	_	0	SENT_4	[p1l1106t462r1412b516],
3	in	IN	O	in	_	0	SENT_4	[p1l1442t462r1500b515],
4	Lung	NN	O	lung	nn	5	SENT_4	[p1l1528t466r1683b531],
5	Cancer	NN	O	cancer	prep_in	2	SENT_4	[p1l1710t465r1920b516],

1	Rafael	NNP	PERSON	Rafael	nn	2	SENT_5	[p1l681t571r778b603],
2	Rosell	NNP	PERSON	Rosell	_	0	SENT_5	[p1l796t572r903b609],
3	,	,	O	,	_	0	SENT_5	[p1l796t572r903b609],
4	M.D.	NNP	O	M.D.	dep	2	SENT_5	[p1l921t574r1011b609],
5	,	,	O	,	_	0	SENT_5	[p1l921t574r1011b609],
6	Teresa	NNP	PERSON	Teresa	nn	7	SENT_5	[p1l1024t574r1135b603],
7	Moran	NNP	PERSON	Moran	appos	4	SENT_5	[p1l1152t574r1270b609],
8	,	,	O	,	_	0	SENT_5	[p1l1152t574r1270b609],
9	M.D.	NNP	O	M.D.	appos	4	SENT_5	[p1l1287t574r1377b609],
10	,	,	O	,	_	0	SENT_5	[p1l1287t574r1377b609],
11	Cristina	NNP	PERSON	Cristina	nn	12	SENT_5	[p1l1392t574r1522b603],
12	Queralt	NNP	PERSON	Queralt	appos	4	SENT_5	[p1l1536t572r1671b612],
13	,	,	O	,	_	0	SENT_5	[p1l1536t572r1671b612],
14	B.S.	NNP	O	B.S.	appos	4	SENT_5	[p1l1689t574r1759b609],
15	,	,	O	,	_	0	SENT_5	[p1l1689t574r1759b609],
16	Rut	NNP	LOCATION	Rut	nn	17	SENT_5	[p1l1777t574r1831b603],
17	Porta	NNP	LOCATION	Porta	appos	4	SENT_5	[p1l1846t574r1941b609],
18	,	,	O	,	_	0	SENT_5	[p1l1846t574r1941b609],
19	M.D.	NNP	O	M.D.	appos	4	SENT_5	[p1l1958t574r2048b609],
20	,	,	O	,	_	0	SENT_5	[p1l1958t574r2048b609],

1	Felipe	NNP	PERSON	Felipe	nn	2	SENT_6	[p1l778t621r876b662],
2	Cardenal	NNP	PERSON	Cardenal	_	0	SENT_6	[p1l889t621r1048b658],
3	,	,	O	,	_	0	SENT_6	[p1l889t621r1048b658],
4	M.D.	NNP	O	M.D.	dep	2	SENT_6	[p1l1065t624r1155b658],
5	,	,	O	,	_	0	SENT_6	[p1l1065t624r1155b658],
6	Carlos	NNP	ORGANIZATION	Carlos	nn	7	SENT_6	[p1l1170t621r1276b652],
7	Camps	NNP	ORGANIZATION	Camps	appos	4	SENT_6	[p1l1290t623r1417b662],
8	,	,	O	,	_	0	SENT_6	[p1l1290t623r1417b662],
9	M.D.	NNP	O	M.D.	appos	4	SENT_6	[p1l1434t624r1524b658],
10	,	,	O	,	_	0	SENT_6	[p1l1434t624r1524b658],
11	Margarita	NNP	PERSON	Margarita	nn	12	SENT_6	[p1l1541t624r1703b662],
12	Majem	NNP	PERSON	Majem	appos	4	SENT_6	[p1l1719t624r1844b662],
13	,	,	O	,	_	0	SENT_6	[p1l1719t624r1844b662],
14	M.D.	NNP	O	M.D.	appos	4	SENT_6	[p1l1861t624r1951b658],
15	,	,	O	,	_	0	SENT_6	[p1l1861t624r1951b658],

1	Guillermo	NNP	PERSON	Guillermo	nn	2	SENT_7	[p1l696t670r865b702],
2	Lopez-Vivanco	NNP	PERSON	Lopez-Vivanco	_	0	SENT_7	[p1l881t673r1136b711],
3	,	,	O	,	_	0	SENT_7	[p1l881t673r1136b711],
4	M.D.	NNP	O	M.D.	dep	2	SENT_7	[p1l1153t673r1243b707],
5	,	,	O	,	_	0	SENT_7	[p1l1153t673r1243b707],
6	Dolores	NNP	PERSON	Dolores	nn	7	SENT_7	[p1l1260t670r1390b701],
7	Isla	NNP	PERSON	Isla	appos	4	SENT_7	[p1l1406t670r1470b707],
8	,	,	O	,	_	0	SENT_7	[p1l1406t670r1470b707],
9	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1487t673r1578b707],
10	,	,	O	,	_	0	SENT_7	[p1l1487t673r1578b707],
11	Mariano	NNP	PERSON	Mariano	nn	12	SENT_7	[p1l1595t673r1734b702],
12	Provencio	NNP	PERSON	Provencio	appos	4	SENT_7	[p1l1750t673r1924b707],
13	,	,	O	,	_	0	SENT_7	[p1l1750t673r1924b707],
14	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1941t673r2031b707],
15	,	,	O	,	_	0	SENT_7	[p1l1941t673r2031b707],
16	Amelia	NNP	PERSON	Amelia	nn	17	SENT_7	[p1l687t720r804b751],
17	lnsa	NN	O	lnsa	appos	4	SENT_7	[p1l821t723r897b757],
18	,	,	O	,	_	0	SENT_7	[p1l821t723r897b757],
19	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l914t723r1005b757],
20	,	,	O	,	_	0	SENT_7	[p1l914t723r1005b757],
21	Bartomeu	NNP	PERSON	Bartomeu	nn	22	SENT_7	[p1l1022t723r1185b751],
22	Massuti	NNP	PERSON	Massuti	appos	4	SENT_7	[p1l1202t723r1345b757],
23	,	,	O	,	_	0	SENT_7	[p1l1202t723r1345b757],
24	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1362t723r1536b760],
25	,	,	O	,	_	0	SENT_7	[p1l1362t723r1536b760],
26	jose	NN	O	jose	nn	28	SENT_7	[p1l1362t723r1536b760],
27	Luis	NNP	PERSON	Luis	nn	28	SENT_7	[p1l1552t723r1617b751],
28	Gonzalez-Larriba	NNP	PERSON	Gonzalez-Larriba	appos	4	SENT_7	[p1l1631t720r1931b757],
29	,	,	O	,	_	0	SENT_7	[p1l1631t720r1931b757],
30	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1948t723r2038b757],
31	,	,	O	,	_	0	SENT_7	[p1l1948t723r2038b757],

1	Luis	NNP	PERSON	Luis	nn	2	SENT_8	[p1l751t772r816b801],
2	Paz	NNP	PERSON	Paz	_	0	SENT_8	[p1l832t771r986b806],
3	.	.	O	.	_	0	SENT_8	[p1l832t771r986b806],

1	—	NN	O	—	_	0	SENT_9	[p1l832t771r986b806],
2	.	.	O	.	_	0	SENT_9	[p1l832t771r986b806],

1	Ares	NNS	O	are	_	0	SENT_10	[p1l832t771r986b806],
2	,	,	O	,	_	0	SENT_10	[p1l832t771r986b806],
3	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1003t772r1093b806],
4	,	,	O	,	_	0	SENT_10	[p1l1003t772r1093b806],
5	Isabel	NNP	PERSON	Isabel	nn	6	SENT_10	[p1l1110t769r1205b800],
6	Bover	NNP	PERSON	Bover	appos	1	SENT_10	[p1l1223t772r1325b806],
7	,	,	O	,	_	0	SENT_10	[p1l1223t772r1325b806],
8	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1342t772r1432b806],
9	,	,	O	,	_	0	SENT_10	[p1l1342t772r1432b806],
10	Rosario	NNP	PERSON	Rosario	nn	11	SENT_10	[p1l1449t772r1574b800],
11	Garcia-Campelo	NNP	PERSON	Garcia-Campelo	appos	1	SENT_10	[p1l1588t769r1872b810],
12	,	,	O	,	_	0	SENT_10	[p1l1588t769r1872b810],
13	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1889t772r1979b806],
14	,	,	O	,	_	0	SENT_10	[p1l1889t772r1979b806],
15	Miguel	NNP	PERSON	Miguel	nn	17	SENT_10	[p1l770t818r882b860],
16	Angel	NNP	PERSON	Angel	nn	17	SENT_10	[p1l895t819r990b860],
17	Moreno	NNP	PERSON	Moreno	appos	1	SENT_10	[p1l1007t821r1147b856],
18	,	,	O	,	_	0	SENT_10	[p1l1007t821r1147b856],
19	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1165t821r1255b856],
20	,	,	O	,	_	0	SENT_10	[p1l1165t821r1255b856],
21	Silvia	NNP	PERSON	Silvia	nn	22	SENT_10	[p1l1270t818r1356b850],
22	Catot	NNP	PERSON	Catot	appos	1	SENT_10	[p1l1370t821r1469b856],
23	,	,	O	,	_	0	SENT_10	[p1l1370t821r1469b856],
24	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1486t821r1576b856],
25	,	,	O	,	_	0	SENT_10	[p1l1486t821r1576b856],
26	Christian	NNP	PERSON	Christian	nn	27	SENT_10	[p1l1591t818r1742b850],
27	Rolfo	NNP	PERSON	Rolfo	appos	1	SENT_10	[p1l1759t818r1852b856],
28	,	,	O	,	_	0	SENT_10	[p1l1759t818r1852b856],
29	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1870t821r1960b856],
30	,	,	O	,	_	0	SENT_10	[p1l1870t821r1960b856],
31	Noemi	NNP	PERSON	Noemi	nn	32	SENT_10	[p1l733t871r845b899],
32	Reguart	NNP	PERSON	Reguart	appos	1	SENT_10	[p1l862t871r999b909],
33	,	,	O	,	_	0	SENT_10	[p1l862t871r999b909],
34	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1016t871r1106b905],
35	,	,	O	,	_	0	SENT_10	[p1l1016t871r1106b905],
36	Ramon	NNP	PERSON	Ramon	nn	37	SENT_10	[p1l1124t871r1240b899],
37	Palmero	NNP	PERSON	Palmero	appos	1	SENT_10	[p1l1258t868r1405b905],
38	,	,	O	,	_	0	SENT_10	[p1l1258t868r1405b905],
39	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1422t871r1596b908],
40	,	,	O	,	_	0	SENT_10	[p1l1422t871r1596b908],
41	José	NNP	PERSON	José	nn	43	SENT_10	[p1l1422t871r1596b908],
42	Miguel	NNP	PERSON	Miguel	nn	43	SENT_10	[p1l1612t868r1724b909],
43	Sanchez	NNP	PERSON	Sanchez	appos	1	SENT_10	[p1l1739t868r1889b905],
44	,	,	O	,	_	0	SENT_10	[p1l1739t868r1889b905],
45	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1906t871r1996b905],
46	,	,	O	,	_	0	SENT_10	[p1l1906t871r1996b905],
47	Roman	NNP	PERSON	Roman	nn	48	SENT_10	[p1l778t920r895b948],
48	Bastus	NNP	PERSON	Bastus	appos	1	SENT_10	[p1l912t920r1033b954],
49	,	,	O	,	_	0	SENT_10	[p1l912t920r1033b954],
50	M.D.	NNP	O	M.D.	appos	1	SENT_10	[p1l1050t920r1140b954],
51	,	,	O	,	_	0	SENT_10	[p1l1050t920r1140b954],
52	Clara	NNP	PERSON	Clara	nn	53	SENT_10	[p1l1155t917r1239b948],
53	Mayo	NNP	PERSON	Mayo	appos	1	SENT_10	[p1l1256t920r1354b958],
54	,	,	O	,	_	0	SENT_10	[p1l1256t920r1354b958],
55	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_10	[p1l1371t917r1561b957],
56	,	,	O	,	_	0	SENT_10	[p1l1371t917r1561b957],
57	Jordi	NNP	PERSON	Jordi	nn	60	SENT_10	[p1l1371t917r1561b957],
58	Bertran-Alamillo	NNP	PERSON	Bertran-Alamillo	nn	60	SENT_10	[p1l1579t917r1863b954],
59	,	,	O	,	_	0	SENT_10	[p1l1579t917r1863b954],
60	B.S.	NNP	O	B.S.	appos	1	SENT_10	[p1l1880t919r1951b954],
61	,	,	O	,	_	0	SENT_10	[p1l1880t919r1951b954],

1	Miguel	NNP	PERSON	Miguel	nn	3	SENT_11	[p1l675t966r787b1007],
2	Angel	NNP	PERSON	Angel	nn	3	SENT_11	[p1l801t966r895b1007],
3	Molina	NNP	PERSON	Molina	_	0	SENT_11	[p1l912t966r1037b1003],
4	,	,	O	,	_	0	SENT_11	[p1l912t966r1037b1003],
5	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_11	[p1l1054t966r1343b1006],
6	,	,	O	,	_	0	SENT_11	[p1l1054t966r1343b1006],
7	JoseJavier	NNP	PERSON	JoseJavier	nn	10	SENT_11	[p1l1054t966r1343b1006],
8	Sanchez	NNP	PERSON	Sanchez	nn	10	SENT_11	[p1l1355t966r1505b1003],
9	,	,	O	,	_	0	SENT_11	[p1l1355t966r1505b1003],
10	M.D.	NNP	O	M.D.	appos	3	SENT_11	[p1l1522t969r1612b1003],
11	,	,	O	,	_	0	SENT_11	[p1l1522t969r1612b1003],
12	and	CC	O	and	_	0	SENT_11	[p1l1627t966r1686b997],
13	Miquel	NNP	PERSON	Miquel	nn	14	SENT_11	[p1l1704t966r1817b1007],
14	Taron	NNP	PERSON	Taron	appos	3	SENT_11	[p1l1830t969r1938b1003],
15	,	,	O	,	_	0	SENT_11	[p1l1830t969r1938b1003],
16	Ph.D.	NNP	O	Ph.D.	appos	10	SENT_11	[p1l1955t966r2054b1003],
17	,	,	O	,	_	0	SENT_11	[p1l1955t966r2054b1003],

1	for	IN	O	for	dep	6	SENT_12	[p1l1061t1015r1108b1047],
2	the	DT	O	the	det	4	SENT_12	[p1l1119t1015r1171b1047],
3	Spanish	JJ	MISC	spanish	amod	4	SENT_12	[p1l1185t1015r1318b1057],
4	Lung	NN	MISC	lung	pobj	1	SENT_12	[p1l1335t1018r1417b1057],
5	Cancer	NNP	MISC	Cancer	nn	6	SENT_12	[p1l1429t1018r1547b1047],
6	Group	NNP	MISC	Group	_	0	SENT_12	[p1l1559t1018r1666b1057],

1	ABSTRACT	NN	O	abstract	_	0	SENT_13	[p1l1253t1163r1475b1186],

1	BACKGROUND	NN	O	background	_	0	SENT_14	[p1l667t1287r882b1306],

1	The	DT	O	the	det	2	SENT_15	[p1l89t1349r137b1373],
2	authors	NNS	O	author	_	0	SENT_15	[p1l146t1349r250b1373],
3	.	.	O	.	_	0	SENT_15	[p1l146t1349r250b1373],

1	affiliations	NNS	O	affiliation	nsubj	51	SENT_16	[p1l261t1349r394b1373],
2	and	CC	O	and	_	0	SENT_16	[p1l404t1349r450b1373],
3	the	DT	O	the	det	4	SENT_16	[p1l459t1349r499b1373],
4	names	NNS	O	name	nsubj	51	SENT_16	[p1l509t1358r592b1373],
5	of	IN	O	of	_	0	SENT_16	[p1l602t1349r630b1373],
6	Activating	VBG	MISC	activate	prepc_of	4	SENT_16	[p1l664t1329r832b1383],
7	mutations	NNS	O	mutation	dobj	6	SENT_16	[p1l843t1329r1008b1383],
8	in	IN	O	in	_	0	SENT_16	[p1l1021t1329r1053b1358],
9	the	DT	O	the	det	16	SENT_16	[p1l1066t1328r1117b1383],
10	epidermal	JJ	O	epidermal	amod	16	SENT_16	[p1l1130t1328r1294b1383],
11	growth	NN	O	growth	nn	16	SENT_16	[p1l1307t1328r1427b1383],
12	factor	NN	O	factor	nn	16	SENT_16	[p1l1439t1328r1534b1383],
13	receptor	NN	O	receptor	nn	16	SENT_16	[p1l1544t1335r1681b1383],
14	gene	NN	O	gene	nn	16	SENT_16	[p1l1692t1338r1771b1383],
15	(	CD	NUMBER	(	num	16	SENT_16	[p1l1783t1331r1882b1383],
16	EGFR	NN	ORGANIZATION	egfr	prep_in	7	SENT_16	[p1l1783t1331r1882b1383],
17	)	CD	NUMBER	)	nsubj	18	SENT_16	[p1l1783t1331r1882b1383],
18	confer	VBP	O	confer	rcmod	7	SENT_16	[p1l1898t1328r2002b1383],
19	hyadditional	JJ	O	hyadditional	amod	20	SENT_16	[p1l2013t1328r2062b1383, p1l91t1386r219b1410],
20	investigators	NNS	O	investigator	nsubjpass	22	SENT_16	[p1l235t1388r401b1417],
21	are	VBP	O	be	auxpass	22	SENT_16	[p1l415t1394r453b1410],
22	listed	VBN	O	list	ccomp	18	SENT_16	[p1l468t1386r535b1410],
23	in	IN	O	in	_	0	SENT_16	[p1l551t1388r571b1409],
24	the	DT	O	the	det	25	SENT_16	[p1l585t1386r626b1410],
25	persensitivity	NN	O	persensitivity	prep_in	22	SENT_16	[p1l665t1384r883b1416],
26	to	TO	O	to	_	0	SENT_16	[p1l893t1384r924b1408],
27	the	DT	O	the	det	31	SENT_16	[p1l936t1377r987b1408],
28	tyrosine	NN	O	tyrosine	nn	31	SENT_16	[p1l998t1384r1130b1416],
29	kinase	NN	O	kinase	nn	31	SENT_16	[p1l1141t1377r1247b1408],
30	inhibitors	NNS	O	inhibitor	nn	31	SENT_16	[p1l1258t1377r1418b1408],
31	gefitinib	NN	O	gefitinib	prep_to	25	SENT_16	[p1l1430t1377r1571b1416],
32	and	CC	O	and	_	0	SENT_16	[p1l1582t1377r1643b1408],
33	erlotinib	NN	O	erlotinib	conj_and	25	SENT_16	[p1l1654t1377r1793b1408],
34	in	IN	O	in	_	0	SENT_16	[p1l1805t1387r1837b1407],
35	patients	NNS	O	patient	prep_in	33	SENT_16	[p1l1847t1384r1977b1416],
36	with	IN	O	with	_	0	SENT_16	[p1l1987t1377r2063b1408],
37	APPe	JJ	O	appe	prep_with	22	SENT_16	[p1l89t1423r220b1454],
38	"	``	O	"	punct	37	SENT_16	[p1l89t1423r220b1454],
39	dlX	NN	O	dlx	nn	40	SENT_16	[p1l89t1423r220b1454],
40	~	NN	O	~	dep	37	SENT_16	[p1l89t1423r220b1454],
41	Add	VB	O	add	parataxis	51	SENT_16	[p1l239t1423r345b1447],
42	'	''	O	'	_	0	SENT_16	[p1l239t1423r345b1447],
43	°	CD	NUMBER	°	num	45	SENT_16	[p1l239t1423r345b1447],
44	55	CD	NUMBER	55	num	45	SENT_16	[p1l239t1423r345b1447],
45	’	NN	O	’	dobj	41	SENT_16	[p1l366t1425r452b1454],
46	°	CD	NUMBER	°	num	49	SENT_16	[p1l366t1425r452b1454],
47	P	NN	O	p	nn	49	SENT_16	[p1l366t1425r452b1454],
48	”“	CD	NUMBER	”“	num	49	SENT_16	[p1l366t1425r452b1454],
49	t	NN	O	t	nsubj	41	SENT_16	[p1l366t1425r452b1454],
50	Vequesls	NNS	O	vequesl	nsubj	51	SENT_16	[p1l472t1427r582b1454],
51	*	VBP	O	*	_	0	SENT_16	[p1l600t1427r625b1447],
52	o	NN	O	o	nsubj	53	SENT_16	[p1l600t1427r625b1447],
53	advanced	VBD	O	advance	ccomp	51	SENT_16	[p1l665t1427r813b1458],
54	non	JJ	O	non	amod	58	SENT_16	[p1l823t1427r1061b1457],
55	—	CD	NUMBER	—	tmod	54	SENT_16	[p1l823t1427r1061b1457],
56	small-cell	JJ	O	small-cell	amod	58	SENT_16	[p1l823t1427r1061b1457],
57	lung	NN	O	lung	nn	58	SENT_16	[p1l1071t1427r1144b1466],
58	cancer	NN	O	cancer	dobj	53	SENT_16	[p1l1153t1437r1264b1457],
59	.	.	O	.	_	0	SENT_16	[p1l1153t1437r1264b1457],

1	We	PRP	O	we	nsubj	2	SENT_17	[p1l1275t1429r1326b1457],
2	evaluated	VBD	O	evaluate	_	0	SENT_17	[p1l1337t1427r1486b1457],
3	the	DT	O	the	det	4	SENT_17	[p1l1497t1427r1547b1457],
4	feasibility	NN	O	feasibility	dobj	2	SENT_17	[p1l1557t1426r1713b1466],
5	of	IN	O	of	_	0	SENT_17	[p1l1722t1426r1760b1457],
6	large	JJ	O	large	amod	9	SENT_17	[p1l1763t1427r1934b1466],
7	—	NN	O	—	nn	9	SENT_17	[p1l1763t1427r1934b1466],
8	scale	NN	O	scale	nn	9	SENT_17	[p1l1763t1427r1934b1466],
9	screenDr	NN	O	screendr	prep_of	4	SENT_17	[p1l1945t1437r2063b1457, p1l92t1463r127b1484],
10	.	.	O	.	_	0	SENT_17	[p1l1945t1437r2063b1457, p1l92t1463r127b1484],

1	Rosell	NNP	PERSON	Rosell	_	0	SENT_18	[p1l143t1461r218b1484],
2	at	IN	O	at	_	0	SENT_18	[p1l233t1465r255b1484],
3	Catalan	NNP	ORGANIZATION	Catalan	nn	4	SENT_18	[p1l268t1461r364b1484],
4	Institute	NNP	ORGANIZATION	Institute	prep_at	1	SENT_18	[p1l381t1463r488b1484],
5	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l501t1460r529b1484],
6	Onco	NNP	ORGANIZATION	Onco	prep_of	4	SENT_18	[p1l538t1461r626b1484],
7	|	SYM	ORGANIZATION	|	dep	1	SENT_18	[p1l538t1461r626b1484],
8	-	:	O	-	_	0	SENT_18	[p1l538t1461r626b1484],
9	. . . . .	NN	O	. . . . .	dep	1	SENT_18	[p1l1751t1477r1756b1482],[p1l668t1477r673b1482],
10	.	.	O	.	_	0	SENT_18	[p1l1794t1477r1799b1482],

1	ing	NN	O	ing	nsubj	9	SENT_19	[p1l665t1487r719b1516],
2	for	IN	O	for	_	0	SENT_19	[p1l732t1476r780b1507],
3	EGFR	NN	ORGANIZATION	egfr	prep_for	1	SENT_19	[p1l793t1479r875b1508],
4	mutations	NNS	O	mutation	_	0	SENT_19	[p1l887t1483r1055b1508],
5	in	IN	O	in	_	0	SENT_19	[p1l1070t1487r1103b1507],
6	such	JJ	O	such	amod	7	SENT_19	[p1l1117t1477r1193b1508],
7	patients	NNS	O	patient	prep_in	4	SENT_19	[p1l1206t1483r1339b1516],
8	and	CC	O	and	_	0	SENT_19	[p1l1354t1477r1415b1507],
9	analyzed	VBD	O	analyze	conj_and	4	SENT_19	[p1l1429t1477r1576b1516],
10	the	DT	O	the	det	11	SENT_19	[p1l1591t1477r1642b1507],
11	association	NN	O	association	dobj	9	SENT_19	[p1l1656t1483r1844b1507],
12	between	IN	O	between	_	0	SENT_19	[p1l1859t1477r1997b1508],
13	the	DT	O	the	det	14	SENT_19	[p1l2012t1477r2063b1507],
14	ogy	NN	O	ogy	prep_between	11	SENT_19	[p1l90t1507r141b1529],
15	,	,	O	,	_	0	SENT_19	[p1l90t1507r141b1529],
16	Hospital	NNP	O	Hospital	nn	17	SENT_19	[p1l154t1498r262b1529],
17	Germans	NNPS	O	Germans	appos	14	SENT_19	[p1l274t1500r392b1522],
18	Trias	NNP	O	Trias	nn	20	SENT_19	[p1l402t1500r463b1522],
19	i	FW	O	i	nn	20	SENT_19	[p1l475t1500r478b1522],
20	Pujol	NNP	PERSON	Pujol	dep	17	SENT_19	[p1l492t1498r562b1529],
21	,	,	O	,	_	0	SENT_19	[p1l492t1498r562b1529],
22	Ctra	NNP	LOCATION	Ctra	appos	20	SENT_19	[p1l573t1500r625b1522],
23	.	.	O	.	_	0	SENT_19	[p1l768t1527r773b1533],

1	_	NN	O	_	_	0	SENT_20	[p1l1270t1527r1274b1533],
2	.	.	O	.	_	0	SENT_20	[p1l1304t1527r1309b1533],

1	canyet	NN	O	canyet	_	0	SENT_21	[p1l90t1538r185b1567],
2	,	,	O	,	_	0	SENT_21	[p1l90t1538r185b1567],
3	08916	CD	NUMBER	08916	num	6	SENT_21	[p1l207t1537r283b1560],
4	Badalona	NNP	O	Badalona	nn	6	SENT_21	[p1l306t1536r433b1564],
5	,	,	O	,	_	0	SENT_21	[p1l306t1536r433b1564],
6	Spain	NNP	LOCATION	Spain	appos	1	SENT_21	[p1l456t1538r534b1567],
7	,	,	O	,	_	0	SENT_21	[p1l456t1538r534b1567],
8	or	CC	O	or	cc	9	SENT_21	[p1l556t1544r583b1560],
9	at	IN	O	at	num	10	SENT_21	[p1l603t1540r626b1560],
10	mutations	NNS	O	mutation	appos	1	SENT_21	[p1l665t1533r834b1558],
11	and	CC	O	and	_	0	SENT_21	[p1l848t1527r909b1558],
12	the	DT	O	the	det	13	SENT_21	[p1l922t1527r974b1558],
13	outcome	NN	O	outcome	conj_and	10	SENT_21	[p1l988t1533r1131b1558],
14	of	IN	O	of	_	0	SENT_21	[p1l1144t1527r1183b1558],
15	erlotinib	NN	O	erlotinib	nn	16	SENT_21	[p1l1190t1527r1332b1558],
16	treatment	NN	O	treatment	prep_of	13	SENT_21	[p1l1346t1533r1518b1558],
17	.	.	O	.	_	0	SENT_21	[p1l1346t1533r1518b1558],

1	rrose	VB	O	rrose	_	0	SENT_22	[p1l92t1573r336b1602],
2	|	RB	O	|	advmod	3	SENT_22	[p1l92t1573r336b1602],
3	|	JJ	O	|	amod	4	SENT_22	[p1l92t1573r336b1602],
4	@ico	NN	O	@ico	dobj	1	SENT_22	[p1l92t1573r336b1602],
5	.	.	O	.	_	0	SENT_22	[p1l92t1573r336b1602],

1	scs	NNS	O	sc	_	0	SENT_23	[p1l92t1573r336b1602],
2	.	.	O	.	_	0	SENT_23	[p1l92t1573r336b1602],

1	es	NNS	O	e	_	0	SENT_24	[p1l92t1573r336b1602],
2	.	.	O	.	_	0	SENT_24	[p1l92t1573r336b1602],

1	M	NN	O	m	nn	4	SENT_25	[p1l668t1609r688b1628],
2	ETH	NN	O	eth	nn	4	SENT_25	[p1l696t1609r751b1628],
3	o	NN	O	o	nn	4	SENT_25	[p1l757t1609r778b1628],
4	DS	NN	O	d	_	0	SENT_25	[p1l784t1609r820b1628],

1	This	DT	O	this	dep	4	SENT_26	[p1l89t1638r144b1662],
2	article	NN	O	article	dep	1	SENT_26	[p1l167t1638r247b1662],
3	(	CD	NUMBER	(	dep	4	SENT_26	[p1l271t1640r623b1669],
4	l0	NN	O	l0	dep	7	SENT_26	[p1l271t1640r623b1669],
5	.1056	CD	NUMBER	.1056	dep	4	SENT_26	[p1l271t1640r623b1669],
6	/	:	O	/	punct	7	SENT_26	[p1l271t1640r623b1669],
7	NEJMoa0904554	NN	O	nejmoa0904554	_	0	SENT_26	[p1l271t1640r623b1669],
8	)	CD	NUMBER	)	num	7	SENT_26	[p1l271t1640r623b1669],
9	. . . .	CD	NUMBER	. . . .	num	10	SENT_26	[p1l2021t1652r2026b1658],[p1l824t1652r829b1658],
10	_	NN	O	_	nsubjpass	12	SENT_26	[p1l2052t1669r2063b1674],
11	was	VBD	O	be	auxpass	12	SENT_26	[p1l89t1684r138b1699],
12	published	VBN	O	publish	rcmod	7	SENT_26	[p1l157t1675r283b1706],
13	on	IN	O	on	_	0	SENT_26	[p1l302t1684r333b1699],
14	August	NNP	DATE	August	prep_on	12	SENT_26	[p1l351t1677r444b1707],
15	19	CD	DATE	19	num	14	SENT_26	[p1l462t1678r496b1703],
16	’	CD	DATE	’	num	18	SENT_26	[p1l462t1678r496b1703],
17	2009	CD	DATE	2009	num	18	SENT_26	[p1l515t1677r584b1703],
18	’	NN	O	’	dobj	12	SENT_26	[p1l515t1677r584b1703],
19	at	IN	O	at	_	0	SENT_26	[p1l603t1680r626b1699],
20	FI	NN	O	fus	prep_at	18	SENT_26	[p1l665t1652r842b1708],
21	‘	CD	NUMBER	‘	num	20	SENT_26	[p1l665t1652r842b1708],
22	.	.	O	.	_	0	SENT_26	[p1l665t1652r842b1708],

1	OII1	NN	O	oii1	_	0	SENT_27	[p1l665t1652r842b1708],
2	.	.	O	.	_	0	SENT_27	[p1l665t1652r842b1708],

1	AplIll	NNP	O	AplIll	nsubjpass	24	SENT_28	[p1l665t1652r842b1708],
2	2005	CD	DATE	2005	num	3	SENT_28	[p1l855t1654r931b1683],
3	‘	CD	NUMBER	‘	npadvmod	1	SENT_28	[p1l938t1652r1075b1708],
4	through	IN	O	through	_	0	SENT_28	[p1l938t1652r1075b1708],
5	November	NNP	DATE	November	prep_through	1	SENT_28	[p1l1087t1652r1254b1683],
6	2008	CD	DATE	2008	num	5	SENT_28	[p1l1266t1654r1352b1689],
7	,	,	O	,	_	0	SENT_28	[p1l1266t1654r1352b1689],
8	lung	NN	O	lung	nn	9	SENT_28	[p1l1367t1652r1439b1691],
9	cancers	NNS	O	cancer	appos	5	SENT_28	[p1l1451t1662r1570b1708],
10	from	IN	O	from	_	0	SENT_28	[p1l1584t1652r1663b1683],
11	210S	NN	O	210	nn	12	SENT_28	[p1l1676t1654r1749b1708],
12	patients	NNS	O	patient	prep_from	9	SENT_28	[p1l1763t1659r1890b1691],
13	in	IN	O	in	_	0	SENT_28	[p1l1903t1662r1935b1682],
14	129	CD	NUMBER	129	prep_in	12	SENT_28	[p1l1949t1654r2005b1683],
15	in	IN	O	in	_	0	SENT_28	[p1l2018t1662r2051b1708],
16	NEJM	NNP	ORGANIZATION	NEJM	prep_in	1	SENT_28	[p1l92t1715r224b1744],
17	,	,	O	,	_	0	SENT_28	[p1l92t1715r224b1744],
18	org	NN	O	org	nn	20	SENT_28	[p1l92t1715r224b1744],
19	_	NN	O	_	nn	20	SENT_28	[p1l92t1715r224b1744],
20	stitutions	NNS	O	stitution	appos	16	SENT_28	[p1l666t1708r819b1733],
21	in	IN	O	in	_	0	SENT_28	[p1l832t1712r864b1732],
22	Spain	NNP	LOCATION	Spain	prep_in	20	SENT_28	[p1l877t1704r968b1741],
23	were	VBD	O	be	auxpass	24	SENT_28	[p1l978t1712r1055b1733],
24	screened	VBN	O	screen	_	0	SENT_28	[p1l1068t1702r1210b1733],
25	for	IN	O	for	_	0	SENT_28	[p1l1222t1702r1269b1733],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_28	[p1l1279t1705r1360b1733],
27	mutations	NNS	O	mutation	prep_for	24	SENT_28	[p1l1370t1708r1544b1733],
28	.	.	O	.	_	0	SENT_28	[p1l1370t1708r1544b1733],

1	The	DT	O	the	det	2	SENT_29	[p1l1557t1702r1618b1732],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_29	[p1l1631t1702r1759b1741],
3	was	VBD	O	be	auxpass	4	SENT_29	[p1l1771t1712r1833b1733],
4	performed	VBN	O	perform	_	0	SENT_29	[p1l1845t1702r2019b1741],
5	in	IN	O	in	_	0	SENT_29	[p1l2031t1712r2063b1732],
6	a	DT	O	a	det	8	SENT_29	[p1l665t1762r682b1782],
7	central	JJ	O	central	amod	8	SENT_29	[p1l694t1752r808b1782],
8	laboratory	NN	O	laboratory	prep_in	4	SENT_29	[p1l819t1752r998b1791],
9	.	.	O	.	_	0	SENT_29	[p1l819t1752r998b1791],

1	Patients	NNS	O	patient	nsubj	8	SENT_30	[p1l1011t1752r1143b1782],
2	with	IN	O	with	_	0	SENT_30	[p1l1153t1752r1229b1783],
3	tumors	NNS	O	tumor	prep_with	1	SENT_30	[p1l1241t1758r1360b1783],
4	carrying	VBG	O	carry	partmod	3	SENT_30	[p1l1373t1752r1514b1791],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_30	[p1l1524t1755r1606b1783],
6	mutations	NNS	O	mutation	dobj	4	SENT_30	[p1l1615t1753r1784b1783],
7	were	VBD	O	be	cop	8	SENT_30	[p1l1794t1762r1873b1783],
8	eligible	JJ	O	eligible	_	0	SENT_30	[p1l1885t1752r2005b1791],
9	for	IN	O	for	prep	8	SENT_30	[p1l2016t1752r2064b1783],

1	N	NN	MISC	n	nn	3	SENT_31	[p1l92t1790r110b1811],
2	Englj	NNP	MISC	Englj	nn	3	SENT_31	[p1l123t1788r191b1819],
3	Med	NNP	O	Med	_	0	SENT_31	[p1l205t1788r260b1812],
4	2009	CD	DATE	2009	num	3	SENT_31	[p1l270t1789r490b1816],
5	;	:	O	;	_	0	SENT_31	[p1l270t1789r490b1816],
6	361:958	CD	NUMBER	361:958	number	7	SENT_31	[p1l270t1789r490b1816],
7	-67	CD	NUMBER	-67	dep	3	SENT_31	[p1l270t1789r490b1816],
8	.	.	O	.	_	0	SENT_31	[p1l270t1789r490b1816],

1	erlotinib	NN	O	erlotinib	_	0	SENT_32	[p1l666t1802r808b1833],
2	treatment	NN	O	treatment	dep	1	SENT_32	[p1l822t1809r994b1833],
3	.	.	O	.	_	0	SENT_32	[p1l822t1809r994b1833],

1	Copyright	NN	O	copyright	_	0	SENT_33	[p1l91t1830r184b1855],
2	©	CD	NUMBER	©	num	6	SENT_33	[p1l193t1832r214b1853],
3	2009	CD	DATE	2009	num	6	SENT_33	[p1l224t1831r274b1849],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_33	[p1l282t1830r422b1849],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_33	[p1l431t1830r508b1849],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_33	[p1l516t1831r588b1855],
7	.	.	O	.	_	0	SENT_33	[p1l516t1831r588b1855],

1	RESULTS	NNS	O	result	nn	3	SENT_34	[p1l667t1894r795b1913],
2	EGFR	NN	O	egfr	nn	3	SENT_34	[p1l665t1935r745b1963],
3	mutations	NNS	O	mutation	nsubjpass	5	SENT_34	[p1l755t1932r916b1963],
4	were	VBD	O	be	auxpass	5	SENT_34	[p1l928t1942r1004b1963],
5	found	VBN	O	find	_	0	SENT_34	[p1l1017t1932r1111b1963],
6	in	IN	O	in	_	0	SENT_34	[p1l1123t1932r1155b1962],
7	350	CD	NUMBER	350	prep_in	5	SENT_34	[p1l1168t1934r1223b1963],
8	of	IN	O	of	_	0	SENT_34	[p1l1236t1932r1274b1963],
9	2105	CD	DATE	2105	num	10	SENT_34	[p1l1280t1934r1354b1963],
10	patients	NNS	O	patient	prep_of	7	SENT_34	[p1l1367t1932r1494b1971],
11	(	IN	O	(	_	0	SENT_34	[p1l1509t1934r1633b1967],
12	16.6	CD	PERCENT	16.6	num	13	SENT_34	[p1l1509t1934r1633b1967],
13	%	NN	PERCENT	%	prep_(	5	SENT_34	[p1l1509t1934r1633b1967],
14	)	CD	NUMBER	)	dep	13	SENT_34	[p1l1509t1934r1633b1967],
15	.	.	O	.	_	0	SENT_34	[p1l1509t1934r1633b1967],

1	Mutations	NNS	O	mutation	nsubj	4	SENT_35	[p1l1647t1932r1809b1963],
2	were	VBD	O	be	cop	4	SENT_35	[p1l1821t1942r1897b1963],
3	more	RBR	O	more	advmod	4	SENT_35	[p1l1909t1942r1992b1963],
4	frequent	JJ	O	frequent	_	0	SENT_35	[p1l2005t1932r2063b1962, p1l666t1988r756b2020],
5	in	IN	O	in	mark	7	SENT_35	[p1l765t1981r797b2011],
6	women	NNS	O	woman	nsubj	7	SENT_35	[p1l806t1991r926b2012],
7	(	VBP	O	(	ccomp	4	SENT_35	[p1l939t1983r1062b2018],
8	69.7	CD	PERCENT	69.7	num	9	SENT_35	[p1l939t1983r1062b2018],
9	%	NN	PERCENT	%	dobj	7	SENT_35	[p1l939t1983r1062b2018],
10	)	CD	NUMBER	)	tmod	7	SENT_35	[p1l939t1983r1062b2018],
11	,	,	O	,	_	0	SENT_35	[p1l939t1983r1062b2018],
12	in	IN	O	in	_	0	SENT_35	[p1l1075t1981r1107b2011],
13	patients	NNS	O	patient	prep_in	7	SENT_35	[p1l1117t1981r1244b2020],
14	who	WP	O	who	nsubj	17	SENT_35	[p1l1254t1981r1324b2012],
15	had	VBD	O	have	aux	17	SENT_35	[p1l1335t1981r1394b2012],
16	never	RB	O	never	neg	17	SENT_35	[p1l1405t1991r1491b2012],
17	smoked	VBN	O	smoke	rcmod	13	SENT_35	[p1l1502t1981r1626b2012],
18	(	CD	PERCENT	(	num	20	SENT_35	[p1l1639t1983r1765b2018],
19	66.6	CD	PERCENT	66.6	num	20	SENT_35	[p1l1639t1983r1765b2018],
20	%	NN	PERCENT	%	dobj	17	SENT_35	[p1l1639t1983r1765b2018],
21	)	CD	NUMBER	)	nsubj	28	SENT_35	[p1l1639t1983r1765b2018],
22	,	,	O	,	_	0	SENT_35	[p1l1639t1983r1765b2018],
23	and	CC	O	and	dep	24	SENT_35	[p1l1778t1981r1838b2012],
24	in	IN	O	in	dep	21	SENT_35	[p1l1848t1981r1880b2011],
25	those	DT	O	those	pobj	24	SENT_35	[p1l1891t1981r1978b2012],
26	with	IN	O	with	_	0	SENT_35	[p1l1987t1981r2063b2012],
27	adenocarcinomas	NNS	O	adenocarcinoma	prep_with	25	SENT_35	[p1l665t2030r958b2061],
28	(	VBP	O	(	rcmod	20	SENT_35	[p1l975t2032r1097b2065],
29	80.9	CD	PERCENT	80.9	num	30	SENT_35	[p1l975t2032r1097b2065],
30	%	NN	PERCENT	%	nsubj	39	SENT_35	[p1l975t2032r1097b2065],
31	)	CD	NUMBER	)	number	32	SENT_35	[p1l975t2032r1097b2065],
32	(	CD	NUMBER	(	num	33	SENT_35	[p1l1114t2032r1257b2065],
33	P	NN	O	p	npadvmod	34	SENT_35	[p1l1114t2032r1257b2065],
34	<	JJR	O	<	amod	30	SENT_35	[p1l1114t2032r1257b2065],
35	0.001	CD	NUMBER	0.001	dep	34	SENT_35	[p1l1114t2032r1257b2065],
36	for	IN	O	for	dep	35	SENT_35	[p1l1271t2030r1319b2061],
37	all	DT	O	all	det	38	SENT_35	[p1l1331t2030r1372b2060],
38	comparisons	NNS	O	comparison	pobj	36	SENT_35	[p1l1386t2030r1619b2069],
39	)	VBP	O	)	ccomp	28	SENT_35	[p1l1386t2030r1619b2069],
40	.	.	O	.	_	0	SENT_35	[p1l1386t2030r1619b2069],

1	The	DT	O	the	det	2	SENT_36	[p1l1634t2030r1696b2060],
2	mutations	NNS	O	mutation	nsubj	4	SENT_36	[p1l1710t2030r1879b2061],
3	were	VBD	O	be	cop	4	SENT_36	[p1l1891t2040r1970b2061],
4	deletions	NNS	O	deletion	_	0	SENT_36	[p1l1984t2030r2063b2061, p1l665t2079r744b2110],
5	in	IN	O	in	_	0	SENT_36	[p1l763t2079r794b2109],
6	exon	NN	O	exon	prep_in	4	SENT_36	[p1l813t2089r888b2110],
7	19	CD	PERCENT	19	num	11	SENT_36	[p1l907t2081r944b2110],
8	(	CD	PERCENT	(	number	9	SENT_36	[p1l964t2081r1082b2114],
9	62.2	CD	PERCENT	62.2	dep	10	SENT_36	[p1l964t2081r1082b2114],
10	%	NN	PERCENT	%	dep	11	SENT_36	[p1l964t2081r1082b2114],
11	)	NN	O	)	dep	6	SENT_36	[p1l964t2081r1082b2114],
12	and	CC	O	and	_	0	SENT_36	[p1l1102t2079r1161b2110],
13	L858R	NN	O	l858r	prep_in	4	SENT_36	[p1l1179t2081r1284b2111],
14	(	CD	PERCENT	(	number	15	SENT_36	[p1l1300t2081r1423b2114],
15	37.8	CD	PERCENT	37.8	num	16	SENT_36	[p1l1300t2081r1423b2114],
16	%	NN	PERCENT	%	dep	13	SENT_36	[p1l1300t2081r1423b2114],
17	)	CD	NUMBER	)	dep	13	SENT_36	[p1l1300t2081r1423b2114],
18	.	.	O	.	_	0	SENT_36	[p1l1300t2081r1423b2114],

1	Median	JJ	MISC	median	amod	5	SENT_37	[p1l1442t2079r1564b2110],
2	progression	NN	O	progression	npadvmod	4	SENT_37	[p1l1582t2079r1844b2118],
3	—	CD	NUMBER	—	num	2	SENT_37	[p1l1582t2079r1844b2118],
4	free	JJ	O	free	amod	5	SENT_37	[p1l1582t2079r1844b2118],
5	survival	NN	O	survival	nsubj	17	SENT_37	[p1l1863t2079r1986b2110],
6	and	CC	O	and	_	0	SENT_37	[p1l2003t2079r2063b2110],
7	overall	JJ	O	overall	amod	8	SENT_37	[p1l666t2128r771b2159],
8	survival	NN	O	survival	nsubj	17	SENT_37	[p1l790t2128r919b2159],
9	for	IN	O	for	_	0	SENT_37	[p1l938t2128r986b2159],
10	217	CD	NUMBER	217	num	11	SENT_37	[p1l1005t2130r1063b2158],
11	patients	NNS	O	patient	prep_for	5	SENT_37	[p1l1083t2128r1215b2167],
12	who	WP	O	who	nsubj	13	SENT_37	[p1l1234t2128r1305b2159],
13	received	VBD	O	receive	rcmod	11	SENT_37	[p1l1325t2128r1460b2159],
14	erlotinib	NN	O	erlotinib	dobj	13	SENT_37	[p1l1480t2128r1622b2159],
15	were	VBD	O	be	cop	17	SENT_37	[p1l1641t2138r1719b2159],
16	14	CD	DURATION	14	num	17	SENT_37	[p1l1740t2130r1776b2158],
17	months	NNS	NUMBER	month	_	0	SENT_37	[p1l1796t2128r1923b2159],
18	and	CC	O	and	_	0	SENT_37	[p1l1944t2128r2005b2159],
19	27	CD	DURATION	27	num	20	SENT_37	[p1l2025t2130r2063b2158],
20	months	NNS	NUMBER	month	conj_and	17	SENT_37	[p1l665t2177r802b2214],
21	,	,	O	,	_	0	SENT_37	[p1l665t2177r802b2214],
22	respectively	RB	O	respectively	advmod	17	SENT_37	[p1l821t2177r1020b2216],
23	.	.	O	.	_	0	SENT_37	[p1l821t2177r1020b2216],

1	The	DT	O	the	det	4	SENT_38	[p1l1037t2177r1100b2207],
2	adjusted	JJ	O	adjusted	amod	4	SENT_38	[p1l1116t2177r1254b2216],
3	hazard	NN	O	hazard	nn	4	SENT_38	[p1l1271t2177r1386b2208],
4	ratios	NNS	O	ratio	nsubj	12	SENT_38	[p1l1403t2177r1496b2208],
5	for	IN	O	for	_	0	SENT_38	[p1l1513t2177r1561b2208],
6	the	DT	O	the	det	7	SENT_38	[p1l1577t2177r1628b2207],
7	duration	NN	O	duration	prep_for	4	SENT_38	[p1l1646t2177r1788b2208],
8	of	IN	O	of	_	0	SENT_38	[p1l1805t2177r1843b2208],
9	progressionfree	JJ	O	progressionfree	amod	10	SENT_38	[p1l1852t2177r2063b2216, p1l665t2226r728b2256],
10	survival	NN	O	survival	prep_of	7	SENT_38	[p1l742t2226r870b2257],
11	were	VBD	O	be	cop	12	SENT_38	[p1l881t2236r959b2257],
12	2.94	CD	NUMBER	2.94	_	0	SENT_38	[p1l972t2228r1042b2257],
13	for	IN	O	for	_	0	SENT_38	[p1l1055t2226r1102b2257],
14	men	NNS	O	man	prep_for	12	SENT_38	[p1l1114t2236r1186b2256],
15	(	CD	NUMBER	(	num	16	SENT_38	[p1l1201t2228r1363b2263],
16	P	NN	O	p	npadvmod	17	SENT_38	[p1l1201t2228r1363b2263],
17	<	JJR	O	<	amod	14	SENT_38	[p1l1201t2228r1363b2263],
18	0.001	CD	NUMBER	0.001	num	19	SENT_38	[p1l1201t2228r1363b2263],
19	)	NN	O	)	dep	12	SENT_38	[p1l1201t2228r1363b2263],
20	;	:	O	;	_	0	SENT_38	[p1l1201t2228r1363b2263],
21	1.92	CD	NUMBER	1.92	dep	12	SENT_38	[p1l1379t2228r1445b2257],
22	for	IN	O	for	_	0	SENT_38	[p1l1458t2226r1506b2257],
23	the	DT	O	the	det	24	SENT_38	[p1l1518t2226r1569b2256],
24	presence	NN	O	presence	prep_for	21	SENT_38	[p1l1582t2236r1727b2265],
25	of	IN	O	of	_	0	SENT_38	[p1l1740t2226r1779b2257],
26	the	DT	O	the	det	28	SENT_38	[p1l1785t2226r1836b2256],
27	L858R	NN	O	l858r	nn	28	SENT_38	[p1l1849t2228r1957b2258],
28	mutation	NN	O	mutation	prep_of	24	SENT_38	[p1l1966t2232r2063b2257, p1l665t2275r740b2312],
29	,	,	O	,	_	0	SENT_38	[p1l1966t2232r2063b2257, p1l665t2275r740b2312],
30	as	IN	O	as	mark	31	SENT_38	[p1l754t2285r788b2305],
31	compared	VBN	O	compare	dep	28	SENT_38	[p1l801t2275r966b2314],
32	with	IN	O	with	_	0	SENT_38	[p1l977t2275r1053b2306],
33	a	DT	O	a	det	34	SENT_38	[p1l1065t2285r1082b2305],
34	deletion	NN	O	deletion	prep_with	31	SENT_38	[p1l1094t2275r1228b2306],
35	in	IN	O	in	_	0	SENT_38	[p1l1240t2275r1272b2305],
36	exon	NN	O	exon	prep_in	34	SENT_38	[p1l1285t2285r1362b2306],
37	19	CD	NUMBER	19	number	38	SENT_38	[p1l1376t2277r1413b2306],
38	(	CD	NUMBER	(	num	39	SENT_38	[p1l1427t2277r1581b2312],
39	P	NN	O	p	dobj	31	SENT_38	[p1l1427t2277r1581b2312],
40	=	JJ	O	=	amod	39	SENT_38	[p1l1427t2277r1581b2312],
41	0.02	CD	NUMBER	0.02	num	42	SENT_38	[p1l1427t2277r1581b2312],
42	)	NN	O	)	dep	40	SENT_38	[p1l1427t2277r1581b2312],
43	;	:	O	;	_	0	SENT_38	[p1l1427t2277r1581b2312],
44	and	CC	O	and	cc	45	SENT_38	[p1l1595t2275r1656b2306],
45	1.68	CD	NUMBER	1.68	dep	12	SENT_38	[p1l1670t2277r1738b2306],
46	for	IN	O	for	_	0	SENT_38	[p1l1751t2275r1799b2306],
47	the	DT	O	the	det	48	SENT_38	[p1l1810t2275r1861b2305],
48	presence	NN	O	presence	prep_for	45	SENT_38	[p1l1873t2285r2019b2314],
49	of	IN	O	of	_	0	SENT_38	[p1l2031t2275r2070b2306],
50	the	DT	O	the	det	52	SENT_38	[p1l665t2324r717b2354],
51	L858R	NN	O	l858r	nn	52	SENT_38	[p1l733t2326r842b2356],
52	mutation	NN	O	mutation	prep_of	48	SENT_38	[p1l855t2324r1007b2355],
53	in	IN	O	in	_	0	SENT_38	[p1l1023t2324r1056b2354],
54	paired	JJ	O	paired	amod	56	SENT_38	[p1l1072t2324r1178b2363],
55	serum	NN	O	serum	nn	56	SENT_38	[p1l1195t2334r1299b2355],
56	DNA	NN	MISC	dna	prep_in	52	SENT_38	[p1l1315t2327r1405b2361],
57	,	,	O	,	_	0	SENT_38	[p1l1315t2327r1405b2361],
58	as	IN	O	as	amod	70	SENT_38	[p1l1423t2334r1456b2354],
59	compared	VBN	O	compare	_	0	SENT_38	[p1l1474t2324r1640b2363],
60	with	IN	O	with	prepc_compared_with	58	SENT_38	[p1l1654t2324r1730b2355],
61	the	DT	O	the	det	62	SENT_38	[p1l1747t2324r1799b2354],
62	absence	NN	O	absence	pobj	58	SENT_38	[p1l1815t2324r1946b2355],
63	of	IN	O	of	_	0	SENT_38	[p1l1963t2324r2002b2355],
64	the	DT	O	the	det	67	SENT_38	[p1l2012t2324r2063b2354],
65	mutation	NN	O	mutation	nn	67	SENT_38	[p1l665t2373r818b2404],
66	(	CD	NUMBER	(	num	67	SENT_38	[p1l835t2375r988b2409],
67	P	NN	O	p	prep_of	62	SENT_38	[p1l835t2375r988b2409],
68	=	JJ	O	=	amod	67	SENT_38	[p1l835t2375r988b2409],
69	0.02	CD	NUMBER	0.02	tmod	68	SENT_38	[p1l835t2375r988b2409],
70	)	NN	O	)	appos	12	SENT_38	[p1l835t2375r988b2409],
71	.	.	O	.	_	0	SENT_38	[p1l835t2375r988b2409],

1	The	DT	O	the	det	5	SENT_39	[p1l1005t2373r1067b2404],
2	most	RBS	O	most	advmod	3	SENT_39	[p1l1083t2380r1167b2404],
3	common	JJ	O	common	amod	5	SENT_39	[p1l1181t2383r1329b2404],
4	adverse	JJ	O	adverse	amod	5	SENT_39	[p1l1345t2373r1467b2404],
5	events	NNS	O	event	nsubj	8	SENT_39	[p1l1483t2379r1585b2404],
6	were	VBD	O	be	cop	8	SENT_39	[p1l1600t2383r1678b2404],
7	mild	JJ	O	mild	amod	8	SENT_39	[p1l1694t2373r1771b2404],
8	rashes	NNS	O	rash	_	0	SENT_39	[p1l1786t2373r1891b2404],
9	and	CC	O	and	_	0	SENT_39	[p1l1908t2373r1969b2404],
10	diarrhea	NN	O	diarrhea	conj_and	8	SENT_39	[p1l1985t2373r2063b2404, p1l665t2423r746b2460],
11	;	:	O	;	_	0	SENT_39	[p1l1985t2373r2063b2404, p1l665t2423r746b2460],
12	grade	NN	O	grade	npadvmod	14	SENT_39	[p1l761t2423r853b2462],
13	3	CD	NUMBER	3	num	12	SENT_39	[p1l866t2425r883b2454],
14	cutaneous	JJ	O	cutaneous	amod	16	SENT_39	[p1l898t2429r1066b2454],
15	toxic	JJ	O	toxic	amod	16	SENT_39	[p1l1080t2423r1160b2454],
16	effects	NNS	O	effect	nsubjpass	18	SENT_39	[p1l1172t2423r1282b2453],
17	were	VBD	O	be	auxpass	18	SENT_39	[p1l1293t2433r1372b2454],
18	recorded	VBN	O	record	parataxis	8	SENT_39	[p1l1384t2423r1530b2454],
19	in	IN	O	in	_	0	SENT_39	[p1l1542t2423r1574b2453],
20	16	CD	NUMBER	16	num	21	SENT_39	[p1l1588t2425r1624b2454],
21	patients	NNS	O	patient	prep_in	18	SENT_39	[p1l1637t2423r1769b2462],
22	(	IN	O	(	_	0	SENT_39	[p1l1784t2425r1882b2458],
23	7.4	CD	PERCENT	7.4	num	24	SENT_39	[p1l1784t2425r1882b2458],
24	%	NN	PERCENT	%	prep_(	18	SENT_39	[p1l1784t2425r1882b2458],
25	)	CD	NUMBER	)	dep	24	SENT_39	[p1l1784t2425r1882b2458],
26	and	CC	O	and	_	0	SENT_39	[p1l1897t2423r1958b2454],
27	grade	NN	O	grade	nn	29	SENT_39	[p1l1971t2423r2063b2462],
28	3	CD	NUMBER	3	num	29	SENT_39	[p1l666t2474r683b2503],
29	diarrhea	NN	O	diarrhea	conj_and	24	SENT_39	[p1l698t2472r838b2503],
30	in	IN	O	in	_	0	SENT_39	[p1l851t2472r883b2502],
31	8	CD	NUMBER	8	num	32	SENT_39	[p1l897t2474r914b2503],
32	patients	NNS	O	patient	prep_in	29	SENT_39	[p1l928t2472r1060b2511],
33	(	IN	O	(	_	0	SENT_39	[p1l1076t2474r1188b2507],
34	3.7	CD	PERCENT	3.7	num	35	SENT_39	[p1l1076t2474r1188b2507],
35	%	NN	PERCENT	%	prep_(	18	SENT_39	[p1l1076t2474r1188b2507],
36	)	CD	NUMBER	)	dep	35	SENT_39	[p1l1076t2474r1188b2507],
37	.	.	O	.	_	0	SENT_39	[p1l1076t2474r1188b2507],

1	cc	NN	O	cc	nn	3	SENT_40	[p1l666t2564r707b2584],
2	N	NN	O	n	nn	3	SENT_40	[p1l713t2564r730b2584],
3	c	NN	O	c	nsubj	14	SENT_40	[p1l736t2564r753b2584],
4	L	NN	O	l	nn	6	SENT_40	[p1l758t2564r770b2584],
5	u	NN	O	u	nn	6	SENT_40	[p1l775t2564r792b2584],
6	s	NNS	O	s	dep	3	SENT_40	[p1l797t2564r811b2584],
7	I	PRP	O	I	dep	3	SENT_40	[p1l817t2564r822b2584],
8	o	NN	O	o	nn	9	SENT_40	[p1l828t2564r849b2584],
9	N	NN	O	n	dep	7	SENT_40	[p1l855t2564r872b2584],
10	s	VBZ	O	s	cop	14	SENT_40	[p1l878t2564r892b2584],
11	Large	JJ	O	large	amod	14	SENT_40	[p1l665t2603r850b2642],
12	—	NN	O	—	nn	14	SENT_40	[p1l665t2603r850b2642],
13	scale	NN	O	scale	nn	14	SENT_40	[p1l665t2603r850b2642],
14	screening	NN	O	screening	_	0	SENT_40	[p1l863t2603r1021b2642],
15	of	IN	O	of	_	0	SENT_40	[p1l1032t2602r1071b2633],
16	patients	NNS	O	patient	prep_of	14	SENT_40	[p1l1075t2603r1205b2642],
17	with	IN	O	with	_	0	SENT_40	[p1l1216t2602r1290b2634],
18	lung	NN	O	lung	nn	19	SENT_40	[p1l1302t2603r1376b2642],
19	cancer	NN	O	cancer	prep_with	16	SENT_40	[p1l1387t2612r1493b2633],
20	for	IN	O	for	mark	24	SENT_40	[p1l1504t2602r1551b2633],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_40	[p1l1561t2605r1642b2634],
22	mutations	NNS	O	mutation	nsubj	24	SENT_40	[p1l1652t2603r1817b2634],
23	is	VBZ	O	be	cop	24	SENT_40	[p1l1830t2603r1855b2633],
24	feasible	JJ	O	feasible	advcl	14	SENT_40	[p1l1868t2602r1990b2633],
25	and	CC	O	and	_	0	SENT_40	[p1l2002t2602r2063b2633],
26	can	MD	O	can	aux	27	SENT_40	[p1l666t2662r723b2683],
27	have	VB	O	have	advcl	14	SENT_40	[p1l737t2652r810b2683],
28	a	DT	O	a	det	29	SENT_40	[p1l824t2662r841b2683],
29	role	NN	O	role	dobj	27	SENT_40	[p1l854t2652r916b2683],
30	in	IN	O	in	_	0	SENT_40	[p1l929t2652r961b2682],
31	decisions	NNS	O	decision	prep_in	29	SENT_40	[p1l975t2652r1128b2683],
32	about	IN	O	about	_	0	SENT_40	[p1l1141t2652r1236b2683],
33	treatment	NN	O	treatment	prep_about	31	SENT_40	[p1l1248t2658r1420b2683],
34	.	.	O	.	_	0	SENT_40	[p1l1248t2658r1420b2683],

1	953	CD	NUMBER	953	num	4	SENT_41	[p1l91t2758r147b2781],
2	N	NN	O	n	nn	4	SENT_41	[p1l872t2768r886b2783],
3	ENGLJ	NN	O	englj	nn	4	SENT_41	[p1l901t2768r979b2790],
4	MED361	NN	O	med361	_	0	SENT_41	[p1l993t2762r1133b2790],
5	;	:	O	;	_	0	SENT_41	[p1l993t2762r1133b2790],
6	1o	NN	O	1o	nn	8	SENT_41	[p1l993t2762r1133b2790],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_41	[p1l1168t2768r1292b2790],
8	SEPTEMBER	NN	DATE	september	dep	4	SENT_41	[p1l1328t2768r1466b2783],
9	3,2009	CD	DATE	3,2009	dep	8	SENT_41	[p1l1476t2768r1570b2790],

1	The	DT	O	the	det	5	SENT_42	[p1l878t2825r929b2849],
2	New	NNP	O	New	nn	5	SENT_42	[p1l938t2826r1000b2849],
3	England	NNP	O	England	nn	5	SENT_42	[p1l1009t2825r1120b2856],
4	J	NNP	O	J	nn	5	SENT_42	[p1l1128t2826r1141b2849],
5	oumal	NN	O	oumal	_	0	SENT_42	[p1l1142t2825r1226b2849],
6	of	IN	O	of	_	0	SENT_42	[p1l1235t2825r1264b2849],
7	Medicine	NN	O	medicine	prep_of	5	SENT_42	[p1l1271t2825r1396b2849],

1	SCREENING	NN	O	screening	_	0	SENT_43	[p1l643t3013r839b3032],
2	FOR	IN	O	for	dep	1	SENT_43	[p1l853t3013r917b3032],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_43	[p1l929t3013r1000b3032],
4	MUTATIONS	NNS	O	mutation	pobj	2	SENT_43	[p1l1013t3013r1208b3032],
5	IN	IN	O	in	dep	1	SENT_43	[p1l1223t3013r1261b3032],
6	LUNG	NN	O	lung	nn	7	SENT_43	[p1l1277t3013r1368b3032],
7	CANCER	NNP	O	CANCER	pobj	5	SENT_43	[p1l1382t3013r1516b3032],

1	OLECULAR-PROFILING	NN	O	olecular-profiling	nn	2	SENT_44	[p1l425t3240r1439b3297],
2	STUDIES	NNS	O	study	nsubj	3	SENT_44	[p1l1473t3240r1849b3297],
3	INDIcate	VBP	O	indicate	_	0	SENT_44	[p1l1886t3241r2132b3297, p1l425t3364r590b3426],

1	that	IN	O	that	dep	26	SENT_45	[p1l619t3347r788b3426],
2	activating	VBG	O	activate	amod	3	SENT_45	[p1l811t3348r1223b3448],
3	mutations	NNS	O	mutation	nsubj	26	SENT_45	[p1l1249t3349r1674b3426],
4	in	IN	O	in	_	0	SENT_45	[p1l1704t3349r1787b3425],
5	the	DT	O	the	det	12	SENT_45	[p1l1815t3347r1946b3426],
6	epidermal	JJ	O	epidermal	amod	12	SENT_45	[p1l1977t3349r2132b3448, p1l425t3476r735b3555],
7	growth	NN	O	growth	nn	12	SENT_45	[p1l773t3476r1095b3577],
8	factor	NN	O	factor	nn	12	SENT_45	[p1l1134t3476r1391b3555],
9	receptor	NN	O	receptor	nn	12	SENT_45	[p1l1427t3493r1792b3577],
10	(	CD	NUMBER	(	num	12	SENT_45	[p1l1833t3483r2128b3572],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_45	[p1l1833t3483r2128b3572],
12	)	NN	O	)	prep_in	3	SENT_45	[p1l1833t3483r2128b3572],
13	,	,	O	,	_	0	SENT_45	[p1l1833t3483r2128b3572],
14	PBK	NNP	ORGANIZATION	PBK	conj_and	12	SENT_45	[p1l9t3612r211b3701],
15	,	,	O	,	_	0	SENT_45	[p1l9t3612r211b3701],
16	BRAF	NNP	O	BRAF	conj_and	12	SENT_45	[p1l247t3611r477b3701],
17	,	,	O	,	_	0	SENT_45	[p1l247t3611r477b3701],
18	and	CC	O	and	_	0	SENT_45	[p1l513t3605r669b3684],
19	K	NNP	O	K	nn	22	SENT_45	[p1l698t3613r891b3684],
20	—	NNP	O	—	nn	22	SENT_45	[p1l698t3613r891b3684],
21	ras	NN	O	ra	nn	22	SENT_45	[p1l698t3613r891b3684],
22	genes	NNS	O	gene	conj_and	12	SENT_45	[p1l919t3631r1155b3706],
23	are	VBP	O	be	cop	26	SENT_45	[p1l1188t3631r1315b3684],
24	generally	RB	O	generally	advmod	26	SENT_45	[p1l1347t3605r1733b3706],
25	nonoVer	JJ	O	nonover	amod	26	SENT_45	[p1l1760t3631r2132b3685],
26	—	NN	O	—	_	0	SENT_45	[p1l1760t3631r2132b3685],

1	lapping	NN	O	lapping	_	0	SENT_46	[p2l10t20r336b121],
2	and	CC	O	and	_	0	SENT_46	[p2l364t20r522b99],
3	identifiable	JJ	O	identifiable	amod	15	SENT_46	[p2l552t20r1044b99],
4	in	IN	O	in	_	0	SENT_46	[p2l1075t21r1158b98],
5	approximately	RB	O	approximately	quantmod	6	SENT_46	[p2l1188t20r1805b121],
6	40	CD	PERCENT	40	num	7	SENT_46	[p2l1830t25r2021b99],
7	%	NN	PERCENT	%	prep_in	3	SENT_46	[p2l1830t25r2021b99],
8	of	IN	O	of	_	0	SENT_46	[p2l2052t20r2152b99],
9	non	JJ	O	non	amod	12	SENT_46	[p2l11t148r625b227],
10	—	JJ	O	—	amod	12	SENT_46	[p2l11t148r625b227],
11	small	JJ	O	small	amod	12	SENT_46	[p2l11t148r625b227],
12	—	NN	O	—	prep_of	7	SENT_46	[p2l11t148r625b227],
13	cell	NN	O	cell	nn	15	SENT_46	[p2l11t148r625b227],
14	lung	NN	O	lung	nn	15	SENT_46	[p2l649t148r837b249],
15	cancers	NNS	O	cancer	conj_and	1	SENT_46	[p2l860t174r1190b227],
16	.	.	O	.	_	0	SENT_46	[p2l860t174r1190b227],

1	These	DT	O	these	det	2	SENT_47	[p2l1218t148r1460b227],
2	mutations	NNS	O	mutation	nsubjpass	22	SENT_47	[p2l1486t149r1925b244],
3	,	,	O	,	_	0	SENT_47	[p2l1486t149r1925b244],
4	plus	CC	O	plus	prep	2	SENT_47	[p2l1956t148r2131b249],
5	others	NNS	O	other	dep	4	SENT_47	[p2l12t276r273b355],
6	that	WDT	O	that	nsubj	7	SENT_47	[p2l303t276r472b355],
7	contribute	VBP	O	contribute	rcmod	5	SENT_47	[p2l494t276r926b355],
8	to	TO	O	to	_	0	SENT_47	[p2l954t293r1034b355],
9	tumor	NN	O	tumor	nn	10	SENT_47	[p2l1062t293r1326b355],
10	progression	NN	O	progression	prep_to	7	SENT_47	[p2l1348t277r1848b377],
11	(	CD	NUMBER	(	number	12	SENT_47	[p2l1880t276r2132b368],
12	“	CD	NUMBER	“	num	13	SENT_47	[p2l1880t276r2132b368],
13	driv	NN	O	driv	dobj	7	SENT_47	[p2l1880t276r2132b368],
14	—	CD	NUMBER	—	num	17	SENT_47	[p2l1880t276r2132b368],
15	er	NN	O	er	nn	17	SENT_47	[p2l12t409r129b481],
16	”	NN	O	”	nn	17	SENT_47	[p2l12t409r129b481],
17	mutations	NNS	O	mutation	nsubj	18	SENT_47	[p2l163t404r648b498],
18	)	VBP	O	)	rcmod	13	SENT_47	[p2l163t404r648b498],
19	,	,	O	,	_	0	SENT_47	[p2l163t404r648b498],
20	can	MD	O	can	aux	22	SENT_47	[p2l686t429r835b481],
21	be	VB	O	be	auxpass	22	SENT_47	[p2l867t403r964b481],
22	found	VBN	O	find	_	0	SENT_47	[p2l996t403r1248b482],
23	in	IN	O	in	_	0	SENT_47	[p2l1279t404r1362b480],
24	almost	RB	O	almost	quantmod	25	SENT_47	[p2l1393t403r1690b481],
25	half	DT	O	half	prep_in	22	SENT_47	[p2l1717t403r1903b481],
26	of	IN	O	of	_	0	SENT_47	[p2l1917t403r2017b481],
27	all	DT	O	all	det	34	SENT_47	[p2l2029t403r2134b481],
28	non	JJ	O	non	amod	34	SENT_47	[p2l11t531r653b610],
29	—	CD	NUMBER	—	tmod	28	SENT_47	[p2l11t531r653b610],
30	small	JJ	O	small	amod	34	SENT_47	[p2l11t531r653b610],
31	—	JJ	O	—	amod	34	SENT_47	[p2l11t531r653b610],
32	cell	NN	O	cell	nn	34	SENT_47	[p2l11t531r653b610],
33	lung	NN	O	lung	nn	34	SENT_47	[p2l687t531r879b632],
34	cancers	NNS	O	cancer	prep_of	25	SENT_47	[p2l912t536r1356b610],
35	.	.	O	.	_	0	SENT_47	[p2l912t536r1356b610],

1	”	NN	O	”	_	0	SENT_48	[p2l912t536r1356b610],

1	The	DT	O	the	det	5	SENT_49	[p2l137t659r297b738],
2	two	CD	NUMBER	two	num	5	SENT_49	[p2l336t676r493b738],
3	proto	NN	O	proto	nn	5	SENT_49	[p2l532t676r1257b760],
4	—	NN	O	—	nn	5	SENT_49	[p2l532t676r1257b760],
5	oncogenes	NNS	O	oncogene	nsubj	17	SENT_49	[p2l532t676r1257b760],
6	that	WDT	O	that	nsubjpass	10	SENT_49	[p2l1298t659r1470b738],
7	are	VBP	O	be	auxpass	10	SENT_49	[p2l1502t685r1631b738],
8	most	RBS	O	most	advmod	9	SENT_49	[p2l1669t676r1885b738],
9	commonly	RB	O	commonly	advmod	10	SENT_49	[p2l1919t685r2132b738, p2l11t787r287b888],
10	mutated	VBN	O	mutate	rcmod	5	SENT_49	[p2l320t787r681b866],
11	in	IN	O	in	_	0	SENT_49	[p2l717t788r802b865],
12	pulmonary	JJ	O	pulmonary	amod	13	SENT_49	[p2l837t787r1326b888],
13	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	10	SENT_49	[p2l1357t787r2131b866],
14	are	VBP	O	be	cop	17	SENT_49	[p2l11t941r142b994],
15	K	NNP	O	K	nn	17	SENT_49	[p2l178t923r380b994],
16	—	NNP	O	—	nn	17	SENT_49	[p2l178t923r380b994],
17	ras	NN	O	ra	_	0	SENT_49	[p2l178t923r380b994],
18	and	CC	O	and	_	0	SENT_49	[p2l413t915r573b994],
19	EGFR	NN	ORGANIZATION	egfr	conj_and	17	SENT_49	[p2l609t922r846b995],
20	.	.	O	.	_	0	SENT_49	[p2l609t922r846b995],

1	Nearly	RB	O	nearly	quantmod	2	SENT_50	[p2l886t915r1176b1016],
2	90	CD	PERCENT	90	num	3	SENT_50	[p2l1209t921r1400b994],
3	%	NN	PERCENT	%	_	0	SENT_50	[p2l1209t921r1400b994],
4	of	IN	O	of	_	0	SENT_50	[p2l1438t915r1539b994],
5	lung	NN	O	lung	nn	7	SENT_50	[p2l1557t915r2136b1016],
6	—	NN	O	—	nn	7	SENT_50	[p2l1557t915r2136b1016],
7	cancer	NN	O	cancer	prep_of	3	SENT_50	[p2l1557t915r2136b1016],
8	—	CD	NUMBER	—	num	11	SENT_50	[p2l1557t915r2136b1016],
9	specific	JJ	O	specific	amod	11	SENT_50	[p2l13t1043r351b1144],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_50	[p2l391t1050r607b1123],
11	mutations	NNS	O	mutation	nsubj	12	SENT_50	[p2l643t1044r1087b1122],
12	comprise	VBP	O	comprise	rcmod	7	SENT_50	[p2l1133t1044r1534b1144],
13	a	DT	O	a	det	14	SENT_50	[p2l1576t1070r1621b1122],
14	leucine	NN	O	leucine	dobj	12	SENT_50	[p2l1660t1043r2132b1122],
15	—	CD	NUMBER	—	number	17	SENT_50	[p2l1660t1043r2132b1122],
16	to	TO	O	to	dep	17	SENT_50	[p2l1660t1043r2132b1122],
17	—	CD	NUMBER	—	num	19	SENT_50	[p2l1660t1043r2132b1122],
18	arginine	NN	O	arginine	nn	19	SENT_50	[p2l11t1172r366b1272],
19	substitution	NN	O	substitution	npadvmod	20	SENT_50	[p2l402t1171r906b1250],
20	at	IN	O	at	advmod	21	SENT_50	[p2l940t1188r1018b1250],
21	position	NN	O	position	dep	7	SENT_50	[p2l1045t1172r1391b1272],
22	858	CD	NUMBER	858	number	23	SENT_50	[p2l1426t1177r1570b1250],
23	(	CD	NUMBER	(	num	25	SENT_50	[p2l1612t1177r1937b1263],
24	L858R	NN	O	l858r	nn	25	SENT_50	[p2l1612t1177r1937b1263],
25	)	NN	O	)	dep	7	SENT_50	[p2l1612t1177r1937b1263],
26	and	CC	O	and	_	0	SENT_50	[p2l1976t1171r2134b1250],
27	deletion	NN	O	deletion	nn	28	SENT_50	[p2l12t1300r357b1379],
28	mutants	NNS	O	mutant	prep_of	3	SENT_50	[p2l395t1317r749b1379],
29	in	IN	O	in	_	0	SENT_50	[p2l789t1301r872b1378],
30	exon	NN	O	exon	prep_in	28	SENT_50	[p2l912t1326r1111b1379],
31	19	CD	NUMBER	19	num	30	SENT_50	[p2l1154t1306r1249b1379],
32	that	WDT	O	that	nsubj	33	SENT_50	[p2l1290t1300r1462b1379],
33	affect	VBP	O	affect	rcmod	28	SENT_50	[p2l1496t1300r1742b1379],
34	the	DT	O	the	nsubj	35	SENT_50	[p2l1776t1300r1908b1379],
35	conserved	VBN	O	conserve	dep	33	SENT_50	[p2l1949t1326r2132b1379, p2l13t1428r290b1507],

1	sequence	NN	O	sequence	nn	2	SENT_51	[p2l332t1454r728b1529],
2	LREA	NN	O	lrea	_	0	SENT_51	[p2l769t1435r1017b1512],
3	(	CD	NUMBER	(	num	4	SENT_51	[p2l1059t1428r1840b1520],
4	delE746	NN	O	dele746	dep	2	SENT_51	[p2l1059t1428r1840b1520],
5	.	.	O	.	_	0	SENT_51	[p2l1059t1428r1840b1520],

1	—	NN	O	—	_	0	SENT_52	[p2l1059t1428r1840b1520],
2	.	.	O	.	_	0	SENT_52	[p2l1059t1428r1840b1520],

1	A75O	NN	O	a75o	nn	4	SENT_53	[p2l1059t1428r1840b1520],
2	)	CD	NUMBER	)	num	4	SENT_53	[p2l1059t1428r1840b1520],
3	.3	NN	NUMBER	.3	nn	4	SENT_53	[p2l1059t1428r1840b1520],
4	‘	NN	O	‘	_	0	SENT_53	[p2l1059t1428r1840b1520],
5	7	CD	NUMBER	7	dep	4	SENT_53	[p2l1059t1428r1840b1520],
6	These	DT	O	these	det	7	SENT_53	[p2l1877t1428r2133b1507],
7	mutations	NNS	O	mutation	nsubj	8	SENT_53	[p2l11t1557r437b1635],
8	cause	VBP	O	cause	rcmod	4	SENT_53	[p2l481t1583r710b1635],
9	constitutive	JJ	O	constitutive	amod	10	SENT_53	[p2l753t1557r1241b1635],
10	activation	NN	O	activation	dobj	8	SENT_53	[p2l1282t1557r1689b1635],
11	of	IN	O	of	_	0	SENT_53	[p2l1733t1556r1831b1635],
12	the	DT	O	the	det	14	SENT_53	[p2l1855t1556r1986b1635],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_53	[p2l2028t1573r2132b1657, p2l11t1685r264b1763],
14	kinase	NN	O	kinase	prep_of	10	SENT_53	[p2l302t1684r570b1764],
15	of	IN	O	of	_	0	SENT_53	[p2l609t1684r707b1763],
16	the	DT	O	the	det	17	SENT_53	[p2l728t1684r856b1763],
17	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_53	[p2l893t1690r1143b1768],
18	by	IN	O	by	_	0	SENT_53	[p2l1172t1684r1266b1785],
19	destabilizing	JJ	O	destabilizing	amod	22	SENT_53	[p2l1302t1684r1836b1785],
20	its	PRP$	O	its	poss	22	SENT_53	[p2l1870t1685r1964b1763],
21	autoinhibited	JJ	O	autoinhibited	amod	22	SENT_53	[p2l2005t1711r2132b1763, p2l12t1812r466b1891],
22	conformation	NN	O	conformation	prep_by	17	SENT_53	[p2l493t1812r1082b1908],
23	,	,	O	,	_	0	SENT_53	[p2l493t1812r1082b1908],
24	which	WDT	O	which	nsubjpass	27	SENT_53	[p2l1109t1812r1363b1892],
25	is	VBZ	O	be	auxpass	27	SENT_53	[p2l1389t1813r1453b1891],
26	normally	RB	O	normally	advmod	27	SENT_53	[p2l1481t1812r1857b1913],
27	maintained	VBN	O	maintain	rcmod	14	SENT_53	[p2l1879t1813r2132b1891, p2l12t1940r281b2019],
28	in	IN	O	in	_	0	SENT_53	[p2l312t1941r396b2018],
29	the	DT	O	the	det	30	SENT_53	[p2l429t1940r561b2019],
30	absence	NN	O	absence	prep_in	27	SENT_53	[p2l593t1940r930b2019],
31	of	IN	O	of	_	0	SENT_53	[p2l964t1940r1064b2019],
32	ligand	NN	O	ligand	nn	33	SENT_53	[p2l1076t1940r1347b2041],
33	stimulation	NN	O	stimulation	prep_of	30	SENT_53	[p2l1381t1940r1942b2019],
34	?	.	O	?	_	0	SENT_53	[p2l1381t1940r1942b2019],

1	The	DT	O	the	det	3	SENT_54	[p2l1973t1940r2133b2019],
2	activating	VBG	O	activate	amod	3	SENT_54	[p2l11t2069r413b2169],
3	mutations	NNS	O	mutation	nsubj	4	SENT_54	[p2l447t2069r864b2147],
4	confer	VBP	O	confer	ccomp	24	SENT_54	[p2l904t2068r1167b2147],
5	hypersensitivity	NN	O	hypersensitivity	dobj	4	SENT_54	[p2l1201t2068r1849b2169],
6	to	TO	O	to	_	0	SENT_54	[p2l1882t2085r1961b2147],
7	the	DT	O	the	det	11	SENT_54	[p2l2001t2068r2133b2147],
8	tyrosine	NN	O	tyrosine	nn	11	SENT_54	[p2l12t2197r343b2297],
9	kinase	NN	O	kinase	nn	11	SENT_54	[p2l365t2196r634b2276],
10	inhibitors	NNS	O	inhibitor	nn	11	SENT_54	[p2l657t2196r1059b2275],
11	gefitinib	NN	O	gefitinib	prep_to	5	SENT_54	[p2l1084t2196r1439b2297],
12	and	CC	O	and	_	0	SENT_54	[p2l1463t2196r1616b2275],
13	erlotinib	NN	O	erlotinib	nn	14	SENT_54	[p2l1640t2196r2130b2275],
14	.3	NN	NUMBER	.3	conj_and	11	SENT_54	[p2l1640t2196r2130b2275],
15	'	''	O	'	_	0	SENT_54	[p2l1640t2196r2130b2275],
16	5	CD	NUMBER	5	dep	4	SENT_54	[p2l1640t2196r2130b2275],
17	In	IN	O	in	dep	16	SENT_54	[p2l9t2332r97b2402],
18	transgenic	JJ	O	transgenic	amod	20	SENT_54	[p2l138t2325r581b2425],
19	mouse	NN	O	mouse	nn	20	SENT_54	[p2l620t2350r896b2403],
20	models	NNS	O	model	pobj	17	SENT_54	[p2l937t2324r1264b2420],
21	,	,	O	,	_	0	SENT_54	[p2l937t2324r1264b2420],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_54	[p2l1307t2331r1516b2404],
23	mutations	NNS	O	mutation	nsubj	24	SENT_54	[p2l1551t2325r1976b2403],
24	induced	VBD	O	induce	_	0	SENT_54	[p2l2018t2325r2132b2402, p2l12t2452r268b2531],
25	adenocarcinomas	NNS	O	adenocarcinoma	dobj	24	SENT_54	[p2l305t2452r1079b2531],
26	that	WDT	O	that	nsubj	27	SENT_54	[p2l1120t2452r1296b2531],
27	responded	VBD	O	respond	rcmod	25	SENT_54	[p2l1329t2452r1786b2553],
28	to	TO	O	to	_	0	SENT_54	[p2l1824t2469r1907b2531],
29	suppression	NN	O	suppression	prep_to	27	SENT_54	[p2l1948t2478r2132b2553, p2l10t2581r372b2681],
30	of	IN	O	of	_	0	SENT_54	[p2l404t2580r504b2659],
31	the	DT	O	the	det	34	SENT_54	[p2l518t2580r651b2659],
32	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_54	[p2l680t2586r937b2664],
33	driving	VBG	O	drive	amod	34	SENT_54	[p2l959t2580r1267b2681],
34	signal	NN	O	signal	prep_of	29	SENT_54	[p2l1297t2580r1555b2681],
35	and	CC	O	and	_	0	SENT_54	[p2l1585t2580r1743b2659],
36	to	TO	O	to	_	0	SENT_54	[p2l1775t2597r1856b2659],
37	EGFR	NN	ORGANIZATION	egfr	nn	40	SENT_54	[p2l1888t2586r2143b2664],
38	tyrosine	NN	O	tyrosine	nn	40	SENT_54	[p2l12t2709r358b2809],
39	kinase	NN	O	kinase	nn	40	SENT_54	[p2l387t2708r666b2788],
40	inhibitors	NNS	O	inhibitor	conj_and	29	SENT_54	[p2l695t2708r1275b2787],
41	.9	CD	NUMBER	.9	num	42	SENT_54	[p2l695t2708r1275b2787],
42	’	NN	O	’	dep	40	SENT_54	[p2l695t2708r1275b2787],
43	1	CD	NUMBER	1	number	44	SENT_54	[p2l695t2708r1275b2787],
44	°	CD	NUMBER	°	dep	42	SENT_54	[p2l695t2708r1275b2787],
45	Furthermore	RB	O	furthermore	advmod	42	SENT_54	[p2l1303t2708r1875b2804],
46	,	,	O	,	_	0	SENT_54	[p2l1303t2708r1875b2804],
47	lungcancer	NN	O	lungcancer	appos	40	SENT_54	[p2l1909t2708r2132b2809, p2l12t2836r680b2937],
48	—	CD	NUMBER	—	num	51	SENT_54	[p2l1909t2708r2132b2809, p2l12t2836r680b2937],
49	specif1c	JJ	O	specif1c	amod	51	SENT_54	[p2l1909t2708r2132b2809, p2l12t2836r680b2937],
50	EGFR	NN	ORGANIZATION	egfr	nn	51	SENT_54	[p2l721t2843r933b2916],
51	mutants	NNS	O	mutant	nsubj	53	SENT_54	[p2l969t2853r1322b2915],
52	can	MD	O	can	aux	53	SENT_54	[p2l1368t2862r1516b2915],
53	transform	VB	O	transform	rcmod	47	SENT_54	[p2l1560t2836r1994b2915],
54	f1	NN	O	f1	nn	56	SENT_54	[p2l2036t2836r2132b2914],
55	—	NN	O	—	nn	56	SENT_54	[p2l2036t2836r2132b2914],
56	broblasts	NNS	O	broblast	dobj	53	SENT_54	[p2l12t2964r403b3043],
57	and	CC	O	and	_	0	SENT_54	[p2l447t2964r604b3043],
58	Ba/F3	NN	O	ba/f3	nn	59	SENT_54	[p2l644t2970r880b3054],
59	cells	NNS	O	cell	dobj	53	SENT_54	[p2l926t2964r1314b3043],
60	.	.	O	.	_	0	SENT_54	[p2l926t2964r1314b3043],

1	“’	NN	O	“’	_	0	SENT_55	[p2l926t2964r1314b3043],
2	12	CD	NUMBER	12	num	1	SENT_55	[p2l926t2964r1314b3043],
3	A	DT	O	a	det	5	SENT_55	[p2l1353t2972r1419b3042],
4	kinetic	JJ	O	kinetic	amod	5	SENT_55	[p2l1457t2964r1751b3044],
5	analysis	NN	O	analysis	nsubj	9	SENT_55	[p2l1792t2964r2131b3065],
6	of	IN	O	of	_	0	SENT_55	[p2l12t3092r110b3171],
7	these	DT	O	these	det	8	SENT_55	[p2l125t3092r345b3171],
8	mutations	NNS	O	mutation	prep_of	5	SENT_55	[p2l377t3093r803b3171],
9	showed	VBD	O	show	rcmod	1	SENT_55	[p2l840t3092r1157b3171],
10	that	IN	O	that	complm	16	SENT_55	[p2l1190t3092r1359b3171],
11	exon	NN	O	exon	nsubj	16	SENT_55	[p2l1388t3118r1585b3171],
12	19	CD	NUMBER	19	num	13	SENT_55	[p2l1620t3098r1715b3171],
13	deletions	NNS	O	deletion	dep	11	SENT_55	[p2l1750t3092r2132b3171],
14	are	VBP	O	be	cop	16	SENT_55	[p2l11t3247r137b3300],
15	more	RBR	O	more	advmod	16	SENT_55	[p2l171t3247r387b3300],
16	sensitive	JJ	O	sensitive	ccomp	9	SENT_55	[p2l422t3222r777b3300],
17	to	TO	O	to	_	0	SENT_55	[p2l812t3238r892b3300],
18	erlotinib	JJ	O	erlotinib	amod	19	SENT_55	[p2l928t3221r1285b3300],
19	inhibition	NN	O	inhibition	prep_to	16	SENT_55	[p2l1320t3221r1739b3300],
20	than	IN	O	than	advmod	16	SENT_55	[p2l1773t3221r1966b3300],
21	the	DT	O	the	dep	20	SENT_55	[p2l2000t3221r2133b3300],

1	L858R	NN	O	l858r	nn	2	SENT_56	[p2l9t3355r294b3433],
2	mutation	NN	O	mutation	_	0	SENT_56	[p2l321t3350r824b3445],
3	,13	CD	NUMBER	,13	num	5	SENT_56	[p2l321t3350r824b3445],
4	a	DT	O	a	det	5	SENT_56	[p2l862t3376r907b3428],
5	finding	NN	O	finding	dep	2	SENT_56	[p2l943t3349r1274b3450],
6	that	WDT	O	that	nsubjpass	9	SENT_56	[p2l1308t3349r1484b3428],
7	has	VBZ	O	have	aux	9	SENT_56	[p2l1516t3349r1662b3428],
8	been	VBN	O	be	auxpass	9	SENT_56	[p2l1703t3349r1907b3428],
9	confirmed	VBN	O	confirm	dep	2	SENT_56	[p2l1945t3375r2132b3428, p2l11t3477r306b3556],
10	in	IN	O	in	_	0	SENT_56	[p2l345t3478r428b3555],
11	retrospective	JJ	O	retrospective	amod	13	SENT_56	[p2l467t3478r1019b3578],
12	clinical	JJ	O	clinical	amod	13	SENT_56	[p2l1060t3477r1373b3556],
13	studies	NNS	O	study	prep_in	9	SENT_56	[p2l1414t3477r1915b3556],
14	.14	CD	NUMBER	.14	number	15	SENT_56	[p2l1414t3477r1915b3556],
15	'16	CD	NUMBER	'16	dep	13	SENT_56	[p2l1414t3477r1915b3556],

1	In	IN	O	in	dep	15	SENT_57	[p2l138t3613r225b3683],
2	retrospective	JJ	O	retrospective	amod	3	SENT_57	[p2l248t3606r775b3706],
3	studies	NNS	O	study	pobj	1	SENT_57	[p2l800t3605r1109b3701],
4	,	,	O	,	_	0	SENT_57	[p2l800t3605r1109b3701],
5	W	NNP	O	W	conj_and	3	SENT_57	[p2l1133t3610r1402b3684],
6	€	CD	MONEY	€	num	5	SENT_57	[p2l1133t3610r1402b3684],
7	17	CD	MONEY	17	number	8	SENT_57	[p2l1133t3610r1402b3684],
8	’18	CD	MONEY	’18	dep	5	SENT_57	[p2l1133t3610r1402b3684],
9	and	CC	O	and	_	0	SENT_57	[p2l1426t3605r1579b3684],
10	others14	CD	NUMBER	others14	num	11	SENT_57	[p2l1603t3605r2134b3684],
11	>	JJR	O	>	conj_and	3	SENT_57	[p2l1603t3605r2134b3684],
12	19	CD	NUMBER	19	num	13	SENT_57	[p2l1603t3605r2134b3684],
13	’	NN	O	’	dep	11	SENT_57	[p2l1603t3605r2134b3684],
14	2	CD	NUMBER	2	num	15	SENT_57	[p2l1603t3605r2134b3684],
15	°	NN	O	°	_	0	SENT_57	[p2l1603t3605r2134b3684],

1	found	VBN	O	find	_	0	SENT_58	[p3l11t20r264b99],
2	that	IN	O	that	complm	8	SENT_58	[p3l302t20r474b99],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_58	[p3l506t27r718b100],
4	mutations	NNS	O	mutation	nsubj	8	SENT_58	[p3l750t21r1184b99],
5	were	VBD	O	be	cop	8	SENT_58	[p3l1220t47r1422b100],
6	an	DT	O	a	det	8	SENT_58	[p3l1459t46r1563b99],
7	independent	JJ	O	independent	amod	8	SENT_58	[p3l1600t20r2139b121],
8	predictor	NN	O	predictor	ccomp	1	SENT_58	[p3l10t148r413b249],
9	of	IN	O	of	_	0	SENT_58	[p3l443t148r544b227],
10	response	NN	O	response	prep_of	8	SENT_58	[p3l558t174r971b249],
11	,	,	O	,	_	0	SENT_58	[p3l558t174r971b249],
12	progression	NN	O	progression	ccomp	1	SENT_58	[p3l1007t148r1730b249],
13	—	CD	NUMBER	—	num	15	SENT_58	[p3l1007t148r1730b249],
14	free	JJ	O	free	amod	15	SENT_58	[p3l1007t148r1730b249],
15	survival	NN	O	survival	dep	12	SENT_58	[p3l1765t148r2128b244],
16	,	,	O	,	_	0	SENT_58	[p3l1765t148r2128b244],
17	and	CC	O	and	_	0	SENT_58	[p3l11t276r168b355],
18	overall	JJ	O	overall	amod	19	SENT_58	[p3l209t276r494b355],
19	survival	NN	O	survival	ccomp	1	SENT_58	[p3l536t276r867b355],
20	in	IN	O	in	_	0	SENT_58	[p3l906t277r990b354],
21	patients	NNS	O	patient	prep_in	19	SENT_58	[p3l1028t277r1369b377],
22	with	IN	O	with	_	0	SENT_58	[p3l1408t276r1603b356],
23	non	JJ	O	non	amod	29	SENT_58	[p3l1642t276r2132b355],
24	—	JJ	O	—	amod	29	SENT_58	[p3l1642t276r2132b355],
25	small	JJ	O	small	amod	29	SENT_58	[p3l1642t276r2132b355],
26	—	NN	O	—	nn	29	SENT_58	[p3l1642t276r2132b355],
27	cell	NN	O	cell	nn	29	SENT_58	[p3l12t404r157b483],
28	lung	NN	O	lung	nn	29	SENT_58	[p3l190t404r384b505],
29	cancer	NN	O	cancer	prep_with	21	SENT_58	[p3l416t430r697b483],
30	who	WP	O	who	nsubjpass	32	SENT_58	[p3l724t404r906b484],
31	were	VBD	O	be	auxpass	32	SENT_58	[p3l938t430r1140b483],
32	treated	VBN	O	treat	rcmod	19	SENT_58	[p3l1175t404r1474b483],
33	with	IN	O	with	_	0	SENT_58	[p3l1503t404r1698b483],
34	gefitinib	NN	O	gefitinib	prep_with	32	SENT_58	[p3l1733t404r2129b505],
35	;	:	O	;	_	0	SENT_58	[p3l1733t404r2129b505],
36	most	JJS	O	most	nsubj	44	SENT_58	[p3l11t549r228b611],
37	of	IN	O	of	_	0	SENT_58	[p3l261t532r361b611],
38	the	DT	O	the	det	39	SENT_58	[p3l381t532r514b611],
39	patients	NNS	O	patient	prep_of	36	SENT_58	[p3l551t533r892b633],
40	in	IN	O	in	_	0	SENT_58	[p3l933t533r1016b610],
41	these	DT	O	these	det	42	SENT_58	[p3l1054t532r1278b611],
42	studies	NNS	O	study	prep_in	39	SENT_58	[p3l1318t532r1618b611],
43	had	VBD	O	have	aux	44	SENT_58	[p3l1658t532r1814b611],
44	undergone	VBN	O	undergo	parataxis	1	SENT_58	[p3l1853t532r2132b611, p3l11t686r211b761],
45	previous	JJ	O	previous	amod	46	SENT_58	[p3l246t661r593b761],
46	chemotherapy	NN	O	chemotherapy	dobj	44	SENT_58	[p3l632t660r1230b761],
47	.	.	O	.	_	0	SENT_58	[p3l632t660r1230b761],

1	Consistent	JJ	O	consistent	dep	124	SENT_59	[p3l1272t661r1712b739],
2	with	IN	O	with	dep	124	SENT_59	[p3l1739t660r1928b739],
3	previous	JJ	O	previous	dep	124	SENT_59	[p3l1962t686r2132b761, p3l7t789r225b867],
4	ﬁndings	NNS	O	ﬁndings	dep	124	SENT_59	[p3l268t788r742b889],
5	,6	CD	NUMBER	,6	dep	124	SENT_59	[p3l268t788r742b889],
6	»	NN	O	»	dep	124	SENT_59	[p3l268t788r742b889],
7	7	CD	NUMBER	7	dep	124	SENT_59	[p3l268t788r742b889],
8	EGFR	NN	ORGANIZATION	egfr	dep	124	SENT_59	[p3l781t795r990b868],
9	mutations	NNS	O	mutation	dep	124	SENT_59	[p3l1024t789r1449b867],
10	were	VBD	O	be	dep	124	SENT_59	[p3l1488t814r1686b868],
11	more	RBR	O	more	dep	124	SENT_59	[p3l1726t814r1942b867],
12	frequent	JJ	O	frequent	dep	124	SENT_59	[p3l1983t788r2132b867, p3l12t933r255b1017],
13	in	IN	O	in	dep	124	SENT_59	[p3l278t917r361b994],
14	women	NNS	O	woman	dep	124	SENT_59	[p3l385t942r724b1012],
15	,	,	O	,	_	0	SENT_59	[p3l385t942r724b1012],
16	patients	NNS	O	patient	dep	124	SENT_59	[p3l757t917r1098b1017],
17	with	IN	O	with	dep	124	SENT_59	[p3l1124t916r1320b995],
18	adenocarcinomas	NNS	O	adenocarcinoma	dep	124	SENT_59	[p3l1348t916r2128b1012],
19	,	,	O	,	_	0	SENT_59	[p3l1348t916r2128b1012],
20	those	DT	O	those	dep	124	SENT_59	[p3l12t1043r243b1121],
21	who	WP	O	who	dep	124	SENT_59	[p3l278t1043r460b1122],
22	had	VBD	O	have	dep	124	SENT_59	[p3l501t1043r657b1121],
23	never	RB	O	never	dep	124	SENT_59	[p3l696t1069r924b1122],
24	smoked	VBN	O	smoke	dep	124	SENT_59	[p3l962t1043r1317b1138],
25	,	,	O	,	_	0	SENT_59	[p3l962t1043r1317b1138],
26	and	CC	O	and	dep	124	SENT_59	[p3l1361t1043r1519b1121],
27	Asians	NNPS	MISC	Asians	dep	124	SENT_59	[p3l1553t1044r1864b1138],
28	,	,	O	,	_	0	SENT_59	[p3l1553t1044r1864b1138],
29	all	DT	O	all	dep	124	SENT_59	[p3l1908t1043r2013b1121],
30	of	IN	O	of	dep	124	SENT_59	[p3l2051t1043r2151b1121],
31	whom	WP	O	whom	dep	124	SENT_59	[p3l7t1171r282b1251],
32	also	RB	O	also	dep	124	SENT_59	[p3l347t1171r522b1250],
33	had	VBD	O	have	dep	124	SENT_59	[p3l590t1171r749b1250],
34	the	DT	O	the	dep	124	SENT_59	[p3l815t1171r950b1250],
35	best	JJS	O	best	dep	124	SENT_59	[p3l1017t1171r1198b1250],
36	response	NN	O	response	dep	124	SENT_59	[p3l1258t1197r1648b1272],
37	to	TO	O	to	dep	124	SENT_59	[p3l1715t1188r1798b1250],
38	gefiti	VB	O	gefiti	dep	124	SENT_59	[p3l1865t1171r2132b1272],
39	—	CD	NUMBER	—	dep	124	SENT_59	[p3l1865t1171r2132b1272],
40	nib	JJ	O	nib	dep	124	SENT_59	[p3l11t1299r524b1378],
41	.14	CD	NUMBER	.14	dep	124	SENT_59	[p3l11t1299r524b1378],
42	>	JJR	O	>	dep	124	SENT_59	[p3l11t1299r524b1378],
43	17	CD	NUMBER	17	dep	124	SENT_59	[p3l11t1299r524b1378],
44	»	NN	O	»	dep	124	SENT_59	[p3l11t1299r524b1378],
45	19	CD	NUMBER	19	dep	124	SENT_59	[p3l11t1299r524b1378],
46	>	JJR	O	>	dep	124	SENT_59	[p3l11t1299r524b1378],
47	2	CD	NUMBER	2	dep	124	SENT_59	[p3l11t1299r524b1378],
48	°	CD	NUMBER	°	dep	124	SENT_59	[p3l11t1299r524b1378],
49	Two	CD	NUMBER	two	dep	124	SENT_59	[p3l562t1305r738b1378],
50	small	JJ	O	small	dep	124	SENT_59	[p3l781t1299r1038b1395],
51	,	,	O	,	_	0	SENT_59	[p3l781t1299r1038b1395],
52	prospective	JJ	O	prospective	dep	124	SENT_59	[p3l1081t1300r1594b1400],
53	,	,	O	,	_	0	SENT_59	[p3l1081t1300r1594b1400],
54	multicenter	JJ	O	multicenter	dep	124	SENT_59	[p3l1639t1299r2136b1378],
55	studies	NNS	O	study	dep	124	SENT_59	[p3l13t1427r312b1506],
56	customized	VBN	O	customize	dep	124	SENT_59	[p3l350t1427r848b1506],
57	gefitinib	NN	O	gefitinib	dep	124	SENT_59	[p3l882t1427r1253b1528],
58	as	IN	O	as	dep	124	SENT_59	[p3l1289t1454r1374b1506],
59	first	JJ	ORDINAL	first	dep	124	SENT_59	[p3l1411t1427r1781b1506],
60	—	NN	O	—	dep	124	SENT_59	[p3l1411t1427r1781b1506],
61	line	NN	O	line	dep	124	SENT_59	[p3l1411t1427r1781b1506],
62	therapy	NN	O	therapy	dep	124	SENT_59	[p3l1816t1427r2138b1528],
63	or	CC	O	or	dep	124	SENT_59	[p3l12t1581r101b1634],
64	after	IN	O	after	dep	124	SENT_59	[p3l138t1555r346b1634],
65	up	RB	O	up	dep	124	SENT_59	[p3l383t1581r488b1656],
66	to	TO	O	to	dep	124	SENT_59	[p3l531t1572r613b1634],
67	two	CD	NUMBER	two	dep	124	SENT_59	[p3l656t1572r816b1634],
68	previous	JJ	O	previous	dep	124	SENT_59	[p3l857t1556r1227b1656],
69	chemotherapy	NN	O	chemotherapy	dep	124	SENT_59	[p3l1271t1555r1896b1656],
70	regimens	NNS	O	regimen	dep	124	SENT_59	[p3l1932t1556r2132b1656, p3l11t1709r235b1762],
71	in	IN	O	in	dep	124	SENT_59	[p3l270t1684r353b1761],
72	patients	NNS	O	patient	dep	124	SENT_59	[p3l385t1684r719b1784],
73	with	IN	O	with	dep	124	SENT_59	[p3l751t1683r942b1762],
74	non	JJ	O	non	dep	124	SENT_59	[p3l977t1683r1605b1762],
75	—	JJ	O	—	dep	124	SENT_59	[p3l977t1683r1605b1762],
76	small	JJ	O	small	dep	124	SENT_59	[p3l977t1683r1605b1762],
77	—	NN	O	—	dep	124	SENT_59	[p3l977t1683r1605b1762],
78	cell	NN	O	cell	dep	124	SENT_59	[p3l977t1683r1605b1762],
79	lung	NN	O	lung	dep	124	SENT_59	[p3l1637t1683r1827b1784],
80	cancer	NN	O	cancer	dep	124	SENT_59	[p3l1859t1709r2137b1762],
81	with	IN	O	with	dep	124	SENT_59	[p3l7t1811r202b1891],
82	EGFR	NN	ORGANIZATION	egfr	dep	124	SENT_59	[p3l232t1818r444b1891],
83	mutations	NNS	O	mutation	dep	124	SENT_59	[p3l470t1812r1106b1890],
84	.21	CD	NUMBER	.21	dep	124	SENT_59	[p3l470t1812r1106b1890],
85	’22	CD	NUMBER	’22	dep	124	SENT_59	[p3l470t1812r1106b1890],
86	Response	NN	O	response	dep	124	SENT_59	[p3l1138t1818r1548b1912],
87	rates	NNS	O	rate	dep	124	SENT_59	[p3l1580t1828r1783b1890],
88	were	VBD	O	be	dep	124	SENT_59	[p3l1813t1838r2014b1891],
89	as	RB	O	as	dep	124	SENT_59	[p3l2046t1838r2131b1890],
90	high	JJ	O	high	dep	124	SENT_59	[p3l11t1939r206b2040],
91	as	IN	O	as	dep	124	SENT_59	[p3l244t1966r330b2018],
92	75	CD	PERCENT	75	dep	124	SENT_59	[p3l373t1945r580b2035],
93	%	NN	PERCENT	%	dep	124	SENT_59	[p3l373t1945r580b2035],
94	,	,	O	,	_	0	SENT_59	[p3l373t1945r580b2035],
95	and	CC	O	and	dep	124	SENT_59	[p3l624t1939r781b2018],
96	1-year	JJ	DURATION	1-year	dep	124	SENT_59	[p3l825t1945r1076b2040],
97	survival	NN	O	survival	dep	124	SENT_59	[p3l1115t1939r1447b2018],
98	was	VBD	O	be	dep	124	SENT_59	[p3l1481t1966r1644b2018],
99	as	RB	O	as	dep	124	SENT_59	[p3l1685t1966r1770b2018],
100	high	JJ	O	high	dep	124	SENT_59	[p3l1811t1939r2006b2040],
101	as	IN	O	as	dep	124	SENT_59	[p3l2046t1966r2131b2018],
102	79	CD	NUMBER	79	dep	124	SENT_59	[p3l12t2072r389b2146],
103	°	CD	NUMBER	°	dep	124	SENT_59	[p3l12t2072r389b2146],
104	/	:	O	/	dep	124	SENT_59	[p3l12t2072r389b2146],
105	o.	SYM	O	o.	dep	124	SENT_59	[p3l12t2072r389b2146],
106	21	CD	NUMBER	21	dep	124	SENT_59	[p3l12t2072r389b2146],
107	»	CD	NUMBER	»	dep	124	SENT_59	[p3l12t2072r389b2146],
108	22	CD	NUMBER	22	dep	124	SENT_59	[p3l12t2072r389b2146],
109	At	IN	O	at	dep	124	SENT_59	[p3l424t2075r522b2146],
110	least	JJS	O	least	dep	124	SENT_59	[p3l554t2067r749b2146],
111	five	CD	NUMBER	five	dep	124	SENT_59	[p3l781t2067r931b2146],
112	additional	JJ	O	additional	dep	124	SENT_59	[p3l968t2067r1395b2146],
113	prospective	JJ	O	prospective	dep	124	SENT_59	[p3l1432t2068r1932b2168],
114	,	,	O	,	_	0	SENT_59	[p3l1432t2068r1932b2168],
115	single	JJ	O	single	dep	124	SENT_59	[p3l1977t2068r2132b2146, p3l11t2195r596b2296],
116	—	NN	O	—	dep	124	SENT_59	[p3l1977t2068r2132b2146, p3l11t2195r596b2296],
117	institution	NN	O	institution	dep	124	SENT_59	[p3l1977t2068r2132b2146, p3l11t2195r596b2296],
118	studies	NNS	O	study	dep	124	SENT_59	[p3l629t2195r915b2274],
119	in	IN	O	in	dep	124	SENT_59	[p3l948t2196r1030b2273],
120	Japan	NNP	LOCATION	Japan	dep	124	SENT_59	[p3l1051t2203r1287b2296],
121	have	VBP	O	have	dep	124	SENT_59	[p3l1318t2195r1501b2274],
122	reported	VBN	O	report	dep	124	SENT_59	[p3l1533t2195r1884b2296],
123	similar	JJ	O	similar	dep	124	SENT_59	[p3l1917t2196r2132b2274, p3l10t2323r126b2401],
124	outcomes	NNS	O	outcome	_	0	SENT_59	[p3l161t2329r675b2402],
125	.	.	O	.	_	0	SENT_59	[p3l161t2329r675b2402],

1	”	NN	O	”	ccomp	7	SENT_60	[p3l161t2329r675b2402],
2	However	RB	O	however	advmod	1	SENT_60	[p3l715t2331r1110b2417],
3	,	,	O	,	_	0	SENT_60	[p3l715t2331r1110b2417],
4	all	PDT	O	all	predet	6	SENT_60	[p3l1152t2323r1257b2401],
5	these	DT	O	these	det	6	SENT_60	[p3l1294t2323r1518b2401],
6	studies	NNS	O	study	nsubj	14	SENT_60	[p3l1557t2323r1857b2402],
7	had	VBD	O	have	_	0	SENT_60	[p3l1897t2323r2053b2402],
8	a	DT	O	a	det	12	SENT_60	[p3l2090t2350r2134b2401],
9	relatively	RB	O	relatively	advmod	10	SENT_60	[p3l10t2451r397b2551],
10	short	JJ	O	short	amod	12	SENT_60	[p3l439t2451r664b2530],
11	observation	NN	O	observation	nn	12	SENT_60	[p3l704t2451r1208b2530],
12	period	NN	O	period	dobj	7	SENT_60	[p3l1252t2451r1530b2551],
13	and	CC	O	and	_	0	SENT_60	[p3l1575t2451r1734b2530],
14	included	VBD	O	include	conj_and	7	SENT_60	[p3l1777t2451r2147b2530],
15	small	JJ	O	small	amod	16	SENT_60	[p3l11t2579r252b2657],
16	numbers	NNS	O	number	dobj	14	SENT_60	[p3l301t2579r688b2659],
17	of	IN	O	of	_	0	SENT_60	[p3l740t2578r842b2658],
18	selected	VBN	O	select	amod	19	SENT_60	[p3l874t2579r1225b2658],
19	patients	NNS	O	patient	prep_of	16	SENT_60	[p3l1272t2580r1651b2679],
20	.	.	O	.	_	0	SENT_60	[p3l1272t2580r1651b2679],

1	Moreover	RB	O	moreover	advmod	8	SENT_61	[p3l1702t2587r2140b2675],
2	,	,	O	,	_	0	SENT_61	[p3l1702t2587r2140b2675],
3	most	JJS	O	most	nsubjpass	8	SENT_61	[p3l10t2724r231b2786],
4	of	IN	O	of	_	0	SENT_61	[p3l275t2706r376b2786],
5	the	DT	O	the	det	6	SENT_61	[p3l406t2707r542b2785],
6	studies	NNS	O	study	prep_of	3	SENT_61	[p3l591t2707r900b2787],
7	were	VBD	O	be	auxpass	8	SENT_61	[p3l946t2733r1152b2787],
8	carried	VBN	O	carry	_	0	SENT_61	[p3l1201t2707r1510b2786],
9	out	RP	O	out	prt	8	SENT_61	[p3l1558t2724r1700b2786],
10	in	IN	O	in	_	0	SENT_61	[p3l1743t2708r1827b2785],
11	Japan	NNP	LOCATION	Japan	prep_in	8	SENT_61	[p3l1866t2715r2140b2807],
12	,	,	O	,	_	0	SENT_61	[p3l1866t2715r2140b2807],
13	whereas	IN	O	whereas	mark	15	SENT_61	[p3l6t2836r359b2916],
14	the	DT	O	the	det	15	SENT_61	[p3l404t2836r537b2915],
15	incidence	NN	O	incidence	dep	11	SENT_61	[p3l578t2836r986b2916],
16	of	IN	O	of	_	0	SENT_61	[p3l1030t2835r1130b2916],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_61	[p3l1151t2843r1365b2917],
18	mutations	NNS	O	mutation	prep_of	15	SENT_61	[p3l1400t2837r1838b2916],
19	in	IN	O	in	dep	15	SENT_61	[p3l1881t2837r1965b2914],
20	Europe	NNP	LOCATION	Europe	pobj	19	SENT_61	[p3l2005t2844r2144b2916, p3l10t2990r200b3064],

1	has	VBZ	O	have	aux	4	SENT_62	[p3l241t2964r385b3042],
2	not	RB	O	not	neg	4	SENT_62	[p3l427t2981r571b3043],
3	been	VBN	O	be	auxpass	4	SENT_62	[p3l606t2964r808b3043],
4	defined	VBN	O	define	_	0	SENT_62	[p3l849t2963r1201b3043],
5	.	.	O	.	_	0	SENT_62	[p3l849t2963r1201b3043],

1	We	PRP	O	we	nsubj	3	SENT_63	[p3l136t3101r268b3172],
2	now	RB	DATE	now	advmod	3	SENT_63	[p3l301t3119r482b3173],
3	report	VBP	O	report	_	0	SENT_63	[p3l511t3110r769b3194],
4	a	DT	O	a	det	6	SENT_63	[p3l796t3120r841b3172],
5	prospective	JJ	O	prospective	amod	6	SENT_63	[p3l871t3094r1342b3194],
6	study	NN	O	study	dobj	3	SENT_63	[p3l1377t3093r1599b3194],
7	of	IN	O	of	_	0	SENT_63	[p3l1628t3092r1726b3173],
8	screening	VBG	O	screen	prepc_of	6	SENT_63	[p3l1743t3094r2149b3195],
9	for	IN	O	for	_	0	SENT_63	[p3l10t3220r130b3300],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_63	[p3l154t3228r361b3301],
11	mutations	NNS	O	mutation	prep_for	8	SENT_63	[p3l384t3222r803b3301],
12	in	IN	O	in	_	0	SENT_63	[p3l834t3222r916b3299],
13	patients	NNS	O	patient	prep_in	11	SENT_63	[p3l943t3222r1272b3321],
14	with	IN	O	with	_	0	SENT_63	[p3l1298t3221r1488b3301],
15	advanced	JJ	O	advanced	amod	17	SENT_63	[p3l1517t3221r1900b3301],
16	nonsmall	JJ	O	nonsmall	amod	17	SENT_63	[p3l1929t3247r2149b3300, p3l11t3350r432b3428],
17	—	NN	O	—	prep_with	13	SENT_63	[p3l1929t3247r2149b3300, p3l11t3350r432b3428],
18	cell	NN	O	cell	nn	20	SENT_63	[p3l1929t3247r2149b3300, p3l11t3350r432b3428],
19	lung	NN	O	lung	nn	20	SENT_63	[p3l464t3350r659b3451],
20	cancer	NN	O	cancer	dobj	8	SENT_63	[p3l690t3376r990b3446],
21	,	,	O	,	_	0	SENT_63	[p3l690t3376r990b3446],
22	conducted	VBN	O	conduct	partmod	20	SENT_63	[p3l1031t3350r1475b3429],
23	by	IN	O	by	_	0	SENT_63	[p3l1509t3350r1607b3450],
24	the	DT	O	the	det	28	SENT_63	[p3l1636t3350r1770b3428],
25	Spanish	JJ	O	spanish	amod	28	SENT_63	[p3l1806t3350r2146b3450],
26	Lung	NN	O	lung	nn	28	SENT_63	[p3l8t3486r230b3580],
27	Cancer	NNP	O	Cancer	nn	28	SENT_63	[p3l261t3484r562b3558],
28	Group	NNP	O	Group	agent	22	SENT_63	[p3l593t3484r886b3579],
29	.	.	O	.	_	0	SENT_63	[p3l593t3484r886b3579],

1	We	PRP	O	we	nsubj	2	SENT_64	[p3l923t3486r1057b3557],
2	registered	VBD	O	register	_	0	SENT_64	[p3l1091t3478r1521b3580],
3	patients	NNS	O	patient	dobj	2	SENT_64	[p3l1554t3479r1897b3579],
4	from	IN	O	from	_	0	SENT_64	[p3l1934t3477r2146b3558],
5	129	CD	NUMBER	129	num	6	SENT_64	[p3l14t3613r162b3687],
6	centers	NNS	O	center	prep_from	2	SENT_64	[p3l203t3624r501b3686],
7	from	IN	O	from	_	0	SENT_64	[p3l541t3606r750b3687],
8	all	DT	O	all	det	9	SENT_64	[p3l787t3607r890b3686],
9	regions	NNS	O	region	prep_from	2	SENT_64	[p3l928t3608r1240b3709],
10	of	IN	O	of	_	0	SENT_64	[p3l1282t3606r1381b3687],
11	Spain	NNP	LOCATION	Spain	prep_of	9	SENT_64	[p3l1403t3608r1638b3708],
12	and	CC	O	and	_	0	SENT_64	[p3l1675t3607r1832b3687],
13	used	VBD	O	use	conj_and	2	SENT_64	[p3l1870t3607r2065b3687],
14	a	DT	O	a	det	16	SENT_64	[p3l2102t3634r2148b3686],
15	central	JJ	O	central	amod	16	SENT_64	[p4l11t20r295b98],
16	laboratory	NN	O	laboratory	dobj	13	SENT_64	[p4l321t20r751b120],
17	and	CC	O	and	_	0	SENT_64	[p4l774t20r928b99],
18	database	NN	O	database	conj_and	16	SENT_64	[p4l956t20r1340b99],
19	.	.	O	.	_	0	SENT_64	[p4l956t20r1340b99],

1	Patients	NNS	O	patient	nsubjpass	6	SENT_65	[p4l1372t21r1698b98],
2	with	IN	O	with	_	0	SENT_65	[p4l1723t20r1913b100],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_65	[p4l1939t26r2153b100],
4	mutations	NNS	O	mutation	prep_with	1	SENT_65	[p4l10t150r447b228],
5	were	VBD	O	be	auxpass	6	SENT_65	[p4l487t175r690b228],
6	considered	VBN	O	consider	_	0	SENT_65	[p4l733t149r1199b228],
7	for	IN	O	for	_	0	SENT_65	[p4l1242t148r1365b228],
8	customized	VBN	O	customize	amod	9	SENT_65	[p4l1405t149r1907b228],
9	erlotinib	NN	O	erlotinib	prep_for	6	SENT_65	[p4l1949t149r2144b228, p4l11t277r209b356],

1	treatment	NN	O	treatment	_	0	SENT_66	[p4l247t294r684b373],
2	,	,	O	,	_	0	SENT_66	[p4l247t294r684b373],
3	and	CC	O	and	dep	1	SENT_66	[p4l725t277r882b356],
4	we	PRP	O	we	nsubj	5	SENT_66	[p4l913t303r1030b356],
5	evaluated	VBD	O	evaluate	dep	1	SENT_66	[p4l1068t277r1464b356],
6	the	DT	O	the	det	7	SENT_66	[p4l1500t277r1631b355],
7	association	NN	O	association	dobj	5	SENT_66	[p4l1666t278r2146b356],
8	between	IN	O	between	_	0	SENT_66	[p4l11t406r371b485],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_66	[p4l409t412r623b486],
10	mutations	NNS	O	mutation	prep_between	7	SENT_66	[p4l656t407r1093b485],
11	and	CC	O	and	_	0	SENT_66	[p4l1134t406r1293b485],
12	outcome	NN	O	outcome	conj_and	10	SENT_66	[p4l1334t423r1727b485],
13	.	.	O	.	_	0	SENT_66	[p4l1334t423r1727b485],

1	METHODS	NNS	O	method	_	0	SENT_67	[p4l804t703r1350b763],

1	PATIENTS	NNS	O	patient	_	0	SENT_68	[p4l16t939r384b990],

1	We	PRP	O	we	nsubj	3	SENT_69	[p4l6t1047r138b1117],
2	prospectively	RB	O	prospectively	advmod	3	SENT_69	[p4l167t1039r711b1139],
3	screened	VBD	O	screen	_	0	SENT_69	[p4l738t1039r1098b1118],
4	2105	CD	DATE	2105	num	5	SENT_69	[p4l1128t1045r1320b1118],
5	patients	NNS	O	patient	dobj	3	SENT_69	[p4l1352t1040r1680b1139],
6	with	IN	O	with	_	0	SENT_69	[p4l1708t1039r1898b1118],
7	nonsmall	JJ	O	nonsmall	amod	11	SENT_69	[p4l1928t1065r2149b1118, p4l12t1168r423b1247],
8	—	NN	O	—	nn	11	SENT_69	[p4l1928t1065r2149b1118, p4l12t1168r423b1247],
9	cell	NN	O	cell	nn	11	SENT_69	[p4l1928t1065r2149b1118, p4l12t1168r423b1247],
10	lung	NN	O	lung	nn	11	SENT_69	[p4l445t1168r636b1270],
11	cancer	NN	O	cancer	prep_with	3	SENT_69	[p4l657t1194r934b1247],
12	for	IN	O	for	_	0	SENT_69	[p4l955t1167r1077b1248],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_69	[p4l1096t1175r1307b1249],
14	mutations	NNS	O	mutation	prep_for	11	SENT_69	[p4l1324t1169r1776b1248],
15	.	.	O	.	_	0	SENT_69	[p4l1324t1169r1776b1248],

1	Patients	NNS	O	patient	nsubjpass	6	SENT_70	[p4l1805t1169r2144b1247],
2	with	IN	O	with	_	0	SENT_70	[p4l6t1297r199b1376],
3	mutations	NNS	O	mutation	prep_with	1	SENT_70	[p4l230t1298r659b1376],
4	were	VBD	O	be	auxpass	6	SENT_70	[p4l688t1323r888b1376],
5	then	RB	O	then	advmod	6	SENT_70	[p4l920t1297r1108b1375],
6	considered	VBN	O	consider	_	0	SENT_70	[p4l1141t1297r1598b1376],
7	for	IN	O	for	_	0	SENT_70	[p4l1629t1296r1751b1376],
8	erlotinib	NN	O	erlotinib	nn	9	SENT_70	[p4l1779t1297r2144b1376],
9	treatment	NN	O	treatment	prep_for	6	SENT_70	[p4l11t1442r437b1504],
10	at	IN	O	at	_	0	SENT_70	[p4l465t1442r545b1504],
11	a	DT	O	a	det	12	SENT_70	[p4l573t1452r618b1504],
12	dose	NN	O	dose	prep_at	6	SENT_70	[p4l651t1425r846b1505],
13	of	IN	O	of	_	0	SENT_70	[p4l881t1424r981b1505],
14	150	CD	NUMBER	150	num	15	SENT_70	[p4l1000t1431r1150b1505],
15	mg	NN	O	mg	prep_of	12	SENT_70	[p4l1185t1451r1325b1527],
16	daily	RB	SET	daily	advmod	6	SENT_70	[p4l1356t1425r1565b1526],
17	until	IN	O	until	_	0	SENT_70	[p4l1595t1425r1799b1505],
18	disease	NN	O	disease	nn	19	SENT_70	[p4l1834t1425r2145b1505],
19	progression	NN	O	progression	prep_until	6	SENT_70	[p4l9t1555r534b1656],
20	or	CC	O	or	_	0	SENT_70	[p4l573t1580r663b1634],
21	the	DT	O	the	det	22	SENT_70	[p4l699t1554r835b1633],
22	advent	NN	O	advent	conj_or	19	SENT_70	[p4l873t1554r1159b1634],
23	of	IN	O	of	_	0	SENT_70	[p4l1193t1553r1295b1634],
24	intolerable	JJ	O	intolerable	amod	25	SENT_70	[p4l1314t1554r1785b1634],
25	adverse	JJ	O	adverse	amod	26	SENT_70	[p4l1822t1554r2146b1634],
26	effects	NNS	O	effect	prep_of	22	SENT_70	[p4l11t1682r303b1763],
27	.	.	O	.	_	0	SENT_70	[p4l11t1682r303b1763],

1	The	DT	O	the	det	2	SENT_71	[p4l332t1683r489b1762],
2	registration	NN	O	registration	nsubjpass	17	SENT_71	[p4l515t1684r997b1785],
3	of	IN	O	of	_	0	SENT_71	[p4l1024t1682r1122b1763],
4	patients	NNS	O	patient	prep_of	2	SENT_71	[p4l1128t1684r1456b1784],
5	in	IN	O	in	_	0	SENT_71	[p4l1484t1684r1565b1761],
6	the	DT	O	the	det	7	SENT_71	[p4l1592t1683r1721b1762],
7	database	NN	O	database	prep_in	4	SENT_71	[p4l1748t1683r2140b1780],
8	,	,	O	,	_	0	SENT_71	[p4l1748t1683r2140b1780],
9	pathological	JJ	O	pathological	amod	10	SENT_71	[p4l9t1812r526b1913],
10	review	NN	O	review	prep_in	4	SENT_71	[p4l550t1813r833b1908],
11	,	,	O	,	_	0	SENT_71	[p4l550t1813r833b1908],
12	and	CC	O	and	_	0	SENT_71	[p4l863t1812r1017b1891],
13	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_71	[p4l1040t1818r1247b1892],
14	mutation	NN	O	mutation	nn	15	SENT_71	[p4l1265t1813r1646b1891],
15	assessment	NN	O	assessment	prep_in	4	SENT_71	[p4l1670t1829r2151b1891],
16	were	VBD	O	be	auxpass	17	SENT_71	[p4l6t1965r209b2019],
17	performed	VBN	O	perform	_	0	SENT_71	[p4l241t1938r701b2039],
18	centrally	RB	O	centrally	dep	17	SENT_71	[p4l735t1939r1111b2039],
19	at	IN	O	at	_	0	SENT_71	[p4l1139t1956r1219b2017],
20	the	DT	O	the	det	22	SENT_71	[p4l1248t1939r1382b2017],
21	Catalan	NNP	ORGANIZATION	Catalan	nn	22	SENT_71	[p4l1416t1939r1747b2018],
22	Institute	NNP	ORGANIZATION	Institute	prep_at	18	SENT_71	[p4l1780t1940r2146b2019],
23	of	IN	ORGANIZATION	of	_	0	SENT_71	[p4l11t2067r110b2148],
24	Oncology	NNP	ORGANIZATION	Oncology	prep_of	22	SENT_71	[p4l123t2068r544b2170],
25	.	.	O	.	_	0	SENT_71	[p4l123t2068r544b2170],

1	Eligibility	NN	O	eligibility	nn	2	SENT_72	[p4l578t2068r993b2170],
2	criteria	NNS	O	criterion	nsubj	5	SENT_72	[p4l1020t2069r1317b2147],
3	were	VBD	O	be	cop	5	SENT_72	[p4l1343t2094r1542b2148],
4	the	DT	O	the	det	5	SENT_72	[p4l1574t2068r1705b2147],
5	diagnosis	NN	O	diagnosis	_	0	SENT_72	[p4l1737t2068r2143b2170],
6	of	IN	O	of	_	0	SENT_72	[p4l11t2196r110b2277],
7	stage	NN	O	stage	nn	9	SENT_72	[p4l122t2214r339b2299],
8	IIIB	NN	O	iiib	nn	9	SENT_72	[p4l367t2204r525b2276],
9	disease	NN	O	disease	prep_of	5	SENT_72	[p4l557t2197r863b2277],
10	with	IN	O	with	_	0	SENT_72	[p4l887t2197r1080b2277],
11	pleural	JJ	O	pleural	amod	12	SENT_72	[p4l1108t2197r1403b2298],
12	effusion	NN	O	effusion	prep_with	9	SENT_72	[p4l1432t2196r1780b2277],
13	or	CC	O	or	_	0	SENT_72	[p4l1809t2223r1897b2277],
14	stage	NN	O	stage	prep_of	5	SENT_72	[p4l1924t2214r2146b2299],
15	IV	CD	NUMBER	iv	num	22	SENT_72	[p4l8t2334r106b2404],
16	non	JJ	O	non	amod	22	SENT_72	[p4l136t2326r782b2405],
17	—	JJ	O	—	amod	22	SENT_72	[p4l136t2326r782b2405],
18	small	JJ	O	small	amod	22	SENT_72	[p4l136t2326r782b2405],
19	—	NN	O	—	nn	22	SENT_72	[p4l136t2326r782b2405],
20	cell	NN	O	cell	nn	22	SENT_72	[p4l136t2326r782b2405],
21	lung	NN	O	lung	nn	22	SENT_72	[p4l815t2326r1010b2427],
22	cancer	NN	O	cancer	dep	14	SENT_72	[p4l1041t2352r1341b2405],
23	.	.	O	.	_	0	SENT_72	[p4l1041t2352r1341b2405],

1	The	DT	O	the	det	3	SENT_73	[p4l1377t2326r1539b2405],
2	smoking	NN	O	smoking	nn	3	SENT_73	[p4l1574t2326r1954b2427],
3	history	NN	O	history	nsubjpass	8	SENT_73	[p4l1984t2326r2144b2404, p4l11t2470r184b2553],
4	of	IN	O	of	_	0	SENT_73	[p4l211t2452r311b2532],
5	the	DT	O	the	det	6	SENT_73	[p4l324t2453r458b2531],
6	patients	NNS	O	patient	prep_of	3	SENT_73	[p4l487t2454r832b2553],
7	was	VBD	O	be	auxpass	8	SENT_73	[p4l860t2479r1024b2533],
8	obtained	VBN	O	obtain	_	0	SENT_73	[p4l1057t2453r1438b2532],
9	at	IN	O	at	_	0	SENT_73	[p4l1468t2470r1547b2531],
10	baseline	NN	O	baseline	prep_at	8	SENT_73	[p4l1574t2453r1952b2549],
11	,	,	O	,	_	0	SENT_73	[p4l1574t2453r1952b2549],
12	and	CC	O	and	_	0	SENT_73	[p4l1987t2453r2146b2532],
13	patients	NNS	O	patient	nsubjpass	15	SENT_73	[p4l9t2583r352b2682],
14	were	VBD	O	be	auxpass	15	SENT_73	[p4l379t2608r582b2661],
15	categorized	VBN	O	categorize	conj_and	8	SENT_73	[p4l612t2582r1113b2683],
16	as	IN	O	as	_	0	SENT_73	[p4l1142t2608r1228b2660],
17	those	DT	O	those	prep_as	15	SENT_73	[p4l1260t2582r1492b2661],
18	who	WP	O	who	nsubj	21	SENT_73	[p4l1517t2582r1701b2661],
19	had	VBD	O	have	aux	21	SENT_73	[p4l1731t2582r1889b2661],
20	never	RB	O	never	neg	21	SENT_73	[p4l1918t2608r2149b2661],
21	smoked	VBN	O	smoke	rcmod	17	SENT_73	[p4l12t2710r340b2790],
22	(	NN	O	(	dep	23	SENT_73	[p4l372t2716r598b2802],
23	<	JJR	O	<	dobj	21	SENT_73	[p4l372t2716r598b2802],
24	100	CD	NUMBER	100	num	26	SENT_73	[p4l372t2716r598b2802],
25	lifetime	NN	O	lifetime	nn	26	SENT_73	[p4l626t2709r955b2789],
26	cigarettes	NNS	O	cigarette	tmod	21	SENT_73	[p4l984t2711r1438b2812],
27	)	RB	O	)	advmod	26	SENT_73	[p4l984t2711r1438b2812],
28	,	,	O	,	_	0	SENT_73	[p4l984t2711r1438b2812],
29	former	JJ	O	former	amod	30	SENT_73	[p4l1471t2709r1764b2790],
30	smokers	NNS	O	smoker	nsubj	31	SENT_73	[p4l1789t2710r2144b2790],
31	(	VBP	O	(	ccomp	8	SENT_73	[p4l15t2845r148b2930],
32	21	CD	DURATION	21	num	33	SENT_73	[p4l15t2845r148b2930],
33	year	NN	NUMBER	year	dobj	31	SENT_73	[p4l172t2865r353b2939],
34	since	IN	O	since	_	0	SENT_73	[p4l379t2840r595b2917],
35	cessation	NN	O	cessation	nn	36	SENT_73	[p4l624t2840r1074b2935],
36	)	NN	O	)	prep_since	33	SENT_73	[p4l624t2840r1074b2935],
37	,	,	O	,	_	0	SENT_73	[p4l624t2840r1074b2935],
38	or	CC	O	or	_	0	SENT_73	[p4l1108t2865r1198b2918],
39	current	JJ	DATE	current	amod	40	SENT_73	[p4l1223t2856r1539b2918],
40	smokers	NNS	O	smoker	nsubj	41	SENT_73	[p4l1564t2839r1922b2919],
41	(	VBP	O	(	conj_or	8	SENT_73	[p4l1957t2839r2146b2930],
42	still	RB	O	still	advmod	43	SENT_73	[p4l1957t2839r2146b2930],
43	smoking	NN	O	smoking	dobj	41	SENT_73	[p4l11t2968r410b3069],
44	,	,	O	,	_	0	SENT_73	[p4l11t2968r410b3069],
45	or	CC	O	or	_	0	SENT_73	[p4l451t2994r540b3047],
46	<	JJR	O	<	dobj	41	SENT_73	[p4l574t2974r676b3047],
47	1	CD	DURATION	1	num	48	SENT_73	[p4l574t2974r676b3047],
48	year	NN	NUMBER	year	tmod	46	SENT_73	[p4l707t2994r888b3068],
49	since	IN	O	since	_	0	SENT_73	[p4l921t2969r1137b3046],
50	cessation	NN	O	cessation	nn	51	SENT_73	[p4l1173t2969r1623b3059],
51	)	NN	O	)	prep_since	41	SENT_73	[p4l1173t2969r1623b3059],
52	.	.	O	.	_	0	SENT_73	[p4l1173t2969r1623b3059],

1	All	DT	O	all	det	2	SENT_74	[p4l136t3095r258b3173],
2	patients	NNS	O	patient	nsubj	3	SENT_74	[p4l286t3096r615b3195],
3	provided	VBD	O	provide	_	0	SENT_74	[p4l647t3095r1008b3195],
4	written	VBN	O	write	amod	6	SENT_74	[p4l1035t3096r1338b3175],
5	informed	VBN	O	inform	amod	6	SENT_74	[p4l1368t3094r1757b3174],
6	consent	NN	O	consent	dobj	3	SENT_74	[p4l1789t3112r2140b3174],
7	.	.	O	.	_	0	SENT_74	[p4l1789t3112r2140b3174],

1	Approval	NN	O	approval	nsubjpass	3	SENT_75	[p4l6t3223r389b3323],
2	was	VBD	O	be	auxpass	3	SENT_75	[p4l425t3249r586b3303],
3	obtained	VBN	O	obtain	_	0	SENT_75	[p4l630t3223r1003b3302],
4	from	IN	O	from	_	0	SENT_75	[p4l1044t3222r1252b3302],
5	the	DT	O	the	det	8	SENT_75	[p4l1294t3223r1425b3301],
6	institutional	JJ	O	institutional	amod	8	SENT_75	[p4l1466t3223r1991b3303],
7	review	NN	O	review	nn	8	SENT_75	[p4l2031t3249r2144b3301, p4l6t3354r198b3432],
8	board	NN	O	board	prep_from	3	SENT_75	[p4l232t3353r472b3432],
9	and	CC	O	and	_	0	SENT_75	[p4l508t3353r663b3432],
10	the	DT	O	the	det	12	SENT_75	[p4l699t3353r828b3432],
11	ethics	NNS	O	ethic	nn	12	SENT_75	[p4l865t3353r1107b3432],
12	committee	NN	O	committee	prep_from	3	SENT_75	[p4l1146t3354r1593b3432],
13	at	IN	O	at	_	0	SENT_75	[p4l1629t3370r1706b3431],
14	each	DT	O	each	det	15	SENT_75	[p4l1738t3353r1924b3431],
15	hospital	NN	O	hospital	prep_at	3	SENT_75	[p4l1961t3353r2144b3432, p4l8t3481r226b3581],
16	.	.	O	.	_	0	SENT_75	[p4l1961t3353r2144b3432, p4l8t3481r226b3581],

1	Details	NNS	O	detail	nsubjpass	13	SENT_76	[p4l271t3481r575b3559],
2	on	IN	O	on	_	0	SENT_76	[p4l619t3507r725b3560],
3	inclusion	NN	O	inclusion	nn	6	SENT_76	[p4l765t3481r1160b3560],
4	and	CC	O	and	_	0	SENT_76	[p4l1200t3481r1359b3560],
5	exclusion	NN	O	exclusion	conj_and	3	SENT_76	[p4l1400t3481r1800b3560],
6	criteria	NNS	O	criterion	prep_on	1	SENT_76	[p4l1841t3482r2148b3559],
7	and	CC	O	and	_	0	SENT_76	[p4l10t3610r168b3689],
8	on	IN	O	on	_	0	SENT_76	[p4l206t3636r312b3689],
9	treatment	NN	O	treatment	prep_on	1	SENT_76	[p4l350t3627r776b3688],
10	and	CC	O	and	_	0	SENT_76	[p4l807t3610r966b3689],
11	evaluation	NN	O	evaluation	conj_and	9	SENT_76	[p4l1004t3610r1447b3689],
12	are	VBP	O	be	auxpass	13	SENT_76	[p4l1483t3636r1613b3688],
13	provided	VBN	O	provide	_	0	SENT_76	[p4l1649t3610r2026b3710],
14	in	IN	O	in	_	0	SENT_76	[p4l2062t3611r2146b3688],
15	the	DT	O	the	det	17	SENT_76	[p5l11t21r144b99],
16	Supplementary	NNP	O	Supplementary	nn	17	SENT_76	[p5l189t21r840b121],
17	Appendix	NNP	O	Appendix	prep_in	13	SENT_76	[p5l873t21r1315b121],
18	,	,	O	,	_	0	SENT_76	[p5l873t21r1315b121],
19	available	JJ	O	available	acomp	13	SENT_76	[p5l1361t21r1735b101],
20	with	IN	O	with	_	0	SENT_76	[p5l1774t21r1970b100],
21	the	DT	O	the	det	23	SENT_76	[p5l2013t21r2146b99],
22	full	JJ	O	full	amod	23	SENT_76	[p5l10t149r159b230],
23	text	NN	O	text	prep_with	19	SENT_76	[p5l199t167r361b229],
24	of	IN	O	of	_	0	SENT_76	[p5l396t149r497b230],
25	this	DT	O	this	det	26	SENT_76	[p5l518t150r679b229],
26	article	NN	O	article	prep_of	23	SENT_76	[p5l720t150r989b229],
27	at	IN	O	at	_	0	SENT_76	[p5l1029t167r1108b229],
28	NEJM.org	NN	O	nejm.org	prep_at	26	SENT_76	[p5l1140t158r1586b252],
29	.	.	O	.	_	0	SENT_76	[p5l1140t158r1586b252],

1	ASSESSMENT	NN	O	assessment	nn	4	SENT_77	[p5l8t427r532b478],
2	or	CC	O	or	_	0	SENT_77	[p5l563t427r666b478],
3	EGFR	NN	O	egfr	conj_or	1	SENT_77	[p5l701t427r899b478],
4	MUTATIONS	NNS	O	mutation	_	0	SENT_77	[p5l939t427r1407b478],
5	A	DT	O	a	det	6	SENT_77	[p5l6t534r72b604],
6	total	NN	O	total	nsubjpass	24	SENT_77	[p5l107t526r301b605],
7	of	IN	O	of	_	0	SENT_77	[p5l338t525r437b605],
8	2105	CD	DATE	2105	num	9	SENT_77	[p5l455t532r650b605],
9	samples	NNS	O	sample	prep_of	6	SENT_77	[p5l692t526r1032b626],
10	of	IN	O	of	_	0	SENT_77	[p5l1072t525r1172b605],
11	tumor	NN	O	tumor	nn	12	SENT_77	[p5l1190t543r1455b606],
12	tissue	NN	O	tissue	prep_of	9	SENT_77	[p5l1489t527r1731b606],
13	from	IN	O	from	_	0	SENT_77	[p5l1769t525r1977b605],
14	patients	NNS	O	patient	prep_from	12	SENT_77	[p5l2012t552r2144b626, p5l11t656r248b734],
15	With	IN	O	with	_	0	SENT_77	[p5l280t655r476b734],
16	non	JJ	O	non	amod	22	SENT_77	[p5l510t655r1156b734],
17	—	JJ	O	—	amod	22	SENT_77	[p5l510t655r1156b734],
18	small	JJ	O	small	amod	22	SENT_77	[p5l510t655r1156b734],
19	—	NN	O	—	nn	22	SENT_77	[p5l510t655r1156b734],
20	cell	NN	O	cell	nn	22	SENT_77	[p5l510t655r1156b734],
21	lung	NN	O	lung	nn	22	SENT_77	[p5l1188t655r1383b756],
22	cancer	NN	O	cancer	prep_with	14	SENT_77	[p5l1414t681r1697b733],
23	were	VBD	O	be	auxpass	24	SENT_77	[p5l1723t681r1926b734],
24	analyzed	VBN	O	analyze	rcmod	4	SENT_77	[p5l1960t681r2144b733, p5l9t782r244b882],
25	:	:	O	:	_	0	SENT_77	[p5l1960t681r2144b733, p5l9t782r244b882],
26	2060	CD	DATE	2060	num	27	SENT_77	[p5l272t788r473b861],
27	paraff1n	NN	O	paraff1n	dep	4	SENT_77	[p5l495t781r1306b882],
28	—	CD	NUMBER	—	num	30	SENT_77	[p5l495t781r1306b882],
29	embedded	JJ	O	embedded	amod	30	SENT_77	[p5l495t781r1306b882],
30	tissues	NNS	O	tissue	dep	27	SENT_77	[p5l1330t783r1607b862],
31	and	CC	O	and	_	0	SENT_77	[p5l1631t782r1786b861],
32	45	CD	NUMBER	45	num	34	SENT_77	[p5l1807t788r1901b861],
33	fresh	JJ	O	fresh	amod	34	SENT_77	[p5l1928t781r2145b860],
34	specimens	NNS	O	specimen	conj_and	30	SENT_77	[p5l11t911r477b1010],
35	.	.	O	.	_	0	SENT_77	[p5l11t911r477b1010],

1	All	DT	O	all	det	2	SENT_78	[p5l511t910r634b988],
2	specimens	NNS	O	specimen	nsubjpass	4	SENT_78	[p5l666t911r1108b1010],
3	were	VBD	O	be	auxpass	4	SENT_78	[p5l1137t936r1337b990],
4	obtained	VBN	O	obtain	_	0	SENT_78	[p5l1369t910r1742b989],
5	from	IN	O	from	_	0	SENT_78	[p5l1773t909r1981b989],
6	the	DT	O	the	det	8	SENT_78	[p5l2013t910r2146b988],
7	original	JJ	O	original	amod	8	SENT_78	[p5l11t1039r359b1141],
8	biopsy	NN	O	biopsy	prep_from	4	SENT_78	[p5l398t1039r698b1140],
9	,	,	O	,	_	0	SENT_78	[p5l398t1039r698b1140],
10	before	IN	O	before	_	0	SENT_78	[p5l743t1038r1019b1119],
11	any	DT	O	any	det	12	SENT_78	[p5l1057t1065r1211b1140],
12	treatment	NN	O	treatment	prep_before	4	SENT_78	[p5l1245t1056r1702b1119],
13	.	.	O	.	_	0	SENT_78	[p5l1245t1056r1702b1119],

1	Genomic	JJ	O	genomic	amod	2	SENT_79	[p5l1747t1040r2147b1119],
2	DNA	NN	O	dna	nsubjpass	4	SENT_79	[p5l8t1175r220b1247],
3	was	VBD	O	be	auxpass	4	SENT_79	[p5l255t1194r421b1247],
4	derived	VBN	O	derive	_	0	SENT_79	[p5l467t1168r784b1247],
5	from	IN	O	from	_	0	SENT_79	[p5l826t1167r1041b1247],
6	tumor	NN	O	tumor	nn	7	SENT_79	[p5l1083t1185r1357b1247],
7	tissue	NN	O	tissue	prep_from	4	SENT_79	[p5l1397t1169r1650b1247],
8	after	IN	O	after	_	0	SENT_79	[p5l1692t1167r1900b1246],
9	laser	NN	O	laser	nn	11	SENT_79	[p5l1939t1168r2149b1246],
10	capture	NN	O	capture	nn	11	SENT_79	[p5l11t1313r332b1396],
11	microdissection	NN	O	microdissection	prep_after	4	SENT_79	[p5l376t1296r1072b1375],
12	(	CD	NUMBER	(	num	16	SENT_79	[p5l1121t1296r1370b1387],
13	Palm	NNP	ORGANIZATION	Palm	nn	16	SENT_79	[p5l1121t1296r1370b1387],
14	Microlaser	NNP	ORGANIZATION	Microlaser	nn	16	SENT_79	[p5l1411t1296r1873b1375],
15	Technologies	NNPS	ORGANIZATION	Technologies	nn	16	SENT_79	[p5l1910t1296r2144b1375, p5l10t1425r424b1526],
16	)	NN	O	)	dep	11	SENT_79	[p5l1910t1296r2144b1375, p5l10t1425r424b1526],
17	.	.	O	.	_	0	SENT_79	[p5l1910t1296r2144b1375, p5l10t1425r424b1526],

1	Baseline	NN	O	baseline	nn	3	SENT_80	[p5l466t1425r828b1504],
2	blood	NN	O	blood	nn	3	SENT_80	[p5l866t1425r1111b1504],
3	samples	NNS	O	sample	nsubj	5	SENT_80	[p5l1150t1425r1496b1525],
4	Were	VBD	O	be	cop	5	SENT_80	[p5l1531t1451r1735b1504],
5	available	JJ	O	available	_	0	SENT_80	[p5l1772t1425r2145b1504],
6	from	IN	O	from	_	0	SENT_80	[p5l10t1551r222b1631],
7	164	CD	NUMBER	164	num	8	SENT_80	[p5l262t1558r411b1631],
8	patients	NNS	O	patient	prep_from	5	SENT_80	[p5l446t1553r815b1652],
9	.	.	O	.	_	0	SENT_80	[p5l446t1553r815b1652],

1	DNA	NN	O	dna	_	0	SENT_81	[p5l856t1559r1065b1632],
2	from	IN	O	from	dep	1	SENT_81	[p5l1099t1551r1310b1631],
3	serum	NN	O	serum	pobj	2	SENT_81	[p5l1348t1578r1642b1648],
4	,	,	O	,	_	0	SENT_81	[p5l1348t1578r1642b1648],
5	plasma	NN	O	plasma	appos	3	SENT_81	[p5l1682t1552r2017b1652],
6	,	,	O	,	_	0	SENT_81	[p5l1682t1552r2017b1652],
7	or	CC	O	or	advmod	3	SENT_81	[p5l2060t1578r2149b1631],

1	MBER3	CD	NUMBER	mber3	_	0	SENT_82	[p5l1068t1737r1153b1759],
2	2009	CD	DATE	2009	num	3	SENT_82	[p5l1172t1737r1236b1758],
3	959	CD	NUMBER	959	dep	1	SENT_82	[p5l1959t1727r2016b1750],

1	GLJ	NN	O	glj	nn	2	SENT_83	[p5l600t1737r644b1759],
2	MED361	NN	O	med361	_	0	SENT_83	[p5l659t1731r799b1759],
3	;	:	O	;	_	0	SENT_83	[p5l659t1731r799b1759],
4	1o	NN	O	1o	nn	5	SENT_83	[p5l659t1731r799b1759],
5	NEjM.ORG	NN	O	nejm.org	dep	2	SENT_83	[p5l834t1737r958b1759],
6	,	,	O	,	_	0	SENT_83	[p5l1156t1749r1160b1757],

1	The	DT	O	the	det	4	SENT_84	[p5l702t1770r753b1794],
2	New	NNP	O	New	nn	4	SENT_84	[p5l762t1771r824b1794],
3	England	NNP	O	England	nn	4	SENT_84	[p5l833t1770r944b1801],
4	Journal	NNP	O	Journal	_	0	SENT_84	[p5l952t1770r1050b1794],
5	of	IN	O	of	_	0	SENT_84	[p5l1059t1770r1088b1794],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_84	[p5l1095t1770r1220b1794],

1	Th	NN	O	th	npadvmod	19	SENT_85	[p5l673t1958r704b1979],
2	e	SYM	O	e	dep	11	SENT_85	[p5l711t1965r719b1979],
3	N	NN	O	n	nn	11	SENT_85	[p5l737t1960r761b1979],
4	E	NN	O	e	nn	11	SENT_85	[p5l769t1960r786b1979],
5	W	NN	O	w	nn	11	SENT_85	[p5l792t1960r822b1979],
6	E	NN	O	e	nn	11	SENT_85	[p5l841t1960r858b1979],
7	N	NN	O	n	nn	11	SENT_85	[p5l866t1960r890b1979],
8	G	NN	O	g	nn	11	SENT_85	[p5l897t1960r919b1979],
9	L	NN	O	l	nn	11	SENT_85	[p5l926t1960r942b1979],
10	A	NN	O	a	nn	11	SENT_85	[p5l948t1960r969b1979],
11	ND	NN	O	nd	dep	1	SENT_85	[p5l976t1960r1061b1986],
12	]	CD	NUMBER	]	num	13	SENT_85	[p5l976t1960r1061b1986],
13	O	NN	O	o	dep	11	SENT_85	[p5l1068t1960r1089b1979],
14	U	NNP	O	U	nn	18	SENT_85	[p5l1096t1960r1118b1979],
15	R	NNP	O	R	nn	18	SENT_85	[p5l1126t1960r1147b1979],
16	N	NNP	O	N	nn	18	SENT_85	[p5l1155t1960r1178b1979],
17	A	NNP	O	A	nn	18	SENT_85	[p5l1184t1960r1204b1979],
18	L	NN	O	l	dep	13	SENT_85	[p5l1212t1960r1228b1979],
19	of	IN	O	of	dep	23	SENT_85	[p5l1248t1958r1276b1985],
20	M	NN	O	m	nn	22	SENT_85	[p5l1288t1960r1315b1979],
21	E	NN	O	e	nn	22	SENT_85	[p5l1323t1960r1340b1979],
22	D	NN	O	d	pobj	19	SENT_85	[p5l1348t1960r1369b1979],
23	I	PRP	O	I	_	0	SENT_85	[p5l1377t1960r1387b1979],
24	C	NN	O	c	prep	23	SENT_85	[p5l1394t1960r1412b1979],
25	I	PRP	O	I	dep	26	SENT_85	[p5l1419t1960r1430b1979],
26	NE	NNS	O	ne	dep	24	SENT_85	[p5l1438t1960r1487b1979],

1	both	DT	O	both	nsubjpass	3	SENT_86	[p5l12t2181r203b2260],
2	was	VBD	O	be	auxpass	3	SENT_86	[p5l226t2207r385b2261],
3	isolated	VBN	O	isolate	_	0	SENT_86	[p5l414t2181r733b2260],
4	with	IN	O	with	_	0	SENT_86	[p5l756t2181r945b2261],
5	the	DT	O	the	det	6	SENT_86	[p5l973t2181r1101b2259],
6	use	NN	O	use	prep_with	3	SENT_86	[p5l1129t2207r1265b2261],
7	of	IN	O	of	_	0	SENT_86	[p5l1293t2180r1391b2260],
8	the	DT	O	the	det	11	SENT_86	[p5l1400t2181r1529b2259],
9	QIAamp	NN	O	qiaamp	nn	11	SENT_86	[p5l1556t2187r1906b2281],
10	DNA	NN	O	dna	nn	11	SENT_86	[p5l1934t2188r2138b2261],
11	Blood	NN	O	blood	prep_of	6	SENT_86	[p5l11t2310r260b2389],
12	Mini	NNP	O	Mini	nn	13	SENT_86	[p5l293t2311r497b2389],
13	Kit	NN	O	kit	nsubjpass	3	SENT_86	[p5l532t2311r662b2391],
14	(	CD	NUMBER	(	num	13	SENT_86	[p5l698t2311r1078b2411],
15	Qiagen	NNP	ORGANIZATION	Qiagen	nn	16	SENT_86	[p5l698t2311r1078b2411],
16	)	NNP	O	)	dep	13	SENT_86	[p5l698t2311r1078b2411],
17	,	,	O	,	_	0	SENT_86	[p5l698t2311r1078b2411],
18	starting	VBG	O	start	partmod	3	SENT_86	[p5l1121t2311r1462b2411],
19	from	IN	O	from	_	0	SENT_86	[p5l1495t2309r1706b2389],
20	0.4	CD	NUMBER	0.4	num	21	SENT_86	[p5l1742t2316r1867b2389],
21	ml	NN	O	ml	prep_from	18	SENT_86	[p5l1903t2310r2016b2388],
22	of	IN	O	of	_	0	SENT_86	[p5l2053t2309r2152b2389],
23	material	NN	O	material	prep_of	21	SENT_86	[p5l12t2439r393b2518],
24	.	.	O	.	_	0	SENT_86	[p5l12t2439r393b2518],

1	For	IN	O	for	_	0	SENT_87	[p5l140t2574r278b2645],
2	tissue	NN	O	tissue	nn	3	SENT_87	[p5l305t2568r540b2646],
3	samples	NNS	O	sample	prep_for	14	SENT_87	[p5l572t2567r926b2666],
4	,	,	O	,	_	0	SENT_87	[p5l572t2567r926b2666],
5	deletions	NNS	O	deletion	nsubjpass	14	SENT_87	[p5l963t2567r1332b2645],
6	in	IN	O	in	_	0	SENT_87	[p5l1363t2568r1444b2644],
7	exon	NN	O	exon	prep_in	5	SENT_87	[p5l1475t2593r1668b2645],
8	19	CD	NUMBER	19	number	9	SENT_87	[p5l1702t2573r1795b2645],
9	(	CD	NUMBER	(	dep	7	SENT_87	[p5l1831t2567r1974b2657],
10	del	DT	O	del	det	12	SENT_87	[p5l1831t2567r1974b2657],
11	19	CD	NUMBER	19	num	12	SENT_87	[p5l2007t2573r2129b2657],
12	)	NN	O	)	dep	9	SENT_87	[p5l2007t2573r2129b2657],
13	were	VBD	O	be	auxpass	14	SENT_87	[p5l7t2721r212b2774],
14	determined	VBN	O	determine	_	0	SENT_87	[p5l260t2695r763b2774],
15	by	IN	O	by	_	0	SENT_87	[p5l810t2695r909b2795],
16	length	NN	O	length	nn	17	SENT_87	[p5l949t2695r1230b2796],
17	analysis	NN	O	analysis	agent	14	SENT_87	[p5l1276t2695r1622b2795],
18	after	IN	O	after	mark	35	SENT_87	[p5l1671t2694r1877b2773],
19	polymerase	NN	O	polymerase	nn	21	SENT_87	[p5l1918t2695r2133b2795, p5l12t2822r978b2901],
20	—	NN	O	—	nn	21	SENT_87	[p5l1918t2695r2133b2795, p5l12t2822r978b2901],
21	chain	NN	O	chain	nsubj	35	SENT_87	[p5l1918t2695r2133b2795, p5l12t2822r978b2901],
22	—	CD	NUMBER	—	num	23	SENT_87	[p5l1918t2695r2133b2795, p5l12t2822r978b2901],
23	reaction	NN	O	reaction	dep	21	SENT_87	[p5l1918t2695r2133b2795, p5l12t2822r978b2901],
24	(	CD	NUMBER	(	num	27	SENT_87	[p5l1026t2828r1269b2913],
25	PCR	NN	O	pcr	nn	27	SENT_87	[p5l1026t2828r1269b2913],
26	)	NN	O	)	nn	27	SENT_87	[p5l1026t2828r1269b2913],
27	amplification	NN	O	amplification	dep	21	SENT_87	[p5l1316t2821r1901b2922],
28	with	IN	O	with	_	0	SENT_87	[p5l1939t2822r2134b2902],
29	the	DT	O	the	det	30	SENT_87	[p5l12t2950r145b3028],
30	use	NN	O	use	prep_with	27	SENT_87	[p5l179t2976r320b3030],
31	of	IN	O	of	_	0	SENT_87	[p5l355t2949r455b3029],
32	a	DT	O	a	det	33	SENT_87	[p5l470t2976r514b3028],
33	FAM	NN	O	fam	prep_of	30	SENT_87	[p5l545t2950r1085b3029],
34	—	CD	NUMBER	—	num	33	SENT_87	[p5l545t2950r1085b3029],
35	labeled	VBN	O	label	advcl	14	SENT_87	[p5l545t2950r1085b3029],
36	primer	NN	O	primer	dobj	35	SENT_87	[p5l1118t2951r1412b3050],
37	in	IN	O	in	_	0	SENT_87	[p5l1443t2951r1527b3028],
38	an	DT	O	a	det	43	SENT_87	[p5l1560t2976r1662b3028],
39	ABI	NNP	MISC	ABI	nn	43	SENT_87	[p5l1693t2957r1853b3028],
40	Prism	NNP	O	Prism	nn	43	SENT_87	[p5l1885t2951r2134b3028],
41	3130	CD	NUMBER	3130	num	43	SENT_87	[p5l13t3085r217b3158],
42	DNA	NN	O	dna	nn	43	SENT_87	[p5l256t3085r466b3158],
43	Analyzer	NN	O	analyzer	prep_in	36	SENT_87	[p5l499t3079r891b3178],
44	(	CD	NUMBER	(	num	47	SENT_87	[p5l932t3079r1296b3178],
45	Applied	NNP	O	Applied	nn	47	SENT_87	[p5l932t3079r1296b3178],
46	Biosystems	NNP	O	Biosystems	nn	47	SENT_87	[p5l1333t3080r1875b3178],
47	)	NN	O	)	dep	43	SENT_87	[p5l1333t3080r1875b3178],
48	.	.	O	.	_	0	SENT_87	[p5l1333t3080r1875b3178],

1	Exon	NN	O	exon	nsubj	27	SENT_88	[p5l1918t3086r2134b3157],
2	21	CD	NUMBER	21	num	4	SENT_88	[p5l12t3213r111b3284],
3	point	NN	O	point	nn	4	SENT_88	[p5l154t3208r385b3306],
4	mutations	NNS	O	mutation	nsubjpass	9	SENT_88	[p5l425t3208r858b3286],
5	in	IN	O	in	_	0	SENT_88	[p5l905t3208r988b3284],
6	codon	NN	O	codon	prep_in	4	SENT_88	[p5l1033t3207r1296b3285],
7	858	CD	NUMBER	858	num	6	SENT_88	[p5l1341t3213r1487b3285],
8	were	VBD	O	be	auxpass	9	SENT_88	[p5l1529t3233r1732b3286],
9	detected	VBN	O	detect	rcmod	1	SENT_88	[p5l1777t3207r2134b3285],
10	with	IN	O	with	_	0	SENT_88	[p5l7t3335r197b3413],
11	a	DT	O	a	det	13	SENT_88	[p5l225t3360r269b3412],
12	5	CD	NUMBER	5	num	13	SENT_88	[p5l299t3332r370b3413],
13	’	NN	O	’	prep_with	9	SENT_88	[p5l299t3332r370b3413],
14	nuclease	NN	O	nuclease	nn	20	SENT_88	[p5l401t3334r750b3413],
15	PCR	NN	O	pcr	nn	20	SENT_88	[p5l778t3341r966b3417],
16	assay	NN	O	assay	nn	20	SENT_88	[p5l983t3360r1202b3434],
17	(	CD	NUMBER	(	num	20	SENT_88	[p5l1232t3341r1599b3434],
18	TaqMan	NN	O	taqman	nn	20	SENT_88	[p5l1232t3341r1599b3434],
19	assay	NN	O	assay	nn	20	SENT_88	[p5l1627t3341r1865b3434],
20	)	NN	O	)	dobj	9	SENT_88	[p5l1627t3341r1865b3434],
21	using	VBG	O	use	partmod	20	SENT_88	[p5l1900t3336r2137b3435],
22	FAM	NN	O	fam	dobj	21	SENT_88	[p5l11t3470r211b3540],
23	and	CC	O	and	_	0	SENT_88	[p5l250t3462r410b3541],
24	VIC	NNP	O	VIC	nn	25	SENT_88	[p5l444t3468r602b3541],
25	MGB	NNP	O	MGB	nsubj	26	SENT_88	[p5l639t3462r1210b3541],
26	—	VBD	O	—	conj_and	9	SENT_88	[p5l639t3462r1210b3541],
27	labeled	VBN	O	label	_	0	SENT_88	[p5l639t3462r1210b3541],
28	probes	NNS	O	probe	dobj	27	SENT_88	[p5l1246t3462r1540b3562],
29	for	IN	O	for	_	0	SENT_88	[p5l1580t3461r1705b3541],
30	the	DT	O	the	det	31	SENT_88	[p5l1740t3462r1876b3540],
31	wildtype	JJ	O	wildtype	prep_for	27	SENT_88	[p5l1909t3462r2133b3542, p5l12t3607r197b3690],
32	and	CC	O	and	_	0	SENT_88	[p5l237t3591r397b3669],
33	the	DT	O	the	det	35	SENT_88	[p5l439t3591r573b3669],
34	mutant	JJ	O	mutant	amod	35	SENT_88	[p5l614t3607r934b3670],
35	sequence	NN	O	sequence	prep_for	27	SENT_88	[p5l971t3617r1391b3690],
36	,	,	O	,	_	0	SENT_88	[p5l971t3617r1391b3690],
37	respectively	RB	O	respectively	advmod	27	SENT_88	[p5l1437t3591r1965b3690],
38	.	.	O	.	_	0	SENT_88	[p5l1437t3591r1965b3690],

1	All	DT	O	all	det	2	SENT_89	[p5l2007t3591r2135b3668],
2	mutants	NNS	O	mutant	nsubjpass	4	SENT_89	[p6l12t39r365b101],
3	were	VBD	O	be	auxpass	4	SENT_89	[p6l391t48r593b101],
4	confirmed	VBN	O	confirm	ccomp	18	SENT_89	[p6l623t21r1076b101],
5	by	IN	O	by	_	0	SENT_89	[p6l1106t22r1204b122],
6	DNA	NN	O	dna	nn	7	SENT_89	[p6l1227t29r1435b101],
7	sequencing	NN	O	sequencing	agent	4	SENT_89	[p6l1462t23r2135b123],
8	.17	CD	NUMBER	.17	npadvmod	9	SENT_89	[p6l1462t23r2135b123],
9	>	JJR	O	>	amod	7	SENT_89	[p6l1462t23r2135b123],
10	24	CD	NUMBER	24	dep	9	SENT_89	[p6l1462t23r2135b123],
11	For	IN	O	for	dep	10	SENT_89	[p6l11t157r150b228],
12	blood	NN	O	blood	nn	13	SENT_89	[p6l177t149r413b228],
13	samples	NNS	O	sample	pobj	11	SENT_89	[p6l444t149r803b249],
14	,	,	O	,	_	0	SENT_89	[p6l444t149r803b249],
15	both	DT	O	both	det	16	SENT_89	[p6l838t149r1031b228],
16	reactions	NNS	O	reaction	nsubjpass	18	SENT_89	[p6l1060t150r1438b228],
17	were	VBD	O	be	auxpass	18	SENT_89	[p6l1465t175r1662b229],
18	performed	VBN	O	perform	_	0	SENT_89	[p6l1690t148r2134b249],
19	in	IN	O	in	_	0	SENT_89	[p6l11t278r93b355],
20	the	DT	O	the	det	21	SENT_89	[p6l141t277r272b355],
21	presence	NN	O	presence	prep_in	18	SENT_89	[p6l318t303r686b377],
22	of	IN	O	of	_	0	SENT_89	[p6l734t276r834b356],
23	a	DT	O	a	det	26	SENT_89	[p6l864t303r909b355],
24	protein	NN	O	protein	nn	26	SENT_89	[p6l955t278r1266b377],
25	nucleic	JJ	O	nucleic	amod	26	SENT_89	[p6l1316t277r1614b357],
26	acid	NN	O	acid	prep_of	21	SENT_89	[p6l1662t277r1832b356],
27	(	CD	NUMBER	(	num	28	SENT_89	[p6l1886t284r2129b368],
28	PNA	NN	ORGANIZATION	pna	dobj	18	SENT_89	[p6l1886t284r2129b368],
29	)	JJ	O	)	amod	30	SENT_89	[p6l1886t284r2129b368],
30	clamp	NN	O	clamp	dep	28	SENT_89	[p6l12t406r295b506],
31	,	,	O	,	_	0	SENT_89	[p6l12t406r295b506],
32	designed	VBN	O	design	partmod	28	SENT_89	[p6l349t406r731b507],
33	to	TO	O	to	aux	34	SENT_89	[p6l778t423r860b485],
34	inhibit	VB	O	inhibit	xcomp	32	SENT_89	[p6l908t406r1198b485],
35	the	DT	O	the	det	36	SENT_89	[p6l1241t406r1373b484],
36	amplification	NN	O	amplification	dobj	34	SENT_89	[p6l1421t405r2004b506],
37	of	IN	O	of	_	0	SENT_89	[p6l2053t405r2152b485],
38	the	DT	O	the	det	40	SENT_89	[p6l12t534r143b612],
39	wild-type	JJ	O	wild-type	amod	40	SENT_89	[p6l175t534r571b633],
40	allele	NN	O	allele	prep_of	36	SENT_89	[p6l607t534r845b612],
41	.	.	O	.	_	0	SENT_89	[p6l607t534r845b612],

1	For	IN	O	for	_	0	SENT_90	[p6l886t541r1026b612],
2	L858R	NN	O	l858r	prep_for	12	SENT_90	[p6l1058t540r1333b617],
3	in	IN	O	in	_	0	SENT_90	[p6l1359t535r1441b611],
4	exon	NN	O	exon	prep_in	2	SENT_90	[p6l1479t560r1675b612],
5	21	CD	NUMBER	21	num	4	SENT_90	[p6l1711t540r1831b629],
6	,	,	O	,	_	0	SENT_90	[p6l1711t540r1831b629],
7	a	DT	O	a	det	9	SENT_90	[p6l1872t560r1916b612],
8	PNA	NN	ORGANIZATION	pna	nn	9	SENT_90	[p6l1951t540r2137b613],
9	clamp	NN	O	clamp	nsubjpass	12	SENT_90	[p6l12t662r278b761],
10	was	VBD	O	be	auxpass	12	SENT_90	[p6l325t688r491b741],
11	also	RB	O	also	advmod	12	SENT_90	[p6l543t661r719b740],
12	added	VBN	O	add	_	0	SENT_90	[p6l770t661r1030b740],
13	to	TO	O	to	_	0	SENT_90	[p6l1080t678r1163b740],
14	the	DT	O	the	det	16	SENT_90	[p6l1215t661r1350b740],
15	5	CD	NUMBER	5	num	16	SENT_90	[p6l1404t659r1477b740],
16	’	NN	O	’	prep_to	12	SENT_90	[p6l1404t659r1477b740],
17	nuclease	NN	O	nuclease	nn	23	SENT_90	[p6l1530t662r1902b741],
18	PCR	NN	O	pcr	nn	23	SENT_90	[p6l1952t668r2145b745],
19	reaction	NN	O	reaction	nn	23	SENT_90	[p6l12t791r367b868],
20	(	CD	NUMBER	(	num	23	SENT_90	[p6l415t796r802b889],
21	TaqMan	NN	O	taqman	nn	23	SENT_90	[p6l415t796r802b889],
22	assay	NN	O	assay	nn	23	SENT_90	[p6l844t796r1111b889],
23	)	NN	O	)	dep	16	SENT_90	[p6l844t796r1111b889],
24	.	.	O	.	_	0	SENT_90	[p6l844t796r1111b889],

1	(	NN	O	(	_	0	SENT_91	[p6l1160t796r1329b880],
2	For	IN	O	for	dep	1	SENT_91	[p6l1160t796r1329b880],
3	additional	JJ	O	additional	amod	4	SENT_91	[p6l1364t790r1791b868],
4	details	NNS	O	detail	pobj	2	SENT_91	[p6l1830t790r2129b885],
5	,	,	O	,	_	0	SENT_91	[p6l1830t790r2129b885],
6	see	VBP	O	see	dep	4	SENT_91	[p6l13t944r141b996],
7	the	DT	O	the	det	11	SENT_91	[p6l179t918r310b996],
8	Supplementary	NNP	O	Supplementary	nn	11	SENT_91	[p6l350t918r990b1017],
9	Appendix	NNP	O	Appendix	nn	11	SENT_91	[p6l1021t918r1488b1017],
10	.	.	O	.	_	0	SENT_91	[p6l1021t918r1488b1017],
11	)	NN	O	)	dobj	6	SENT_91	[p6l1021t918r1488b1017],

1	STU	NNP	O	STU	nn	4	SENT_92	[p6l12t1192r154b1242],
2	DY	NNP	O	DY	nn	4	SENT_92	[p6l173t1193r268b1241],
3	OVERSIGHT	NNP	O	OVERSIGHT	nn	4	SENT_92	[p6l300t1192r761b1242],
4	None	NN	O	none	nsubjpass	10	SENT_92	[p6l9t1299r234b1370],
5	of	IN	O	of	_	0	SENT_92	[p6l266t1290r364b1370],
6	the	DT	O	the	det	8	SENT_92	[p6l377t1291r507b1370],
7	funding	NN	O	funding	nn	8	SENT_92	[p6l537t1290r878b1392],
8	agencies	NNS	O	agency	prep_of	4	SENT_92	[p6l905t1292r1259b1392],
9	were	VBD	O	be	auxpass	10	SENT_92	[p6l1287t1317r1485b1370],
10	involved	VBN	O	involve	_	0	SENT_92	[p6l1515t1291r1859b1370],
11	in	IN	O	in	_	0	SENT_92	[p6l1889t1292r1971b1369],
12	the	DT	O	the	det	13	SENT_92	[p6l2001t1291r2134b1369],
13	study	NN	O	study	poss	15	SENT_92	[p6l13t1419r309b1519],
14	’s	POS	O	’s	_	0	SENT_92	[p6l13t1419r309b1519],
15	design	NN	O	design	prep_in	10	SENT_92	[p6l350t1419r637b1520],
16	or	CC	O	or	_	0	SENT_92	[p6l675t1445r764b1498],
17	conduct	NN	O	conduct	conj_or	15	SENT_92	[p6l800t1419r1171b1515],
18	,	,	O	,	_	0	SENT_92	[p6l800t1419r1171b1515],
19	data	NNS	O	datum	nn	20	SENT_92	[p6l1215t1419r1401b1498],
20	management	NN	O	management	conj_or	17	SENT_92	[p6l1437t1436r2014b1520],
21	or	CC	O	or	_	0	SENT_92	[p6l2047t1445r2137b1498],
22	analysis	NN	O	analysis	conj_or	17	SENT_92	[p6l11t1547r367b1646],
23	,	,	O	,	_	0	SENT_92	[p6l11t1547r367b1646],
24	manuscript	NN	O	manuscript	nn	25	SENT_92	[p6l405t1548r888b1646],
25	preparation	NN	O	preparation	conj_or	15	SENT_92	[p6l915t1548r1407b1646],
26	or	CC	O	or	_	0	SENT_92	[p6l1440t1573r1528b1625],
27	review	NN	O	review	conj_or	17	SENT_92	[p6l1557t1548r1844b1642],
28	,	,	O	,	_	0	SENT_92	[p6l1557t1548r1844b1642],
29	or	CC	O	or	_	0	SENT_92	[p6l1884t1573r1971b1625],
30	the	DT	O	the	det	31	SENT_92	[p6l2001t1547r2134b1625],
31	decision	NN	O	decision	conj_or	17	SENT_92	[p6l12t1674r357b1753],
32	to	TO	O	to	aux	33	SENT_92	[p6l386t1691r466b1753],
33	submit	VB	O	submit	xcomp	10	SENT_92	[p6l498t1674r791b1754],
34	the	DT	O	the	det	35	SENT_92	[p6l815t1674r946b1752],
35	manuscript	NN	O	manuscript	dobj	33	SENT_92	[p6l974t1675r1457b1774],
36	for	IN	O	for	_	0	SENT_92	[p6l1480t1673r1601b1753],
37	publication	NN	O	publication	prep_for	35	SENT_92	[p6l1626t1674r2129b1774],
38	.	.	O	.	_	0	SENT_92	[p6l1626t1674r2129b1774],

1	The	DT	O	the	det	2	SENT_93	[p6l8t1803r169b1881],
2	erlotinib	NN	O	erlotinib	nsubjpass	10	SENT_93	[p6l208t1803r566b1881],
3	that	WDT	O	that	nsubjpass	5	SENT_93	[p6l603t1803r772b1881],
4	was	VBD	O	be	auxpass	5	SENT_93	[p6l798t1829r958b1882],
5	used	VBN	O	use	rcmod	2	SENT_93	[p6l996t1803r1189b1882],
6	in	IN	O	in	_	0	SENT_93	[p6l1224t1804r1306b1880],
7	the	DT	O	the	det	8	SENT_93	[p6l1342t1803r1472b1881],
8	study	NN	O	study	prep_in	5	SENT_93	[p6l1509t1803r1734b1902],
9	was	VBD	O	be	auxpass	10	SENT_93	[p6l1761t1829r1922b1882],
10	purchased	VBN	O	purchase	_	0	SENT_93	[p6l1958t1829r2133b1902, p6l12t1930r305b2009],
11	from	IN	O	from	_	0	SENT_93	[p6l364t1929r574b2009],
12	the	DT	O	the	det	13	SENT_93	[p6l633t1930r766b2008],
13	manufacturer	NN	O	manufacturer	prep_from	10	SENT_93	[p6l824t1929r1432b2026],
14	,	,	O	,	_	0	SENT_93	[p6l824t1929r1432b2026],
15	which	WDT	O	which	nsubj	16	SENT_93	[p6l1491t1930r1754b2009],
16	had	VBD	O	have	rcmod	13	SENT_93	[p6l1813t1930r1969b2009],
17	no	DT	O	no	det	18	SENT_93	[p6l2027t1956r2133b2009],
18	role	NN	O	role	dobj	16	SENT_93	[p6l12t2059r171b2137],
19	in	IN	O	in	_	0	SENT_93	[p6l205t2060r289b2136],
20	the	DT	O	the	det	21	SENT_93	[p6l324t2059r457b2137],
21	study	NN	O	study	prep_in	18	SENT_93	[p6l493t2059r736b2158],
22	.	.	O	.	_	0	SENT_93	[p6l493t2059r736b2158],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_94	[p6l12t2333r501b2383],
2	ANALYSIS	NN	O	analysis	nsubj	30	SENT_94	[p6l531t2333r906b2383],
3	Approximately	RB	O	approximately	quantmod	4	SENT_94	[p6l8t2432r645b2532],
4	18,800	CD	NUMBER	18,800	num	6	SENT_94	[p6l687t2438r971b2528],
5	new	JJ	O	new	amod	6	SENT_94	[p6l1014t2458r1192b2511],
6	cases	NNS	O	case	nsubjpass	11	SENT_94	[p6l1231t2458r1453b2510],
7	of	IN	O	of	_	0	SENT_94	[p6l1499t2431r1599b2511],
8	lung	NN	O	lung	nn	9	SENT_94	[p6l1623t2432r1816b2533],
9	cancer	NN	O	cancer	prep_of	6	SENT_94	[p6l1856t2458r2137b2511],
10	are	VBP	O	be	auxpass	11	SENT_94	[p6l11t2586r140b2638],
11	diagnosed	VBN	O	diagnose	rcmod	2	SENT_94	[p6l170t2560r613b2661],
12	per	IN	O	per	_	0	SENT_94	[p6l641t2586r781b2660],
13	year	NN	DURATION	year	prep_per	11	SENT_94	[p6l802t2586r982b2660],
14	in	IN	O	in	_	0	SENT_94	[p6l1007t2561r1091b2638],
15	Spain	NNP	LOCATION	Spain	prep_in	13	SENT_94	[p6l1121t2561r1459b2660],
16	.25	CD	NUMBER	.25	num	15	SENT_94	[p6l1121t2561r1459b2660],
17	On	IN	O	on	_	0	SENT_94	[p6l1491t2566r1618b2639],
18	the	DT	O	the	det	19	SENT_94	[p6l1647t2560r1780b2639],
19	basis	NN	O	basis	prep_on	30	SENT_94	[p6l1810t2560r2021b2639],
20	of	IN	O	of	_	0	SENT_94	[p6l2053t2559r2152b2639],
21	our	PRP$	O	we	poss	27	SENT_94	[p6l12t2714r158b2767],
22	preliminary	JJ	O	preliminary	amod	27	SENT_94	[p6l189t2688r704b2787],
23	study	NN	O	study	nn	27	SENT_94	[p6l735t2688r965b2787],
24	(	CD	NUMBER	(	num	27	SENT_94	[p6l1000t2688r1558b2787],
25	unpublished	JJ	O	unpublished	amod	27	SENT_94	[p6l1000t2688r1558b2787],
26	data	NNS	O	datum	nn	27	SENT_94	[p6l1593t2688r1826b2783],
27	)	NN	O	)	prep_of	19	SENT_94	[p6l1593t2688r1826b2783],
28	,	,	O	,	_	0	SENT_94	[p6l1593t2688r1826b2783],
29	we	PRP	O	we	appos	27	SENT_94	[p6l1862t2714r1980b2767],
30	expected	VBD	O	expect	_	0	SENT_94	[p6l2016t2714r2133b2766, p6l11t2815r282b2915],
31	approximately	RB	O	approximately	quantmod	33	SENT_94	[p6l305t2815r895b2915],
32	15	CD	NUMBER	15	number	33	SENT_94	[p6l917t2820r1096b2894],
33	°	CD	NUMBER	°	dobj	30	SENT_94	[p6l917t2820r1096b2894],
34	/	:	O	/	punct	35	SENT_94	[p6l917t2820r1096b2894],
35	o	NN	O	o	dep	33	SENT_94	[p6l917t2820r1096b2894],
36	of	IN	O	of	_	0	SENT_94	[p6l1119t2814r1217b2894],
37	these	DT	O	these	det	38	SENT_94	[p6l1223t2815r1438b2893],
38	patients	NNS	O	patient	prep_of	35	SENT_94	[p6l1459t2816r1786b2915],
39	to	TO	O	to	aux	40	SENT_94	[p6l1813t2832r1892b2894],
40	carry	VB	O	carry	xcomp	30	SENT_94	[p6l1917t2841r2139b2915],
41	EGFR	NN	ORGANIZATION	egfr	nn	42	SENT_94	[p6l10t2951r222b3024],
42	mutations	NNS	O	mutation	dobj	40	SENT_94	[p6l254t2945r713b3023],
43	.	.	O	.	_	0	SENT_94	[p6l254t2945r713b3023],

1	With	IN	O	with	_	0	SENT_95	[p6l753t2944r967b3022],
2	an	DT	O	a	det	5	SENT_95	[p6l1004t2970r1106b3022],
3	estimated	VBN	O	estimate	amod	5	SENT_95	[p6l1146t2944r1567b3023],
4	error	NN	O	error	nn	5	SENT_95	[p6l1606t2970r1818b3023],
5	rate	NN	O	rate	prep_with	11	SENT_95	[p6l1854t2961r2013b3022],
6	of	IN	O	of	_	0	SENT_95	[p6l2053t2943r2152b3023],
7	5	CD	PERCENT	5	num	8	SENT_95	[p6l14t3077r168b3167],
8	%	NN	PERCENT	%	prep_of	5	SENT_95	[p6l14t3077r168b3167],
9	,	,	O	,	_	0	SENT_95	[p6l14t3077r168b3167],
10	we	PRP	O	we	nsubj	11	SENT_95	[p6l204t3098r322b3151],
11	calculated	VBD	O	calculate	_	0	SENT_95	[p6l357t3072r792b3151],
12	that	IN	O	that	complm	16	SENT_95	[p6l826t3072r999b3150],
13	2105	CD	NUMBER	2105	num	14	SENT_95	[p6l1027t3078r1224b3150],
14	patients	NNS	O	patient	nsubj	16	SENT_95	[p6l1260t3073r1601b3171],
15	would	MD	O	would	aux	16	SENT_95	[p6l1633t3072r1899b3151],
16	need	VB	O	need	ccomp	11	SENT_95	[p6l1933t3072r2134b3150],
17	to	TO	O	to	aux	19	SENT_95	[p6l12t3217r94b3279],
18	be	VB	O	be	auxpass	19	SENT_95	[p6l129t3200r225b3279],
19	enrolled	VBN	O	enrol	xcomp	16	SENT_95	[p6l260t3200r611b3279],
20	during	IN	O	during	_	0	SENT_95	[p6l645t3200r934b3301],
21	a	DT	O	a	det	23	SENT_95	[p6l964t3226r1008b3278],
22	3-year	JJ	DURATION	3-year	amod	23	SENT_95	[p6l1041t3206r1302b3300],
23	period	NN	O	period	prep_during	19	SENT_95	[p6l1331t3200r1608b3300],
24	for	IN	O	for	_	0	SENT_95	[p6l1641t3199r1765b3279],
25	a	DT	O	a	det	26	SENT_95	[p6l1795t3226r1839b3278],
26	power	NN	O	power	prep_for	23	SENT_95	[p6l1870t3226r2138b3300],
27	of	IN	O	of	_	0	SENT_95	[p6l12t3326r113b3406],
28	80	CD	PERCENT	80	num	29	SENT_95	[p6l124t3332r335b3406],
29	%	NN	PERCENT	%	prep_of	26	SENT_95	[p6l124t3332r335b3406],
30	.	.	O	.	_	0	SENT_95	[p6l124t3332r335b3406],

1	We	PRP	O	we	nsubj	3	SENT_96	[p6l366t3335r499b3405],
2	randomly	RB	O	randomly	advmod	3	SENT_96	[p6l528t3327r942b3427],
3	chose	VBD	O	choose	_	0	SENT_96	[p6l968t3327r1209b3406],
4	100	CD	NUMBER	100	dobj	3	SENT_96	[p6l1241t3333r1389b3406],
5	of	IN	O	of	_	0	SENT_96	[p6l1419t3326r1519b3406],
6	the	DT	O	the	det	9	SENT_96	[p6l1530t3327r1663b3405],
7	879	CD	NUMBER	879	num	9	SENT_96	[p6l1693t3333r1841b3406],
8	public	JJ	O	public	amod	9	SENT_96	[p6l1869t3327r2134b3427],
9	hospitals	NNS	O	hospital	prep_of	4	SENT_96	[p6l12t3455r408b3555],
10	in	IN	O	in	_	0	SENT_96	[p6l449t3456r534b3533],
11	Spain	NNP	LOCATION	Spain	prep_in	9	SENT_96	[p6l576t3456r817b3555],
12	to	TO	O	to	aux	13	SENT_96	[p6l858t3472r941b3534],
13	contact	VB	O	contact	xcomp	3	SENT_96	[p6l982t3472r1305b3534],
14	with	IN	O	with	_	0	SENT_96	[p6l1334t3455r1533b3535],
15	a	DT	O	a	det	16	SENT_96	[p6l1573t3481r1617b3533],
16	request	NN	O	request	prep_with	13	SENT_96	[p6l1655t3472r1977b3555],
17	for	IN	O	for	_	0	SENT_96	[p6l2012t3454r2137b3534],
18	samples	NNS	O	sample	prep_for	16	SENT_96	[p6l13t3583r358b3683],
19	for	IN	O	for	_	0	SENT_96	[p6l400t3582r523b3662],
20	inclusion	NN	O	inclusion	prep_for	18	SENT_96	[p6l560t3583r953b3663],
21	in	IN	O	in	_	0	SENT_96	[p6l992t3584r1075b3661],
22	the	DT	O	the	det	23	SENT_96	[p6l1116t3583r1249b3661],
23	database	NN	O	database	prep_in	13	SENT_96	[p6l1290t3583r1689b3662],
24	.	.	O	.	_	0	SENT_96	[p6l1290t3583r1689b3662],

1	However	RB	O	however	_	0	SENT_97	[p6l1734t3591r2129b3679],
2	,	,	O	,	_	0	SENT_97	[p6l1734t3591r2129b3679],
3	because	IN	O	because	_	0	SENT_97	[p6l12t3712r349b3791],
4	of	IN	O	of	_	0	SENT_97	[p6l383t3711r483b3791],
5	extensive	JJ	O	extensive	amod	7	SENT_97	[p6l499t3713r887b3791],
6	media	NNS	O	media	nn	7	SENT_97	[p6l920t3712r1185b3791],
7	coverage	NN	O	coverage	prep_because_of	1	SENT_97	[p6l1218t3738r1587b3813],
8	of	IN	O	of	_	0	SENT_97	[p6l1622t3711r1722b3791],
9	this	DT	O	this	det	10	SENT_97	[p6l1738t3712r1897b3790],
10	project	NN	O	project	prep_of	7	SENT_97	[p6l1931t3713r2133b3812, p7l12t39r157b118],
11	,	,	O	,	_	0	SENT_97	[p6l1931t3713r2133b3812, p7l12t39r157b118],

1	other	JJ	O	other	amod	2	SENT_98	[p7l207t23r434b101],
2	centers	NNS	O	center	nsubj	3	SENT_98	[p7l476t40r779b101],
3	requested	VBD	O	request	_	0	SENT_98	[p7l825t23r1239b122],
4	permission	NN	O	permission	dobj	3	SENT_98	[p7l1282t24r1765b122],
5	to	TO	O	to	aux	6	SENT_98	[p7l1810t40r1891b101],
6	send	VB	O	send	xcomp	3	SENT_98	[p7l1938t23r2134b101],
7	samples	NNS	O	sample	dobj	6	SENT_98	[p7l13t150r358b250],
8	for	IN	O	for	_	0	SENT_98	[p7l398t149r520b229],
9	inclusion	NN	O	inclusion	prep_for	7	SENT_98	[p7l554t150r946b230],
10	in	IN	O	in	_	0	SENT_98	[p7l983t151r1066b228],
11	the	DT	O	the	det	12	SENT_98	[p7l1103t150r1236b228],
12	database	NN	O	database	prep_in	6	SENT_98	[p7l1275t150r1673b246],
13	,	,	O	,	_	0	SENT_98	[p7l1275t150r1673b246],
14	and	CC	O	and	_	0	SENT_98	[p7l1715t150r1872b229],
15	these	DT	O	these	det	16	SENT_98	[p7l1911t150r2134b228],
16	samples	NNS	O	sample	nsubjpass	19	SENT_98	[p7l13t279r358b378],
17	were	VBD	O	be	auxpass	19	SENT_98	[p7l385t305r586b358],
18	also	RB	O	also	advmod	19	SENT_98	[p7l614t279r786b357],
19	included	VBN	O	include	conj_and	3	SENT_98	[p7l815t279r1205b358],
20	.	.	O	.	_	0	SENT_98	[p7l815t279r1205b358],

1	All	DT	O	all	det	2	SENT_99	[p7l1236t279r1361b356],
2	centers	NNS	O	center	nsubj	3	SENT_99	[p7l1390t295r1693b357],
3	sent	VBD	O	send	_	0	SENT_99	[p7l1725t296r1901b357],
4	samples	NNS	O	sample	dobj	3	SENT_99	[p7l1926t305r2133b357, p7l11t407r178b507],
5	from	IN	O	from	_	0	SENT_99	[p7l217t406r428b486],
6	patients	NNS	O	patient	prep_from	3	SENT_99	[p7l465t408r806b507],
7	who	WP	O	who	nsubj	9	SENT_99	[p7l841t407r1025b486],
8	had	VBD	O	have	aux	9	SENT_99	[p7l1063t407r1220b486],
9	received	VBN	O	receive	rcmod	6	SENT_99	[p7l1258t407r1603b486],
10	a	DT	O	a	det	11	SENT_99	[p7l1640t433r1684b485],
11	diagnosis	NN	O	diagnosis	dobj	9	SENT_99	[p7l1721t407r2132b508],
12	of	IN	O	of	_	0	SENT_99	[p7l12t534r113b614],
13	lung	NN	O	lung	nn	14	SENT_99	[p7l131t535r324b636],
14	cancer	NN	O	cancer	prep_of	11	SENT_99	[p7l360t561r640b613],
15	in	IN	O	in	_	0	SENT_99	[p7l675t536r758b613],
16	a	DT	O	a	det	18	SENT_99	[p7l796t561r840b613],
17	nonconsecutive	JJ	O	nonconsecutive	amod	18	SENT_99	[p7l877t536r1541b614],
18	manner	NN	O	manner	prep_in	9	SENT_99	[p7l1579t561r1934b631],
19	,	,	O	,	_	0	SENT_99	[p7l1579t561r1934b631],
20	and	CC	O	and	_	0	SENT_99	[p7l1977t535r2135b614],
21	there	EX	O	there	expl	22	SENT_99	[p7l12t663r229b741],
22	was	VBD	O	be	conj_and	3	SENT_99	[p7l259t689r421b742],
23	no	DT	O	no	det	24	SENT_99	[p7l458t689r563b742],
24	stratification	NN	O	stratification	nsubj	22	SENT_99	[p7l600t662r1160b742],
25	according	VBG	O	accord	_	0	SENT_99	[p7l1194t663r1621b764],
26	to	TO	O	to	prepc_according_to	22	SENT_99	[p7l1652t680r1733b742],
27	sex	NN	O	sex	pobj	22	SENT_99	[p7l1770t689r1926b759],
28	,	,	O	,	_	0	SENT_99	[p7l1770t689r1926b759],
29	performance	NN	O	performance	nn	30	SENT_99	[p7l1965t689r2133b763, p7l12t790r429b870],
30	status	NN	O	status	conj_or	27	SENT_99	[p7l480t808r763b887],
31	,	,	O	,	_	0	SENT_99	[p7l480t808r763b887],
32	smoking	NN	O	smoking	nn	33	SENT_99	[p7l819t791r1202b892],
33	history	NN	O	history	conj_or	27	SENT_99	[p7l1248t791r1573b891],
34	,	,	O	,	_	0	SENT_99	[p7l1248t791r1573b891],
35	or	CC	O	or	_	0	SENT_99	[p7l1628t817r1718b870],
36	previous	JJ	O	previous	amod	37	SENT_99	[p7l1762t792r2132b891],
37	treatment	NN	O	treatment	conj_or	27	SENT_99	[p7l12t936r437b998],
38	.	.	O	.	_	0	SENT_99	[p7l12t936r437b998],

1	A	DT	O	a	det	2	SENT_100	[p7l469t927r535b997],
2	database	NN	O	database	nsubjpass	12	SENT_100	[p7l561t919r922b998],
3	and	CC	O	and	_	0	SENT_100	[p7l951t919r1105b998],
4	a	DT	O	a	det	8	SENT_100	[p7l1133t945r1177b997],
5	case	NN	O	case	nn	8	SENT_100	[p7l1206t919r1675b998],
6	—	CD	NUMBER	—	num	8	SENT_100	[p7l1206t919r1675b998],
7	record	NN	O	record	nn	8	SENT_100	[p7l1206t919r1675b998],
8	form	NN	O	form	conj_and	2	SENT_100	[p7l1704t918r1907b998],
9	Were	VBD	O	be	auxpass	10	SENT_100	[p7l1932t945r2134b998],
10	designed	VBN	O	design	_	0	SENT_100	[p7l12t1047r394b1148],
11	and	CC	O	and	_	0	SENT_100	[p7l429t1047r586b1126],
12	sent	VBN	O	send	conj_and	10	SENT_100	[p7l622t1064r799b1125],
13	to	TO	O	to	_	0	SENT_100	[p7l829t1064r910b1126],
14	all	DT	O	all	det	16	SENT_100	[p7l946t1047r1050b1125],
15	participating	VBG	O	participate	amod	16	SENT_100	[p7l1083t1048r1644b1148],
16	hospitals	NNS	O	hospital	prep_to	10	SENT_100	[p7l1675t1047r2088b1147],
17	.	.	O	.	_	0	SENT_100	[p7l1675t1047r2088b1147],

1	Progression	NN	O	progression	npadvmod	3	SENT_101	[p7l140t1174r864b1276],
2	—	CD	NUMBER	—	num	1	SENT_101	[p7l140t1174r864b1276],
3	free	JJ	O	free	amod	4	SENT_101	[p7l140t1174r864b1276],
4	survival	NN	O	survival	nsubjpass	16	SENT_101	[p7l901t1175r1240b1254],
5	was	VBD	O	be	auxpass	6	SENT_101	[p7l1271t1201r1435b1254],
6	defined	VBN	O	define	_	0	SENT_101	[p7l1474t1174r1807b1254],
7	as	IN	O	as	_	0	SENT_101	[p7l1841t1201r1928b1253],
8	survival	NN	O	survival	prep_as	6	SENT_101	[p7l1967t1201r2133b1254, p7l7t1303r202b1382],
9	Without	IN	O	without	_	0	SENT_101	[p7l248t1303r587b1382],
10	disease	NN	O	disease	nn	11	SENT_101	[p7l632t1303r942b1382],
11	progression	NN	O	progression	prep_without	6	SENT_101	[p7l991t1304r1502b1404],
12	or	CC	O	or	_	0	SENT_101	[p7l1553t1329r1643b1382],
13	death	NN	O	death	conj_or	11	SENT_101	[p7l1690t1303r1927b1382],
14	and	CC	O	and	_	0	SENT_101	[p7l1976t1303r2134b1382],
15	was	VBD	O	be	auxpass	16	SENT_101	[p7l7t1456r171b1510],
16	calculated	VBN	O	calculate	conj_and	6	SENT_101	[p7l205t1430r643b1510],
17	from	IN	O	from	_	0	SENT_101	[p7l674t1429r886b1509],
18	the	DT	O	the	det	19	SENT_101	[p7l918t1430r1052b1508],
19	start	NN	O	start	prep_from	16	SENT_101	[p7l1084t1447r1285b1508],
20	of	IN	O	of	_	0	SENT_101	[p7l1312t1429r1412b1509],
21	erlotinib	NN	O	erlotinib	nn	22	SENT_101	[p7l1426t1430r1795b1509],
22	therapy	NN	O	therapy	prep_of	19	SENT_101	[p7l1828t1430r2153b1530],
23	until	IN	O	until	_	0	SENT_101	[p7l12t1559r212b1639],
24	the	DT	O	the	det	26	SENT_101	[p7l247t1559r379b1638],
25	first	JJ	ORDINAL	first	amod	26	SENT_101	[p7l414t1558r595b1638],
26	observation	NN	O	observation	prep_until	16	SENT_101	[p7l626t1559r1120b1639],
27	of	IN	O	of	_	0	SENT_101	[p7l1156t1558r1255b1639],
28	disease	NN	O	disease	nn	29	SENT_101	[p7l1273t1559r1578b1639],
29	progression	NN	O	progression	prep_of	26	SENT_101	[p7l1613t1560r2143b1661],
30	.	.	O	.	_	0	SENT_101	[p7l1613t1560r2143b1661],

1	Survival	NN	O	survival	nsubjpass	3	SENT_102	[p7l14t1688r349b1767],
2	was	VBD	O	be	auxpass	3	SENT_102	[p7l377t1714r538b1767],
3	calculated	VBN	O	calculate	_	0	SENT_102	[p7l574t1688r1002b1767],
4	from	IN	O	from	_	0	SENT_102	[p7l1035t1687r1243b1767],
5	the	DT	O	the	det	6	SENT_102	[p7l1277t1688r1408b1766],
6	start	NN	O	start	prep_from	3	SENT_102	[p7l1443t1705r1639b1766],
7	of	IN	O	of	_	0	SENT_102	[p7l1667t1687r1766b1767],
8	erlotinib	NN	O	erlotinib	nn	9	SENT_102	[p7l1782t1688r2147b1767],
9	therapy	NN	O	therapy	prep_of	6	SENT_102	[p7l12t1815r330b1915],
10	until	IN	O	until	mark	15	SENT_102	[p7l358t1815r559b1895],
11	death	NN	O	death	nsubj	15	SENT_102	[p7l592t1815r826b1894],
12	or	CC	O	or	_	0	SENT_102	[p7l860t1841r948b1894],
13	the	DT	O	the	det	14	SENT_102	[p7l979t1815r1111b1893],
14	last	JJ	O	last	conj_or	11	SENT_102	[p7l1143t1815r1294b1893],
15	follow	VB	O	follow	advcl	3	SENT_102	[p7l1322t1814r1725b1915],
16	—	CD	NUMBER	—	dobj	15	SENT_102	[p7l1322t1814r1725b1915],
17	up	IN	O	up	_	0	SENT_102	[p7l1322t1814r1725b1915],
18	visit	NN	O	visit	prep_up	15	SENT_102	[p7l1754t1816r1950b1895],
19	.	.	O	.	_	0	SENT_102	[p7l1754t1816r1950b1895],

1	The	DT	O	the	det	2	SENT_103	[p7l1985t1815r2148b1893],
2	associations	NNS	O	association	nsubjpass	16	SENT_103	[p7l11t1945r528b2023],
3	between	IN	O	between	_	0	SENT_103	[p7l564t1944r917b2023],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_103	[p7l948t1950r1159b2024],
5	status	NN	O	status	prep_between	2	SENT_103	[p7l1187t1961r1458b2040],
6	,	,	O	,	_	0	SENT_103	[p7l1187t1961r1458b2040],
7	clinical	JJ	O	clinical	amod	8	SENT_103	[p7l1497t1944r1805b2022],
8	characteristics	NNS	O	characteristic	prep_between	2	SENT_103	[p7l1838t1944r2147b2022, p7l12t2074r386b2169],
9	,	,	O	,	_	0	SENT_103	[p7l1838t1944r2147b2022, p7l12t2074r386b2169],
10	and	CC	O	and	_	0	SENT_103	[p7l435t2073r597b2152],
11	tumor	NN	O	tumor	nn	12	SENT_103	[p7l640t2090r915b2152],
12	response	NN	O	response	conj_and	5	SENT_103	[p7l956t2099r1348b2173],
13	to	TO	O	to	_	0	SENT_103	[p7l1392t2090r1475b2152],
14	erlotinib	NN	O	erlotinib	prep_to	12	SENT_103	[p7l1521t2073r1900b2152],
15	Were	VBD	O	be	auxpass	16	SENT_103	[p7l1940t2099r2147b2153],
16	analyzed	VBN	O	analyze	_	0	SENT_103	[p7l11t2201r401b2301],
17	with	IN	O	with	_	0	SENT_103	[p7l439t2201r639b2281],
18	the	DT	O	the	det	19	SENT_103	[p7l683t2201r819b2279],
19	use	NN	O	use	prep_with	16	SENT_103	[p7l863t2227r1007b2281],
20	of	IN	O	of	_	0	SENT_103	[p7l1051t2200r1152b2280],
21	the	DT	O	the	det	25	SENT_103	[p7l1178t2201r1314b2279],
22	chi	NN	O	chus	nn	25	SENT_103	[p7l1358t2201r1818b2301],
23	—	NN	O	—	nn	25	SENT_103	[p7l1358t2201r1818b2301],
24	square	JJ	O	square	amod	25	SENT_103	[p7l1358t2201r1818b2301],
25	test	NN	O	test	prep_of	19	SENT_103	[p7l1863t2218r2022b2279],
26	or	CC	O	or	_	0	SENT_103	[p7l2061t2227r2151b2280],
27	Fisher	NNP	PERSON	Fisher	poss	30	SENT_103	[p7l11t2329r337b2407],
28	’s	POS	O	’s	_	0	SENT_103	[p7l11t2329r337b2407],
29	exact	JJ	O	exact	amod	30	SENT_103	[p7l378t2346r600b2407],
30	test	NN	O	test	conj_or	25	SENT_103	[p7l634t2346r809b2408],
31	.	.	O	.	_	0	SENT_103	[p7l634t2346r809b2408],

1	The	DT	O	the	det	2	SENT_104	[p7l849t2329r1012b2407],
2	normality	NN	O	normality	nsubjpass	7	SENT_104	[p7l1049t2329r1479b2429],
3	of	IN	O	of	_	0	SENT_104	[p7l1514t2328r1614b2408],
4	quantitative	JJ	O	quantitative	amod	5	SENT_104	[p7l1635t2330r2148b2429],
5	variables	NNS	O	variable	prep_of	2	SENT_104	[p7l7t2457r380b2537],
6	was	VBD	O	be	auxpass	7	SENT_104	[p7l415t2483r576b2537],
7	analyzed	VBN	O	analyze	_	0	SENT_104	[p7l614t2457r989b2557],
8	with	IN	O	with	_	0	SENT_104	[p7l1021t2457r1215b2537],
9	the	DT	O	the	det	10	SENT_104	[p7l1252t2457r1383b2535],
10	use	NN	O	use	prep_with	7	SENT_104	[p7l1421t2483r1560b2537],
11	of	IN	O	of	_	0	SENT_104	[p7l1598t2456r1697b2536],
12	the	DT	O	the	det	15	SENT_104	[p7l1716t2457r1848b2535],
13	Kolm	NNP	O	Kolm	nn	15	SENT_104	[p7l1884t2457r2147b2538],
14	—	NN	O	—	nn	15	SENT_104	[p7l1884t2457r2147b2538],
15	ogorov	NN	O	ogorov	prep_of	10	SENT_104	[p7l12t2587r733b2687],
16	.	.	O	.	_	0	SENT_104	[p7l12t2587r733b2687],

1	—	NN	O	—	_	0	SENT_105	[p7l12t2587r733b2687],
2	.	.	O	.	_	0	SENT_105	[p7l12t2587r733b2687],

1	Smirnov	NNP	PERSON	Smirnov	dep	2	SENT_106	[p7l12t2587r733b2687],
2	test	NN	O	test	nsubj	4	SENT_106	[p7l768t2603r922b2664],
3	and	CC	O	and	cc	2	SENT_106	[p7l955t2586r1114b2665],
4	compared	VBN	O	compare	_	0	SENT_106	[p7l1153t2586r1582b2686],
5	by	IN	O	by	_	0	SENT_106	[p7l1621t2586r1718b2686],
6	Student	NN	O	student	poss	11	SENT_106	[p7l1754t2586r2145b2665],
7	’s	POS	O	’s	_	0	SENT_106	[p7l1754t2586r2145b2665],
8	t	NN	O	t	nn	11	SENT_106	[p7l12t2730r228b2791],
9	—	CD	NUMBER	—	num	11	SENT_106	[p7l12t2730r228b2791],
10	test	NN	O	test	nn	11	SENT_106	[p7l12t2730r228b2791],
11	analysis	NN	O	analysis	prep_by	4	SENT_106	[p7l260t2713r602b2813],
12	of	IN	O	of	_	0	SENT_106	[p7l643t2712r743b2792],
13	variance	NN	O	variance	prep_of	11	SENT_106	[p7l759t2714r1120b2793],
14	or	CC	O	or	_	0	SENT_106	[p7l1159t2739r1248b2792],
15	Mann	NNP	PERSON	Mann	prep_of	11	SENT_106	[p7l1280t2713r1957b2813],
16	.	.	O	.	_	0	SENT_106	[p7l1280t2713r1957b2813],

1	—	NN	O	—	_	0	SENT_107	[p7l1280t2713r1957b2813],
2	.	.	O	.	_	0	SENT_107	[p7l1280t2713r1957b2813],

1	Whitney	NNP	PERSON	Whitney	_	0	SENT_108	[p7l1280t2713r1957b2813],
2	and	CC	O	and	_	0	SENT_108	[p7l1989t2713r2148b2792],
3	Krusl	NNP	O	Krusl	conj_and	1	SENT_108	[p7l11t2842r672b2923],
4	<	JJR	O	<	dep	1	SENT_108	[p7l11t2842r672b2923],
5	al	NNP	O	al	dep	4	SENT_108	[p7l11t2842r672b2923],
6	.	.	O	.	_	0	SENT_108	[p7l11t2842r672b2923],

1	—	NN	O	—	_	0	SENT_109	[p7l11t2842r672b2923],
2	.	.	O	.	_	0	SENT_109	[p7l11t2842r672b2923],

1	Wallis	NNP	PERSON	Wallis	_	0	SENT_110	[p7l11t2842r672b2923],
2	tests	NNS	O	test	dep	1	SENT_110	[p7l721t2859r940b2922],
3	.	.	O	.	_	0	SENT_110	[p7l721t2859r940b2922],

1	Confidence	NN	O	confidence	nn	2	SENT_111	[p7l991t2841r1486b2922],
2	intervals	NNS	O	interval	nsubjpass	4	SENT_111	[p7l1531t2842r1901b2922],
3	were	VBD	O	be	auxpass	4	SENT_111	[p7l1944t2868r2148b2922],
4	calculated	VBN	O	calculate	_	0	SENT_111	[p7l12t2971r450b3050],
5	with	IN	O	with	_	0	SENT_111	[p7l482t2971r678b3050],
6	the	DT	O	the	det	7	SENT_111	[p7l714t2971r847b3050],
7	use	NN	O	use	prep_with	4	SENT_111	[p7l883t2997r1025b3050],
8	of	IN	O	of	_	0	SENT_111	[p7l1061t2970r1162b3050],
9	binomial	JJ	O	binomial	amod	10	SENT_111	[p7l1180t2971r1570b3050],
10	distribution	NN	O	distribution	prep_of	7	SENT_111	[p7l1606t2971r2142b3050],
11	.	.	O	.	_	0	SENT_111	[p7l1606t2971r2142b3050],

1	Progression	NN	O	progression	nsubjpass	9	SENT_112	[p7l11t3098r707b3201],
2	—	CD	NUMBER	—	num	4	SENT_112	[p7l11t3098r707b3201],
3	free	JJ	O	free	amod	4	SENT_112	[p7l11t3098r707b3201],
4	survival	NN	O	survival	dep	1	SENT_112	[p7l741t3099r1067b3179],
5	and	CC	O	and	_	0	SENT_112	[p7l1099t3099r1255b3179],
6	survival	NN	O	survival	nn	7	SENT_112	[p7l1289t3099r1615b3179],
7	curves	NNS	O	curve	conj_and	4	SENT_112	[p7l1648t3125r1914b3179],
8	were	VBD	O	be	auxpass	9	SENT_112	[p7l1945t3125r2148b3179],
9	constructed	VBN	O	construct	_	0	SENT_112	[p7l12t3228r534b3307],
10	by	IN	O	by	_	0	SENT_112	[p7l588t3228r687b3328],
11	the	DT	O	the	det	12	SENT_112	[p7l737t3228r873b3307],
12	Kaplan	NNP	PERSON	Kaplan	agent	9	SENT_112	[p7l926t3228r1544b3328],
13	.	.	O	.	_	0	SENT_112	[p7l926t3228r1544b3328],

1	—	NN	O	—	_	0	SENT_113	[p7l926t3228r1544b3328],
2	.	.	O	.	_	0	SENT_113	[p7l926t3228r1544b3328],

1	Meier	JJR	PERSON	meier	amod	2	SENT_114	[p7l926t3228r1544b3328],
2	method	NN	O	method	_	0	SENT_114	[p7l1595t3228r1934b3307],
3	and	CC	O	and	_	0	SENT_114	[p7l1988t3228r2148b3307],
4	compared	VBN	O	compare	conj_and	2	SENT_114	[p7l12t3357r442b3458],
5	with	IN	O	with	_	0	SENT_114	[p7l481t3357r677b3437],
6	the	DT	O	the	det	7	SENT_114	[p7l721t3357r855b3436],
7	use	NN	O	use	prep_with	4	SENT_114	[p7l897t3384r1039b3437],
8	of	IN	O	of	_	0	SENT_114	[p7l1083t3356r1184b3437],
9	the	DT	O	the	det	11	SENT_114	[p7l1209t3357r1343b3436],
10	log-rank	JJ	O	log-rank	amod	11	SENT_114	[p7l1385t3357r1757b3459],
11	test	NN	O	test	prep_of	7	SENT_114	[p7l1796t3374r1952b3436],
12	and	CC	O	and	_	0	SENT_114	[p7l1989t3357r2148b3437],
13	the	DT	O	the	det	14	SENT_114	[p7l12t3487r146b3565],
14	Tarone	NNP	O	Tarone	prep_of	7	SENT_114	[p7l182t3493r760b3566],
15	.	.	O	.	_	0	SENT_114	[p7l182t3493r760b3566],

1	—	NN	O	—	_	0	SENT_115	[p7l182t3493r760b3566],
2	.	.	O	.	_	0	SENT_115	[p7l182t3493r760b3566],

1	Ware	NNP	O	Ware	nsubj	2	SENT_116	[p7l182t3493r760b3566],
2	test	NN	O	test	_	0	SENT_116	[p7l800t3504r976b3566],
3	.	.	O	.	_	0	SENT_116	[p7l800t3504r976b3566],

1	In	IN	O	in	_	0	SENT_117	[p7l141t3623r229b3693],
2	addition	NN	O	addition	_	0	SENT_117	[p7l269t3615r628b3694],
3	to	TO	O	to	_	0	SENT_117	[p7l669t3632r751b3694],
4	the	DT	O	the	det	6	SENT_117	[p7l793t3615r926b3693],
5	principal	NN	O	principal	nn	6	SENT_117	[p7l965t3615r1353b3715],
6	analyses	NNS	O	analysis	prep_in_addition_to	9	SENT_117	[p7l1392t3615r1779b3715],
7	,	,	O	,	_	0	SENT_117	[p7l1392t3615r1779b3715],
8	We	PRP	O	we	nsubj	9	SENT_117	[p7l1820t3641r1939b3695],
9	performed	VBD	O	perform	_	0	SENT_117	[p7l1977t3641r2147b3715, p8l12t20r325b100],

1	five	CD	NUMBER	five	num	2	SENT_118	[p8l368t20r521b101],
2	post	NN	O	post	_	0	SENT_118	[p8l562t38r752b121],
3	hoc	FW	O	hoc	nn	4	SENT_118	[p8l789t21r943b100],
4	analyses	NNS	O	analysis	npadvmod	2	SENT_118	[p8l984t21r1346b121],
5	of	IN	O	of	_	0	SENT_118	[p8l1391t20r1491b100],
6	patients	NNS	O	patient	prep_of	2	SENT_118	[p8l1513t22r1881b121],
7	’	CD	NUMBER	’	num	8	SENT_118	[p8l1513t22r1881b121],
8	characteristics	NNS	O	characteristic	dep	6	SENT_118	[p8l1928t21r2147b99, p8l11t151r422b228],
9	and	CC	O	and	_	0	SENT_118	[p8l455t150r608b229],
10	response	NN	O	response	prep_of	2	SENT_118	[p8l639t176r1008b250],
11	according	VBG	O	accord	_	0	SENT_118	[p8l1039t150r1451b251],
12	to	TO	O	to	prepc_according_to	10	SENT_118	[p8l1479t167r1558b229],
13	sex	NN	O	sex	pobj	10	SENT_118	[p8l1592t176r1743b246],
14	,	,	O	,	_	0	SENT_118	[p8l1592t176r1743b246],
15	smoking	NN	O	smoking	nn	16	SENT_118	[p8l1780t150r2152b251],
16	history	NN	O	history	pobj	10	SENT_118	[p8l12t278r324b378],
17	,	,	O	,	_	0	SENT_118	[p8l12t278r324b378],
18	age	NN	O	age	pobj	10	SENT_118	[p8l359t304r523b379],
19	,	,	O	,	_	0	SENT_118	[p8l359t304r523b379],
20	Eastern	NNP	ORGANIZATION	Eastern	nn	25	SENT_118	[p8l558t286r876b357],
21	Cooperative	NNP	ORGANIZATION	Cooperative	nn	25	SENT_118	[p8l907t279r1409b378],
22	Oncology	NNP	ORGANIZATION	Oncology	nn	25	SENT_118	[p8l1440t278r1850b379],
23	Group	NNP	ORGANIZATION	Group	nn	25	SENT_118	[p8l1876t284r2147b378],
24	(	CD	NUMBER	(	num	25	SENT_118	[p8l17t411r340b496],
25	ECOG	NNP	O	ECOG	pobj	10	SENT_118	[p8l17t411r340b496],
26	)	CD	NUMBER	)	num	28	SENT_118	[p8l17t411r340b496],
27	performance	NN	O	performance	nn	28	SENT_118	[p8l382t404r941b505],
28	status	NN	O	status	dep	25	SENT_118	[p8l980t422r1259b501],
29	,	,	O	,	_	0	SENT_118	[p8l980t422r1259b501],
30	and	CC	O	and	_	0	SENT_118	[p8l1301t405r1460b484],
31	treatment	NN	O	treatment	pobj	10	SENT_118	[p8l1499t422r1946b484],
32	.	.	O	.	_	0	SENT_118	[p8l1499t422r1946b484],

1	The	DT	O	the	det	3	SENT_119	[p8l1987t405r2148b483],
2	Bonferroni	NNP	MISC	Bonferroni	nn	3	SENT_119	[p8l11t532r496b612],
3	method	NN	O	method	nsubjpass	5	SENT_119	[p8l541t533r881b612],
4	was	VBD	O	be	auxpass	5	SENT_119	[p8l922t559r1089b613],
5	used	VBN	O	use	_	0	SENT_119	[p8l1136t533r1339b613],
6	in	IN	O	in	_	0	SENT_119	[p8l1383t534r1469b611],
7	multiple	JJ	O	multiple	amod	8	SENT_119	[p8l1514t533r1882b633],
8	comparisons	NNS	O	comparison	prep_in	5	SENT_119	[p8l1928t559r2147b612, p8l11t664r406b763],
9	.	.	O	.	_	0	SENT_119	[p8l1928t559r2147b612, p8l11t664r406b763],

1	All	DT	O	all	det	3	SENT_120	[p8l138t791r259b869],
2	statistical	JJ	O	statistical	amod	3	SENT_120	[p8l294t791r691b869],
3	calculations	NNS	O	calculation	nsubjpass	5	SENT_120	[p8l725t791r1220b870],
4	were	VBD	O	be	auxpass	5	SENT_120	[p8l1252t817r1448b871],
5	performed	VBN	O	perform	_	0	SENT_120	[p8l1480t790r1922b891],
6	with	IN	O	with	_	0	SENT_120	[p8l1952t791r2148b871],
7	the	DT	O	the	det	8	SENT_120	[p8l12t920r144b999],
8	use	NN	O	use	prep_with	5	SENT_120	[p8l178t946r318b1000],
9	of	IN	O	of	_	0	SENT_120	[p8l353t919r453b999],
10	SPSS	NNP	ORGANIZATION	SPSS	nn	13	SENT_120	[p8l471t926r666b999],
11	software	NN	O	software	nn	13	SENT_120	[p8l705t919r1073b1000],
12	(	NN	O	(	nn	13	SENT_120	[p8l1112t921r1437b1011],
13	version	NN	O	version	prep_of	8	SENT_120	[p8l1112t921r1437b1011],
14	17.0	CD	NUMBER	17.0	num	15	SENT_120	[p8l1475t926r1660b1011],
15	)	NN	O	)	dep	13	SENT_120	[p8l1475t926r1660b1011],
16	and	CC	O	and	_	0	SENT_120	[p8l1700t920r1856b999],
17	S	NN	O	s	conj_and	13	SENT_120	[p8l1893t920r2145b1000],
18	.	.	O	.	_	0	SENT_120	[p8l1893t920r2145b1000],

1	—	NN	O	—	_	0	SENT_121	[p8l1893t920r2145b1000],
2	.	.	O	.	_	0	SENT_121	[p8l1893t920r2145b1000],

1	Plus	CC	O	plus	nsubj	3	SENT_122	[p8l1893t920r2145b1000],
2	(	JJ	O	(	amod	3	SENT_122	[p8l17t1050r342b1140],
3	version	NN	O	version	_	0	SENT_122	[p8l17t1050r342b1140],
4	6.1	CD	NUMBER	6.1	num	5	SENT_122	[p8l377t1055r550b1140],
5	)	NN	O	)	dep	3	SENT_122	[p8l377t1055r550b1140],
6	.	.	O	.	_	0	SENT_122	[p8l377t1055r550b1140],

1	TWo	CD	NUMBER	two	num	2	SENT_123	[p8l587t1049r1021b1129],
2	—	CD	NUMBER	—	nsubj	3	SENT_123	[p8l587t1049r1021b1129],
3	sided	VBD	O	side	_	0	SENT_123	[p8l587t1049r1021b1129],
4	P	NN	O	p	nn	5	SENT_123	[p8l1055t1056r1107b1127],
5	values	NNS	O	value	nsubjpass	11	SENT_123	[p8l1136t1049r1395b1129],
6	of	IN	O	of	_	0	SENT_123	[p8l1433t1048r1533b1128],
7	less	JJR	O	less	mwe	8	SENT_123	[p8l1548t1049r1701b1127],
8	than	IN	O	than	quantmod	9	SENT_123	[p8l1740t1049r1934b1127],
9	0.05	CD	NUMBER	0.05	prep_of	5	SENT_123	[p8l1970t1055r2144b1128],
10	were	VBD	O	be	auxpass	11	SENT_123	[p8l7t1204r203b1258],
11	considered	VBN	O	consider	ccomp	3	SENT_123	[p8l238t1178r681b1258],
12	to	TO	O	to	aux	13	SENT_123	[p8l716t1195r795b1258],
13	indicate	VB	O	indicate	xcomp	11	SENT_123	[p8l831t1178r1156b1258],
14	statistical	JJ	O	statistical	amod	15	SENT_123	[p8l1192t1178r1584b1257],
15	significance	NN	O	significance	dobj	13	SENT_123	[p8l1620t1177r2139b1280],
16	.	.	O	.	_	0	SENT_123	[p8l1620t1177r2139b1280],

1	RESULTS	NNS	O	result	_	0	SENT_124	[p8l841t1477r1320b1535],

1	PATIENTS	NNS	O	patient	nsubjpass	25	SENT_125	[p8l17t1710r386b1761],
2	From	IN	O	from	_	0	SENT_125	[p8l11t1818r238b1889],
3	April	NNP	DATE	April	prep_from	25	SENT_125	[p8l265t1810r484b1910],
4	2005	CD	DATE	2005	num	3	SENT_125	[p8l514t1816r718b1889],
5	through	IN	O	through	_	0	SENT_125	[p8l753t1810r1103b1911],
6	November	NNP	DATE	November	prep_through	25	SENT_125	[p8l1132t1810r1579b1889],
7	2008	CD	DATE	2008	num	6	SENT_125	[p8l1607t1816r1840b1906],
8	,	,	O	,	_	0	SENT_125	[p8l1607t1816r1840b1906],
9	a	DT	O	a	det	10	SENT_125	[p8l1876t1836r1921b1888],
10	total	NN	O	total	nsubjpass	25	SENT_125	[p8l1950t1810r2148b1889],
11	of	IN	O	of	_	0	SENT_125	[p8l12t1937r113b2018],
12	2105	CD	DATE	2105	num	13	SENT_125	[p8l128t1944r326b2018],
13	patients	NNS	O	patient	prep_of	10	SENT_125	[p8l361t1939r704b2039],
14	with	IN	O	with	_	0	SENT_125	[p8l735t1938r932b2018],
15	non	JJ	O	non	amod	19	SENT_125	[p8l965t1938r1612b2018],
16	—	JJ	O	—	amod	19	SENT_125	[p8l965t1938r1612b2018],
17	small-cell	NN	O	small-cell	nn	19	SENT_125	[p8l965t1938r1612b2018],
18	lung	NN	O	lung	nn	19	SENT_125	[p8l1644t1938r1838b2040],
19	cancer	NN	O	cancer	prep_with	13	SENT_125	[p8l1869t1964r2151b2017],
20	from	IN	O	from	_	0	SENT_125	[p8l12t2065r224b2145],
21	129	CD	NUMBER	129	num	22	SENT_125	[p8l253t2072r403b2145],
22	institutions	NNS	O	institution	prep_from	13	SENT_125	[p8l430t2067r929b2146],
23	were	VBD	O	be	auxpass	25	SENT_125	[p8l952t2092r1156b2146],
24	prospectively	RB	O	prospectively	advmod	25	SENT_125	[p8l1180t2066r1750b2166],
25	screened	VBN	O	screen	_	0	SENT_125	[p8l1773t2066r2148b2145],
26	for	IN	O	for	_	0	SENT_125	[p8l12t2193r134b2273],
27	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_125	[p8l159t2201r370b2274],
28	mutations	NNS	O	mutation	prep_for	25	SENT_125	[p8l394t2195r846b2274],
29	.	.	O	.	_	0	SENT_125	[p8l394t2195r846b2274],

1	The	DT	O	the	det	3	SENT_126	[p8l878t2194r1038b2272],
2	median	JJ	O	median	amod	3	SENT_126	[p8l1069t2194r1388b2273],
3	time	NN	O	time	nsubj	11	SENT_126	[p8l1419t2195r1609b2272],
4	required	VBN	O	require	partmod	3	SENT_126	[p8l1640t2194r1996b2294],
5	for	IN	O	for	_	0	SENT_126	[p8l2027t2193r2151b2273],
6	such	JJ	O	such	amod	7	SENT_126	[p8l13t2323r208b2403],
7	analysis	NN	O	analysis	prep_for	4	SENT_126	[p8l242t2323r584b2424],
8	was	VBD	O	be	cop	11	SENT_126	[p8l615t2350r779b2403],
9	7	CD	DURATION	7	num	10	SENT_126	[p8l816t2331r863b2402],
10	days	NNS	NUMBER	day	tmod	11	SENT_126	[p8l898t2323r1083b2424],
11	(	JJ	O	(	_	0	SENT_126	[p8l1124t2330r1416b2425],
12	range	NN	O	range	tmod	11	SENT_126	[p8l1124t2330r1416b2425],
13	,	,	O	,	_	0	SENT_126	[p8l1124t2330r1416b2425],
14	5	CD	NUMBER	5	number	17	SENT_126	[p8l1457t2331r1500b2403],
15	to	TO	O	to	dep	17	SENT_126	[p8l1538t2340r1620b2403],
16	9	CD	NUMBER	9	number	17	SENT_126	[p8l1655t2329r1729b2415],
17	)	CD	NUMBER	)	appos	12	SENT_126	[p8l1655t2329r1729b2415],
18	from	IN	O	from	_	0	SENT_126	[p8l1768t2322r1980b2403],
19	the	DT	O	the	det	20	SENT_126	[p8l2014t2323r2148b2402],
20	time	NN	O	time	prep_from	17	SENT_126	[p8l12t2453r203b2530],
21	the	DT	O	the	det	22	SENT_126	[p8l235t2452r366b2530],
22	sample	NN	O	sample	nsubj	23	SENT_126	[p8l399t2452r698b2552],
23	arrived	VBD	O	arrive	rcmod	20	SENT_126	[p8l728t2452r1021b2531],
24	at	IN	O	at	_	0	SENT_126	[p8l1052t2469r1130b2530],
25	the	DT	O	the	det	26	SENT_126	[p8l1156t2452r1287b2530],
26	laboratory	NN	O	laboratory	prep_at	23	SENT_126	[p8l1318t2452r1757b2552],
27	until	IN	O	until	mark	31	SENT_126	[p8l1784t2452r1984b2531],
28	the	DT	O	the	det	29	SENT_126	[p8l2015t2452r2148b2530],
29	results	NNS	O	result	nsubjpass	31	SENT_126	[p8l12t2581r297b2660],
30	were	VBD	O	be	auxpass	31	SENT_126	[p8l333t2607r536b2660],
31	reported	VBN	O	report	advcl	23	SENT_126	[p8l575t2581r943b2681],
32	to	TO	O	to	_	0	SENT_126	[p8l982t2598r1064b2660],
33	the	DT	O	the	det	34	SENT_126	[p8l1104t2581r1238b2659],
34	investigators	NNS	O	investigator	prep_to	31	SENT_126	[p8l1276t2582r1852b2682],
35	.	.	O	.	_	0	SENT_126	[p8l1276t2582r1852b2682],

1	Mutations	NNS	O	mutation	nsubjpass	7	SENT_127	[p8l1893t2589r2147b2660, p8l12t2710r216b2789],
2	in	IN	O	in	_	0	SENT_127	[p8l246t2710r328b2787],
3	the	DT	O	the	det	5	SENT_127	[p8l356t2709r485b2788],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_127	[p8l512t2716r719b2790],
5	gene	NN	O	gene	prep_in	1	SENT_127	[p8l740t2735r934b2811],
6	were	VBD	O	be	auxpass	7	SENT_127	[p8l957t2735r1154b2789],
7	detected	VBN	O	detect	_	0	SENT_127	[p8l1183t2709r1528b2789],
8	in	IN	O	in	_	0	SENT_127	[p8l1556t2710r1637b2787],
9	350	CD	NUMBER	350	prep_in	7	SENT_127	[p8l1666t2715r1809b2789],
10	of	IN	O	of	_	0	SENT_127	[p8l1839t2708r1938b2789],
11	2105	CD	DATE	2105	num	12	SENT_127	[p8l1947t2715r2145b2789],
12	patients	NNS	O	patient	prep_of	9	SENT_127	[p8l11t2838r354b2937],
13	(	IN	O	(	_	0	SENT_127	[p8l391t2843r729b2928],
14	16.6	CD	PERCENT	16.6	num	15	SENT_127	[p8l391t2843r729b2928],
15	%	NN	PERCENT	%	prep_(	7	SENT_127	[p8l391t2843r729b2928],
16	)	CD	NUMBER	)	dep	15	SENT_127	[p8l391t2843r729b2928],
17	.	.	O	.	_	0	SENT_127	[p8l391t2843r729b2928],

1	Mutations	NNS	O	mutation	nsubjpass	3	SENT_128	[p8l761t2838r1201b2917],
2	were	VBD	O	be	auxpass	3	SENT_128	[p8l1229t2863r1432b2917],
3	found	VBN	O	find	dep	8	SENT_128	[p8l1462t2836r1716b2917],
4	more	RBR	O	more	advmod	5	SENT_128	[p8l1746t2863r1966b2916],
5	frequently	RB	O	frequently	advmod	3	SENT_128	[p8l1997t2836r2147b2915, p8l13t2966r333b3066],
6	in	IN	O	in	_	0	SENT_128	[p8l372t2967r456b3044],
7	women	NNS	O	woman	prep_in	3	SENT_128	[p8l496t2992r814b3046],
8	(	VBP	O	(	_	0	SENT_128	[p8l864t2971r1198b3062],
9	69.7	CD	PERCENT	69.7	num	10	SENT_128	[p8l864t2971r1198b3062],
10	%	NN	PERCENT	%	dobj	8	SENT_128	[p8l864t2971r1198b3062],
11	)	CD	NUMBER	)	nsubj	8	SENT_128	[p8l864t2971r1198b3062],
12	,	,	O	,	_	0	SENT_128	[p8l864t2971r1198b3062],
13	in	IN	O	in	mark	29	SENT_128	[p8l1248t2967r1331b3044],
14	patients	NNS	O	patient	nsubj	29	SENT_128	[p8l1374t2967r1718b3066],
15	who	WP	O	who	nsubj	18	SENT_128	[p8l1761t2966r1944b3045],
16	had	VBD	O	have	aux	18	SENT_128	[p8l1991t2966r2148b3045],
17	never	RB	O	never	neg	18	SENT_128	[p8l12t3121r243b3174],
18	smoked	VBN	O	smoke	rcmod	14	SENT_128	[p8l279t3095r613b3174],
19	(	CD	PERCENT	(	num	21	SENT_128	[p8l656t3100r996b3191],
20	66.6	CD	PERCENT	66.6	num	21	SENT_128	[p8l656t3100r996b3191],
21	%	NN	PERCENT	%	dobj	18	SENT_128	[p8l656t3100r996b3191],
22	)	CD	NUMBER	)	dep	21	SENT_128	[p8l656t3100r996b3191],
23	,	,	O	,	_	0	SENT_128	[p8l656t3100r996b3191],
24	and	CC	O	and	_	0	SENT_128	[p8l1039t3095r1197b3174],
25	in	IN	O	in	conj_and	21	SENT_128	[p8l1234t3096r1317b3173],
26	those	DT	O	those	pobj	25	SENT_128	[p8l1356t3095r1589b3174],
27	with	IN	O	with	_	0	SENT_128	[p8l1622t3095r1818b3174],
28	adenocarcinomas	NNS	O	adenocarcinoma	prep_with	26	SENT_128	[p8l1856t3095r2147b3174, p8l13t3224r500b3302],
29	(	VBP	O	(	dep	11	SENT_128	[p8l539t3229r849b3314],
30	80.9	CD	PERCENT	80.9	num	31	SENT_128	[p8l539t3229r849b3314],
31	%	NN	PERCENT	%	nsubj	40	SENT_128	[p8l539t3229r849b3314],
32	)	CD	NUMBER	)	number	33	SENT_128	[p8l539t3229r849b3314],
33	(	CD	NUMBER	(	num	34	SENT_128	[p8l891t3229r1253b3314],
34	P	NN	O	p	npadvmod	35	SENT_128	[p8l891t3229r1253b3314],
35	<	JJR	O	<	amod	31	SENT_128	[p8l891t3229r1253b3314],
36	0.001	CD	NUMBER	0.001	dep	35	SENT_128	[p8l891t3229r1253b3314],
37	for	IN	O	for	dep	36	SENT_128	[p8l1285t3222r1407b3302],
38	all	DT	O	all	det	39	SENT_128	[p8l1434t3223r1537b3301],
39	comparisons	NNS	O	comparison	pobj	37	SENT_128	[p8l1569t3224r2142b3323],
40	)	VBP	O	)	ccomp	29	SENT_128	[p8l1569t3224r2142b3323],
41	(	CD	NUMBER	(	num	42	SENT_128	[p8l17t3352r276b3444],
42	Table	NNP	O	Table	dobj	40	SENT_128	[p8l17t3352r276b3444],
43	1	CD	NUMBER	1	num	42	SENT_128	[p8l307t3358r403b3444],
44	)	CD	NUMBER	)	dep	42	SENT_128	[p8l307t3358r403b3444],
45	.	.	O	.	_	0	SENT_128	[p8l307t3358r403b3444],

1	Although	IN	O	although	mark	10	SENT_129	[p8l431t3352r842b3454],
2	no	DT	O	no	det	4	SENT_129	[p8l869t3378r974b3432],
3	special	JJ	O	special	amod	4	SENT_129	[p8l1005t3352r1300b3453],
4	call	NN	O	call	nsubjpass	10	SENT_129	[p8l1328t3352r1479b3431],
5	for	IN	O	for	_	0	SENT_129	[p8l1506t3351r1630b3432],
6	an	DT	O	a	det	8	SENT_129	[p8l1654t3378r1757b3431],
7	enriched	JJ	O	enriched	amod	8	SENT_129	[p8l1785t3352r2148b3432],
8	population	NN	O	population	prep_for	4	SENT_129	[p8l11t3481r465b3581],
9	was	VBD	O	be	auxpass	10	SENT_129	[p8l491t3507r650b3560],
10	made	VBN	O	make	advcl	15	SENT_129	[p8l682t3481r930b3577],
11	,	,	O	,	_	0	SENT_129	[p8l682t3481r930b3577],
12	the	DT	O	the	det	14	SENT_129	[p8l966t3481r1095b3559],
13	participating	VBG	O	participate	amod	14	SENT_129	[p8l1125t3482r1664b3582],
14	centers	NNS	O	center	nsubj	15	SENT_129	[p8l1691t3498r1995b3560],
15	included	VBD	O	include	_	0	SENT_129	[p8l2031t3482r2147b3559, p8l12t3608r293b3688],
16	more	RBR	O	more	advmod	15	SENT_129	[p8l335t3634r556b3687],
17	samples	NNS	O	sample	dobj	15	SENT_129	[p8l601t3608r947b3708],
18	from	IN	O	from	_	0	SENT_129	[p8l992t3607r1204b3687],
19	women	NNS	O	woman	prep_from	15	SENT_129	[p8l1243t3634r1560b3688],
20	and	CC	O	and	_	0	SENT_129	[p8l1602t3608r1761b3687],
21	patients	NNS	O	patient	prep_from	15	SENT_129	[p8l1802t3609r2146b3708],
22	who	WP	O	who	nsubj	25	SENT_129	[p9l7t21r187b100],
23	had	VBD	O	have	aux	25	SENT_129	[p9l210t21r363b100],
24	never	RB	O	never	neg	25	SENT_129	[p9l385t47r607b100],
25	smoked	VBN	O	smoke	rcmod	19	SENT_129	[p9l626t21r971b117],
26	,	,	O	,	_	0	SENT_129	[p9l626t21r971b117],
27	since	IN	O	since	mark	30	SENT_129	[p9l1000t22r1208b99],
28	physicians	NNS	O	physician	nsubj	30	SENT_129	[p9l1227t21r1659b121],
29	were	VBD	O	be	cop	30	SENT_129	[p9l1678t47r1874b100],
30	aware	JJ	O	aware	advcl	15	SENT_129	[p9l1896t47r2147b100],
31	that	IN	O	that	complm	36	SENT_129	[p9l12t149r189b227],
32	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_129	[p9l221t156r438b229],
33	mutations	NNS	O	mutation	nsubj	36	SENT_129	[p9l469t150r915b229],
34	are	VBP	O	be	cop	36	SENT_129	[p9l955t175r1087b227],
35	more	RBR	O	more	advmod	36	SENT_129	[p9l1126t175r1350b228],
36	frequent	JJ	O	frequent	ccomp	30	SENT_129	[p9l1388t148r1762b249],
37	in	IN	O	in	_	0	SENT_129	[p9l1795t150r1879b227],
38	these	DT	O	these	det	39	SENT_129	[p9l1918t149r2148b227],
39	subgroups	NNS	O	subgroup	prep_in	36	SENT_129	[p9l13t278r487b379],
40	.	.	O	.	_	0	SENT_129	[p9l13t278r487b379],

1	We	PRP	O	we	nsubj	2	SENT_130	[p9l531t286r664b357],
2	considered	VBD	O	consider	_	0	SENT_130	[p9l707t278r1173b357],
3	296	CD	NUMBER	296	num	4	SENT_130	[p9l1214t284r1368b357],
4	patients	NNS	O	patient	dobj	2	SENT_130	[p9l1409t279r1753b378],
5	with	IN	O	with	_	0	SENT_130	[p9l1792t278r1988b357],
6	tumors	NNS	O	tumor	prep_with	2	SENT_130	[p9l2030t295r2147b357, p9l12t432r229b486],
7	carrying	VBG	O	carry	partmod	6	SENT_130	[p9l261t407r627b508],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_130	[p9l651t413r864b487],
9	mutations	NNS	O	mutation	dobj	7	SENT_130	[p9l887t407r1325b486],
10	for	IN	O	for	_	0	SENT_130	[p9l1356t405r1479b486],
11	treatment	NN	O	treatment	prep_for	7	SENT_130	[p9l1506t423r1932b485],
12	with	IN	O	with	_	0	SENT_130	[p9l1952t406r2148b486],
13	erlotinib	NN	O	erlotinib	prep_with	11	SENT_130	[p9l13t534r407b630],
14	;	:	O	;	_	0	SENT_130	[p9l13t534r407b630],
15	of	IN	O	of	_	0	SENT_130	[p9l446t533r547b613],
16	these	DT	O	these	det	17	SENT_130	[p9l564t534r789b612],
17	patients	NNS	O	patient	prep_of	22	SENT_130	[p9l822t535r1191b634],
18	,	,	O	,	_	0	SENT_130	[p9l822t535r1191b634],
19	79	CD	NUMBER	79	nsubj	22	SENT_130	[p9l1232t540r1330b613],
20	did	VBD	O	do	aux	22	SENT_130	[p9l1367t534r1503b613],
21	not	RB	O	not	neg	22	SENT_130	[p9l1537t551r1681b613],
22	receive	VB	O	receive	parataxis	2	SENT_130	[p9l1710t535r2001b613],
23	erlotinib	NN	O	erlotinib	dobj	22	SENT_130	[p9l2037t560r2148b612, p9l11t663r298b743],
24	for	IN	O	for	_	0	SENT_130	[p9l329t662r453b743],
25	a	DT	O	a	det	26	SENT_130	[p9l479t690r524b742],
26	variety	NN	O	variety	prep_for	22	SENT_130	[p9l548t664r840b764],
27	of	IN	O	of	_	0	SENT_130	[p9l866t662r967b743],
28	reasons	NNS	O	reason	prep_of	26	SENT_130	[p9l978t689r1307b743],
29	(	CD	NUMBER	(	num	30	SENT_130	[p9l1344t664r1527b765],
30	Fig	NN	O	fig	dep	28	SENT_130	[p9l1344t664r1527b765],
31	.	.	O	.	_	0	SENT_130	[p9l1344t664r1527b765],

1	1	CD	NUMBER	1	_	0	SENT_131	[p9l1569t670r1665b755],
2	)	NN	O	)	dep	1	SENT_131	[p9l1569t670r1665b755],
3	.	.	O	.	_	0	SENT_131	[p9l1569t670r1665b755],

1	Of	IN	O	of	_	0	SENT_132	[p9l1701t662r1822b743],
2	the	DT	O	the	det	3	SENT_132	[p9l1835t663r1968b742],
3	217	CD	NUMBER	217	pobj	1	SENT_132	[p9l1998t669r2148b742],

1	960	CD	NUMBER	960	num	2	SENT_133	[p9l149t822r206b846],
2	N	NN	O	n	_	0	SENT_133	[p9l931t833r945b848],
3	EN	IN	O	en	dep	2	SENT_133	[p9l959t833r988b848],
4	L	NN	O	l	nn	5	SENT_133	[p9l1014t833r1023b848],
5	MED	NN	O	med	pobj	3	SENT_133	[p9l1052t833r1104b848],
6	361	CD	NUMBER	361	nsubj	11	SENT_133	[p9l1114t827r1192b855],
7	;	:	O	;	_	0	SENT_133	[p9l1114t827r1192b855],
8	1o	CD	NUMBER	1o	num	10	SENT_133	[p9l1114t827r1192b855],
9	NEjM.ORG	NN	O	nejm.org	nn	10	SENT_133	[p9l1227t833r1351b855],
10	s	NNS	O	s	dep	6	SENT_133	[p9l1386t833r1396b849],
11	EEEEEE	VBP	O	eeeeee	rcmod	5	SENT_133	[p9l1402t833r1494b848],
12	ER	NN	O	er	dobj	11	SENT_133	[p9l1499t833r1525b848],
13	3	CD	NUMBER	3	num	12	SENT_133	[p9l1535t833r1553b855],
14	,	,	O	,	_	0	SENT_133	[p9l1535t833r1553b855],
15	2oo9	CD	NUMBER	2oo9	appos	12	SENT_133	[p9l1564t833r1628b854],

1	The	DT	O	the	det	3	SENT_134	[p9l936t866r987b890],
2	England	NNP	LOCATION	England	nn	3	SENT_134	[p9l1067t866r1178b897],
3	Joumal	NNP	O	Joumal	_	0	SENT_134	[p9l1187t866r1284b890],
4	of	IN	O	of	_	0	SENT_134	[p9l1294t866r1323b890],
5	Medicine	NNP	O	Medicine	prep_of	3	SENT_134	[p9l1330t866r1455b890],

1	SCREENING	NN	O	screening	_	0	SENT_135	[p9l645t991r841b1010],
2	FOR	IN	O	for	dep	1	SENT_135	[p9l855t991r919b1010],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_135	[p9l931t991r1002b1010],
4	MUTATIONS	NNS	O	mutation	pobj	2	SENT_135	[p9l1015t991r1210b1010],
5	IN	IN	O	in	dep	1	SENT_135	[p9l1225t991r1262b1010],
6	LUNG	NN	O	lung	nn	7	SENT_135	[p9l1278t991r1370b1010],
7	CANCER	NNP	O	CANCER	pobj	5	SENT_135	[p9l1384t991r1518b1010],

1	Table	NNP	O	Table	_	0	SENT_136	[p9l263t1112r337b1137],
2	1	CD	NUMBER	1	dep	1	SENT_136	[p9l347t1114r369b1137],
3	.	.	O	.	_	0	SENT_136	[p9l347t1114r369b1137],

1	Frequency	NN	O	frequency	_	0	SENT_137	[p9l380t1114r520b1145],
2	of	IN	O	of	_	0	SENT_137	[p9l529t1111r641b1137],
3	'	''	O	'	_	0	SENT_137	[p9l529t1111r641b1137],
4	EGFR	NN	O	egfr	nn	5	SENT_137	[p9l529t1111r641b1137],
5	Mutations	NNS	O	mutation	prep_of	1	SENT_137	[p9l652t1112r815b1137],
6	.	.	O	.	_	0	SENT_137	[p9l652t1112r815b1137],

1	*	NN	O	*	_	0	SENT_138	[p9l652t1112r815b1137],

1	ients	NNS	O	ient	poss	5	SENT_139	[p9l1159t1187r1223b1211],
2	'	POS	O	'	_	0	SENT_139	[p9l1120t1224r1124b1230],
3	EGFR	NN	O	egfr	nn	5	SENT_139	[p9l1165t1225r1243b1249],
4	M	NN	O	m	nn	5	SENT_139	[p9l1100t1263r1123b1286],
5	utations	NNS	O	utation	nsubj	6	SENT_139	[p9l1128t1262r1238b1286],
6	(	VBP	O	(	_	0	SENT_139	[p9l1110t1300r1227b1332],
7	N	NN	O	n	dobj	6	SENT_139	[p9l1110t1300r1227b1332],
8	=	JJ	O	=	advmod	6	SENT_139	[p9l1110t1300r1227b1332],
9	350	CD	NUMBER	350	num	10	SENT_139	[p9l1110t1300r1227b1332],
10	)	NN	O	)	dep	8	SENT_139	[p9l1110t1300r1227b1332],

1	All	DT	O	all	det	2	SENT_140	[p9l853t1261r887b1286],
2	Patients	NNS	O	patient	nsubj	3	SENT_140	[p9l900t1262r1008b1286],
3	(	VBP	O	(	_	0	SENT_140	[p9l864t1301r894b1332],
4	N	NN	O	n	dep	5	SENT_140	[p9l864t1301r894b1332],
5	=	JJ	O	=	acomp	3	SENT_140	[p9l902t1300r998b1332],
6	2105	CD	DATE	2105	number	7	SENT_140	[p9l902t1300r998b1332],
7	)	CD	NUMBER	)	num	8	SENT_140	[p9l902t1300r998b1332],
8	Frequency	NN	O	frequency	dep	5	SENT_140	[p9l1442t1301r1581b1331],
9	of	IN	O	of	_	0	SENT_140	[p9l1591t1298r1622b1324],
10	Mutations	NNS	O	mutation	prep_of	8	SENT_140	[p9l1629t1299r1768b1324],

1	350	CD	NUMBER	350	num	2	SENT_141	[p9l1668t1358r1715b1381],
2	Patients	NNS	O	patient	_	0	SENT_141	[p9l1727t1358r1834b1381],
3	All	DT	O	all	det	5	SENT_141	[p9l1331t1394r1364b1418],
4	2105	CD	NUMBER	2105	num	5	SENT_141	[p9l1376t1395r1438b1419],
5	Patients	NNS	O	patient	dep	2	SENT_141	[p9l1452t1396r1559b1419],
6	with	IN	O	with	_	0	SENT_141	[p9l1646t1394r1703b1419],
7	Mutations	NNS	O	mutation	nn	8	SENT_141	[p9l1716t1396r1854b1419],
8	number	NN	O	number	prep_with	5	SENT_141	[p9l928t1451r1031b1477],
9	of	IN	O	of	_	0	SENT_141	[p9l1038t1451r1068b1485],
10	patients	NNS	O	patient	nn	11	SENT_141	[p9l1069t1453r1173b1484],
11	percent	NN	O	percent	nn	16	SENT_141	[p9l1490t1456r1586b1484],
12	(	CD	PERCENT	(	number	13	SENT_141	[p9l1598t1453r1667b1485],
13	95	CD	PERCENT	95	dep	14	SENT_141	[p9l1598t1453r1667b1485],
14	%	NN	PERCENT	%	dep	16	SENT_141	[p9l1598t1453r1667b1485],
15	CI	NN	O	ci	nn	16	SENT_141	[p9l1677t1453r1714b1485],
16	)	NN	O	)	prep_of	8	SENT_141	[p9l1677t1453r1714b1485],

1	Sex	NN	O	sex	_	0	SENT_142	[p9l265t1511r309b1534],

1	Female	JJ	O	female	_	0	SENT_143	[p9l316t1567r413b1592],
2	814	CD	NUMBER	814	number	3	SENT_143	[p9l906t1569r953b1592],
3	244	CD	NUMBER	244	dep	1	SENT_143	[p9l1143t1569r1190b1592],
4	Male	JJ	O	male	advmod	7	SENT_143	[p9l316t1624r381b1650],
5	1287	CD	DATE	1287	num	6	SENT_143	[p9l891t1626r953b1650],
6	106	CD	NUMBER	106	dep	4	SENT_143	[p9l1145t1626r1190b1650],
7	Missing	VBG	O	miss	dep	1	SENT_143	[p9l316t1684r423b1715],
8	data	NNS	O	datum	nsubj	10	SENT_143	[p9l432t1682r490b1707],
9	4	CD	NUMBER	4	num	10	SENT_143	[p9l938t1684r953b1707],
10	o	NN	O	o	xcomp	7	SENT_143	[p9l1176t1684r1191b1707],

1	Age	NN	O	age	_	0	SENT_144	[p9l263t1742r314b1773],

1	<	JJR	O	<	dep	8	SENT_145	[p9l314t1800r388b1823],
2	56.7	CD	DURATION	56.7	num	3	SENT_145	[p9l314t1800r388b1823],
3	yr	NN	DURATION	yr	dep	1	SENT_145	[p9l397t1806r422b1830],
4	638	CD	NUMBER	638	number	5	SENT_145	[p9l906t1799r953b1823],
5	89	CD	NUMBER	89	dep	3	SENT_145	[p9l1159t1799r1190b1823],
6	56.7-69	CD	NUMBER	56.7-69	dep	8	SENT_145	[p9l314t1857r444b1880],
7	.1	CD	DURATION	.1	num	8	SENT_145	[p9l314t1857r444b1880],
8	yr	NN	DURATION	yr	dep	14	SENT_145	[p9l454t1864r479b1888],
9	638	CD	NUMBER	638	number	10	SENT_145	[p9l906t1857r953b1880],
10	99	CD	NUMBER	99	num	11	SENT_145	[p9l1159t1857r1190b1880],
11	>	JJR	O	>	dep	8	SENT_145	[p9l314t1915r387b1938],
12	69.1	CD	DURATION	69.1	num	13	SENT_145	[p9l314t1915r387b1938],
13	yr	NN	DURATION	yr	dep	11	SENT_145	[p9l397t1922r422b1946],
14	632	CD	NUMBER	632	_	0	SENT_145	[p9l906t1915r952b1938],
15	Missing	VBG	O	miss	rcmod	14	SENT_145	[p9l316t1973r423b2004],
16	data	NNS	O	datum	nsubj	18	SENT_145	[p9l432t1970r489b1996],
17	197	CD	NUMBER	197	num	18	SENT_145	[p9l907t1973r953b1996],
18	21	CD	NUMBER	21	xcomp	15	SENT_145	[p9l1159t1973r1189b1995],

1	Smoking	NN	O	smoking	_	0	SENT_146	[p9l264t2028r385b2061],
2	history	NN	O	history	nn	3	SENT_146	[p9l395t2028r486b2061],
3	3o	NN	O	3o	dep	1	SENT_146	[p9l1335t1568r1391b1592],
4	.	.	O	.	_	0	SENT_146	[p9l1335t1568r1391b1592],

1	o	NN	O	o	_	0	SENT_147	[p9l1335t1568r1391b1592],
2	(	CD	NUMBER	(	number	3	SENT_147	[p9l1404t1569r1553b1600],
3	26.9	CD	NUMBER	26.9	num	4	SENT_147	[p9l1404t1569r1553b1600],
4	—	NN	O	—	dep	1	SENT_147	[p9l1404t1569r1553b1600],
5	33.2	CD	NUMBER	33.2	number	6	SENT_147	[p9l1404t1569r1553b1600],
6	)	CD	NUMBER	)	num	4	SENT_147	[p9l1404t1569r1553b1600],
7	8.2	CD	NUMBER	8.2	num	8	SENT_147	[p9l1351t1626r1390b1650],
8	(	NN	O	(	dep	4	SENT_147	[p9l1404t1626r1520b1657],
9	68-99	CD	NUMBER	68-99	num	10	SENT_147	[p9l1404t1626r1520b1657],
10	)	NN	O	)	dep	1	SENT_147	[p9l1404t1626r1520b1657],

1	69.7	CD	NUMBER	69.7	num	2	SENT_148	[p9l1653t1569r1708b1592],
2	(	CD	NUMBER	(	dep	18	SENT_148	[p9l1721t1569r1871b1600],
3	64.7	CD	NUMBER	64.7	num	4	SENT_148	[p9l1721t1569r1871b1600],
4	—	NN	O	—	dep	2	SENT_148	[p9l1721t1569r1871b1600],
5	74.3	CD	NUMBER	74.3	number	6	SENT_148	[p9l1721t1569r1871b1600],
6	)	CD	NUMBER	)	num	8	SENT_148	[p9l1721t1569r1871b1600],
7	30.3	CD	NUMBER	30.3	number	8	SENT_148	[p9l1653t1626r1706b1650],
8	(	CD	NUMBER	(	dep	4	SENT_148	[p9l1721t1627r1871b1657],
9	25.7	CD	NUMBER	25.7	num	10	SENT_148	[p9l1721t1627r1871b1657],
10	—	NN	O	—	dep	4	SENT_148	[p9l1721t1627r1871b1657],
11	35.3	CD	NUMBER	35.3	number	12	SENT_148	[p9l1721t1627r1871b1657],
12	)	CD	NUMBER	)	num	13	SENT_148	[p9l1721t1627r1871b1657],
13	13.9	CD	NUMBER	13.9	dep	10	SENT_148	[p9l1336t1800r1390b1823],
14	(	NN	O	(	dep	18	SENT_148	[p9l1403t1800r1553b1830],
15	11.5	CD	NUMBER	11.5	num	14	SENT_148	[p9l1403t1800r1553b1830],
16	—	CD	NUMBER	—	num	18	SENT_148	[p9l1403t1800r1553b1830],
17	16.9	CD	NUMBER	16.9	num	18	SENT_148	[p9l1403t1800r1553b1830],
18	)	NN	O	)	dep	24	SENT_148	[p9l1403t1800r1553b1830],
19	15.5	CD	NUMBER	15.5	num	20	SENT_148	[p9l1336t1857r1389b1880],
20	(	NN	O	(	dep	18	SENT_148	[p9l1403t1857r1553b1888],
21	12.9	CD	NUMBER	12.9	number	22	SENT_148	[p9l1403t1857r1553b1888],
22	—	CD	NUMBER	—	dep	20	SENT_148	[p9l1403t1857r1553b1888],
23	18.6	CD	NUMBER	18.6	num	24	SENT_148	[p9l1403t1857r1553b1888],
24	)	NN	O	)	dep	31	SENT_148	[p9l1403t1857r1553b1888],
25	22.1	CD	NUMBER	22.1	number	26	SENT_148	[p9l1334t1915r1389b1938],
26	(	CD	NUMBER	(	num	28	SENT_148	[p9l1403t1915r1553b1946],
27	19.1	CD	NUMBER	19.1	number	28	SENT_148	[p9l1403t1915r1553b1946],
28	—	CD	NUMBER	—	dep	24	SENT_148	[p9l1403t1915r1553b1946],
29	25.6	CD	NUMBER	25.6	num	30	SENT_148	[p9l1403t1915r1553b1946],
30	)	NN	O	)	dep	28	SENT_148	[p9l1403t1915r1553b1946],
31	27.1	CD	NUMBER	27.1	dep	39	SENT_148	[p9l1652t1800r1707b1823],
32	(	CD	NUMBER	(	number	33	SENT_148	[p9l1721t1800r1871b1830],
33	24.9	CD	NUMBER	24.9	num	34	SENT_148	[p9l1721t1800r1871b1830],
34	—	NN	O	—	dep	31	SENT_148	[p9l1721t1800r1871b1830],
35	29.2	CD	NUMBER	29.2	number	36	SENT_148	[p9l1721t1800r1871b1830],
36	)	CD	NUMBER	)	num	34	SENT_148	[p9l1721t1800r1871b1830],
37	30.1	CD	NUMBER	30.1	num	38	SENT_148	[p9l1653t1857r1707b1880],
38	(	NN	O	(	dep	34	SENT_148	[p9l1721t1857r1871b1888],
39	27.8	CD	NUMBER	27.8	_	0	SENT_148	[p9l1721t1857r1871b1888],
40	—	CD	NUMBER	—	number	41	SENT_148	[p9l1721t1857r1871b1888],
41	32.4	CD	NUMBER	32.4	num	42	SENT_148	[p9l1721t1857r1871b1888],
42	)	NN	O	)	dep	39	SENT_148	[p9l1721t1857r1871b1888],
43	42.8	CD	NUMBER	42.8	number	44	SENT_148	[p9l1651t1914r1708b1938],
44	(	CD	NUMBER	(	num	49	SENT_148	[p9l1721t1914r1871b1946],
45	4o	NN	O	4o	nn	49	SENT_148	[p9l1721t1914r1871b1946],
46	.2	NN	NUMBER	.2	nn	49	SENT_148	[p9l1721t1914r1871b1946],
47	—	CD	NUMBER	—	number	48	SENT_148	[p9l1721t1914r1871b1946],
48	45.5	CD	NUMBER	45.5	num	49	SENT_148	[p9l1721t1914r1871b1946],
49	)	NN	O	)	dep	42	SENT_148	[p9l1721t1914r1871b1946],

1	Former	JJ	O	former	amod	2	SENT_149	[p9l316t2088r414b2111],
2	smoker	NN	O	smoker	_	0	SENT_149	[p9l424t2086r525b2111],
3	958	CD	NUMBER	958	num	2	SENT_149	[p9l905t2087r952b2111],
4	91	CD	NUMBER	91	num	6	SENT_149	[p9l1159t2088r1189b2111],
5	Current	JJ	DATE	current	amod	6	SENT_149	[p9l314t2145r417b2169],
6	smoker	NN	O	smoker	dep	2	SENT_149	[p9l427t2143r528b2169],
7	424	CD	NUMBER	424	num	8	SENT_149	[p9l905t2146r953b2168],
8	25	CD	NUMBER	25	npadvmod	9	SENT_149	[p9l1159t2146r1188b2169],
9	Never	RB	O	never	advmod	6	SENT_149	[p9l316t2203r395b2226],
10	smoked	JJ	O	smoked	amod	6	SENT_149	[p9l405t2201r510b2226],
11	612	CD	NUMBER	612	tmod	10	SENT_149	[p9l906t2203r952b2226],

1	9.5	CD	NUMBER	9.5	num	2	SENT_150	[p9l1351t2088r1389b2111],
2	(	NN	O	(	_	0	SENT_150	[p9l1403t2087r1536b2119],
3	7.8	CD	NUMBER	7.8	number	4	SENT_150	[p9l1403t2087r1536b2119],
4	—	CD	NUMBER	—	dep	2	SENT_150	[p9l1403t2087r1536b2119],
5	11.6	CD	NUMBER	11.6	num	6	SENT_150	[p9l1403t2087r1536b2119],
6	)	NN	O	)	dep	4	SENT_150	[p9l1403t2087r1536b2119],
7	5.8	CD	NUMBER	5.8	dep	2	SENT_150	[p9l1351t2145r1390b2169],
8	(	CD	NUMBER	(	number	9	SENT_150	[p9l1403t2145r1520b2176],
9	4.0	CD	NUMBER	4.0	dep	7	SENT_150	[p9l1403t2145r1520b2176],
10	—	NN	O	—	dep	9	SENT_150	[p9l1403t2145r1520b2176],
11	8.6	CD	NUMBER	8.6	num	10	SENT_150	[p9l1403t2145r1520b2176],
12	)	CD	NUMBER	)	number	13	SENT_150	[p9l1403t2145r1520b2176],
13	37.7	CD	NUMBER	37.7	dep	2	SENT_150	[p9l1335t2203r1390b2226],
14	(	NN	O	(	dep	13	SENT_150	[p9l1403t2203r1553b2234],
15	34	CD	NUMBER	34	num	14	SENT_150	[p9l1403t2203r1553b2234],
16	.	.	O	.	_	0	SENT_150	[p9l1403t2203r1553b2234],

1	c	NN	O	c	dep	12	SENT_151	[p9l1403t2203r1553b2234],
2	»	CD	NUMBER	»	num	3	SENT_151	[p9l1403t2203r1553b2234],
3	41.7	CD	NUMBER	41.7	dep	1	SENT_151	[p9l1403t2203r1553b2234],
4	)	CD	NUMBER	)	number	5	SENT_151	[p9l1403t2203r1553b2234],
5	26.2	CD	NUMBER	26.2	num	6	SENT_151	[p9l1652t2088r1707b2111],
6	(	NN	O	(	dep	3	SENT_151	[p9l1721t2087r1871b2119],
7	24.2	CD	NUMBER	24.2	number	8	SENT_151	[p9l1721t2087r1871b2119],
8	—	CD	NUMBER	—	num	6	SENT_151	[p9l1721t2087r1871b2119],
9	28.2	CD	NUMBER	28.2	num	10	SENT_151	[p9l1721t2087r1871b2119],
10	)	NN	O	)	dep	12	SENT_151	[p9l1721t2087r1871b2119],
11	7.2	CD	NUMBER	7.2	num	12	SENT_151	[p9l1670t2146r1707b2169],
12	(	CD	NUMBER	(	dep	18	SENT_151	[p9l1721t2145r1837b2176],
13	6.5	CD	NUMBER	6.5	num	14	SENT_151	[p9l1721t2145r1837b2176],
14	—	NN	O	—	dep	12	SENT_151	[p9l1721t2145r1837b2176],
15	7.9	CD	NUMBER	7.9	number	16	SENT_151	[p9l1721t2145r1837b2176],
16	)	CD	NUMBER	)	dep	14	SENT_151	[p9l1721t2145r1837b2176],
17	66.6	CD	NUMBER	66.6	num	18	SENT_151	[p9l1652t2203r1708b2226],
18	(	NN	O	(	dep	22	SENT_151	[p9l1721t2203r1871b2234],
19	64.2	CD	NUMBER	64.2	num	20	SENT_151	[p9l1721t2203r1871b2234],
20	—	CD	NUMBER	—	dep	18	SENT_151	[p9l1721t2203r1871b2234],
21	68.9	CD	NUMBER	68.9	num	22	SENT_151	[p9l1721t2203r1871b2234],
22	)	NN	O	)	_	0	SENT_151	[p9l1721t2203r1871b2234],

1	Missing	VBG	O	miss	_	0	SENT_152	[p9l316t2261r423b2292],
2	data	NNS	O	datum	nsubj	4	SENT_152	[p9l432t2259r489b2284],
3	111	CD	NUMBER	111	num	4	SENT_152	[p9l907t2261r952b2284],
4	3	CD	NUMBER	3	xcomp	1	SENT_152	[p9l1176t2261r1188b2284],

1	Tumor	NN	O	tumor	nn	2	SENT_153	[p9l263t2319r356b2342],
2	type	NN	O	type	_	0	SENT_153	[p9l364t2321r420b2349],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_154	[p9l313t2374r545b2399],
2	1634	CD	DATE	1634	num	4	SENT_154	[p9l890t2376r953b2399],
3	Bronchioloalveolar	JJ	O	bronchioloalveolar	amod	4	SENT_154	[p9l316t2432r571b2457],
4	adenocarcinoma	NN	O	adenocarcinoma	dep	1	SENT_154	[p9l580t2432r807b2457],
5	147	CD	NUMBER	147	dep	1	SENT_154	[p9l907t2434r953b2457],

1	80.9	CD	NUMBER	80.9	_	0	SENT_155	[p9l1652t2376r1708b2399],
2	(	CD	NUMBER	(	number	3	SENT_155	[p9l1721t2376r1870b2407],
3	76.4	CD	NUMBER	76.4	num	5	SENT_155	[p9l1721t2376r1870b2407],
4	—	CD	NUMBER	—	number	5	SENT_155	[p9l1721t2376r1870b2407],
5	84.7	CD	NUMBER	84.7	dep	1	SENT_155	[p9l1721t2376r1870b2407],
6	)	NN	O	)	dep	5	SENT_155	[p9l1721t2376r1870b2407],
7	9.7	CD	NUMBER	9.7	num	8	SENT_155	[p9l1669t2434r1708b2457],
8	(	NN	O	(	dep	1	SENT_155	[p9l1721t2433r1854b2465],
9	7	CD	NUMBER	7	dep	8	SENT_155	[p9l1721t2433r1854b2465],
10	.	.	O	.	_	0	SENT_155	[p9l1721t2433r1854b2465],

1	o	NN	O	o	_	0	SENT_156	[p9l1721t2433r1854b2465],
2	—	CD	NUMBER	—	number	3	SENT_156	[p9l1721t2433r1854b2465],
3	13.3	CD	NUMBER	13.3	num	4	SENT_156	[p9l1721t2433r1854b2465],
4	)	NN	O	)	dep	1	SENT_156	[p9l1721t2433r1854b2465],
5	9.4	CD	NUMBER	9.4	num	6	SENT_156	[p9l1669t2491r1708b2515],
6	(	NN	O	(	dep	1	SENT_156	[p9l1721t2491r1854b2522],
7	6.8	CD	NUMBER	6.8	number	8	SENT_156	[p9l1721t2491r1854b2522],
8	—	CD	NUMBER	—	dep	6	SENT_156	[p9l1721t2491r1854b2522],
9	13.0	CD	NUMBER	13.0	num	10	SENT_156	[p9l1721t2491r1854b2522],
10	)	NN	O	)	dep	8	SENT_156	[p9l1721t2491r1854b2522],

1	Large-cell	JJ	O	large-cell	amod	2	SENT_157	[p9l316t2489r442b2523],
2	carcinoma	NN	O	carcinoma	_	0	SENT_157	[p9l453t2492r595b2515],
3	287	CD	NUMBER	287	num	2	SENT_157	[p9l905t2491r953b2515],
4	Missing	VBG	O	miss	partmod	2	SENT_157	[p9l316t2549r423b2580],
5	data	NNS	O	datum	dobj	4	SENT_157	[p9l432t2547r489b2572],
6	37	CD	NUMBER	37	tmod	4	SENT_157	[p9l922t2549r953b2572],

1	*	NN	O	*	nsubj	4	SENT_158	[p9l237t2634r252b2649],
2	‘	CD	NUMBER	‘	num	3	SENT_158	[p9l237t2634r252b2649],
3	Cl	NN	O	cl	dep	1	SENT_158	[p9l262t2634r288b2657],
4	denotes	VBZ	O	denote	_	0	SENT_158	[p9l301t2632r409b2657],
5	confidence	NN	O	confidence	nn	6	SENT_158	[p9l421t2632r569b2657],
6	interval	NN	O	interval	dobj	4	SENT_158	[p9l582t2632r688b2657],
7	.	.	O	.	_	0	SENT_158	[p9l582t2632r688b2657],

1	patients	NNS	O	patient	nsubjpass	9	SENT_159	[p9l10t2887r344b2987],
2	who	WP	O	who	nsubj	3	SENT_159	[p9l372t2887r553b2966],
3	received	VBD	O	receive	rcmod	1	SENT_159	[p9l585t2886r923b2966],
4	erlotinib	NN	O	erlotinib	dobj	3	SENT_159	[p9l954t2887r1333b2982],
5	,	,	O	,	_	0	SENT_159	[p9l954t2887r1333b2982],
6	197	CD	NUMBER	197	appos	4	SENT_159	[p9l1373t2892r1516b2965],
7	could	MD	O	could	aux	9	SENT_159	[p9l1549t2887r1779b2966],
8	be	VB	O	be	auxpass	9	SENT_159	[p9l1810t2887r1905b2965],
9	evaluated	VBN	O	evaluate	_	0	SENT_159	[p9l1937t2886r2132b2966, p9l11t3014r250b3094],
10	for	IN	O	for	_	0	SENT_159	[p9l289t3014r414b3093],
11	a	DT	O	a	det	12	SENT_159	[p9l449t3041r494b3093],
12	response	NN	O	response	prep_for	9	SENT_159	[p9l532t3040r944b3115],
13	.	.	O	.	_	0	SENT_159	[p9l532t3040r944b3115],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_160	[p9l986t3021r1202b3094],
2	mutations	NNS	O	mutation	nsubjpass	5	SENT_160	[p9l1235t3015r1678b3094],
3	were	VBD	O	be	auxpass	5	SENT_160	[p9l1714t3041r1919b3094],
4	also	RB	O	also	advmod	5	SENT_160	[p9l1958t3015r2133b3093],
5	assessed	VBN	O	assess	_	0	SENT_160	[p9l11t3142r379b3221],
6	in	IN	O	in	_	0	SENT_160	[p9l419t3143r503b3220],
7	paired	JJ	O	paired	amod	9	SENT_160	[p9l542t3142r815b3243],
8	serum	NN	O	serum	nn	9	SENT_160	[p9l857t3169r1125b3222],
9	samples	NNS	O	sample	prep_in	5	SENT_160	[p9l1168t3142r1512b3243],
10	from	IN	O	from	_	0	SENT_160	[p9l1556t3142r1765b3221],
11	the	DT	O	the	det	13	SENT_160	[p9l1807t3143r1940b3221],
12	164	CD	NUMBER	164	num	13	SENT_160	[p9l1984t3148r2133b3221],
13	patients	NNS	O	patient	prep_from	5	SENT_160	[p9l10t3271r351b3371],
14	for	IN	O	for	_	0	SENT_160	[p9l395t3270r518b3349],
15	whom	WP	O	whom	dobj	19	SENT_160	[p9l553t3271r824b3350],
16	baseline	NN	O	baseline	nn	18	SENT_160	[p9l867t3270r1218b3349],
17	blood	NN	O	blood	nn	18	SENT_160	[p9l1262t3271r1504b3349],
18	samples	NNS	O	sample	nsubj	19	SENT_160	[p9l1547t3271r1892b3371],
19	were	VBD	O	be	prepc_for	13	SENT_160	[p9l1931t3297r2133b3350],
20	available	JJ	O	available	acomp	19	SENT_160	[p9l11t3398r382b3478],
21	(	CD	NUMBER	(	num	22	SENT_160	[p9l422t3399r683b3490],
22	Table	NNP	O	Table	dep	20	SENT_160	[p9l422t3399r683b3490],
23	2	CD	NUMBER	2	num	22	SENT_160	[p9l720t3404r768b3476],
24	and	CC	O	and	_	0	SENT_160	[p9l804t3398r962b3477],
25	Fig	NN	O	fig	dep	20	SENT_160	[p9l995t3399r1149b3499],
26	.	.	O	.	_	0	SENT_160	[p9l995t3399r1149b3499],

1	1	CD	NUMBER	1	_	0	SENT_161	[p9l1195t3404r1290b3490],
2	)	NN	O	)	dep	1	SENT_161	[p9l1195t3404r1290b3490],
3	.	.	O	.	_	0	SENT_161	[p9l1195t3404r1290b3490],

1	Table	NNP	O	Table	dep	2	SENT_162	[p9l137t3527r371b3605],
2	2	CD	NUMBER	2	amod	3	SENT_162	[p9l414t3532r461b3604],
3	shows	NNS	O	show	_	0	SENT_162	[p9l506t3527r774b3606],
4	characteristics	NNS	O	characteristic	dep	3	SENT_162	[p9l820t3527r1456b3605],
5	of	IN	O	of	_	0	SENT_162	[p9l1502t3526r1603b3605],
6	the	DT	O	the	det	8	SENT_162	[p9l1627t3527r1762b3605],
7	217	CD	NUMBER	217	num	8	SENT_162	[p9l1805t3532r1956b3605],
8	patients	NNS	O	patient	prep_of	4	SENT_162	[p9l1998t3553r2132b3627, p9l12t3655r242b3733],
9	who	WP	O	who	nsubj	10	SENT_162	[p9l270t3655r451b3734],
10	received	VBD	O	receive	rcmod	4	SENT_162	[p9l483t3655r821b3734],
11	erlotinib	NN	O	erlotinib	dobj	10	SENT_162	[p9l852t3655r1231b3733],
12	.	.	O	.	_	0	SENT_162	[p9l852t3655r1231b3733],

1	The	DT	O	the	det	3	SENT_163	[p9l1265t3655r1423b3733],
2	median	JJ	O	median	amod	3	SENT_163	[p9l1454t3654r1772b3733],
3	age	NN	O	age	nsubj	4	SENT_163	[p9l1801t3681r1942b3755],
4	was	VBD	O	be	_	0	SENT_163	[p9l1969t3681r2131b3734],

1	67	CD	DURATION	67	num	2	SENT_164	[p10l12t26r109b99],
2	years	NNS	DURATION	year	_	0	SENT_164	[p10l139t47r383b121],
3	;	:	O	;	_	0	SENT_164	[p10l139t47r383b121],
4	most	JJS	O	most	nsubj	10	SENT_164	[p10l421t37r637b99],
5	of	IN	O	of	_	0	SENT_164	[p10l666t20r766b99],
6	the	DT	O	the	det	7	SENT_164	[p10l781t21r914b99],
7	patients	NNS	O	patient	prep_of	4	SENT_164	[p10l946t21r1288b121],
8	were	VBD	O	be	cop	10	SENT_164	[p10l1319t47r1520b100],
9	White	NNP	MISC	White	nn	10	SENT_164	[p10l1549t21r1788b100],
10	Women	NNP	MISC	Women	dep	2	SENT_164	[p10l1817t46r2133b100],
11	Who	WP	MISC	who	nsubj	14	SENT_164	[p10l7t149r185b228],
12	had	VBD	O	have	aux	14	SENT_164	[p10l224t149r376b227],
13	never	RB	O	never	neg	14	SENT_164	[p10l412t174r633b228],
14	smoked	VBN	O	smoke	rcmod	10	SENT_164	[p10l669t149r990b228],
15	and	CC	O	and	_	0	SENT_164	[p10l1026t149r1180b227],
16	had	VBD	O	have	conj_and	14	SENT_164	[p10l1217t148r1368b227],
17	an	DT	O	a	det	20	SENT_164	[p10l1405t174r1505b227],
18	adenocarcino	NN	O	adenocarcino	nn	20	SENT_164	[p10l1542t149r2132b227],
19	—	CD	NUMBER	—	num	20	SENT_164	[p10l1542t149r2132b227],
20	ma	NN	O	ma	dobj	16	SENT_164	[p10l11t303r168b372],
21	,	,	O	,	_	0	SENT_164	[p10l11t303r168b372],
22	With	IN	O	with	_	0	SENT_164	[p10l207t277r406b356],
23	an	DT	O	a	det	26	SENT_164	[p10l443t302r547b355],
24	ECOG	NN	O	ecog	nn	26	SENT_164	[p10l584t282r853b355],
25	performance	NN	O	performance	nn	26	SENT_164	[p10l892t276r1457b377],
26	status	NN	O	status	prep_with	10	SENT_164	[p10l1497t293r1754b356],
27	of	IN	O	of	_	0	SENT_164	[p10l1794t276r1895b355],
28	1	CD	NUMBER	1	prep_of	26	SENT_164	[p10l1918t282r1986b355],
29	.	.	O	.	_	0	SENT_164	[p10l1918t282r1986b355],

1	Of	IN	O	of	_	0	SENT_165	[p10l2029t276r2152b355],
2	these	DT	O	these	det	3	SENT_165	[p10l12t405r235b483],
3	patients	NNS	O	patient	prep_of	6	SENT_165	[p10l268t405r634b505],
4	,	,	O	,	_	0	SENT_165	[p10l268t405r634b505],
5	113	CD	NUMBER	113	nsubj	6	SENT_165	[p10l676t410r823b483],
6	received	VBD	O	receive	_	0	SENT_165	[p10l861t405r1205b484],
7	erlotinib	NN	O	erlotinib	dobj	6	SENT_165	[p10l1240t405r1607b483],
8	as	IN	O	as	_	0	SENT_165	[p10l1641t431r1727b483],
9	first	JJ	ORDINAL	first	amod	12	SENT_165	[p10l1763t404r2133b483],
10	—	NN	O	—	nn	12	SENT_165	[p10l1763t404r2133b483],
11	line	NN	O	line	nn	12	SENT_165	[p10l1763t404r2133b483],
12	therapy	NN	O	therapy	prep_as	6	SENT_165	[p10l12t533r346b633],
13	,	,	O	,	_	0	SENT_165	[p10l12t533r346b633],
14	and	CC	O	and	_	0	SENT_165	[p10l387t533r545b611],
15	104	CD	NUMBER	104	nsubj	16	SENT_165	[p10l585t538r733b611],
16	received	VBD	O	receive	conj_and	6	SENT_165	[p10l769t532r1114b612],
17	the	DT	O	the	det	18	SENT_165	[p10l1151t533r1283b611],
18	drug	NN	O	drug	dobj	16	SENT_165	[p10l1320t533r1524b633],
19	as	IN	O	as	_	0	SENT_165	[p10l1556t559r1641b611],
20	second	JJ	ORDINAL	second	amod	21	SENT_165	[p10l1682t533r2009b611],
21	—	NN	O	—	prep_as	16	SENT_165	[p10l1682t533r2009b611],
22	or	CC	O	or	_	0	SENT_165	[p10l2047t558r2136b611],
23	third	JJ	ORDINAL	third	amod	26	SENT_165	[p10l12t660r398b739],
24	—	NN	O	—	nn	26	SENT_165	[p10l12t660r398b739],
25	line	NN	O	line	nn	26	SENT_165	[p10l12t660r398b739],
26	therapy	NN	O	therapy	prep_as	16	SENT_165	[p10l435t661r754b761],
27	.	.	O	.	_	0	SENT_165	[p10l435t661r754b761],

1	EGFR	NN	ORGANIZATION	egfr	nsubjpass	6	SENT_166	[p10l794t667r1000b740],
2	del	FW	O	del	dep	1	SENT_166	[p10l1030t661r1150b739],
3	19	CD	NUMBER	19	num	4	SENT_166	[p10l1190t666r1283b739],
4	mutations	NNS	O	mutation	dep	1	SENT_166	[p10l1320t661r1737b740],
5	were	VBD	O	be	auxpass	6	SENT_166	[p10l1770t687r1965b740],
6	detected	VBN	O	detect	_	0	SENT_166	[p10l2003t661r2132b739, p10l12t787r268b866],
7	in	IN	O	in	_	0	SENT_166	[p10l300t788r383b864],
8	135	CD	NUMBER	135	num	9	SENT_166	[p10l419t793r563b866],
9	tumors	NNS	O	tumor	prep_in	6	SENT_166	[p10l599t804r931b882],
10	,	,	O	,	_	0	SENT_166	[p10l599t804r931b882],
11	and	CC	O	and	_	0	SENT_166	[p10l969t788r1127b866],
12	the	DT	O	the	det	14	SENT_166	[p10l1160t788r1292b865],
13	L858R	NN	O	l858r	nn	14	SENT_166	[p10l1324t793r1604b871],
14	mutation	NN	O	mutation	prep_in	6	SENT_166	[p10l1626t788r2018b866],
15	in	IN	O	in	_	0	SENT_166	[p10l2050t788r2133b864],
16	82	CD	NUMBER	82	num	17	SENT_166	[p10l12t921r107b994],
17	tumors	NNS	O	tumor	prep_in	14	SENT_166	[p10l141t932r460b995],
18	.	.	O	.	_	0	SENT_166	[p10l141t932r460b995],

1	Of	IN	O	of	_	0	SENT_167	[p10l497t915r616b994],
2	the	DT	O	the	det	4	SENT_167	[p10l631t916r759b994],
3	164	CD	NUMBER	164	num	4	SENT_167	[p10l795t921r940b994],
4	patients	NNS	O	patient	prep_of	15	SENT_167	[p10l969t916r1296b1016],
5	in	IN	O	in	_	0	SENT_167	[p10l1329t916r1411b993],
6	whom	WP	O	whom	rel	10	SENT_167	[p10l1438t916r1702b995],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_167	[p10l1733t922r1939b995],
8	mutations	NNS	O	mutation	nsubjpass	10	SENT_167	[p10l1965t942r2132b995, p10l12t1043r305b1121],
9	Were	VBD	O	be	auxpass	10	SENT_167	[p10l336t1069r537b1122],
10	assessed	VBN	O	assess	rcmod	4	SENT_167	[p10l570t1043r938b1121],
11	in	IN	O	in	_	0	SENT_167	[p10l970t1043r1053b1119],
12	serum	NN	O	serum	prep_in	10	SENT_167	[p10l1088t1069r1379b1137],
13	,	,	O	,	_	0	SENT_167	[p10l1088t1069r1379b1137],
14	97	CD	NUMBER	97	nsubj	15	SENT_167	[p10l1418t1048r1515b1121],
15	carried	VBD	O	carry	_	0	SENT_167	[p10l1550t1043r1850b1121],
16	mutations	NNS	O	mutation	dobj	15	SENT_167	[p10l1882t1059r2132b1122, p10l12t1171r242b1249],
17	:	:	O	:	_	0	SENT_167	[p10l1882t1059r2132b1122, p10l12t1171r242b1249],
18	del	FW	O	del	dep	16	SENT_167	[p10l289t1170r411b1249],
19	19	CD	NUMBER	19	dep	18	SENT_167	[p10l456t1176r550b1249],
20	in	IN	O	in	_	0	SENT_167	[p10l593t1171r675b1248],
21	64	CD	NUMBER	64	num	22	SENT_167	[p10l718t1176r819b1249],
22	patients	NNS	O	patient	prep_in	15	SENT_167	[p10l859t1171r1193b1271],
23	and	CC	O	and	_	0	SENT_167	[p10l1236t1171r1392b1249],
24	L858R	NN	O	l858r	prep_in	15	SENT_167	[p10l1432t1176r1709b1254],
25	in	IN	O	in	_	0	SENT_167	[p10l1739t1171r1822b1248],
26	33	CD	NUMBER	33	num	27	SENT_167	[p10l1864t1176r1957b1249],
27	patients	NNS	O	patient	prep_in	15	SENT_167	[p10l2001t1197r2132b1271, p10l12t1299r273b1377],
28	.	.	O	.	_	0	SENT_167	[p10l2001t1197r2132b1271, p10l12t1299r273b1377],

1	(	NN	O	(	npadvmod	12	SENT_168	[p10l314t1305r486b1390],
2	For	IN	O	for	_	0	SENT_168	[p10l314t1305r486b1390],
3	additional	JJ	O	additional	amod	4	SENT_168	[p10l514t1298r950b1377],
4	details	NNS	O	detail	prep_for	12	SENT_168	[p10l982t1299r1264b1377],
5	on	IN	O	on	_	0	SENT_168	[p10l1298t1324r1404b1377],
6	patients	NNS	O	patient	prep_on	4	SENT_168	[p10l1434t1299r1775b1399],
7	with	IN	O	with	_	0	SENT_168	[p10l1805t1299r2000b1378],
8	an	DT	O	a	det	10	SENT_168	[p10l2031t1324r2133b1377],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_168	[p10l9t1433r215b1506],
10	mutation	NN	O	mutation	prep_with	6	SENT_168	[p10l244t1427r643b1522],
11	,	,	O	,	_	0	SENT_168	[p10l244t1427r643b1522],
12	see	VB	O	see	_	0	SENT_168	[p10l685t1453r811b1505],
13	the	DT	O	the	det	17	SENT_168	[p10l846t1427r975b1505],
14	Supplementary	NNP	O	Supplementary	nn	17	SENT_168	[p10l1013t1427r1633b1527],
15	Appendix	NNP	O	Appendix	nn	17	SENT_168	[p10l1660t1427r2116b1527],
16	.	.	O	.	_	0	SENT_168	[p10l1660t1427r2116b1527],
17	)	NN	O	)	dobj	12	SENT_168	[p10l1660t1427r2116b1527],

1	R	NN	O	r	nn	3	SENT_169	[p10l16t1552r53b1601],
2	E	NN	O	e	nn	3	SENT_169	[p10l68t1552r101b1601],
3	s	NNS	O	s	nsubj	4	SENT_169	[p10l113t1552r150b1601],
4	PO	VBP	O	po	_	0	SENT_169	[p10l164t1552r265b1601],
5	N	NN	O	n	nn	7	SENT_169	[p10l282t1552r325b1601],
6	s	NNS	O	s	nn	7	SENT_169	[p10l341t1552r377b1601],
7	E	NN	O	e	dobj	4	SENT_169	[p10l392t1552r426b1601],

1	Of	IN	O	of	_	0	SENT_170	[p10l11t1660r130b1740],
2	the	DT	O	the	det	4	SENT_170	[p10l141t1661r269b1739],
3	197	CD	NUMBER	197	num	4	SENT_170	[p10l301t1667r443b1740],
4	patients	NNS	O	patient	prep_of	11	SENT_170	[p10l471t1662r798b1761],
5	who	WP	O	who	nsubjpass	8	SENT_170	[p10l825t1661r1003b1741],
6	could	MD	O	could	aux	8	SENT_170	[p10l1034t1661r1260b1740],
7	be	VB	O	be	auxpass	8	SENT_170	[p10l1289t1661r1383b1740],
8	evaluated	VBN	O	evaluate	rcmod	4	SENT_170	[p10l1413t1661r1818b1757],
9	,	,	O	,	_	0	SENT_170	[p10l1413t1661r1818b1757],
10	24	CD	NUMBER	24	nsubj	11	SENT_170	[p10l1853t1667r1948b1739],
11	had	VBD	O	have	_	0	SENT_170	[p10l1977t1661r2133b1740],
12	a	DT	O	a	det	14	SENT_170	[p10l11t1815r55b1866],
13	complete	JJ	O	complete	amod	14	SENT_170	[p10l97t1789r493b1888],
14	response	NN	O	response	dobj	11	SENT_170	[p10l536t1814r948b1888],
15	,	,	O	,	_	0	SENT_170	[p10l536t1814r948b1888],
16	and	CC	O	and	_	0	SENT_170	[p10l996t1789r1156b1867],
17	115	CD	NUMBER	115	nsubj	18	SENT_170	[p10l1202t1794r1350b1867],
18	had	VBD	O	have	conj_and	11	SENT_170	[p10l1396t1789r1555b1867],
19	a	DT	O	a	det	21	SENT_170	[p10l1597t1815r1641b1866],
20	partial	JJ	O	partial	amod	21	SENT_170	[p10l1681t1789r1974b1888],
21	response	NN	O	response	dobj	18	SENT_170	[p10l2017t1815r2132b1866, p10l12t1943r318b2017],
22	;	:	O	;	_	0	SENT_170	[p10l2017t1815r2132b1866, p10l12t1943r318b2017],
23	38	CD	NUMBER	38	nsubj	24	SENT_170	[p10l353t1922r448b1996],
24	had	VBD	O	have	conj_and	11	SENT_170	[p10l480t1917r633b1996],
25	stable	JJ	O	stable	amod	26	SENT_170	[p10l664t1917r901b1996],
26	disease	NN	O	disease	dobj	24	SENT_170	[p10l932t1917r1249b2013],
27	,	,	O	,	_	0	SENT_170	[p10l932t1917r1249b2013],
28	and	CC	O	and	_	0	SENT_170	[p10l1285t1917r1439b1996],
29	20	CD	NUMBER	20	nsubj	30	SENT_170	[p10l1468t1922r1565b1996],
30	had	VBD	O	have	conj_and	11	SENT_170	[p10l1596t1917r1749b1996],
31	progressive	JJ	O	progressive	amod	32	SENT_170	[p10l1777t1943r2132b2018, p10l12t2046r166b2124],
32	disease	NN	O	disease	dobj	30	SENT_170	[p10l204t2045r514b2124],
33	(	CD	NUMBER	(	num	34	SENT_170	[p10l556t2045r818b2136],
34	Table	NNP	O	Table	dep	32	SENT_170	[p10l556t2045r818b2136],
35	2	CD	NUMBER	2	num	34	SENT_170	[p10l858t2050r929b2141],
36	,	,	O	,	_	0	SENT_170	[p10l858t2050r929b2141],
37	and	CC	O	and	_	0	SENT_170	[p10l972t2045r1129b2124],
38	Tables	NNP	O	Tables	dobj	30	SENT_170	[p10l1163t2045r1441b2124],
39	1	CD	NUMBER	1	num	38	SENT_170	[p10l1486t2050r1530b2122],
40	through	IN	O	through	_	0	SENT_170	[p10l1570t2045r1925b2146],
41	5	CD	NUMBER	5	prep_through	38	SENT_170	[p10l1966t2052r2009b2124],
42	in	IN	O	in	_	0	SENT_170	[p10l2050t2046r2133b2122],
43	the	DT	O	the	det	46	SENT_170	[p10l12t2173r144b2250],
44	Supplementary	NNP	O	Supplementary	nn	46	SENT_170	[p10l184t2173r831b2272],
45	Appendix	NNP	O	Appendix	nn	46	SENT_170	[p10l860t2173r1326b2272],
46	)	NN	O	)	prep_in	30	SENT_170	[p10l860t2173r1326b2272],
47	.	.	O	.	_	0	SENT_170	[p10l860t2173r1326b2272],

1	A	DT	O	a	det	47	SENT_171	[p10l1365t2180r1431b2249],
2	better	JJR	O	better	amod	47	SENT_171	[p10l1467t2173r1719b2251],
3	response	NN	O	response	nsubjpass	5	SENT_171	[p10l1753t2198r2134b2272],
4	was	VBD	O	be	auxpass	5	SENT_171	[p10l7t2328r167b2381],
5	associated	VBN	O	associate	ccomp	2	SENT_171	[p10l196t2302r631b2381],
6	with	IN	O	with	_	0	SENT_171	[p10l654t2302r846b2381],
7	the	DT	O	the	det	8	SENT_171	[p10l874t2302r1004b2380],
8	del	FW	O	del	prep_with	5	SENT_171	[p10l1033t2302r1155b2381],
9	19	CD	NUMBER	19	num	10	SENT_171	[p10l1186t2307r1280b2381],
10	mutation	NN	O	mutation	npadvmod	11	SENT_171	[p10l1309t2303r1694b2381],
11	than	IN	O	than	advmod	5	SENT_171	[p10l1722t2302r1915b2380],
12	with	IN	O	with	_	0	SENT_171	[p10l1938t2302r2133b2381],
13	the	DT	O	the	det	18	SENT_171	[p10l12t2430r144b2508],
14	L858R	NN	O	l858r	nn	18	SENT_171	[p10l175t2436r455b2513],
15	mutation	NN	O	mutation	nn	18	SENT_171	[p10l476t2431r869b2509],
16	(	CD	NUMBER	(	num	18	SENT_171	[p10l906t2430r1133b2521],
17	odds	NNS	O	odds	nn	18	SENT_171	[p10l906t2430r1133b2521],
18	ratio	NN	O	ratio	prep_with	5	SENT_171	[p10l1167t2431r1386b2526],
19	,	,	O	,	_	0	SENT_171	[p10l1167t2431r1386b2526],
20	3.08	CD	NUMBER	3.08	appos	18	SENT_171	[p10l1425t2436r1626b2525],
21	;	:	O	;	_	0	SENT_171	[p10l1425t2436r1626b2525],
22	95	CD	PERCENT	95	number	23	SENT_171	[p10l1663t2435r1847b2509],
23	%	NN	PERCENT	%	amod	24	SENT_171	[p10l1663t2435r1847b2509],
24	confidence	NN	O	confidence	dep	18	SENT_171	[p10l1878t2429r2132b2509, p10l12t2558r256b2636],
25	interval	NN	O	interval	nn	28	SENT_171	[p10l285t2558r611b2636],
26	[	CD	NUMBER	[	num	28	SENT_171	[p10l649t2563r825b2653],
27	CI	NN	O	ci	nn	28	SENT_171	[p10l649t2563r825b2653],
28	]	NN	O	]	dep	24	SENT_171	[p10l649t2563r825b2653],
29	,	,	O	,	_	0	SENT_171	[p10l649t2563r825b2653],
30	1.63	CD	NUMBER	1.63	number	32	SENT_171	[p10l863t2563r1035b2636],
31	to	TO	O	to	dep	32	SENT_171	[p10l1068t2574r1150b2636],
32	5.81	CD	NUMBER	5.81	conj_and	18	SENT_171	[p10l1183t2563r1382b2652],
33	;	:	O	;	_	0	SENT_171	[p10l1183t2563r1382b2652],
34	P	NN	O	p	dep	32	SENT_171	[p10l1414t2563r1809b2648],
35	=	JJ	O	=	amod	37	SENT_171	[p10l1414t2563r1809b2648],
36	0.001	CD	NUMBER	0.001	tmod	35	SENT_171	[p10l1414t2563r1809b2648],
37	)	NN	O	)	dep	34	SENT_171	[p10l1414t2563r1809b2648],
38	and	CC	O	and	_	0	SENT_171	[p10l1844t2558r2001b2636],
39	an	DT	O	a	det	40	SENT_171	[p10l2031t2583r2133b2635],
40	age	NN	O	age	conj_and	18	SENT_171	[p10l11t2711r152b2786],
41	between	IN	O	between	_	0	SENT_171	[p10l179t2685r530b2764],
42	61	CD	NUMBER	61	prep_between	40	SENT_171	[p10l557t2690r652b2764],
43	and	CC	O	and	_	0	SENT_171	[p10l678t2685r834b2764],
44	70	CD	DURATION	70	num	45	SENT_171	[p10l861t2690r955b2764],
45	years	NNS	NUMBER	year	tmod	46	SENT_171	[p10l978t2711r1194b2785],
46	(	JJ	O	(	amod	47	SENT_171	[p10l1227t2685r1450b2776],
47	odds	NNS	O	odds	_	0	SENT_171	[p10l1227t2685r1450b2776],
48	ratio	NN	O	ratio	dep	47	SENT_171	[p10l1479t2686r1693b2781],
49	,	,	O	,	_	0	SENT_171	[p10l1479t2686r1693b2781],
50	2.55	CD	NUMBER	2.55	appos	48	SENT_171	[p10l1725t2690r1919b2780],
51	;	:	O	;	_	0	SENT_171	[p10l1725t2690r1919b2780],
52	95	CD	PERCENT	95	number	53	SENT_171	[p10l1950t2690r2134b2764],
53	%	NN	PERCENT	%	amod	54	SENT_171	[p10l1950t2690r2134b2764],
54	CI	NN	O	ci	dep	47	SENT_171	[p10l11t2819r126b2909],
55	,	,	O	,	_	0	SENT_171	[p10l11t2819r126b2909],
56	1.32	CD	NUMBER	1.32	num	58	SENT_171	[p10l170t2819r342b2892],
57	to	TO	O	to	dep	58	SENT_171	[p10l378t2830r460b2892],
58	4.96	CD	NUMBER	4.96	appos	54	SENT_171	[p10l494t2819r697b2908],
59	;	:	O	;	_	0	SENT_171	[p10l494t2819r697b2908],
60	P	NN	O	p	dep	47	SENT_171	[p10l735t2819r1162b2904],
61	=	JJ	O	=	amod	63	SENT_171	[p10l735t2819r1162b2904],
62	0.006	CD	NUMBER	0.006	tmod	61	SENT_171	[p10l735t2819r1162b2904],
63	)	NN	O	)	dep	60	SENT_171	[p10l735t2819r1162b2904],
64	.	.	O	.	_	0	SENT_171	[p10l735t2819r1162b2904],

1	PROGRESSION-FREE	JJ	O	progression-free	nsubj	6	SENT_172	[p10l17t3088r813b3138],
2	AND	CC	O	and	_	0	SENT_172	[p10l846t3089r1015b3137],
3	OVERALL	JJ	O	overall	amod	4	SENT_172	[p10l1050t3088r1399b3138],
4	SURVIVAL	NN	O	survival	conj_and	1	SENT_172	[p10l1431t3088r1810b3138],
5	Median	JJ	O	median	amod	6	SENT_172	[p10l8t3188r328b3267],
6	folloW	NN	O	follow	_	0	SENT_172	[p10l359t3187r759b3288],
7	—	CD	NUMBER	—	nsubj	13	SENT_172	[p10l359t3187r759b3288],
8	up	RP	O	up	advmod	7	SENT_172	[p10l359t3187r759b3288],
9	was	VBD	O	be	cop	13	SENT_172	[p10l787t3214r947b3267],
10	14	CD	DURATION	14	num	11	SENT_172	[p10l984t3193r1075b3266],
11	months	NNS	NUMBER	month	tmod	12	SENT_172	[p10l1106t3188r1428b3267],
12	(	JJ	O	(	amod	13	SENT_172	[p10l1466t3195r1748b3289],
13	range	NN	O	range	rcmod	6	SENT_172	[p10l1466t3195r1748b3289],
14	,	,	O	,	_	0	SENT_172	[p10l1466t3195r1748b3289],
15	1	CD	NUMBER	1	number	17	SENT_172	[p10l1789t3194r1833b3265],
16	to	TO	O	to	dep	17	SENT_172	[p10l1865t3205r1946b3267],
17	42	CD	NUMBER	42	num	18	SENT_172	[p10l1976t3194r2128b3279],
18	)	CD	NUMBER	)	dobj	6	SENT_172	[p10l1976t3194r2128b3279],
19	.	.	O	.	_	0	SENT_172	[p10l1976t3194r2128b3279],

1	Median	JJ	O	median	amod	5	SENT_173	[p10l8t3316r323b3395],
2	progression	NN	O	progression	nn	5	SENT_173	[p10l355t3315r1030b3417],
3	—	CD	NUMBER	—	num	5	SENT_173	[p10l355t3315r1030b3417],
4	free	JJ	O	free	amod	5	SENT_173	[p10l355t3315r1030b3417],
5	survival	NN	O	survival	nsubj	8	SENT_173	[p10l1066t3316r1382b3395],
6	was	VBD	O	be	cop	8	SENT_173	[p10l1410t3342r1569b3395],
7	14.0	CD	DURATION	14.0	num	8	SENT_173	[p10l1607t3322r1770b3395],
8	months	NNS	NUMBER	month	dep	9	SENT_173	[p10l1804t3316r2131b3395],
9	(	VBP	O	(	_	0	SENT_173	[p10l16t3449r227b3535],
10	95	CD	PERCENT	95	num	11	SENT_173	[p10l16t3449r227b3535],
11	%	NN	PERCENT	%	dobj	9	SENT_173	[p10l16t3449r227b3535],
12	CI	NN	O	ci	nsubj	9	SENT_173	[p10l264t3450r379b3540],
13	,	,	O	,	_	0	SENT_173	[p10l264t3450r379b3540],
14	11.3	CD	NUMBER	11.3	number	17	SENT_173	[p10l426t3450r598b3523],
15	to	TO	O	to	dep	17	SENT_173	[p10l639t3461r720b3523],
16	16.7	CD	NUMBER	16.7	number	17	SENT_173	[p10l763t3450r965b3535],
17	)	CD	NUMBER	)	appos	12	SENT_173	[p10l763t3450r965b3535],
18	(	CD	NUMBER	(	num	19	SENT_173	[p10l1013t3445r1195b3545],
19	Fig	NN	O	fig	dep	17	SENT_173	[p10l1013t3445r1195b3545],
20	.	.	O	.	_	0	SENT_173	[p10l1013t3445r1195b3545],

1	2A	NN	O	2a	_	0	SENT_174	[p10l1241t3450r1409b3535],
2	)	NN	O	)	dep	1	SENT_174	[p10l1241t3450r1409b3535],
3	.	.	O	.	_	0	SENT_174	[p10l1241t3450r1409b3535],

1	The	DT	O	the	det	2	SENT_175	[p10l1449t3444r1609b3522],
2	duration	NN	O	duration	nsubj	6	SENT_175	[p10l1648t3444r2014b3523],
3	of	IN	O	of	_	0	SENT_175	[p10l2052t3443r2152b3523],
4	response	NN	O	response	prep_of	2	SENT_175	[p10l11t3598r392b3672],
5	was	VBD	O	be	cop	6	SENT_175	[p10l424t3598r586b3651],
6	similar	JJ	O	similar	_	0	SENT_175	[p10l626t3572r932b3650],
7	for	IN	O	for	_	0	SENT_175	[p10l966t3571r1089b3651],
8	patients	NNS	O	patient	prep_for	6	SENT_175	[p10l1121t3573r1462b3672],
9	receiving	VBG	O	receive	partmod	8	SENT_175	[p10l1500t3573r1891b3673],
10	firstline	NN	O	firstline	nn	11	SENT_175	[p10l1924t3571r2132b3650, p10l10t3700r166b3777],
11	therapy	NN	O	therapy	dobj	9	SENT_175	[p10l194t3700r509b3799],
12	(	CD	NUMBER	(	number	13	SENT_175	[p10l536t3705r731b3790],
13	14.0	CD	DURATION	14.0	num	14	SENT_175	[p10l536t3705r731b3790],
14	months	NNS	NUMBER	month	tmod	11	SENT_175	[p10l758t3700r1104b3794],
15	;	:	O	;	_	0	SENT_175	[p10l758t3700r1104b3794],
16	95	CD	NUMBER	95	number	17	SENT_175	[p10l1134t3705r1316b3779],
17	°	CD	NUMBER	°	dep	11	SENT_175	[p10l1134t3705r1316b3779],
18	/	:	O	/	punct	20	SENT_175	[p10l1134t3705r1316b3779],
19	o	NN	O	o	nn	20	SENT_175	[p10l1134t3705r1316b3779],
20	CI	NN	O	ci	dep	17	SENT_175	[p10l1343t3705r1456b3795],
21	,	,	O	,	_	0	SENT_175	[p10l1343t3705r1456b3795],
22	9.7	CD	NUMBER	9.7	number	24	SENT_175	[p10l1488t3705r1607b3778],
23	to	TO	O	to	dep	24	SENT_175	[p10l1636t3716r1716b3778],
24	18.3	CD	NUMBER	18.3	num	25	SENT_175	[p10l1747t3705r1943b3790],
25	)	CD	NUMBER	)	dep	11	SENT_175	[p10l1747t3705r1943b3790],
26	and	CC	O	and	_	0	SENT_175	[p10l1975t3700r2133b3778],
27	second	JJ	ORDINAL	second	amod	30	SENT_175	[p11l12t21r503b99],
28	—	NN	O	—	nn	30	SENT_175	[p11l12t21r503b99],
29	line	NN	O	line	nn	30	SENT_175	[p11l12t21r503b99],
30	therapy	NN	O	therapy	dep	11	SENT_175	[p11l537t21r859b120],
31	(	CD	NUMBER	(	number	32	SENT_175	[p11l893t26r1098b111],
32	13.0	CD	DURATION	13.0	num	33	SENT_175	[p11l893t26r1098b111],
33	months	NNS	NUMBER	month	tmod	30	SENT_175	[p11l1133t21r1484b115],
34	;	:	O	;	_	0	SENT_175	[p11l1133t21r1484b115],
35	95	CD	PERCENT	95	number	36	SENT_175	[p11l1522t26r1707b100],
36	%	NN	PERCENT	%	amod	37	SENT_175	[p11l1522t26r1707b100],
37	CI	NN	O	ci	dep	11	SENT_175	[p11l1740t26r1854b116],
38	,	,	O	,	_	0	SENT_175	[p11l1740t26r1854b116],
39	9.7	CD	NUMBER	9.7	appos	37	SENT_175	[p11l1894t26r2016b99],
40	to	TO	O	to	dep	11	SENT_175	[p11l2051t37r2132b99],

1	N	NN	O	n	nn	3	SENT_176	[p11l538t190r552b205],
2	ENGLJ	NN	O	englj	nn	3	SENT_176	[p11l566t190r644b212],
3	MED	NN	O	med	_	0	SENT_176	[p11l659t190r711b205],
4	361	CD	NUMBER	361	dep	3	SENT_176	[p11l721t184r799b212],
5	;	:	O	;	_	0	SENT_176	[p11l721t184r799b212],
6	1o	CD	NUMBER	1o	num	8	SENT_176	[p11l721t184r799b212],
7	NEjM.ORG	NN	O	nejm.org	nn	8	SENT_176	[p11l834t190r958b212],
8	SEPTEMBER	NN	DATE	september	dep	4	SENT_176	[p11l993t190r1132b206],
9	3,2009	CD	NUMBER	3,2009	num	10	SENT_176	[p11l1142t190r1236b212],
10	961	CD	NUMBER	961	dep	8	SENT_176	[p11l1959t179r2016b203],

1	The	DT	O	the	det	4	SENT_177	[p11l702t223r753b247],
2	New	NNP	O	New	nn	4	SENT_177	[p11l762t224r824b247],
3	England	NNP	O	England	nn	4	SENT_177	[p11l833t223r944b254],
4	Journal	NNP	O	Journal	_	0	SENT_177	[p11l952t223r1050b247],
5	of	IN	O	of	_	0	SENT_177	[p11l1059t223r1088b247],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_177	[p11l1095t223r1220b247],

1	The	DT	O	the	det	4	SENT_178	[p11l673t348r718b369],
2	NEW	NNP	O	NEW	nn	4	SENT_178	[p11l737t350r822b369],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_178	[p11l841t350r1029b369],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_178	[p11l1048t350r1228b376],
5	of	IN	O	of	_	0	SENT_178	[p11l1247t348r1276b375],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_178	[p11l1288t350r1487b369],

1	350	CD	NUMBER	350	nsubj	2	SENT_179	[p11l928t760r969b780],
2	Had	VBD	O	have	_	0	SENT_179	[p11l980t758r1027b780],
3	EGFR	NN	O	egfr	nn	4	SENT_179	[p11l1039t760r1105b780],
4	mutations	NNS	O	mutation	dobj	2	SENT_179	[p11l1115t760r1235b780],

1	54	CD	NUMBER	54	nsubj	4	SENT_180	[p11l1272t894r1299b914],
2	Were	VBD	O	be	cop	4	SENT_180	[p11l1307t894r1368b914],
3	not	RB	O	not	neg	4	SENT_180	[p11l1379t896r1417b914],
4	eligible	JJ	O	eligible	_	0	SENT_180	[p11l1425t892r1509b921],
5	for	IN	O	for	_	0	SENT_180	[p11l1518t892r1551b914],
6	erlotinib	NN	O	erlotinib	nn	7	SENT_180	[p11l1559t892r1658b914],
7	treatment	NN	O	treatment	prep_for	4	SENT_180	[p11l1667t896r1785b914],
8	owing	VBG	O	owe	partmod	7	SENT_180	[p11l1329t927r1401b954],
9	to	TO	O	to	_	0	SENT_180	[p11l1409t929r1432b947],
10	incomplete	JJ	O	incomplete	amod	12	SENT_180	[p11l1442t925r1575b954],
11	patient	NN	O	patient	nn	12	SENT_180	[p11l1585t927r1667b954],
12	data	NNS	O	datum	prep_to	8	SENT_180	[p11l1676t925r1726b947],

1	296	CD	NUMBER	296	nsubj	2	SENT_181	[p11l901t1055r943b1075],
2	Were	VBD	O	be	_	0	SENT_181	[p11l951t1055r1013b1075],
3	e	SYM	O	e	dep	7	SENT_181	[p11l1022t1061r1034b1075],
4	i	FW	O	i	nn	5	SENT_181	[p11l1043t1055r1047b1075],
5	i	FW	O	i	npadvmod	7	SENT_181	[p11l1065t1055r1069b1075],
6	e	SYM	O	e	dep	5	SENT_181	[p11l1094t1061r1106b1075],
7	for	IN	O	for	dep	10	SENT_181	[p11l1114t1053r1147b1075],
8	erlotinib	NN	O	erlotinib	nn	9	SENT_181	[p11l1156t1053r1254b1075],
9	trea	NNS	O	trea	pobj	7	SENT_181	[p11l1022t1090r1067b1108],
10	ment	NN	O	ment	dep	2	SENT_181	[p11l1080t1090r1140b1108],

1	197	CD	NUMBER	197	nsubjpass	4	SENT_182	[p11l304t1741r344b1761],
2	Could	MD	O	could	aux	4	SENT_182	[p11l353t1739r421b1761],
3	be	VB	O	be	auxpass	4	SENT_182	[p11l433t1739r459b1761],
4	evaluated	VBN	O	evaluate	_	0	SENT_182	[p11l468t1739r581b1761],
5	for	IN	O	for	_	0	SENT_182	[p11l591t1739r624b1761],
6	response	NN	O	response	nn	8	SENT_182	[p11l633t1747r741b1768],
7	217	CD	NUMBER	217	num	8	SENT_182	[p11l867t1724r909b1744],
8	gould	NN	O	gould	prep_for	4	SENT_182	[p11l918t1722r987b1761],
9	be	VB	O	be	auxpass	10	SENT_182	[p11l998t1722r1024b1744],
10	evaluated	VBN	O	evaluate	ccomp	4	SENT_182	[p11l1033t1722r1146b1744],
11	for	IN	O	for	_	0	SENT_182	[p11l1156t1722r1189b1744],
12	p.	NN	O	p.	prep_for	10	SENT_182	[p11l1198t1730r1296b1761],
13	r	NN	O	r	nn	15	SENT_182	[p11l1198t1730r1296b1761],
14	°	CD	NUMBER	°	num	15	SENT_182	[p11l1198t1730r1296b1761],
15	greS	NNP	O	greS	tmod	10	SENT_182	[p11l1198t1730r1296b1761],
16	_	CD	NUMBER	_	number	17	SENT_182	[p11l1198t1730r1296b1761],
17	sion-free	JJ	O	sion-free	dep	15	SENT_182	[p11l910t1755r1013b1778],
18	and	CC	O	and	_	0	SENT_182	[p11l1023t1755r1065b1777],
19	overall	JJ	O	overall	amod	20	SENT_182	[p11l1075t1755r1152b1778],
20	survival	NN	O	survival	conj_and	17	SENT_182	[p11l1163t1755r1252b1778],

1	97	CD	NUMBER	97	nsubj	2	SENT_183	[p11l1440t1949r1467b1969],
2	Had	VBD	O	have	_	0	SENT_183	[p11l1478t1947r1525b1969],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_183	[p11l1537t1949r1603b1969],
4	mutation	NN	O	mutation	dobj	2	SENT_183	[p11l1613t1949r1719b1969],
5	in	IN	O	in	_	0	SENT_183	[p11l1731t1949r1750b1969],
6	serum	NN	O	serum	prep_in	4	SENT_183	[p11l1761t1955r1834b1969],

1	Figure	NNP	O	Figure	_	0	SENT_184	[p11l266t2077r350b2109],
2	1	CD	NUMBER	1	dep	1	SENT_184	[p11l362t2078r384b2101],
3	.	.	O	.	_	0	SENT_184	[p11l362t2078r384b2101],

1	Enrollment	NN	O	enrollment	_	0	SENT_185	[p11l397t2076r548b2101],
2	and	CC	O	and	_	0	SENT_185	[p11l558t2076r607b2101],
3	Outcomes	NNS	O	outcome	conj_and	1	SENT_185	[p11l619t2078r772b2101],
4	.	.	O	.	_	0	SENT_185	[p11l619t2078r772b2101],

1	16.3	CD	NUMBER	16.3	_	0	SENT_186	[p11l12t2359r201b2450],
2	;	:	O	;	_	0	SENT_186	[p11l12t2359r201b2450],
3	P	NN	O	p	nsubj	4	SENT_186	[p11l232t2359r561b2446],
4	=	JJ	O	=	dep	1	SENT_186	[p11l232t2359r561b2446],
5	O.	NNP	O	O.	iobj	4	SENT_186	[p11l232t2359r561b2446],
6	62	CD	NUMBER	62	num	5	SENT_186	[p11l232t2359r561b2446],
7	)	CD	NUMBER	)	num	9	SENT_186	[p11l232t2359r561b2446],
8	(	CD	NUMBER	(	num	9	SENT_186	[p11l599t2354r772b2455],
9	Fig	NN	O	fig	dobj	4	SENT_186	[p11l599t2354r772b2455],
10	.	.	O	.	_	0	SENT_186	[p11l599t2354r772b2455],

1	2B	NN	O	2b	_	0	SENT_187	[p11l806t2359r961b2446],
2	)	NN	O	)	dep	1	SENT_187	[p11l806t2359r961b2446],
3	.	.	O	.	_	0	SENT_187	[p11l806t2359r961b2446],

1	Median	JJ	O	median	amod	3	SENT_188	[p11l992t2353r1310b2433],
2	overall	JJ	O	overall	amod	3	SENT_188	[p11l1339t2353r1615b2433],
3	survival	NN	O	survival	nsubj	6	SENT_188	[p11l1644t2353r1964b2433],
4	was	VBD	O	be	cop	6	SENT_188	[p11l1987t2380r2151b2434],
5	27.0	CD	DURATION	27.0	num	6	SENT_188	[p11l8t2489r176b2563],
6	months	NNS	NUMBER	month	dep	7	SENT_188	[p11l210t2483r540b2563],
7	(	VBP	O	(	_	0	SENT_188	[p11l580t2489r793b2576],
8	95	CD	PERCENT	95	num	9	SENT_188	[p11l580t2489r793b2576],
9	%	NN	PERCENT	%	dobj	7	SENT_188	[p11l580t2489r793b2576],
10	CI	NN	O	ci	nsubj	7	SENT_188	[p11l826t2489r942b2580],
11	,	,	O	,	_	0	SENT_188	[p11l826t2489r942b2580],
12	22.7	CD	NUMBER	22.7	number	15	SENT_188	[p11l980t2489r1160b2563],
13	to	TO	O	to	dep	15	SENT_188	[p11l1195t2500r1277b2563],
14	31.3	CD	NUMBER	31.3	number	15	SENT_188	[p11l1312t2489r1514b2576],
15	)	CD	NUMBER	)	appos	10	SENT_188	[p11l1312t2489r1514b2576],
16	(	CD	NUMBER	(	num	17	SENT_188	[p11l1557t2484r1741b2585],
17	Fig	NN	O	fig	dep	15	SENT_188	[p11l1557t2484r1741b2585],
18	.	.	O	.	_	0	SENT_188	[p11l1557t2484r1741b2585],

1	2C	NN	O	2c	_	0	SENT_189	[p11l1782t2489r1951b2575],
2	)	NN	O	)	dep	1	SENT_189	[p11l1782t2489r1951b2575],
3	.	.	O	.	_	0	SENT_189	[p11l1782t2489r1951b2575],

1	Median	JJ	O	median	amod	3	SENT_190	[p11l1986t2491r2152b2563, p11l9t2613r200b2693],
2	overall	JJ	O	overall	amod	3	SENT_190	[p11l244t2613r532b2694],
3	survival	NN	O	survival	nsubj	11	SENT_190	[p11l577t2613r912b2693],
4	for	IN	O	for	_	0	SENT_190	[p11l954t2613r1079b2693],
5	patients	NNS	O	patient	prep_for	3	SENT_190	[p11l1118t2614r1462b2715],
6	receiving	VBG	O	receive	partmod	5	SENT_190	[p11l1508t2614r1902b2715],
7	firstline	NN	O	firstline	nn	8	SENT_190	[p11l1942t2613r2152b2693, p11l7t2743r168b2823],
8	therapy	NN	O	therapy	dobj	6	SENT_190	[p11l216t2743r542b2845],
9	was	VBD	O	be	cop	11	SENT_190	[p11l581t2770r744b2823],
10	28.0	CD	DURATION	28.0	num	11	SENT_190	[p11l794t2749r975b2823],
11	months	NNS	NUMBER	month	dep	35	SENT_190	[p11l1024t2743r1354b2823],
12	(	VBP	O	(	rcmod	11	SENT_190	[p11l1410t2748r1623b2836],
13	95	CD	PERCENT	95	number	14	SENT_190	[p11l1410t2748r1623b2836],
14	%	NN	PERCENT	%	amod	15	SENT_190	[p11l1410t2748r1623b2836],
15	CI	NN	O	ci	dobj	12	SENT_190	[p11l1670t2749r1786b2840],
16	,	,	O	,	_	0	SENT_190	[p11l1670t2749r1786b2840],
17	22.7	CD	NUMBER	22.7	appos	15	SENT_190	[p11l1839t2749r2020b2823],
18	to	TO	O	to	_	0	SENT_190	[p11l2069t2760r2152b2823],
19	33	CD	NUMBER	33	number	20	SENT_190	[p11l10t2879r157b2970],
20	)	CD	NUMBER	)	prep_to	12	SENT_190	[p11l10t2879r157b2970],
21	,	,	O	,	_	0	SENT_190	[p11l10t2879r157b2970],
22	and	CC	O	and	_	0	SENT_190	[p11l203t2873r362b2953],
23	for	IN	O	for	_	0	SENT_190	[p11l402t2873r527b2953],
24	those	DT	O	those	nsubj	25	SENT_190	[p11l565t2873r799b2953],
25	receiving	VBG	O	receive	prepc_for	34	SENT_190	[p11l840t2874r1234b2975],
26	second	JJ	ORDINAL	second	amod	29	SENT_190	[p11l1273t2873r1769b2953],
27	—	NN	O	—	nn	29	SENT_190	[p11l1273t2873r1769b2953],
28	line	NN	O	line	nn	29	SENT_190	[p11l1273t2873r1769b2953],
29	therapy	NN	O	therapy	dobj	25	SENT_190	[p11l1810t2873r2148b2975],
30	,	,	O	,	_	0	SENT_190	[p11l1810t2873r2148b2975],
31	it	PRP	O	it	nsubj	34	SENT_190	[p11l7t3003r67b3081],
32	was	VBD	O	be	cop	34	SENT_190	[p11l88t3029r251b3082],
33	27.0	CD	DURATION	27.0	num	34	SENT_190	[p11l283t3008r451b3081],
34	months	NNS	NUMBER	month	dep	35	SENT_190	[p11l482t3002r812b3081],
35	(	VBP	O	(	_	0	SENT_190	[p11l849t3007r1062b3093],
36	95	CD	PERCENT	95	num	37	SENT_190	[p11l849t3007r1062b3093],
37	%	NN	PERCENT	%	dobj	35	SENT_190	[p11l849t3007r1062b3093],
38	CI	NN	O	ci	nsubj	35	SENT_190	[p11l1092t3008r1208b3098],
39	,	,	O	,	_	0	SENT_190	[p11l1092t3008r1208b3098],
40	19.9	CD	NUMBER	19.9	number	42	SENT_190	[p11l1246t3008r1418b3081],
41	to	TO	O	to	dep	42	SENT_190	[p11l1449t3019r1531b3081],
42	34.1	CD	NUMBER	34.1	appos	38	SENT_190	[p11l1563t3008r1765b3098],
43	;	:	O	;	_	0	SENT_190	[p11l1563t3008r1765b3098],
44	P	NN	O	p	dep	42	SENT_190	[p11l1797t3008r2148b3093],
45	=	JJ	O	=	advmod	49	SENT_190	[p11l1797t3008r2148b3093],
46	0.67	CD	NUMBER	0.67	dep	45	SENT_190	[p11l1797t3008r2148b3093],
47	)	CD	NUMBER	)	number	48	SENT_190	[p11l1797t3008r2148b3093],
48	(	CD	NUMBER	(	num	49	SENT_190	[p11l13t3133r198b3233],
49	Fig	NN	O	fig	rcmod	44	SENT_190	[p11l13t3133r198b3233],
50	.	.	O	.	_	0	SENT_190	[p11l13t3133r198b3233],

1	21	CD	NUMBER	21	num	2	SENT_191	[p11l240t3138r417b3223],
2	)	CD	NUMBER	)	_	0	SENT_191	[p11l240t3138r417b3223],
3	)	NN	O	)	dep	2	SENT_191	[p11l240t3138r417b3223],
4	.	.	O	.	_	0	SENT_191	[p11l240t3138r417b3223],

1	Median	JJ	O	median	amod	5	SENT_192	[p11l136t3261r472b3341],
2	progression	NN	O	progression	nn	5	SENT_192	[p11l534t3261r1269b3363],
3	—	CD	NUMBER	—	num	5	SENT_192	[p11l534t3261r1269b3363],
4	free	JJ	O	free	amod	5	SENT_192	[p11l534t3261r1269b3363],
5	survival	NN	O	survival	nsubj	8	SENT_192	[p11l1334t3261r1679b3341],
6	was	VBD	O	be	cop	8	SENT_192	[p11l1737t3288r1904b3341],
7	16.0	CD	DURATION	16.0	num	8	SENT_192	[p11l1974t3267r2152b3341],
8	months	NNS	NUMBER	month	dep	23	SENT_192	[p11l8t3390r339b3469],
9	(	VBP	O	(	rcmod	8	SENT_192	[p11l381t3395r594b3481],
10	95	CD	PERCENT	95	number	11	SENT_192	[p11l381t3395r594b3481],
11	%	NN	PERCENT	%	amod	12	SENT_192	[p11l381t3395r594b3481],
12	CI	NN	O	ci	dobj	9	SENT_192	[p11l628t3396r744b3486],
13	,	,	O	,	_	0	SENT_192	[p11l628t3396r744b3486],
14	12.7	CD	NUMBER	12.7	number	17	SENT_192	[p11l789t3396r966b3469],
15	to	TO	O	to	dep	17	SENT_192	[p11l1002t3407r1084b3469],
16	19.2	CD	NUMBER	19.2	number	17	SENT_192	[p11l1124t3396r1326b3482],
17	)	CD	NUMBER	)	appos	12	SENT_192	[p11l1124t3396r1326b3482],
18	in	IN	O	in	_	0	SENT_192	[p11l1366t3391r1450b3468],
19	Women	NNS	O	woman	prep_in	17	SENT_192	[p11l1480t3416r1800b3470],
20	and	CC	O	and	_	0	SENT_192	[p11l1835t3390r1994b3469],
21	9.0	CD	DURATION	9.0	num	22	SENT_192	[p11l2029t3396r2152b3469],
22	months	NNS	NUMBER	month	conj_and	19	SENT_192	[p11l8t3519r339b3598],
23	(	VBP	O	(	_	0	SENT_192	[p11l385t3525r599b3611],
24	95	CD	PERCENT	95	num	25	SENT_192	[p11l385t3525r599b3611],
25	%	NN	PERCENT	%	dobj	23	SENT_192	[p11l385t3525r599b3611],
26	CI	NN	O	ci	nsubj	23	SENT_192	[p11l638t3525r754b3615],
27	,	,	O	,	_	0	SENT_192	[p11l638t3525r754b3615],
28	6.1	CD	NUMBER	6.1	number	31	SENT_192	[p11l800t3525r925b3598],
29	to	TO	O	to	dep	31	SENT_192	[p11l967t3536r1049b3598],
30	11.9	CD	NUMBER	11.9	number	31	SENT_192	[p11l1093t3525r1294b3610],
31	)	CD	NUMBER	)	appos	26	SENT_192	[p11l1093t3525r1294b3610],
32	in	IN	O	in	_	0	SENT_192	[p11l1338t3520r1423b3597],
33	men	NNS	O	man	prep_in	31	SENT_192	[p11l1462t3545r1650b3598],
34	(	CD	NUMBER	(	num	35	SENT_192	[p11l1694t3525r2148b3610],
35	P	NN	O	p	npadvmod	36	SENT_192	[p11l1694t3525r2148b3610],
36	=	JJ	O	=	amod	33	SENT_192	[p11l1694t3525r2148b3610],
37	0.003	CD	NUMBER	0.003	num	38	SENT_192	[p11l1694t3525r2148b3610],
38	)	NN	O	)	dep	31	SENT_192	[p11l1694t3525r2148b3610],
39	.	.	O	.	_	0	SENT_192	[p11l1694t3525r2148b3610],

1	Median	JJ	O	median	amod	3	SENT_193	[p11l6t3648r329b3727],
2	overall	JJ	O	overall	amod	3	SENT_193	[p11l360t3648r642b3728],
3	survival	NN	O	survival	nsubj	6	SENT_193	[p11l674t3648r1002b3728],
4	was	VBD	O	be	cop	6	SENT_193	[p11l1028t3675r1190b3728],
5	29.0	CD	DURATION	29.0	num	6	SENT_193	[p11l1222t3654r1396b3727],
6	months	NNS	NUMBER	month	_	0	SENT_193	[p11l1428t3648r1753b3727],
7	(	VBP	O	(	rcmod	6	SENT_193	[p11l1791t3653r2001b3740],
8	95	CD	PERCENT	95	number	9	SENT_193	[p11l1791t3653r2001b3740],
9	%	NN	PERCENT	%	amod	10	SENT_193	[p11l1791t3653r2001b3740],
10	CI	NN	O	ci	dobj	7	SENT_193	[p11l2031t3654r2147b3744],
11	,	,	O	,	_	0	SENT_193	[p11l2031t3654r2147b3744],

1	24.9	CD	NUMBER	24.9	number	4	SENT_194	[p12l8t29r180b102],
2	to	TO	O	to	dep	4	SENT_194	[p12l214t40r296b102],
3	33.1	CD	NUMBER	33.1	number	4	SENT_194	[p12l331t29r527b115],
4	)	CD	NUMBER	)	nsubj	10	SENT_194	[p12l331t29r527b115],
5	in	IN	O	in	_	0	SENT_194	[p12l565t24r648b101],
6	women	NNS	O	woman	prep_in	4	SENT_194	[p12l676t49r992b103],
7	and	CC	O	and	_	0	SENT_194	[p12l1024t23r1181b102],
8	18.0	CD	DURATION	18.0	num	9	SENT_194	[p12l1217t29r1391b102],
9	months	NNS	NUMBER	month	prep_in	4	SENT_194	[p12l1424t23r1749b102],
10	(	VBP	O	(	ccomp	23	SENT_194	[p12l1789t28r1999b114],
11	95	CD	PERCENT	95	number	12	SENT_194	[p12l1789t28r1999b114],
12	%	NN	PERCENT	%	amod	13	SENT_194	[p12l1789t28r1999b114],
13	CI	NN	O	ci	dobj	10	SENT_194	[p12l2032t29r2148b119],
14	,	,	O	,	_	0	SENT_194	[p12l2032t29r2148b119],
15	14.5	CD	NUMBER	14.5	number	18	SENT_194	[p12l12t159r180b233],
16	to	TO	O	to	dep	18	SENT_194	[p12l219t170r301b233],
17	21.5	CD	NUMBER	21.5	number	18	SENT_194	[p12l337t159r547b246],
18	)	CD	NUMBER	)	nsubj	23	SENT_194	[p12l337t159r547b246],
19	in	IN	O	in	_	0	SENT_194	[p12l586t154r671b232],
20	men	NNS	O	man	prep_in	18	SENT_194	[p12l706t179r893b233],
21	(	CD	NUMBER	(	num	22	SENT_194	[p12l933t159r1311b246],
22	P	NN	O	p	dep	20	SENT_194	[p12l933t159r1311b246],
23	=	JJ	O	=	_	0	SENT_194	[p12l933t159r1311b246],
24	0.05	CD	NUMBER	0.05	num	25	SENT_194	[p12l933t159r1311b246],
25	)	CD	NUMBER	)	iobj	23	SENT_194	[p12l933t159r1311b246],
26	(	CD	NUMBER	(	num	27	SENT_194	[p12l1356t154r1538b255],
27	Fig	NN	O	fig	dobj	23	SENT_194	[p12l1356t154r1538b255],
28	.	.	O	.	_	0	SENT_194	[p12l1356t154r1538b255],

1	1A	NN	O	1a	_	0	SENT_195	[p12l1582t159r1697b232],
2	and	CC	O	and	_	0	SENT_195	[p12l1729t153r1888b233],
3	1B	NN	O	1b	conj_and	1	SENT_195	[p12l1926t159r2033b233],
4	in	IN	O	in	_	0	SENT_195	[p12l2069t154r2153b232],
5	the	DT	O	the	det	8	SENT_195	[p12l9t283r140b363],
6	Supplementary	NNP	O	Supplementary	nn	8	SENT_195	[p12l179t283r820b385],
7	Appendix	NNP	O	Appendix	nn	8	SENT_195	[p12l847t283r1308b385],
8	)	NN	O	)	prep_in	1	SENT_195	[p12l847t283r1308b385],
9	.	.	O	.	_	0	SENT_195	[p12l847t283r1308b385],

1	There	EX	O	there	expl	2	SENT_196	[p12l1346t283r1589b363],
2	were	VBD	O	be	_	0	SENT_196	[p12l1620t310r1821b363],
3	no	DT	O	no	det	5	SENT_196	[p12l1857t309r1962b363],
4	significant	JJ	O	significant	amod	5	SENT_196	[p12l2001t284r2152b385, p12l8t413r363b493],
5	differences	NNS	O	difference	nsubj	2	SENT_196	[p12l394t413r885b493],
6	in	IN	O	in	_	0	SENT_196	[p12l922t414r1007b492],
7	progression	NN	O	progression	npadvmod	9	SENT_196	[p12l1041t413r1773b515],
8	—	CD	NUMBER	—	num	7	SENT_196	[p12l1041t413r1773b515],
9	free	JJ	O	free	amod	10	SENT_196	[p12l1041t413r1773b515],
10	survival	NN	O	survival	prep_in	5	SENT_196	[p12l1811t413r2153b493],
11	according	VBG	O	accord	_	0	SENT_196	[p12l7t543r448b645],
12	to	TO	O	to	prepc_according_to	2	SENT_196	[p12l485t560r568b623],
13	performance	NN	O	performance	nn	14	SENT_196	[p12l608t543r1179b645],
14	status	NN	O	status	pobj	2	SENT_196	[p12l1222t560r1507b640],
15	,	,	O	,	_	0	SENT_196	[p12l1222t560r1507b640],
16	age	NN	O	age	conj_or	14	SENT_196	[p12l1552t570r1723b645],
17	,	,	O	,	_	0	SENT_196	[p12l1552t570r1723b645],
18	first	JJ	ORDINAL	first	amod	21	SENT_196	[p12l1770t543r2153b623],
19	—	NN	O	—	nn	21	SENT_196	[p12l1770t543r2153b623],
20	line	NN	O	line	nn	21	SENT_196	[p12l1770t543r2153b623],
21	therapy	NN	O	therapy	conj_or	14	SENT_196	[p12l9t673r334b775],
22	versus	CC	O	versus	prep	21	SENT_196	[p12l368t699r637b753],
23	second	JJ	ORDINAL	second	amod	25	SENT_196	[p12l685t673r1180b753],
24	—	NN	O	—	nn	25	SENT_196	[p12l685t673r1180b753],
25	line	NN	O	line	dep	22	SENT_196	[p12l685t673r1180b753],
26	or	CC	O	or	_	0	SENT_196	[p12l1225t699r1314b753],
27	third	JJ	ORDINAL	third	amod	30	SENT_196	[p12l1355t673r1766b753],
28	—	NN	O	—	nn	30	SENT_196	[p12l1355t673r1766b753],
29	line	NN	O	line	nn	30	SENT_196	[p12l1355t673r1766b753],
30	therapy	NN	O	therapy	conj_or	14	SENT_196	[p12l1810t673r2148b775],
31	,	,	O	,	_	0	SENT_196	[p12l1810t673r2148b775],
32	smoking	NN	O	smoking	nn	33	SENT_196	[p12l12t802r400b903],
33	history	NN	O	history	pobj	2	SENT_196	[p12l438t802r767b903],
34	,	,	O	,	_	0	SENT_196	[p12l438t802r767b903],
35	or	CC	O	or	_	0	SENT_196	[p12l815t828r906b881],
36	type	NN	O	type	conj_or	14	SENT_196	[p12l945t819r1131b903],
37	of	IN	O	of	_	0	SENT_196	[p12l1174t802r1276b881],
38	mutation	NN	O	mutation	prep_of	36	SENT_196	[p12l1300t803r1704b881],
39	(	CD	NUMBER	(	num	40	SENT_196	[p12l1751t802r1965b894],
40	data	NNS	O	datum	npadvmod	41	SENT_196	[p12l1751t802r1965b894],
41	not	RB	O	not	neg	42	SENT_196	[p12l2006t819r2152b881],
42	shown	VBN	O	show	partmod	38	SENT_196	[p12l12t930r354b1022],
43	)	NN	O	)	dobj	42	SENT_196	[p12l12t930r354b1022],
44	.	.	O	.	_	0	SENT_196	[p12l12t930r354b1022],

1	(	NN	O	(	_	0	SENT_197	[p12l414t937r590b1022],
2	For	IN	O	for	dep	1	SENT_197	[p12l414t937r590b1022],
3	details	NNS	O	detail	pobj	2	SENT_197	[p12l637t930r928b1009],
4	regarding	VBG	O	regard	_	0	SENT_197	[p12l979t930r1416b1031],
5	differences	NNS	O	difference	prep_regarding	3	SENT_197	[p12l1462t930r1952b1009],
6	observed	VBN	O	observe	partmod	5	SENT_197	[p12l2004t930r2145b1009, p12l12t1058r284b1137],
7	in	IN	O	in	_	0	SENT_197	[p12l323t1059r406b1136],
8	specific	JJ	O	specific	amod	9	SENT_197	[p12l447t1058r779b1159],
9	subgroups	NNS	O	subgroup	prep_in	6	SENT_197	[p12l819t1058r1268b1159],
10	and	CC	O	and	_	0	SENT_197	[p12l1308t1058r1467b1137],
11	for	IN	O	for	_	0	SENT_197	[p12l1506t1058r1630b1137],
12	differences	NNS	O	difference	prep_for	6	SENT_197	[p12l1667t1058r2144b1137],
13	according	VBG	O	accord	_	0	SENT_197	[p12l10t1186r431b1287],
14	to	TO	O	to	prepc_according_to	6	SENT_197	[p12l459t1203r540b1265],
15	response	NN	O	response	pobj	6	SENT_197	[p12l572t1212r969b1287],
16	,	,	O	,	_	0	SENT_197	[p12l572t1212r969b1287],
17	see	VB	O	see	ccomp	6	SENT_197	[p12l1008t1213r1136b1265],
18	the	DT	O	the	det	22	SENT_197	[p12l1167t1186r1298b1265],
19	Supplementary	NNP	O	Supplementary	nn	22	SENT_197	[p12l1332t1186r1969b1287],
20	Appendix	NNP	O	Appendix	nn	22	SENT_197	[p12l1992t1194r2145b1287, p12l10t1314r357b1415],
21	.	.	O	.	_	0	SENT_197	[p12l1992t1194r2145b1287, p12l10t1314r357b1415],
22	)	NN	O	)	dobj	17	SENT_197	[p12l1992t1194r2145b1287, p12l10t1314r357b1415],

1	In	IN	O	in	dep	114	SENT_198	[p12l139t1450r227b1520],
2	a	DT	O	a	dep	114	SENT_198	[p12l261t1469r306b1521],
3	multivariate	JJ	O	multivariate	dep	114	SENT_198	[p12l339t1442r836b1521],
4	analysis	NN	O	analysis	dep	114	SENT_198	[p12l870t1442r1198b1543],
5	(	NN	O	(	dep	114	SENT_198	[p12l1239t1442r1661b1543],
6	including	VBG	O	include	dep	114	SENT_198	[p12l1239t1442r1661b1543],
7	sex	NN	O	sex	dep	114	SENT_198	[p12l1695t1469r1844b1538],
8	,	,	O	,	_	0	SENT_198	[p12l1695t1469r1844b1538],
9	smoking	NN	O	smoking	dep	114	SENT_198	[p12l1887t1442r2145b1522, p12l10t1571r150b1671],
10	status	NN	O	status	dep	114	SENT_198	[p12l185t1587r463b1666],
11	,	,	O	,	_	0	SENT_198	[p12l185t1587r463b1666],
12	performance	NN	O	performance	dep	114	SENT_198	[p12l503t1570r1061b1671],
13	status	NN	O	status	dep	114	SENT_198	[p12l1099t1587r1377b1666],
14	,	,	O	,	_	0	SENT_198	[p12l1099t1587r1377b1666],
15	first	JJ	ORDINAL	first	dep	114	SENT_198	[p12l1418t1570r1791b1649],
16	—	NN	O	—	dep	114	SENT_198	[p12l1418t1570r1791b1649],
17	line	NN	O	line	dep	114	SENT_198	[p12l1418t1570r1791b1649],
18	therapy	NN	O	therapy	dep	114	SENT_198	[p12l1828t1570r2152b1671],
19	vs.	CC	O	vs.	dep	114	SENT_198	[p12l6t1725r119b1777],
20	second	JJ	ORDINAL	second	dep	114	SENT_198	[p12l171t1698r677b1777],
21	—	NN	O	—	dep	114	SENT_198	[p12l171t1698r677b1777],
22	line	NN	O	line	dep	114	SENT_198	[p12l171t1698r677b1777],
23	or	CC	O	or	dep	114	SENT_198	[p12l723t1724r813b1777],
24	third	JJ	ORDINAL	third	dep	114	SENT_198	[p12l856t1698r1276b1777],
25	—	NN	O	—	dep	114	SENT_198	[p12l856t1698r1276b1777],
26	line	NN	O	line	dep	114	SENT_198	[p12l856t1698r1276b1777],
27	therapy	NN	O	therapy	dep	114	SENT_198	[p12l1322t1698r1667b1799],
28	,	,	O	,	_	0	SENT_198	[p12l1322t1698r1667b1799],
29	del	FW	O	del	dep	114	SENT_198	[p12l1718t1698r1847b1777],
30	19	CD	NUMBER	19	dep	114	SENT_198	[p12l1894t1704r1992b1777],
31	vs.	CC	O	vs.	dep	114	SENT_198	[p12l2033t1725r2140b1777],
32	L858R	NN	O	l858r	dep	114	SENT_198	[p12l10t1832r300b1922],
33	,	,	O	,	_	0	SENT_198	[p12l10t1832r300b1922],
34	the	DT	O	the	dep	114	SENT_198	[p12l346t1826r477b1905],
35	presence	NN	O	presence	dep	114	SENT_198	[p12l516t1852r886b1927],
36	or	CC	O	or	dep	114	SENT_198	[p12l927t1852r1015b1905],
37	absence	NN	O	absence	dep	114	SENT_198	[p12l1051t1826r1384b1905],
38	of	IN	O	of	dep	114	SENT_198	[p12l1425t1826r1525b1905],
39	brain	NN	O	brain	dep	114	SENT_198	[p12l1547t1826r1769b1905],
40	or	CC	O	or	dep	114	SENT_198	[p12l1810t1852r1899b1905],
41	bone	NN	O	bone	dep	114	SENT_198	[p12l1939t1826r2147b1905],
42	metastases	NNS	O	metastase	dep	114	SENT_198	[p12l11t1971r510b2050],
43	,	,	O	,	_	0	SENT_198	[p12l11t1971r510b2050],
44	and	CC	O	and	dep	114	SENT_198	[p12l551t1954r710b2033],
45	the	DT	O	the	dep	114	SENT_198	[p12l746t1954r880b2033],
46	presence	NN	O	presence	dep	114	SENT_198	[p12l914t1980r1292b2055],
47	or	CC	O	or	dep	114	SENT_198	[p12l1329t1980r1418b2033],
48	absence	NN	O	absence	dep	114	SENT_198	[p12l1451t1954r1790b2033],
49	of	IN	O	of	dep	114	SENT_198	[p12l1827t1954r1927b2033],
50	EGFR	NN	ORGANIZATION	egfr	dep	114	SENT_198	[p12l1943t1961r2153b2034],
51	mutations	NNS	O	mutation	dep	114	SENT_198	[p12l11t2083r439b2161],
52	in	IN	O	in	dep	114	SENT_198	[p12l481t2083r563b2160],
53	serum	NN	O	serum	dep	114	SENT_198	[p12l605t2108r871b2162],
54	DNA	NN	MISC	dna	dep	114	SENT_198	[p12l909t2089r1163b2178],
55	)	NN	O	)	dep	114	SENT_198	[p12l909t2089r1163b2178],
56	,	,	O	,	_	0	SENT_198	[p12l909t2089r1163b2178],
57	there	EX	O	there	dep	114	SENT_198	[p12l1209t2082r1422b2161],
58	was	VBD	O	be	dep	114	SENT_198	[p12l1458t2109r1620b2162],
59	an	DT	O	a	dep	114	SENT_198	[p12l1661t2108r1764b2161],
60	association	NN	O	association	dep	114	SENT_198	[p12l1802t2083r2145b2161, p12l11t2212r182b2290],
61	between	IN	O	between	dep	114	SENT_198	[p12l223t2211r582b2290],
62	poor	JJ	O	poor	dep	114	SENT_198	[p12l621t2237r825b2312],
63	progression	NN	O	progression	dep	114	SENT_198	[p12l861t2211r1573b2312],
64	—	CD	NUMBER	—	dep	114	SENT_198	[p12l861t2211r1573b2312],
65	free	JJ	O	free	dep	114	SENT_198	[p12l861t2211r1573b2312],
66	survival	NN	O	survival	dep	114	SENT_198	[p12l1615t2211r1949b2290],
67	and	CC	O	and	dep	114	SENT_198	[p12l1988t2211r2147b2290],
68	male	JJ	O	male	dep	114	SENT_198	[p12l11t2339r219b2418],
69	sex	NN	O	sex	dep	114	SENT_198	[p12l278t2366r414b2418],
70	(	NN	O	(	dep	114	SENT_198	[p12l473t2339r801b2430],
71	hazard	NN	O	hazard	dep	114	SENT_198	[p12l473t2339r801b2430],
72	ratio	NN	O	ratio	dep	114	SENT_198	[p12l857t2340r1078b2435],
73	,	,	O	,	_	0	SENT_198	[p12l857t2340r1078b2435],
74	2.94	CD	NUMBER	2.94	dep	114	SENT_198	[p12l1142t2345r1346b2435],
75	;	:	O	;	_	0	SENT_198	[p12l1142t2345r1346b2435],
76	95	CD	PERCENT	95	dep	114	SENT_198	[p12l1408t2344r1592b2418],
77	%	NN	PERCENT	%	dep	114	SENT_198	[p12l1408t2344r1592b2418],
78	CI	NN	O	ci	dep	114	SENT_198	[p12l1649t2345r1765b2435],
79	,	,	O	,	_	0	SENT_198	[p12l1649t2345r1765b2435],
80	1.72	CD	NUMBER	1.72	dep	114	SENT_198	[p12l1831t2345r2004b2418],
81	to	TO	O	to	dep	114	SENT_198	[p12l2063t2356r2145b2418],
82	5.03	CD	NUMBER	5.03	dep	114	SENT_198	[p12l13t2474r201b2564],
83	;	:	O	;	_	0	SENT_198	[p12l13t2474r201b2564],
84	P	NN	O	p	dep	114	SENT_198	[p12l241t2474r592b2559],
85	<	JJR	O	<	dep	114	SENT_198	[p12l241t2474r592b2559],
86	0.001	CD	NUMBER	0.001	dep	114	SENT_198	[p12l241t2474r592b2559],
87	)	NN	O	)	dep	114	SENT_198	[p12l241t2474r592b2559],
88	and	CC	O	and	dep	114	SENT_198	[p12l634t2468r789b2547],
89	the	DT	O	the	dep	114	SENT_198	[p12l827t2468r956b2547],
90	presence	NN	O	presence	dep	114	SENT_198	[p12l992t2494r1355b2569],
91	of	IN	O	of	dep	114	SENT_198	[p12l1393t2468r1492b2547],
92	the	DT	O	the	dep	114	SENT_198	[p12l1512t2468r1640b2547],
93	L858R	NN	O	l858r	dep	114	SENT_198	[p12l1677t2474r1950b2552],
94	mutation	NN	O	mutation	dep	114	SENT_198	[p12l1977t2494r2145b2547, p12l11t2597r270b2675],
95	(	NN	O	(	dep	114	SENT_198	[p12l315t2596r648b2688],
96	hazard	NN	O	hazard	dep	114	SENT_198	[p12l315t2596r648b2688],
97	ratio	NN	O	ratio	dep	114	SENT_198	[p12l687t2597r913b2692],
98	,	,	O	,	_	0	SENT_198	[p12l687t2597r913b2692],
99	1.92	CD	NUMBER	1.92	dep	114	SENT_198	[p12l961t2602r1162b2692],
100	;	:	O	;	_	0	SENT_198	[p12l961t2602r1162b2692],
101	95	CD	NUMBER	95	dep	114	SENT_198	[p12l1205t2601r1393b2676],
102	°	CD	NUMBER	°	dep	114	SENT_198	[p12l1205t2601r1393b2676],
103	/	:	O	/	dep	114	SENT_198	[p12l1205t2601r1393b2676],
104	o	NN	O	o	dep	114	SENT_198	[p12l1205t2601r1393b2676],
105	CI	NN	O	ci	dep	114	SENT_198	[p12l1431t2602r1549b2692],
106	,	,	O	,	_	0	SENT_198	[p12l1431t2602r1549b2692],
107	1.19	CD	NUMBER	1.19	dep	114	SENT_198	[p12l1597t2602r1774b2675],
108	to	TO	O	to	dep	114	SENT_198	[p12l1815t2613r1898b2675],
109	3.10	CD	NUMBER	3.10	dep	114	SENT_198	[p12l1939t2602r2142b2692],
110	;	:	O	;	_	0	SENT_198	[p12l1939t2602r2142b2692],
111	P	NN	O	p	dep	114	SENT_198	[p12l10t2731r389b2817],
112	=	JJ	O	=	dep	114	SENT_198	[p12l10t2731r389b2817],
113	0.02	CD	NUMBER	0.02	dep	114	SENT_198	[p12l10t2731r389b2817],
114	)	NN	O	)	_	0	SENT_198	[p12l10t2731r389b2817],
115	.	.	O	.	_	0	SENT_198	[p12l10t2731r389b2817],

1	In	IN	O	in	dep	16	SENT_199	[p12l437t2733r528b2803],
2	the	DT	O	the	det	4	SENT_199	[p12l571t2725r707b2804],
3	multivariate	JJ	O	multivariate	amod	4	SENT_199	[p12l750t2725r1285b2804],
4	analysis	NN	O	analysis	pobj	1	SENT_199	[p12l1328t2725r1679b2826],
5	of	IN	O	of	_	0	SENT_199	[p12l1725t2725r1827b2804],
6	overall	JJ	O	overall	amod	7	SENT_199	[p12l1852t2725r2147b2804],
7	survival	NN	O	survival	prep_of	4	SENT_199	[p12l12t2853r360b2949],
8	,	,	O	,	_	0	SENT_199	[p12l12t2853r360b2949],
9	an	DT	O	a	det	12	SENT_199	[p12l401t2879r503b2932],
10	ECOG	NN	O	ecog	nn	12	SENT_199	[p12l538t2859r803b2932],
11	performance	NN	O	performance	nn	12	SENT_199	[p12l839t2853r1386b2954],
12	status	NN	O	status	appos	7	SENT_199	[p12l1423t2870r1671b2932],
13	of	IN	O	of	_	0	SENT_199	[p12l1710t2853r1809b2932],
14	1	CD	NUMBER	1	prep_of	12	SENT_199	[p12l1830t2859r1896b2949],
15	,	,	O	,	_	0	SENT_199	[p12l1830t2859r1896b2949],
16	male	NN	O	male	_	0	SENT_199	[p12l1938t2853r2146b2932],

1	962	CD	NUMBER	962	num	3	SENT_200	[p12l149t3012r206b3036],
2	N	NN	O	n	nn	3	SENT_200	[p12l931t3023r945b3038],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_200	[p12l959t3023r1037b3045],
4	MED	VBD	O	med	_	0	SENT_200	[p12l1052t3023r1104b3038],
5	36110	CD	NUMBER	36110	num	7	SENT_200	[p12l1114t3017r1192b3045],
6	NEJM	NNP	O	NEJM	nn	7	SENT_200	[p12l1227t3023r1288b3045],
7	ORG	NNP	O	ORG	dobj	4	SENT_200	[p12l1301t3023r1351b3039],
8	SEPTEMBER	NNP	DATE	SEPTEMBER	dep	7	SENT_200	[p12l1386t3023r1525b3038],
9	3	CD	DATE	3	num	8	SENT_200	[p12l1535t3023r1553b3045],
10	,	,	DATE	,	_	0	SENT_200	[p12l1535t3023r1553b3045],
11	2009	CD	DATE	2009	num	8	SENT_200	[p12l1564t3023r1628b3044],

1	The	DT	O	the	det	4	SENT_201	[p12l936t3056r987b3080],
2	New	NNP	O	New	nn	4	SENT_201	[p12l996t3057r1058b3080],
3	England	NNP	O	England	nn	4	SENT_201	[p12l1067t3056r1178b3087],
4	Journal	NNP	O	Journal	_	0	SENT_201	[p12l1187t3056r1284b3080],
5	of	IN	O	of	_	0	SENT_201	[p12l1294t3056r1323b3080],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_201	[p12l1330t3056r1455b3080],

1	NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN	NNP	O	NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN	_	0	SENT_202	[p12l643t3244r1470b3263],
2	ER	NN	O	er	dep	1	SENT_202	[p12l1475t3244r1516b3263],

1	sex	NN	O	sex	nsubjpass	17	SENT_203	[p12l12t3484r168b3554],
2	,	,	O	,	_	0	SENT_203	[p12l12t3484r168b3554],
3	the	DT	O	the	det	4	SENT_203	[p12l207t3458r340b3536],
4	presence	NN	O	presence	appos	1	SENT_203	[p12l370t3484r745b3558],
5	of	IN	O	of	_	0	SENT_203	[p12l778t3457r878b3537],
6	the	DT	O	the	det	8	SENT_203	[p12l893t3458r1025b3536],
7	L858R	NN	O	l858r	nn	8	SENT_203	[p12l1056t3464r1336b3542],
8	mutation	NN	O	mutation	prep_of	4	SENT_203	[p12l1358t3459r1773b3554],
9	,	,	O	,	_	0	SENT_203	[p12l1358t3459r1773b3554],
10	and	CC	O	and	_	0	SENT_203	[p12l1810t3458r1968b3537],
11	the	DT	O	the	det	12	SENT_203	[p12l2001t3458r2133b3536],
12	diagnosis	NN	O	diagnosis	conj_and	4	SENT_203	[p12l12t3587r422b3688],
13	of	IN	O	of	_	0	SENT_203	[p12l462t3586r562b3666],
14	bronchioloalveolar	JJ	O	bronchioloalveolar	amod	15	SENT_203	[p12l581t3587r1387b3666],
15	adenocarcinoma	NN	O	adenocarcinoma	prep_of	12	SENT_203	[p12l1420t3587r2135b3666],
16	were	VBD	O	be	auxpass	17	SENT_203	[p13l7t46r208b99],
17	associated	VBN	O	associate	_	0	SENT_203	[p13l248t20r692b99],
18	with	IN	O	with	_	0	SENT_203	[p13l727t20r922b99],
19	poor	JJ	O	poor	amod	20	SENT_203	[p13l960t46r1163b120],
20	prognosis	NN	O	prognosis	prep_with	17	SENT_203	[p13l1199t21r1624b121],
21	(	CD	NUMBER	(	num	24	SENT_203	[p13l1671t20r1933b111],
22	Table	NNP	O	Table	nn	24	SENT_203	[p13l1671t20r1933b111],
23	3	CD	NUMBER	3	num	24	SENT_203	[p13l1976t26r2074b111],
24	)	NN	O	)	xcomp	17	SENT_203	[p13l1976t26r2074b111],
25	.	.	O	.	_	0	SENT_203	[p13l1976t26r2074b111],

1	THERAPY	NN	O	therapy	nsubj	10	SENT_204	[p13l9t296r368b344],
2	AFTER	IN	O	after	_	0	SENT_204	[p13l399t296r638b344],
3	DISEASE	NN	O	disease	nn	6	SENT_204	[p13l676t295r1002b345],
4	PROGRESSION	NN	O	progression	nn	6	SENT_204	[p13l1041t295r1606b345],
5	A	NN	O	a	nn	6	SENT_204	[p13l7t401r73b471],
6	total	NN	O	total	prep_after	1	SENT_204	[p13l97t393r290b472],
7	of	IN	O	of	_	0	SENT_204	[p13l315t392r414b472],
8	55	CD	NUMBER	55	num	9	SENT_204	[p13l424t401r514b472],
9	patients	NNS	O	patient	prep_of	6	SENT_204	[p13l542t394r877b493],
10	received	VBD	O	receive	_	0	SENT_204	[p13l905t393r1243b473],
11	additional	JJ	O	additional	amod	12	SENT_204	[p13l1267t393r1694b472],
12	treatment	NN	O	treatment	dobj	10	SENT_204	[p13l1721t410r2139b471],
13	after	IN	O	after	_	0	SENT_204	[p13l11t521r204b600],
14	the	DT	O	the	det	15	SENT_204	[p13l230t522r358b600],
15	discontinuation	NN	O	discontinuation	prep_after	10	SENT_204	[p13l389t522r1039b601],
16	of	IN	O	of	_	0	SENT_204	[p13l1069t521r1167b601],
17	erlotinib	NN	O	erlotinib	prep_of	15	SENT_204	[p13l1178t522r1550b601],
18	:	:	O	:	_	0	SENT_204	[p13l1178t522r1550b601],
19	49	CD	PERCENT	49	num	20	SENT_204	[p13l1581t528r1764b601],
20	%	NN	PERCENT	%	nsubj	21	SENT_204	[p13l1581t528r1764b601],
21	received	VBD	O	receive	conj_and	10	SENT_204	[p13l1792t522r2134b601],
22	cisplatin-based	JJ	O	cisplatin-based	amod	23	SENT_204	[p13l12t650r644b749],
23	chemotherapy	NN	O	chemotherapy	dobj	21	SENT_204	[p13l674t650r1289b749],
24	;	:	O	;	_	0	SENT_204	[p13l674t650r1289b749],
25	25.5	CD	PERCENT	25.5	num	26	SENT_204	[p13l1322t655r1581b729],
26	%	NN	PERCENT	%	nsubj	27	SENT_204	[p13l1322t655r1581b729],
27	received	VBD	O	receive	conj_and	10	SENT_204	[p13l1609t650r1947b729],
28	single	JJ	O	single	amod	31	SENT_204	[p13l1977t651r2132b727, p13l11t778r411b879],
29	—	JJ	O	—	amod	31	SENT_204	[p13l1977t651r2132b727, p13l11t778r411b879],
30	agent	NN	O	agent	nn	31	SENT_204	[p13l1977t651r2132b727, p13l11t778r411b879],
31	chemotherapy	NN	O	chemotherapy	dobj	27	SENT_204	[p13l437t778r1066b878],
32	;	:	O	;	_	0	SENT_204	[p13l437t778r1066b878],
33	14.5	CD	PERCENT	14.5	num	34	SENT_204	[p13l1104t783r1359b857],
34	%	NN	PERCENT	%	nsubj	35	SENT_204	[p13l1104t783r1359b857],
35	received	VBD	O	receive	conj_and	10	SENT_204	[p13l1389t778r1734b857],
36	erlotinib	NN	O	erlotinib	dobj	35	SENT_204	[p13l1765t778r2132b857],
37	plus	CC	O	plus	_	0	SENT_204	[p13l9t905r185b1005],
38	vorinostat	NN	O	vorinostat	dobj	35	SENT_204	[p13l214t906r674b1001],
39	,	,	O	,	_	0	SENT_204	[p13l214t906r674b1001],
40	fulvestrant	NN	O	fulvestrant	conj_plus	36	SENT_204	[p13l711t904r1199b1001],
41	,	,	O	,	_	0	SENT_204	[p13l711t904r1199b1001],
42	or	CC	O	or	_	0	SENT_204	[p13l1237t931r1325b984],
43	bevacizumab	NN	O	bevacizumab	conj_plus	36	SENT_204	[p13l1355t905r1941b1000],
44	;	:	O	;	_	0	SENT_204	[p13l1355t905r1941b1000],
45	and	CC	O	and	_	0	SENT_204	[p13l1975t905r2134b984],
46	11	CD	PERCENT	11	num	47	SENT_204	[p13l15t1039r186b1113],
47	%	NN	PERCENT	%	nsubj	48	SENT_204	[p13l15t1039r186b1113],
48	received	VBD	O	receive	conj_and	10	SENT_204	[p13l217t1034r548b1113],
49	neratinib	JJ	O	neratinib	amod	52	SENT_204	[p13l579t1034r953b1112],
50	(	NN	O	(	nn	52	SENT_204	[p13l991t1040r1409b1124],
51	HKI	NN	O	hkus	nn	52	SENT_204	[p13l991t1040r1409b1124],
52	—	NN	O	—	iobj	48	SENT_204	[p13l991t1040r1409b1124],
53	272	CD	NUMBER	272	num	54	SENT_204	[p13l991t1040r1409b1124],
54	)	NN	O	)	dobj	48	SENT_204	[p13l991t1040r1409b1124],
55	.	.	O	.	_	0	SENT_204	[p13l991t1040r1409b1124],

1	The	DT	O	the	det	4	SENT_205	[p13l1443t1034r1599b1112],
2	objective	JJ	O	objective	amod	4	SENT_205	[p13l1632t1034r1987b1133],
3	response	NN	O	response	nn	4	SENT_205	[p13l2019t1060r2132b1112, p13l12t1187r307b1261],
4	rate	NN	O	rate	nsubj	15	SENT_205	[p13l341t1178r501b1239],
5	for	IN	O	for	_	0	SENT_205	[p13l536t1160r659b1240],
6	first	JJ	ORDINAL	first	amod	12	SENT_205	[p13l690t1160r1060b1239],
7	—	NN	O	—	nn	12	SENT_205	[p13l690t1160r1060b1239],
8	line	NN	O	line	nn	12	SENT_205	[p13l690t1160r1060b1239],
9	post	NN	O	post	nn	12	SENT_205	[p13l1093t1161r1679b1261],
10	—	NN	O	—	nn	12	SENT_205	[p13l1093t1161r1679b1261],
11	erlotinib	NN	O	erlotinib	nn	12	SENT_205	[p13l1093t1161r1679b1261],
12	treatment	NN	O	treatment	prep_for	4	SENT_205	[p13l1715t1178r2138b1239],
13	was	VBD	O	be	cop	15	SENT_205	[p13l7t1316r167b1369],
14	33	CD	PERCENT	33	num	15	SENT_205	[p13l199t1295r402b1386],
15	%	NN	PERCENT	%	_	0	SENT_205	[p13l199t1295r402b1386],
16	,	,	O	,	_	0	SENT_205	[p13l199t1295r402b1386],
17	including	VBG	O	include	partmod	15	SENT_205	[p13l436t1290r838b1391],
18	one	CD	NUMBER	one	number	19	SENT_205	[p13l865t1316r1013b1369],
19	complete	JJ	O	complete	dobj	17	SENT_205	[p13l1044t1290r1425b1390],
20	and	CC	O	and	_	0	SENT_205	[p13l1453t1290r1609b1369],
21	nine	CD	NUMBER	nine	num	23	SENT_205	[p13l1638t1291r1822b1368],
22	partial	JJ	O	partial	amod	23	SENT_205	[p13l1850t1290r2134b1390],
23	remissions	NNS	O	remission	conj_and	19	SENT_205	[p13l11t1419r490b1497],
24	.	.	O	.	_	0	SENT_205	[p13l11t1419r490b1497],

1	For	IN	O	for	_	0	SENT_206	[p13l521t1426r661b1497],
2	11	CD	NUMBER	11	num	3	SENT_206	[p13l689t1424r784b1496],
3	patients	NNS	O	patient	prep_for	54	SENT_206	[p13l811t1419r1145b1518],
4	receiving	VBG	O	receive	partmod	3	SENT_206	[p13l1174t1419r1555b1519],
5	a	DT	DURATION	a	det	12	SENT_206	[p13l1579t1444r1623b1496],
6	second	JJ	DURATION	second	amod	12	SENT_206	[p13l1651t1418r2133b1497],
7	—	NN	O	—	nn	12	SENT_206	[p13l1651t1418r2133b1497],
8	line	NN	O	line	nn	12	SENT_206	[p13l1651t1418r2133b1497],
9	post	NN	O	post	nn	12	SENT_206	[p13l9t1546r612b1645],
10	—	NN	O	—	nn	12	SENT_206	[p13l9t1546r612b1645],
11	erlotinib	NN	O	erlotinib	nn	12	SENT_206	[p13l9t1546r612b1645],
12	treatment	NN	O	treatment	dobj	4	SENT_206	[p13l656t1562r1111b1641],
13	,	,	O	,	_	0	SENT_206	[p13l656t1562r1111b1641],
14	the	DT	O	the	det	16	SENT_206	[p13l1159t1546r1293b1624],
15	response	NN	O	response	nn	16	SENT_206	[p13l1334t1572r1724b1645],
16	rate	NN	O	rate	appos	12	SENT_206	[p13l1765t1563r1929b1624],
17	was	VBD	O	be	partmod	16	SENT_206	[p13l1966t1572r2131b1625],
18	40	CD	NUMBER	40	num	19	SENT_206	[p13l9t1678r224b1753],
19	°	CD	NUMBER	°	dep	4	SENT_206	[p13l9t1678r224b1753],
20	/	:	O	/	punct	19	SENT_206	[p13l9t1678r224b1753],
21	o.	NNP	O	o.	nn	23	SENT_206	[p13l9t1678r224b1753],
22	Median	JJ	O	median	amod	23	SENT_206	[p13l257t1673r583b1752],
23	survival	NN	O	survival	nsubj	30	SENT_206	[p13l616t1673r947b1753],
24	for	IN	O	for	_	0	SENT_206	[p13l978t1672r1101b1752],
25	all	DT	O	all	det	27	SENT_206	[p13l1129t1673r1233b1751],
26	55	CD	NUMBER	55	num	27	SENT_206	[p13l1266t1681r1358b1752],
27	patients	NNS	O	patient	prep_for	23	SENT_206	[p13l1391t1674r1733b1773],
28	was	VBD	O	be	cop	30	SENT_206	[p13l1761t1699r1924b1753],
29	29.0	CD	DURATION	29.0	num	30	SENT_206	[p13l1957t1679r2132b1752],
30	months	NNS	NUMBER	month	dep	19	SENT_206	[p13l11t1801r344b1880],
31	(	VBP	O	(	rcmod	30	SENT_206	[p13l394t1806r608b1892],
32	95	CD	PERCENT	95	number	33	SENT_206	[p13l394t1806r608b1892],
33	%	NN	PERCENT	%	amod	34	SENT_206	[p13l394t1806r608b1892],
34	CI	NN	O	ci	dobj	31	SENT_206	[p13l650t1807r767b1897],
35	,	,	O	,	_	0	SENT_206	[p13l650t1807r767b1897],
36	20.2	CD	NUMBER	20.2	number	39	SENT_206	[p13l816t1807r998b1880],
37	to	TO	O	to	dep	39	SENT_206	[p13l1042t1818r1124b1880],
38	31.4	CD	NUMBER	31.4	number	39	SENT_206	[p13l1170t1807r1402b1897],
39	)	CD	NUMBER	)	appos	34	SENT_206	[p13l1170t1807r1402b1897],
40	;	:	O	;	_	0	SENT_206	[p13l1170t1807r1402b1897],
41	survival	NN	O	survival	dep	39	SENT_206	[p13l1451t1801r1790b1880],
42	for	IN	O	for	_	0	SENT_206	[p13l1832t1800r1958b1880],
43	the	DT	O	the	det	45	SENT_206	[p13l1998t1801r2133b1879],
44	159	CD	NUMBER	159	num	45	SENT_206	[p13l15t1936r163b2008],
45	patients	NNS	O	patient	prep_for	41	SENT_206	[p13l207t1931r556b2029],
46	who	WP	O	who	nsubj	49	SENT_206	[p13l598t1930r783b2009],
47	did	VBD	O	do	aux	49	SENT_206	[p13l830t1930r966b2008],
48	not	RB	O	not	neg	49	SENT_206	[p13l1009t1947r1155b2008],
49	receive	VB	O	receive	rcmod	3	SENT_206	[p13l1194t1931r1489b2009],
50	post-erlotinib	JJ	O	post-erlotinib	amod	51	SENT_206	[p13l1532t1930r2132b2029],
51	treatment	NN	O	treatment	dobj	49	SENT_206	[p13l12t2073r435b2134],
52	was	VBD	O	be	cop	54	SENT_206	[p13l456t2083r619b2136],
53	27.0	CD	DURATION	27.0	num	54	SENT_206	[p13l651t2063r817b2135],
54	months	NNS	NUMBER	month	_	0	SENT_206	[p13l849t2057r1176b2135],
55	(	VBP	O	(	attr	54	SENT_206	[p13l1213t2062r1424b2147],
56	95	CD	PERCENT	95	num	57	SENT_206	[p13l1213t2062r1424b2147],
57	%	NN	PERCENT	%	dobj	55	SENT_206	[p13l1213t2062r1424b2147],
58	CI	NN	O	ci	nsubj	54	SENT_206	[p13l1454t2063r1569b2152],
59	,	,	O	,	_	0	SENT_206	[p13l1454t2063r1569b2152],
60	22.4	CD	NUMBER	22.4	number	62	SENT_206	[p13l1605t2063r1786b2135],
61	to	TO	O	to	dep	62	SENT_206	[p13l1816t2073r1898b2135],
62	31.6	CD	NUMBER	31.6	appos	58	SENT_206	[p13l1930t2063r2129b2152],
63	;	:	O	;	_	0	SENT_206	[p13l1930t2063r2129b2152],
64	P	NN	O	p	dep	62	SENT_206	[p13l9t2191r379b2275],
65	=	JJ	O	=	amod	66	SENT_206	[p13l9t2191r379b2275],
66	O.	NNP	O	O.	dep	64	SENT_206	[p13l9t2191r379b2275],
67	48	CD	NUMBER	48	number	68	SENT_206	[p13l9t2191r379b2275],
68	)	CD	NUMBER	)	dep	66	SENT_206	[p13l9t2191r379b2275],
69	.	.	O	.	_	0	SENT_206	[p13l9t2191r379b2275],

1	ADVERSEEVENTS	NNP	O	ADVERSEEVENTS	_	0	SENT_207	[p13l9t2459r693b2509],
2	The	DT	O	the	det	6	SENT_207	[p13l7t2559r166b2637],
3	most	RBS	O	most	advmod	4	SENT_207	[p13l198t2576r412b2638],
4	common	JJ	O	common	amod	6	SENT_207	[p13l439t2585r816b2638],
5	adverse	JJ	O	adverse	amod	6	SENT_207	[p13l848t2559r1155b2638],
6	events	NNS	O	event	nsubj	9	SENT_207	[p13l1189t2576r1447b2638],
7	were	VBD	O	be	cop	9	SENT_207	[p13l1477t2585r1675b2638],
8	skin	NN	O	skin	nn	9	SENT_207	[p13l1709t2559r1886b2638],
9	rashes	NNS	O	rash	rcmod	1	SENT_207	[p13l1918t2559r2132b2637, p13l12t2713r95b2765],
10	in	IN	O	in	_	0	SENT_207	[p13l131t2688r214b2764],
11	151	CD	NUMBER	151	num	12	SENT_207	[p13l252t2693r399b2765],
12	patients	NNS	O	patient	prep_in	9	SENT_207	[p13l432t2688r774b2786],
13	(	IN	O	(	_	0	SENT_207	[p13l816t2692r1123b2777],
14	69.6	CD	PERCENT	69.6	num	15	SENT_207	[p13l816t2692r1123b2777],
15	%	NN	PERCENT	%	prep_(	9	SENT_207	[p13l816t2692r1123b2777],
16	)	CD	NUMBER	)	dep	15	SENT_207	[p13l816t2692r1123b2777],
17	and	CC	O	and	_	0	SENT_207	[p13l1163t2687r1320b2765],
18	diarrhea	NN	O	diarrhea	prep_(	9	SENT_207	[p13l1356t2687r1718b2765],
19	in	IN	O	in	_	0	SENT_207	[p13l1750t2688r1834b2764],
20	95	CD	NUMBER	95	num	21	SENT_207	[p13l1868t2693r1964b2765],
21	patients	NNS	O	patient	prep_in	18	SENT_207	[p13l2000t2713r2132b2786, p13l12t2816r247b2893],
22	(	IN	O	(	dep	1	SENT_207	[p13l294t2820r632b2911],
23	43.8	CD	PERCENT	43.8	num	24	SENT_207	[p13l294t2820r632b2911],
24	%	NN	PERCENT	%	pobj	22	SENT_207	[p13l294t2820r632b2911],
25	)	CD	NUMBER	)	dep	24	SENT_207	[p13l294t2820r632b2911],
26	;	:	O	;	_	0	SENT_207	[p13l294t2820r632b2911],
27	most	RBS	O	most	advmod	28	SENT_207	[p13l675t2832r892b2894],
28	events	NNS	O	event	nsubj	30	SENT_207	[p13l928t2832r1191b2894],
29	were	VBD	O	be	cop	30	SENT_207	[p13l1228t2841r1430b2894],
30	grade	NN	O	grade	parataxis	1	SENT_207	[p13l1470t2815r1708b2916],
31	1	CD	NUMBER	1	npadvmod	30	SENT_207	[p13l1752t2821r1796b2893],
32	or	CC	O	or	_	0	SENT_207	[p13l1837t2841r1926b2894],
33	2	CD	NUMBER	2	npadvmod	30	SENT_207	[p13l1962t2821r2009b2893],
34	in	IN	O	in	_	0	SENT_207	[p13l2050t2816r2133b2893],
35	severity	NN	O	severity	prep_in	30	SENT_207	[p13l12t2943r350b3042],
36	.	.	O	.	_	0	SENT_207	[p13l12t2943r350b3042],

1	Grade	NNP	O	Grade	nn	3	SENT_208	[p13l389t2942r644b3021],
2	3	CD	NUMBER	3	num	3	SENT_208	[p13l679t2948r722b3021],
3	skin	NN	O	skin	nsubjpass	7	SENT_208	[p13l760t2942r941b3022],
4	toxic	JJ	O	toxic	amod	5	SENT_208	[p13l974t2943r1180b3021],
5	effects	NNS	O	effect	dep	3	SENT_208	[p13l1213t2941r1493b3020],
6	were	VBD	O	be	auxpass	7	SENT_208	[p13l1524t2968r1726b3022],
7	recorded	VBN	O	record	_	0	SENT_208	[p13l1759t2942r2134b3021],
8	in	IN	O	in	_	0	SENT_208	[p13l11t3072r91b3149],
9	16	CD	NUMBER	16	num	10	SENT_208	[p13l128t3077r219b3150],
10	patients	NNS	O	patient	prep_in	7	SENT_208	[p13l252t3072r578b3171],
11	(	IN	O	(	_	0	SENT_208	[p13l618t3076r859b3162],
12	7.4	CD	PERCENT	7.4	num	13	SENT_208	[p13l618t3076r859b3162],
13	%	NN	PERCENT	%	prep_(	7	SENT_208	[p13l618t3076r859b3162],
14	)	CD	NUMBER	)	dep	13	SENT_208	[p13l618t3076r859b3162],
15	and	CC	O	and	_	0	SENT_208	[p13l897t3071r1051b3150],
16	grade	NN	O	grade	nn	18	SENT_208	[p13l1083t3071r1313b3172],
17	3	CD	NUMBER	3	num	18	SENT_208	[p13l1347t3077r1391b3150],
18	diarrhea	NN	O	diarrhea	prep_(	7	SENT_208	[p13l1428t3071r1775b3150],
19	in	IN	O	in	_	0	SENT_208	[p13l1806t3072r1888b3149],
20	8	CD	NUMBER	8	num	21	SENT_208	[p13l1921t3077r1966b3150],
21	patients	NNS	O	patient	prep_in	18	SENT_208	[p13l2000t3097r2132b3171, p13l12t3200r242b3277],
22	(	IN	O	(	_	0	SENT_208	[p13l275t3204r556b3289],
23	3.7	CD	PERCENT	3.7	num	24	SENT_208	[p13l275t3204r556b3289],
24	%	NN	PERCENT	%	prep_(	7	SENT_208	[p13l275t3204r556b3289],
25	)	CD	NUMBER	)	dep	24	SENT_208	[p13l275t3204r556b3289],
26	.	.	O	.	_	0	SENT_208	[p13l275t3204r556b3289],

1	One	CD	NUMBER	one	num	5	SENT_209	[p13l587t3205r758b3277],
2	62	CD	NUMBER	62	number	3	SENT_209	[p13l784t3199r1248b3298],
3	—	CD	NUMBER	—	dep	4	SENT_209	[p13l784t3199r1248b3298],
4	year-old	JJ	O	year-old	dep	5	SENT_209	[p13l784t3199r1248b3298],
5	man	NN	O	man	nsubj	9	SENT_209	[p13l1275t3225r1463b3277],
6	with	IN	O	with	_	0	SENT_209	[p13l1485t3199r1677b3278],
7	del	DT	O	del	det	8	SENT_209	[p13l1704t3199r1826b3277],
8	19	CD	NUMBER	19	prep_with	5	SENT_209	[p13l1855t3205r1950b3277],
9	had	VBD	O	have	_	0	SENT_209	[p13l1977t3199r2133b3277],
10	interstitial	JJ	O	interstitial	amod	12	SENT_209	[p13l11t3327r460b3405],
11	lung	NN	O	lung	nn	12	SENT_209	[p13l488t3327r681b3428],
12	disease	NN	O	disease	dobj	9	SENT_209	[p13l707t3327r1017b3406],
13	1	CD	DURATION	1	num	14	SENT_209	[p13l1050t3333r1094b3405],
14	month	NN	NUMBER	month	tmod	12	SENT_209	[p13l1124t3327r1408b3406],
15	after	IN	O	after	_	0	SENT_209	[p13l1437t3326r1639b3405],
16	the	DT	O	the	det	17	SENT_209	[p13l1666t3327r1798b3405],
17	start	NN	O	start	prep_after	12	SENT_209	[p13l1828t3344r2027b3405],
18	of	IN	O	of	_	0	SENT_209	[p13l2052t3326r2152b3406],
19	erlotinib	NN	O	erlotinib	prep_of	17	SENT_209	[p13l12t3455r401b3551],
20	,	,	O	,	_	0	SENT_209	[p13l12t3455r401b3551],
21	resulting	VBG	O	result	partmod	12	SENT_209	[p13l448t3455r834b3556],
22	in	IN	O	in	_	0	SENT_209	[p13l872t3456r955b3533],
23	temporary	JJ	O	temporary	amod	24	SENT_209	[p13l997t3472r1447b3555],
24	interruption	NN	O	interruption	prep_in	21	SENT_209	[p13l1484t3456r2009b3555],
25	of	IN	O	of	_	0	SENT_209	[p13l2052t3454r2152b3534],
26	treatment	NN	O	treatment	prep_of	24	SENT_209	[p13l12t3600r435b3661],
27	with	IN	O	with	_	0	SENT_209	[p13l457t3583r652b3662],
28	the	DT	O	the	det	29	SENT_209	[p13l685t3583r817b3661],
29	drug	NN	O	drug	prep_with	21	SENT_209	[p13l850t3583r1074b3684],
30	;	:	O	;	_	0	SENT_209	[p13l850t3583r1074b3684],
31	he	PRP	O	he	nsubj	32	SENT_209	[p13l1109t3583r1207b3662],
32	recovered	VBD	O	recover	parataxis	9	SENT_209	[p13l1239t3583r1648b3662],
33	with	IN	O	with	_	0	SENT_209	[p13l1675t3583r1871b3662],
34	corticosteroid	NN	O	corticosteroid	nn	35	SENT_209	[p13l1903t3584r2132b3662, p13l12t3711r395b3789],
35	therapy	NN	O	therapy	prep_with	32	SENT_209	[p13l429t3711r744b3810],
36	and	CC	O	and	_	0	SENT_209	[p13l772t3711r928b3789],
37	reinitiated	VBD	O	reinitiate	parataxis	9	SENT_209	[p13l961t3711r1394b3789],
38	erlotinib	NN	O	erlotinib	nn	39	SENT_209	[p13l1428t3711r1786b3789],
39	therapy	NN	O	therapy	dobj	37	SENT_209	[p13l1822t3711r2138b3810],
40	at	IN	O	at	_	0	SENT_209	[p14l11t40r89b101],
41	a	DT	O	a	det	43	SENT_209	[p14l120t49r164b101],
42	lower	JJR	O	lower	amod	43	SENT_209	[p14l199t23r437b103],
43	dose	NN	O	dose	prep_at	37	SENT_209	[p14l470t23r688b102],
44	.	.	O	.	_	0	SENT_209	[p14l470t23r688b102],

1	No	DT	O	no	det	2	SENT_210	[p14l728t31r852b102],
2	patient	NN	O	patient	nsubjpass	4	SENT_210	[p14l889t24r1191b123],
3	was	VBD	O	be	auxpass	4	SENT_210	[p14l1218t49r1381b103],
4	withdrawn	VBN	O	withdraw	_	0	SENT_210	[p14l1414t23r1886b103],
5	from	IN	O	from	_	0	SENT_210	[p14l1923t22r2133b102],
6	the	DT	O	the	det	7	SENT_210	[p14l12t151r142b229],
7	study	NN	O	study	prep_from	4	SENT_210	[p14l173t151r399b251],
8	because	IN	O	because	mark	12	SENT_210	[p14l425t151r755b231],
9	of	IN	O	of	_	0	SENT_210	[p14l786t150r884b230],
10	adverse	JJ	O	adverse	amod	11	SENT_210	[p14l895t151r1203b230],
11	events	NNS	O	event	prep_of	12	SENT_210	[p14l1234t168r1492b231],
12	(	VBP	O	(	dep	7	SENT_210	[p14l1529t151r1781b242],
13	Table	NNP	O	Table	dobj	12	SENT_210	[p14l1529t151r1781b242],
14	7	CD	NUMBER	7	num	13	SENT_210	[p14l1812t159r1858b230],
15	in	IN	O	in	_	0	SENT_210	[p14l1889t152r1971b229],
16	the	DT	O	the	det	19	SENT_210	[p14l2001t151r2134b229],
17	Supplementary	NNP	O	Supplementary	nn	19	SENT_210	[p14l13t280r660b379],
18	Appendix	NNP	O	Appendix	nn	19	SENT_210	[p14l687t280r1152b379],
19	)	NN	O	)	prep_in	13	SENT_210	[p14l687t280r1152b379],
20	.	.	O	.	_	0	SENT_210	[p14l687t280r1152b379],

1	DISCUSSION	NN	O	discussion	_	0	SENT_211	[p14l733t576r1411b635],

1	We	PRP	O	we	nsubj	14	SENT_212	[p14l7t853r141b923],
2	prospectively	RB	O	prospectively	advmod	3	SENT_212	[p14l184t845r765b945],
3	examined	VBD	O	examine	_	0	SENT_212	[p14l805t845r1234b924],
4	2105	CD	DATE	2105	num	5	SENT_212	[p14l1277t851r1478b924],
5	patients	NNS	O	patient	dobj	3	SENT_212	[p14l1523t846r1874b945],
6	from	IN	O	from	_	0	SENT_212	[p14l1920t844r2133b924],
7	Spain	NNP	LOCATION	Spain	prep_from	3	SENT_212	[p14l13t975r251b1074],
8	with	IN	O	with	_	0	SENT_212	[p14l287t974r482b1053],
9	adenocarcinoma	NN	O	adenocarcinoma	prep_with	3	SENT_212	[p14l523t974r1238b1053],
10	of	IN	O	of	_	0	SENT_212	[p14l1277t973r1377b1053],
11	the	DT	O	the	det	12	SENT_212	[p14l1400t974r1533b1052],
12	lung	NN	O	lung	prep_of	9	SENT_212	[p14l1573t974r1767b1075],
13	and	CC	O	and	_	0	SENT_212	[p14l1804t974r1961b1053],
14	determined	VBD	O	determine	conj_and	3	SENT_212	[p14l2003t974r2132b1053, p14l12t1102r397b1180],
15	that	IN	O	that	complm	17	SENT_212	[p14l423t1102r593b1179],
16	350	CD	NUMBER	350	nsubj	17	SENT_212	[p14l614t1108r759b1181],
17	carried	VBD	O	carry	ccomp	14	SENT_212	[p14l787t1102r1081b1180],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_212	[p14l1105t1108r1314b1181],
19	mutations	NNS	O	mutation	nsubj	20	SENT_212	[p14l1334t1103r1760b1181],
20	(	VBP	O	(	ccomp	17	SENT_212	[p14l1793t1107r2128b1192],
21	16.6	CD	PERCENT	16.6	num	22	SENT_212	[p14l1793t1107r2128b1192],
22	%	NN	PERCENT	%	dobj	20	SENT_212	[p14l1793t1107r2128b1192],
23	)	CD	NUMBER	)	dobj	3	SENT_212	[p14l1793t1107r2128b1192],
24	.	.	O	.	_	0	SENT_212	[p14l1793t1107r2128b1192],

1	Mutations	NNS	O	mutation	nsubj	4	SENT_213	[p14l8t1230r436b1309],
2	Were	VBD	O	be	cop	4	SENT_213	[p14l464t1255r662b1309],
3	more	RBR	O	more	advmod	4	SENT_213	[p14l693t1255r909b1308],
4	frequent	JJ	O	frequent	_	0	SENT_213	[p14l939t1228r1296b1329],
5	in	IN	O	in	_	0	SENT_213	[p14l1320t1230r1402b1307],
6	Women	NNS	O	woman	prep_in	4	SENT_213	[p14l1428t1255r1739b1308],
7	who	WP	O	who	nsubj	10	SENT_213	[p14l1765t1229r1946b1309],
8	had	VBD	O	have	aux	10	SENT_213	[p14l1978t1229r2134b1308],
9	never	RB	O	never	neg	10	SENT_213	[p14l11t1385r232b1438],
10	smoked	VBN	O	smoke	rcmod	6	SENT_213	[p14l261t1359r581b1438],
11	and	CC	O	and	_	0	SENT_213	[p14l612t1359r765b1438],
12	in	IN	O	in	_	0	SENT_213	[p14l794t1360r875b1437],
13	those	DT	O	those	prep_in	4	SENT_213	[p14l906t1359r1128b1438],
14	with	IN	O	with	_	0	SENT_213	[p14l1155t1359r1343b1438],
15	adenocarcinomas	NNS	O	adenocarcinoma	prep_with	13	SENT_213	[p14l1373t1359r2128b1438],
16	.	.	O	.	_	0	SENT_213	[p14l1373t1359r2128b1438],

1	In	IN	O	in	_	0	SENT_214	[p14l9t1495r97b1565],
2	Europe	NNP	LOCATION	Europe	prep_in	17	SENT_214	[p14l127t1495r447b1587],
3	,	,	O	,	_	0	SENT_214	[p14l127t1495r447b1587],
4	the	DT	O	the	det	6	SENT_214	[p14l485t1487r615b1566],
5	only	JJ	O	only	amod	6	SENT_214	[p14l648t1487r829b1587],
6	report	NN	O	report	nsubj	17	SENT_214	[p14l855t1504r1117b1587],
7	of	IN	O	of	_	0	SENT_214	[p14l1144t1486r1243b1566],
8	lung	NN	O	lung	nn	10	SENT_214	[p14l1254t1486r2134b1588],
9	—	NN	O	—	nn	10	SENT_214	[p14l1254t1486r2134b1588],
10	cancer	NN	O	cancer	prep_of	6	SENT_214	[p14l1254t1486r2134b1588],
11	—	CD	NUMBER	—	num	14	SENT_214	[p14l1254t1486r2134b1588],
12	specif1c	JJ	O	specif1c	amod	14	SENT_214	[p14l1254t1486r2134b1588],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_214	[p14l9t1621r221b1695],
14	mutations	NNS	O	mutation	dep	10	SENT_214	[p14l244t1616r678b1694],
15	to	TO	O	to	_	0	SENT_214	[p14l710t1632r791b1693],
16	date	NN	O	date	prep_to	14	SENT_214	[p14l822t1615r1000b1693],
17	involved	VBD	O	involve	_	0	SENT_214	[p14l1028t1615r1380b1694],
18	two	CD	NUMBER	two	num	19	SENT_214	[p14l1409t1632r1566b1694],
19	sites	NNS	O	site	dobj	17	SENT_214	[p14l1598t1616r1783b1693],
20	in	IN	O	in	_	0	SENT_214	[p14l1814t1616r1897b1692],
21	Italy	NNP	LOCATION	Italy	prep_in	17	SENT_214	[p14l1925t1615r2128b1714],
22	,	,	O	,	_	0	SENT_214	[p14l1925t1615r2128b1714],
23	where	WRB	O	where	advmod	27	SENT_214	[p14l7t1743r266b1822],
24	EGFR	NN	ORGANIZATION	egfr	nn	25	SENT_214	[p14l300t1750r512b1823],
25	mutations	NNS	O	mutation	nsubjpass	27	SENT_214	[p14l541t1744r975b1822],
26	were	VBD	O	be	auxpass	27	SENT_214	[p14l1008t1769r1209b1822],
27	found	VBN	O	find	advcl	17	SENT_214	[p14l1244t1742r1497b1822],
28	in	IN	O	in	_	0	SENT_214	[p14l1530t1744r1614b1820],
29	10	CD	PERCENT	10	num	30	SENT_214	[p14l1653t1748r1833b1822],
30	%	NN	PERCENT	%	prep_in	27	SENT_214	[p14l1653t1748r1833b1822],
31	of	IN	O	of	_	0	SENT_214	[p14l1868t1742r1968b1822],
32	375	CD	NUMBER	375	num	34	SENT_214	[p14l1986t1749r2130b1822],
33	lung	NN	O	lung	nn	34	SENT_214	[p14l10t1871r200b1972],
34	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	30	SENT_214	[p14l225t1871r966b1950],
35	but	CC	O	but	_	0	SENT_214	[p14l998t1871r1136b1950],
36	in	IN	O	in	_	0	SENT_214	[p14l1159t1872r1241b1949],
37	none	NN	O	none	prep_in	27	SENT_214	[p14l1270t1897r1475b1950],
38	of	IN	O	of	_	0	SENT_214	[p14l1506t1870r1604b1950],
39	31	CD	NUMBER	31	num	43	SENT_214	[p14l1616t1877r1711b1950],
40	large	JJ	O	large	amod	43	SENT_214	[p14l1739t1871r2134b1972],
41	—	NN	O	—	nn	43	SENT_214	[p14l1739t1871r2134b1972],
42	cell	NN	O	cell	nn	43	SENT_214	[p14l1739t1871r2134b1972],
43	carcinomas	NNS	O	carcinoma	prep_of	37	SENT_214	[p14l12t2000r610b2077],
44	.	.	O	.	_	0	SENT_214	[p14l12t2000r610b2077],

1	”	NN	O	”	npadvmod	10	SENT_215	[p14l12t2000r610b2077],
2	In	IN	O	in	_	0	SENT_215	[p14l644t2006r732b2076],
3	our	PRP$	O	we	poss	4	SENT_215	[p14l767t2025r913b2078],
4	study	NN	O	study	prep_in	10	SENT_215	[p14l946t1999r1188b2098],
5	,	,	O	,	_	0	SENT_215	[p14l946t1999r1188b2098],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_215	[p14l1226t2005r1438b2078],
7	mutations	NNS	O	mutation	nsubjpass	10	SENT_215	[p14l1466t2000r1900b2078],
8	were	VBD	O	be	auxpass	10	SENT_215	[p14l1931t2025r2133b2078],
9	also	RB	O	also	advmod	10	SENT_215	[p14l11t2127r181b2206],
10	found	VBN	O	find	_	0	SENT_215	[p14l217t2126r470b2206],
11	in	IN	O	in	_	0	SENT_215	[p14l503t2128r587b2205],
12	33	CD	NUMBER	33	number	14	SENT_215	[p14l623t2133r716b2206],
13	of	IN	O	of	quantmod	14	SENT_215	[p14l755t2126r855b2206],
14	287	CD	NUMBER	287	num	18	SENT_215	[p14l871t2133r1022b2206],
15	large	JJ	O	large	amod	18	SENT_215	[p14l1057t2127r1458b2228],
16	—	NN	O	—	nn	18	SENT_215	[p14l1057t2127r1458b2228],
17	cell	NN	O	cell	nn	18	SENT_215	[p14l1057t2127r1458b2228],
18	carcinomas	NNS	O	carcinoma	prep_in	10	SENT_215	[p14l1493t2128r2012b2206],
19	.	.	O	.	_	0	SENT_215	[p14l1493t2128r2012b2206],

1	The	DT	O	the	det	3	SENT_216	[p14l136t2254r293b2332],
2	overall	JJ	O	overall	amod	3	SENT_216	[p14l327t2254r599b2333],
3	rate	NN	O	rate	nsubj	13	SENT_216	[p14l630t2271r784b2332],
4	of	IN	O	of	_	0	SENT_216	[p14l817t2253r915b2333],
5	complete	JJ	O	complete	amod	8	SENT_216	[p14l929t2254r1303b2354],
6	or	CC	O	or	_	0	SENT_216	[p14l1336t2280r1422b2333],
7	partial	JJ	O	partial	conj_or	5	SENT_216	[p14l1450t2254r1725b2354],
8	response	NN	O	response	prep_of	3	SENT_216	[p14l1757t2280r2133b2354],
9	to	TO	O	to	_	0	SENT_216	[p14l12t2399r92b2461],
10	erlotinib	NN	O	erlotinib	prep_to	8	SENT_216	[p14l132t2382r499b2461],
11	was	VBD	O	be	cop	13	SENT_216	[p14l533t2408r695b2462],
12	70.6	CD	PERCENT	70.6	num	13	SENT_216	[p14l735t2387r1017b2478],
13	%	NN	PERCENT	%	_	0	SENT_216	[p14l735t2387r1017b2478],
14	,	,	O	,	_	0	SENT_216	[p14l735t2387r1017b2478],
15	akin	JJ	O	akin	dep	13	SENT_216	[p14l1059t2382r1249b2462],
16	to	TO	O	to	_	0	SENT_216	[p14l1286t2399r1368b2461],
17	that	DT	O	that	prep_to	15	SENT_216	[p14l1406t2382r1579b2460],
18	reported	VBN	O	report	partmod	17	SENT_216	[p14l1611t2382r1977b2482],
19	for	IN	O	for	_	0	SENT_216	[p14l2014t2381r2137b2461],
20	gefitinib	NN	O	gefitinib	prep_for	18	SENT_216	[p14l11t2510r365b2612],
21	in	IN	O	in	_	0	SENT_216	[p14l399t2512r481b2589],
22	retrospective14v17	NN	O	retrospective14v17	prep_in	20	SENT_216	[p14l514t2512r1287b2611],
23	'	''	O	'	_	0	SENT_216	[p14l514t2512r1287b2611],
24	2	CD	NUMBER	2	num	25	SENT_216	[p14l514t2512r1287b2611],
25	°	NN	O	°	dep	20	SENT_216	[p14l514t2512r1287b2611],
26	and	CC	O	and	_	0	SENT_216	[p14l1320t2511r1474b2590],
27	prospective21	NN	O	prospective21	prep_for	18	SENT_216	[p14l1506t2512r2132b2611],
28	'23	CD	NUMBER	'23	num	29	SENT_216	[p14l1506t2512r2132b2611],
29	studies	NNS	O	study	dep	27	SENT_216	[p14l12t2639r330b2718],
30	.	.	O	.	_	0	SENT_216	[p14l12t2639r330b2718],

1	A	DT	O	a	det	3	SENT_217	[p14l371t2647r437b2717],
2	higher	JJR	O	higher	amod	3	SENT_217	[p14l474t2639r749b2740],
3	probability	NN	O	probability	nsubj	7	SENT_217	[p14l784t2639r1247b2739],
4	of	IN	O	of	_	0	SENT_217	[p14l1282t2638r1381b2718],
5	response	NN	O	response	prep_of	3	SENT_217	[p14l1402t2665r1775b2739],
6	was	VBD	O	be	cop	7	SENT_217	[p14l1810t2665r1971b2718],
7	asTable	JJ	O	astable	_	0	SENT_217	[p14l2012t2665r2132b2717, p15l58t130r199b178],

1	2	LS	NUMBER	2	_	0	SENT_218	[p15l216t134r260b178],
2	.	.	O	.	_	0	SENT_218	[p15l216t134r260b178],

1	Characteristics	NNS	O	characteristic	_	0	SENT_219	[p15l279t130r669b178],
2	and	CC	O	and	_	0	SENT_219	[p15l688t130r781b178],
3	Treatment	NN	O	treatment	nn	4	SENT_219	[p15l800t134r1074b178],
4	Responses	NNS	O	response	conj_and	1	SENT_219	[p15l1094t134r1372b192],
5	of	IN	O	of	_	0	SENT_219	[p15l1390t129r1450b178],
6	217	CD	NUMBER	217	num	7	SENT_219	[p15l1457t134r1549b177],
7	Patients	NNS	O	patient	prep_of	1	SENT_219	[p15l1572t131r1779b178],
8	Receiving	VBG	O	receive	partmod	7	SENT_219	[p15l1801t131r2050b193],
9	Er	NN	O	er	nn	11	SENT_219	[p15l63t210r328b258],
10	|	NN	O	|	nn	11	SENT_219	[p15l63t210r328b258],
11	otinib	NN	O	otinib	dobj	8	SENT_219	[p15l63t210r328b258],
12	.	.	O	.	_	0	SENT_219	[p15l63t210r328b258],
13	"	''	O	"	punct	1	SENT_219	[p15l63t210r328b258],

1	‘	NN	O	‘	_	0	SENT_220	[p15l63t210r328b258],

1	Variable	JJ	O	variable	amod	2	SENT_221	[p15l58t352r270b401],
2	Value	NN	O	value	_	0	SENT_221	[p15l1599t352r1745b401],

1	Age	NNP	O	Age	_	0	SENT_222	[p15l58t462r156b522],
2	—	CD	NUMBER	—	num	3	SENT_222	[p15l172t489r237b493],
3	yr	NN	DURATION	yr	dep	1	SENT_222	[p15l252t476r299b522],

1	Median	JJ	O	median	amod	2	SENT_223	[p15l160t561r350b608],
2	67	CD	NUMBER	67	_	0	SENT_223	[p15l1644t565r1702b609],
3	Range	NNP	O	Range	dep	2	SENT_223	[p15l160t667r316b726],
4	22-88	CD	NUMBER	22-88	num	3	SENT_223	[p15l1595t665r1750b711],

1	Sex	NN	O	sex	nn	3	SENT_224	[p15l61t767r226b812],
2	—	CD	NUMBER	—	num	3	SENT_224	[p15l61t767r226b812],
3	no.	NN	O	no.	_	0	SENT_224	[p15l246t781r322b812],
4	(	CD	PERCENT	(	num	5	SENT_224	[p15l349t766r434b827],
5	%	NN	PERCENT	%	dep	3	SENT_224	[p15l349t766r434b827],
6	)	CD	NUMBER	)	dep	3	SENT_224	[p15l349t766r434b827],

1	Male	JJ	O	male	_	0	SENT_225	[p15l160t866r283b914],
2	59	CD	NUMBER	59	number	3	SENT_225	[p15l1560t870r1618b914],
3	(	CD	NUMBER	(	num	5	SENT_225	[p15l1644t870r1786b929],
4	27.2	CD	NUMBER	27.2	number	5	SENT_225	[p15l1644t870r1786b929],
5	)	CD	NUMBER	)	npadvmod	6	SENT_225	[p15l1644t870r1786b929],
6	Female	JJ	O	female	amod	1	SENT_225	[p15l160t967r345b1015],
7	158	CD	NUMBER	158	dep	1	SENT_225	[p15l1531t971r1618b1016],
8	(	CD	NUMBER	(	number	9	SENT_225	[p15l1644t971r1786b1031],
9	72.8	CD	NUMBER	72.8	num	10	SENT_225	[p15l1644t971r1786b1031],
10	)	NN	O	)	dep	7	SENT_225	[p15l1644t971r1786b1031],

1	Race	NN	O	race	_	0	SENT_226	[p15l64t1074r181b1117],
2	—	CD	NUMBER	—	num	3	SENT_226	[p15l198t1099r263b1103],
3	no.	NN	O	no.	dep	1	SENT_226	[p15l282t1086r358b1117],
4	(	CD	PERCENT	(	rcmod	3	SENT_226	[p15l385t1072r511b1132],
5	%	NN	PERCENT	%	prep	4	SENT_226	[p15l385t1072r511b1132],
6	)	NN	O	)	dep	5	SENT_226	[p15l385t1072r511b1132],
7	'	''	O	'	_	0	SENT_226	[p15l385t1072r511b1132],
8	i	FW	O	i	dep	4	SENT_226	[p15l385t1072r511b1132],
9	'	''	O	'	_	0	SENT_226	[p15l385t1072r511b1132],

1	Black	JJ	O	black	amod	2	SENT_227	[p15l160t1171r294b1219],
2	3	CD	NUMBER	3	_	0	SENT_227	[p15l1592t1175r1615b1219],
3	(	NN	O	(	dep	2	SENT_227	[p15l1644t1175r1754b1234],
4	1.4	CD	NUMBER	1.4	num	3	SENT_227	[p15l1644t1175r1754b1234],
5	)	JJ	O	)	amod	6	SENT_227	[p15l1644t1175r1754b1234],
6	Asian	JJ	ORGANIZATION	asian	amod	3	SENT_227	[p15l154t1276r296b1321],
7	1	CD	NUMBER	1	number	8	SENT_227	[p15l1595t1277r1616b1320],
8	(	CD	NUMBER	(	num	10	SENT_227	[p15l1644t1276r1755b1336],
9	0.5	CD	NUMBER	0.5	number	10	SENT_227	[p15l1644t1276r1755b1336],
10	)	CD	NUMBER	)	dep	3	SENT_227	[p15l1644t1276r1755b1336],
11	White	NNP	O	White	dep	10	SENT_227	[p15l154t1374r307b1422],
12	213	CD	NUMBER	213	num	11	SENT_227	[p15l1527t1378r1615b1422],
13	(	CD	NUMBER	(	num	15	SENT_227	[p15l1644t1377r1786b1437],
14	98.2	CD	NUMBER	98.2	num	15	SENT_227	[p15l1644t1377r1786b1437],
15	)	NN	O	)	dep	2	SENT_227	[p15l1644t1377r1786b1437],

1	Smoking	NN	O	smoking	nn	2	SENT_228	[p15l61t1476r291b1540],
2	history	NN	O	history	_	0	SENT_228	[p15l311t1476r486b1539],
3	—	CD	NUMBER	—	num	4	SENT_228	[p15l501t1506r566b1510],
4	no.	NN	O	no.	dep	2	SENT_228	[p15l586t1493r662b1524],
5	(	CD	PERCENT	(	num	6	SENT_228	[p15l689t1478r774b1539],
6	%	NN	PERCENT	%	dep	4	SENT_228	[p15l689t1478r774b1539],
7	)	CD	NUMBER	)	dep	2	SENT_228	[p15l689t1478r774b1539],

1	Former	JJ	O	former	amod	8	SENT_229	[p15l160t1582r348b1626],
2	smoker	NN	O	smoker	nn	8	SENT_229	[p15l367t1578r561b1626],
3	56	CD	NUMBER	56	num	8	SENT_229	[p15l1560t1582r1618b1626],
4	(	CD	NUMBER	(	num	8	SENT_229	[p15l1644t1581r1786b1641],
5	25.8	CD	NUMBER	25.8	num	8	SENT_229	[p15l1644t1581r1786b1641],
6	)	CD	NUMBER	)	num	8	SENT_229	[p15l1644t1581r1786b1641],
7	Current	JJ	DATE	current	amod	8	SENT_229	[p15l156t1683r353b1728],
8	smoker	NN	O	smoker	nsubj	14	SENT_229	[p15l373t1679r567b1727],
9	13	CD	NUMBER	13	tmod	14	SENT_229	[p15l1563t1683r1615b1727],
10	(	CD	NUMBER	(	number	11	SENT_229	[p15l1644t1682r1755b1742],
11	6.0	CD	NUMBER	6.0	num	12	SENT_229	[p15l1644t1682r1755b1742],
12	)	NN	O	)	npadvmod	13	SENT_229	[p15l1644t1682r1755b1742],
13	Never	RB	O	never	neg	14	SENT_229	[p15l160t1785r312b1829],
14	smoked	VBD	O	smoke	_	0	SENT_229	[p15l330t1781r533b1829],
15	148	CD	NUMBER	148	dobj	14	SENT_229	[p15l1531t1784r1618b1830],
16	(	CD	NUMBER	(	number	17	SENT_229	[p15l1644t1784r1786b1844],
17	68.2	CD	NUMBER	68.2	num	18	SENT_229	[p15l1644t1784r1786b1844],
18	)	NN	O	)	dobj	14	SENT_229	[p15l1644t1784r1786b1844],

1	ECOG	NN	ORGANIZATION	ecog	nn	3	SENT_230	[p15l64t1887r219b1931],
2	performance	NN	O	performance	nn	3	SENT_230	[p15l245t1882r576b1946],
3	status	NN	O	status	_	0	SENT_230	[p15l596t1892r751b1931],
4	—	CD	NUMBER	—	num	5	SENT_230	[p15l769t1913r834b1917],
5	no.	NN	O	no.	dep	3	SENT_230	[p15l853t1900r929b1931],
6	(	CD	PERCENT	(	num	7	SENT_230	[p15l956t1885r1041b1946],
7	%	NN	PERCENT	%	dep	5	SENT_230	[p15l956t1885r1041b1946],
8	)	CD	NUMBER	)	dep	3	SENT_230	[p15l956t1885r1041b1946],

1	Tumor	NN	O	tumor	nn	2	SENT_231	[p15l58t2294r236b2338],
2	type	NN	O	type	_	0	SENT_231	[p15l252t2299r360b2353],
3	—	CD	NUMBER	—	num	4	SENT_231	[p15l376t2319r441b2324],
4	no.	NN	O	no.	dep	2	SENT_231	[p15l461t2307r536b2338],
5	(	CD	PERCENT	(	num	6	SENT_231	[p15l563t2292r649b2353],
6	%	NN	PERCENT	%	dep	4	SENT_231	[p15l563t2292r649b2353],
7	)	CD	NUMBER	)	dep	2	SENT_231	[p15l563t2292r649b2353],

1	Adenocarcinoma	NN	O	adenocarcinoma	dep	7	SENT_232	[p15l154t2391r600b2439],
2	176	CD	NUMBER	176	dep	1	SENT_232	[p15l1531t2396r1618b2439],
3	(	NN	O	(	dep	7	SENT_232	[p15l1644t2395r1786b2455],
4	81.1	CD	NUMBER	81.1	num	3	SENT_232	[p15l1644t2395r1786b2455],
5	)	CD	NUMBER	)	num	7	SENT_232	[p15l1644t2395r1786b2455],
6	Bronchioloalveolar	JJ	O	bronchioloalveolar	amod	7	SENT_232	[p15l160t2493r650b2541],
7	adenocarcinoma	NN	O	adenocarcinoma	dep	15	SENT_232	[p15l668t2493r1104b2541],
8	22	CD	NUMBER	22	num	9	SENT_232	[p15l1559t2498r1617b2540],
9	(	NN	O	(	dep	7	SENT_232	[p15l1644t2496r1786b2556],
10	10.1	CD	NUMBER	10.1	number	11	SENT_232	[p15l1644t2496r1786b2556],
11	)	CD	NUMBER	)	num	13	SENT_232	[p15l1644t2496r1786b2556],
12	Large-cell	JJ	O	large-cell	amod	13	SENT_232	[p15l160t2595r401b2658],
13	carcinoma	NN	O	carcinoma	dep	9	SENT_232	[p15l423t2599r696b2643],
14	19	CD	NUMBER	19	num	15	SENT_232	[p15l1563t2599r1618b2643],
15	(	NN	O	(	dep	17	SENT_232	[p15l1644t2598r1755b2658],
16	8.8	CD	NUMBER	8.8	num	17	SENT_232	[p15l1644t2598r1755b2658],
17	)	NN	O	)	_	0	SENT_232	[p15l1644t2598r1755b2658],

1	Tumor	NN	O	tumor	nn	2	SENT_233	[p15l58t2701r236b2745],
2	stage	NN	O	stage	_	0	SENT_233	[p15l255t2706r390b2760],
3	—	CD	NUMBER	—	num	4	SENT_233	[p15l407t2726r472b2730],
4	no.	NN	O	no.	dep	2	SENT_233	[p15l491t2714r567b2745],
5	(	CD	PERCENT	(	num	6	SENT_233	[p15l594t2699r679b2760],
6	%	NN	PERCENT	%	dep	4	SENT_233	[p15l594t2699r679b2760],
7	)	CD	NUMBER	)	dep	2	SENT_233	[p15l594t2699r679b2760],

1	IIIB	NN	O	iiib	nn	3	SENT_234	[p15l160t2803r245b2846],
2	12	CD	NUMBER	12	num	3	SENT_234	[p15l1563t2803r1617b2846],
3	(	NN	O	(	_	0	SENT_234	[p15l1644t2802r1755b2861],
4	5.5	CD	NUMBER	5.5	num	5	SENT_234	[p15l1644t2802r1755b2861],
5	)	NN	O	)	dep	3	SENT_234	[p15l1644t2802r1755b2861],
6	IV	CD	NUMBER	iv	number	7	SENT_234	[p15l160t2904r209b2948],
7	205	CD	NUMBER	205	num	8	SENT_234	[p15l1527t2903r1615b2948],
8	(	NN	O	(	dep	5	SENT_234	[p15l1644t2904r1786b2963],
9	94.5	CD	NUMBER	94.5	num	10	SENT_234	[p15l1644t2904r1786b2963],
10	)	NN	O	)	dep	3	SENT_234	[p15l1644t2904r1786b2963],

1	Erlotinib	NN	O	erlotinib	nn	2	SENT_235	[p15l64t3002r280b3050],
2	therapy	NN	O	therapy	_	0	SENT_235	[p15l298t3002r494b3065],
3	—	CD	NUMBER	—	num	4	SENT_235	[p15l509t3031r574b3036],
4	no.	NN	O	no.	dep	2	SENT_235	[p15l593t3019r669b3050],
5	(	CD	PERCENT	(	num	6	SENT_235	[p15l696t3004r781b3065],
6	%	NN	PERCENT	%	dep	4	SENT_235	[p15l696t3004r781b3065],
7	)	CD	NUMBER	)	dep	2	SENT_235	[p15l696t3004r781b3065],

1	First	JJ	ORDINAL	first	amod	2	SENT_236	[p15l160t3108r271b3152],
2	line	NN	O	line	_	0	SENT_236	[p15l292t3103r382b3152],
3	113	CD	NUMBER	113	num	4	SENT_236	[p15l1531t3107r1615b3151],
4	(	NN	O	(	dep	2	SENT_236	[p15l1644t3107r1786b3166],
5	52.1	CD	NUMBER	52.1	number	6	SENT_236	[p15l1644t3107r1786b3166],
6	)	CD	NUMBER	)	dep	4	SENT_236	[p15l1644t3107r1786b3166],
7	Second	JJ	ORDINAL	second	advmod	6	SENT_236	[p15l157t3205r344b3253],
8	or	CC	O	or	_	0	SENT_236	[p15l367t3222r420b3253],
9	third	JJ	ORDINAL	third	amod	10	SENT_236	[p15l435t3205r556b3253],
10	line	NN	O	line	conj_or	4	SENT_236	[p15l580t3205r670b3253],
11	104	CD	NUMBER	104	num	12	SENT_236	[p15l1531t3208r1618b3253],
12	(	NN	O	(	dep	10	SENT_236	[p15l1644t3209r1786b3268],
13	47.9	CD	NUMBER	47.9	num	14	SENT_236	[p15l1644t3209r1786b3268],
14	)	NN	O	)	dep	2	SENT_236	[p15l1644t3209r1786b3268],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_237	[p15l62t3311r207b3355],
2	mutation	NN	O	mutation	_	0	SENT_237	[p15l228t3312r461b3355],
3	—	CD	NUMBER	—	num	4	SENT_237	[p15l481t3337r546b3341],
4	no.	NN	O	no.	dep	2	SENT_237	[p15l565t3324r641b3355],
5	(	CD	PERCENT	(	num	6	SENT_237	[p15l668t3310r753b3370],
6	%	NN	PERCENT	%	dep	4	SENT_237	[p15l668t3310r753b3370],
7	)	CD	NUMBER	)	dep	2	SENT_237	[p15l668t3310r753b3370],

1	del	DT	O	del	det	4	SENT_238	[p15l156t3409r228b3457],
2	19	CD	NUMBER	19	number	3	SENT_238	[p15l254t3413r309b3457],
3	135	CD	NUMBER	135	num	4	SENT_238	[p15l1531t3413r1615b3457],
4	(	NN	O	(	_	0	SENT_238	[p15l1644t3413r1786b3472],
5	62.2	CD	NUMBER	62.2	number	6	SENT_238	[p15l1644t3413r1786b3472],
6	)	CD	NUMBER	)	num	7	SENT_238	[p15l1644t3413r1786b3472],
7	L858R	NN	O	l858r	dep	4	SENT_238	[p15l160t3514r316b3559],
8	82	CD	NUMBER	82	dep	4	SENT_238	[p15l1559t3514r1617b3559],
9	(	CD	NUMBER	(	number	10	SENT_238	[p15l1644t3514r1786b3574],
10	37.8	CD	NUMBER	37.8	num	11	SENT_238	[p15l1644t3514r1786b3574],
11	)	NN	O	)	dep	8	SENT_238	[p15l1644t3514r1786b3574],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_239	[p15l63t3617r207b3661],
2	mutation	NN	O	mutation	dep	6	SENT_239	[p15l228t3617r461b3661],
3	in	IN	O	in	_	0	SENT_239	[p15l486t3617r527b3660],
4	serum	NN	O	serum	prep_in	2	SENT_239	[p15l550t3630r711b3661],
5	—	CD	NUMBER	—	dep	6	SENT_239	[p15l731t3643r795b3647],
6	no.	NN	O	no.	dep	9	SENT_239	[p15l815t3630r891b3661],
7	(	CD	PERCENT	(	num	8	SENT_239	[p15l918t3615r1044b3676],
8	%	NN	PERCENT	%	dep	6	SENT_239	[p15l918t3615r1044b3676],
9	)	CD	NUMBER	)	_	0	SENT_239	[p15l918t3615r1044b3676],
10	:	:	O	:	_	0	SENT_239	[p15l918t3615r1044b3676],
11	i	FW	O	i	dep	9	SENT_239	[p15l918t3615r1044b3676],
12	:	:	O	:	_	0	SENT_239	[p15l918t3615r1044b3676],

1	del	DT	O	del	det	4	SENT_240	[p15l156t3714r228b3763],
2	19	CD	NUMBER	19	number	3	SENT_240	[p15l254t3719r309b3763],
3	64	CD	NUMBER	64	num	4	SENT_240	[p15l1560t3719r1618b3763],
4	(	NN	O	(	_	0	SENT_240	[p15l1644t3718r1786b3778],
5	39.0	CD	NUMBER	39.0	number	6	SENT_240	[p15l1644t3718r1786b3778],
6	)	CD	NUMBER	)	num	4	SENT_240	[p15l1644t3718r1786b3778],
7	IfIl	NN	ORGANIZATION	ifil	dep	4	SENT_240	[p15l160t3820r314b3834],
8	'	''	O	'	_	0	SENT_240	[p15l160t3820r314b3834],
9	fIl	NN	O	fil	dep	4	SENT_240	[p15l160t3820r314b3834],
10	'	''	O	'	_	0	SENT_240	[p15l160t3820r314b3834],
11	\	SYM	O	\	dep	12	SENT_240	[p15l160t3820r314b3834],
12	‘	CD	NUMBER	‘	rcmod	9	SENT_240	[p15l1561t3820r1613b3834],
13	I	PRP	O	I	nsubj	14	SENT_240	[p15l1561t3820r1613b3834],
14	’	VBP	O	’	rcmod	4	SENT_240	[p15l1561t3820r1613b3834],
15	!	.	O	!	_	0	SENT_240	[p15l1561t3820r1613b3834],

1	Iﬁf	NN	O	iﬁf	nn	2	SENT_241	[p15l1646t3820r1720b3834],
2	\	NN	O	\	_	0	SENT_241	[p15l1646t3820r1720b3834],
3	1	CD	NUMBER	1	num	4	SENT_241	[p15l1745t3820r1784b3834],
4	\	NN	O	\	dep	2	SENT_241	[p15l1745t3820r1784b3834],

1	LZSDESK	NNP	ORGANIZATION	LZSDESK	_	0	SENT_242	[p16l160t6r316b37],
2	33	CD	NUMBER	33	number	3	SENT_242	[p16l1560t6r1615b36],
3	(	CD	NUMBER	(	num	4	SENT_242	[p16l1644t6r1786b51],
4	2u	NN	O	2u	dep	1	SENT_242	[p16l1644t6r1786b51],
5	.1	CD	NUMBER	.1	num	6	SENT_242	[p16l1644t6r1786b51],
6	)	CD	NUMBER	)	npadvmod	7	SENT_242	[p16l1644t6r1786b51],
7	Not	RB	O	not	neg	8	SENT_242	[p16l160t95r255b138],
8	detected	VBN	O	detect	partmod	1	SENT_242	[p16l273t90r493b138],
9	67	CD	NUMBER	67	dobj	8	SENT_242	[p16l1560t94r1618b138],
10	(	CD	NUMBER	(	number	11	SENT_242	[p16l1644t93r1786b153],
11	40.9	CD	NUMBER	40.9	num	12	SENT_242	[p16l1644t93r1786b153],
12	)	NN	O	)	dep	9	SENT_242	[p16l1644t93r1786b153],

1	Response	NN	O	response	nn	3	SENT_243	[p16l64t196r313b254],
2	—	CD	NUMBER	—	num	3	SENT_243	[p16l330t221r395b226],
3	no.	NN	O	no.	_	0	SENT_243	[p16l415t209r490b240],
4	(	CD	PERCENT	(	num	5	SENT_243	[p16l517t191r632b255],
5	%	NN	PERCENT	%	dep	3	SENT_243	[p16l517t191r632b255],
6	)	CD	NUMBER	)	num	7	SENT_243	[p16l517t191r632b255],
7	§	NN	O	§	dep	3	SENT_243	[p16l517t191r632b255],

1	Complete	JJ	O	complete	amod	2	SENT_244	[p16l156t293r408b356],
2	response	NN	O	response	dep	13	SENT_244	[p16l430t311r666b356],
3	24	CD	NUMBER	24	number	4	SENT_244	[p16l1559t298r1618b341],
4	(	CD	NUMBER	(	num	6	SENT_244	[p16l1644t297r1786b357],
5	12.2	CD	NUMBER	12.2	number	6	SENT_244	[p16l1644t297r1786b357],
6	)	CD	NUMBER	)	dep	2	SENT_244	[p16l1644t297r1786b357],
7	Partial	JJ	O	partial	amod	8	SENT_244	[p16l160t395r317b443],
8	response	NN	O	response	dep	6	SENT_244	[p16l342t412r578b458],
9	115	CD	NUMBER	115	num	8	SENT_244	[p16l1531t400r1615b443],
10	(	NN	O	(	dep	13	SENT_244	[p16l1644t398r1786b458],
11	58.4	CD	NUMBER	58.4	num	10	SENT_244	[p16l1644t398r1786b458],
12	)	CD	NUMBER	)	number	13	SENT_244	[p16l1644t398r1786b458],
13	Complete	JJ	O	complete	dep	23	SENT_244	[p16l156t497r408b560],
14	or	CC	O	or	_	0	SENT_244	[p16l427t514r481b545],
15	partial	JJ	O	partial	amod	16	SENT_244	[p16l501t497r659b560],
16	response	NN	O	response	dep	23	SENT_244	[p16l684t514r919b560],
17	139	CD	NUMBER	139	num	18	SENT_244	[p16l1531t501r1618b545],
18	(	NN	O	(	dep	13	SENT_244	[p16l1644t500r1786b560],
19	70.6	CD	NUMBER	70.6	number	20	SENT_244	[p16l1644t500r1786b560],
20	)	CD	NUMBER	)	num	22	SENT_244	[p16l1644t500r1786b560],
21	Stable	JJ	O	stable	amod	22	SENT_244	[p16l156t599r315b647],
22	disease	NN	O	disease	dep	18	SENT_244	[p16l334t599r528b647],
23	38	CD	NUMBER	38	dep	25	SENT_244	[p16l1560t602r1618b647],
24	(	CD	NUMBER	(	num	25	SENT_244	[p16l1644t603r1786b662],
25	19.3	CD	NUMBER	19.3	dep	29	SENT_244	[p16l1644t603r1786b662],
26	)	CD	NUMBER	)	num	28	SENT_244	[p16l1644t603r1786b662],
27	Progressive	JJ	O	progressive	amod	28	SENT_244	[p16l160t705r458b764],
28	disease	NN	O	disease	dep	25	SENT_244	[p16l478t700r671b749],
29	20	CD	NUMBER	20	dep	30	SENT_244	[p16l1559t703r1619b749],
30	(	NN	O	(	dep	33	SENT_244	[p16l1644t703r1786b763],
31	10.2	CD	NUMBER	10.2	num	30	SENT_244	[p16l1644t703r1786b763],
32	)	CD	NUMBER	)	number	33	SENT_244	[p16l1644t703r1786b763],
33	Stable	JJ	O	stable	_	0	SENT_244	[p16l157t802r315b850],
34	or	CC	O	or	_	0	SENT_244	[p16l334t819r387b850],
35	progressive	JJ	O	progressive	amod	36	SENT_244	[p16l407t807r706b866],
36	disease	NN	O	disease	conj_or	33	SENT_244	[p16l726t802r919b850],
37	58	CD	NUMBER	58	number	38	SENT_244	[p16l1560t805r1618b851],
38	(	CD	NUMBER	(	dep	33	SENT_244	[p16l1644t806r1786b865],
39	29.4	CD	NUMBER	29.4	num	40	SENT_244	[p16l1644t806r1786b865],
40	)	NN	O	)	dep	38	SENT_244	[p16l1644t806r1786b865],

1	*	NN	O	*	nn	2	SENT_245	[p16l8t969r37b997],
2	ECOG	NN	O	ecog	nsubj	3	SENT_245	[p16l61t969r216b1013],
3	denotes	VBZ	O	denote	_	0	SENT_245	[p16l242t965r448b1013],
4	Eastern	NNP	ORGANIZATION	Eastern	nn	7	SENT_245	[p16l475t969r664b1013],
5	Cooperative	NNP	ORGANIZATION	Cooperative	nn	7	SENT_245	[p16l689t969r1002b1028],
6	Oncology	NNP	ORGANIZATION	Oncology	nn	7	SENT_245	[p16l1025t965r1276b1028],
7	Group	NNP	ORGANIZATION	Group	dobj	3	SENT_245	[p16l1296t969r1476b1028],
8	.	.	O	.	_	0	SENT_245	[p16l1296t969r1476b1028],

1	1	CD	NUMBER	1	dep	5	SENT_246	[p16l10t1042r40b1100],
2	'	''	O	'	_	0	SENT_246	[p16l10t1042r40b1100],
3	Race	NN	O	race	nsubj	5	SENT_246	[p16l61t1042r178b1085],
4	was	VBD	O	be	cop	5	SENT_246	[p16l198t1054r296b1085],
5	self-reported	JJ	O	self-reported	_	0	SENT_246	[p16l321t1037r666b1100],
6	.	.	O	.	_	0	SENT_246	[p16l321t1037r666b1100],

1	Ii	NN	O	ii	_	0	SENT_247	[p16l10t1113r40b1171],
2	:	:	O	:	_	0	SENT_247	[p16l10t1113r40b1171],
3	The	DT	O	the	det	5	SENT_247	[p16l54t1109r151b1156],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_247	[p16l176t1112r320b1156],
5	mutation	NN	O	mutation	nsubjpass	7	SENT_247	[p16l344t1113r578b1156],
6	was	VBD	O	be	auxpass	7	SENT_247	[p16l600t1125r698b1156],
7	evaluated	VBN	O	evaluate	dep	1	SENT_247	[p16l722t1109r968b1156],
8	in	IN	O	in	_	0	SENT_247	[p16l996t1113r1037b1156],
9	the	DT	O	the	det	10	SENT_247	[p16l1060t1109r1141b1156],
10	serum	NN	O	serum	prep_in	7	SENT_247	[p16l1165t1125r1325b1156],
11	of	IN	O	of	_	0	SENT_247	[p16l1350t1108r1407b1156],
12	164	CD	NUMBER	164	num	13	SENT_247	[p16l1424t1113r1511b1156],
13	patients	NNS	O	patient	prep_of	10	SENT_247	[p16l1536t1113r1757b1171],
14	.	.	O	.	_	0	SENT_247	[p16l1536t1113r1757b1171],

1	§	NN	O	§	nsubjpass	8	SENT_248	[p16l9t1179r29b1242],
2	The	DT	O	the	det	3	SENT_248	[p16l54t1180r151b1227],
3	response	NN	O	response	dep	1	SENT_248	[p16l176t1196r411b1242],
4	to	TO	O	to	_	0	SENT_248	[p16l431t1188r482b1227],
5	erlotinib	NN	O	erlotinib	nn	6	SENT_248	[p16l505t1180r721b1227],
6	therapy	NN	O	therapy	prep_to	1	SENT_248	[p16l741t1180r937b1242],
7	was	VBD	O	be	auxpass	8	SENT_248	[p16l956t1196r1054b1227],
8	evaluated	VBN	O	evaluate	_	0	SENT_248	[p16l1077t1180r1324b1227],
9	in	IN	O	in	_	0	SENT_248	[p16l1351t1184r1392b1227],
10	197	CD	NUMBER	197	num	11	SENT_248	[p16l1421t1184r1508b1227],
11	patients	NNS	O	patient	prep_in	8	SENT_248	[p16l1533t1184r1754b1242],
12	.	.	O	.	_	0	SENT_248	[p16l1533t1184r1754b1242],

1	N	NN	O	n	nn	3	SENT_249	[p16l538t1377r552b1392],
2	ENGLJ	NN	O	englj	nn	3	SENT_249	[p16l566t1377r644b1399],
3	MED	NN	O	med	_	0	SENT_249	[p16l659t1377r711b1392],
4	361	CD	NUMBER	361	dep	3	SENT_249	[p16l721t1371r799b1399],
5	;	:	O	;	_	0	SENT_249	[p16l721t1371r799b1399],
6	1o	CD	NUMBER	1o	num	8	SENT_249	[p16l721t1371r799b1399],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_249	[p16l834t1377r958b1399],
8	SEPTEMBER	NN	DATE	september	dep	4	SENT_249	[p16l993t1377r1132b1392],
9	3	CD	DATE	3	dep	8	SENT_249	[p16l1142t1377r1160b1399],
10	,	,	DATE	,	_	0	SENT_249	[p16l1142t1377r1160b1399],
11	2009	CD	DATE	2009	num	12	SENT_249	[p16l1172t1377r1236b1398],
12	963	CD	NUMBER	963	appos	8	SENT_249	[p16l1959t1366r2015b1390],

1	The	DT	O	the	det	4	SENT_250	[p16l702t1410r753b1434],
2	New	NNP	O	New	nn	4	SENT_250	[p16l762t1411r824b1434],
3	England	NNP	O	England	nn	4	SENT_250	[p16l833t1410r944b1441],
4	Journal	NNP	O	Journal	_	0	SENT_250	[p16l952t1410r1050b1434],
5	of	IN	O	of	_	0	SENT_250	[p16l1059t1410r1088b1434],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_250	[p16l1095t1410r1220b1434],

1	The	DT	O	the	det	4	SENT_251	[p16l816t1535r862b1556],
2	NEW	NNP	O	NEW	nn	4	SENT_251	[p16l880t1537r965b1556],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_251	[p16l984t1537r1173b1556],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_251	[p16l1192t1537r1371b1563],
5	of	IN	O	of	_	0	SENT_251	[p16l1391t1535r1419b1562],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_251	[p16l1431t1537r1630b1556],

1	A	DT	O	a	det	3	SENT_252	[p16l113t1670r135b1696],
2	Progression-free	JJ	O	progression-free	amod	3	SENT_252	[p16l159t1672r367b1703],
3	Survival	NN	O	survival	_	0	SENT_252	[p16l376t1673r477b1696],
4	in	IN	O	in	_	0	SENT_252	[p16l488t1673r509b1696],
5	All	DT	O	all	det	7	SENT_252	[p16l519t1672r551b1696],
6	Patients	NNS	O	patient	nn	7	SENT_252	[p16l563t1673r664b1696],
7	B	NN	O	b	prep_in	3	SENT_252	[p16l1104t1671r1122b1696],
8	Progression-free	JJ	O	progression-free	amod	9	SENT_252	[p16l1148t1672r1356b1703],
9	Survival	NNP	O	Survival	dep	7	SENT_252	[p16l1365t1672r1466b1696],
10	According	VBG	O	accord	_	0	SENT_252	[p16l1475t1672r1605b1703],
11	to	TO	O	to	prepc_according_to	3	SENT_252	[p16l1613t1676r1638b1696],
12	Therapy	NN	O	therapy	pobj	3	SENT_252	[p16l1647t1672r1751b1703],

1	L	NN	O	l	_	0	SENT_253	[p16l1740t2092r1887b2122],
2	---	CD	NUMBER	---	num	3	SENT_253	[p16l1740t2092r1887b2122],
3	¢	NN	O	¢	dep	1	SENT_253	[p16l1740t2092r1887b2122],
4	.	.	O	.	_	0	SENT_253	[p16l1740t2092r1887b2122],

1	-	:	O	-	_	0	SENT_254	[p16l1740t2092r1887b2122],
2	.	.	O	.	_	0	SENT_254	[p16l1740t2092r1887b2122],

1	---	CD	NUMBER	---	_	0	SENT_255	[p16l1740t2092r1887b2122],
2	.	.	O	.	_	0	SENT_255	[p16l1740t2092r1887b2122],

1	.	.	O	.	_	0	SENT_256	[p16l1740t2092r1887b2122],

1	First	JJ	ORDINAL	first	amod	2	SENT_257	[p16l1767t2132r1818b2152],
2	line	NN	O	line	_	0	SENT_257	[p16l1828t2130r1869b2152],

1	0.2	CD	NUMBER	0.2	num	2	SENT_258	[p16l371t2100r425b2121, p16l267t2027r298b2162],
2	Probability	NN	O	probability	_	0	SENT_258	[p16l371t2100r425b2121, p16l267t2027r298b2162],
3	of	IN	O	of	_	0	SENT_258	[p16l267t1989r291b2018],
4	Progression-free	JJ	O	progression-free	amod	5	SENT_258	[p16l267t1775r298b1983],
5	Probability	NN	O	probability	prep_of	2	SENT_258	[p16l1257t2027r1287b2162],
6	of	IN	O	of	_	0	SENT_258	[p16l1256t1989r1280b2018],
7	Progression-free	JJ	O	progression-free	prep_of	2	SENT_258	[p16l1256t1775r1287b1983],

1	No.	NN	O	no.	dep	20	SENT_259	[p16l194t2333r237b2354],
2	at	IN	O	at	_	0	SENT_259	[p16l247t2335r271b2354],
3	Risk	NN	O	risk	nn	7	SENT_259	[p16l281t2331r333b2354],
4	217	CD	NUMBER	217	num	7	SENT_259	[p16l399t2334r441b2354],
5	First	NNP	ORDINAL	First	nn	7	SENT_259	[p16l1177t2331r1233b2354],
6	Line	NNP	O	Line	nn	7	SENT_259	[p16l1243t2331r1295b2354],
7	No.	NN	O	no.	prep_at	1	SENT_259	[p16l194t2368r237b2390],
8	of	IN	O	of	_	0	SENT_259	[p16l247t2366r276b2390],
9	Events	NNS	O	event	nn	11	SENT_259	[p16l282t2368r365b2390],
10	o	NN	O	o	nn	11	SENT_259	[p16l428t2369r441b2390],
11	No.	NN	O	no.	prep_of	1	SENT_259	[p16l1207t2368r1247b2388],
12	at	IN	O	at	_	0	SENT_259	[p16l1257t2370r1279b2388],
13	risk	NN	O	risk	nn	16	SENT_259	[p16l1289t2366r1329b2388],
14	113	CD	NUMBER	113	num	16	SENT_259	[p16l1390t2368r1428b2388],
15	No.	NN	O	no.	nn	16	SENT_259	[p16l1207t2401r1247b2421],
16	ofevents	NNS	O	ofevent	prep_at	1	SENT_259	[p16l1257t2399r1364b2421],
17	o	NN	O	o	nn	19	SENT_259	[p16l1417t2403r1430b2423],
18	Second	NNP	DURATION	Second	nn	19	SENT_259	[p16l1175t2433r1268b2457],
19	Line	NNP	O	Line	dep	20	SENT_259	[p16l1280t2434r1332b2457],
20	No.	NN	O	no.	_	0	SENT_259	[p16l1207t2470r1247b2490],
21	at	IN	O	at	_	0	SENT_259	[p16l1257t2472r1279b2490],
22	risk	NN	O	risk	nn	26	SENT_259	[p16l1289t2468r1329b2490],
23	104	CD	NUMBER	104	num	26	SENT_259	[p16l1390t2473r1430b2494],
24	No.	NN	O	no.	nn	26	SENT_259	[p16l1207t2503r1247b2523],
25	ofevents	NNS	O	ofevent	nn	26	SENT_259	[p16l1257t2501r1364b2523],
26	o	NN	O	o	prep_at	20	SENT_259	[p16l1417t2509r1430b2530],

1	C	NN	O	c	_	0	SENT_260	[p16l113t2585r134b2611],
2	Overall	JJ	O	overall	amod	3	SENT_260	[p16l157t2587r248b2611],
3	Survival	NN	O	survival	dep	1	SENT_260	[p16l258t2587r359b2611],
4	in	IN	O	in	_	0	SENT_260	[p16l370t2588r392b2611],
5	All	DT	O	all	det	6	SENT_260	[p16l401t2587r433b2611],
6	Patients	NNS	O	patient	prep_in	3	SENT_260	[p16l445t2588r546b2611],

1	0.2	CD	NUMBER	0.2	num	2	SENT_261	[p16l371t3017r406b3038],
2	Probability	NN	O	probability	_	0	SENT_261	[p16l1292t2941r1323b3075],
3	of	IN	O	of	_	0	SENT_261	[p16l1292t2903r1316b2932],
4	Overall	JJ	O	overall	amod	5	SENT_261	[p16l1292t2808r1316b2899],
5	Survival	NN	O	survival	prep_of	2	SENT_261	[p16l1292t2697r1316b2798],

1	Ta	NN	O	ta	nn	3	SENT_262	[p16l303t2697r326b2717],
2	.2	NN	NUMBER	.2	nn	3	SENT_262	[p16l304t2718r326b2738],
3	E	NN	O	e	_	0	SENT_262	[p16l311t2740r326b2763],
4	3	CD	NUMBER	3	num	5	SENT_262	[p16l311t2767r326b2780],
5	tn	NN	O	tn	dep	3	SENT_262	[p16l305t2783r326b2798],
6	3	CD	NUMBER	3	num	7	SENT_262	[p16l303t2816r326b2835],
7	E	NN	O	e	dep	5	SENT_262	[p16l311t2836r327b2861],
8	‘	CD	NUMBER	‘	dep	3	SENT_262	[p16l311t2836r327b2861],
9	:	:	O	:	_	0	SENT_262	[p16l311t2836r327b2861],
10	>	JJR	O	>	amod	12	SENT_262	[p16l311t2861r326b2876],
11	E	NN	O	e	nn	12	SENT_262	[p16l303t2877r326b2917],
12	o	NN	O	o	dep	8	SENT_262	[p16l311t2917r326b2932],
13	:2	CD	NUMBER	:2	number	14	SENT_262	[p16l303t2941r334b2970],
14	‘	CD	NUMBER	‘	dep	3	SENT_262	[p16l303t2941r334b2970],
15	25	CD	NUMBER	25	num	16	SENT_262	[p16l303t2980r327b3001],
16	N	NN	O	n	dep	14	SENT_262	[p16l311t3004r326b3017],
17	.	.	O	.	_	0	SENT_262	[p16l303t3018r327b3032],

1	n	NN	O	n	nn	2	SENT_263	[p16l303t3018r327b3032],
2	E	NN	O	e	_	0	SENT_263	[p16l311t3034r326b3059],
3	n.	IN	O	n.	dep	2	SENT_263	[p16l305t3061r326b3075],

1	No.	NN	O	no.	dep	20	SENT_264	[p16l194t3250r237b3272],
2	at	IN	O	at	_	0	SENT_264	[p16l247t3252r271b3272],
3	Risk	NN	O	risk	nn	7	SENT_264	[p16l281t3248r333b3272],
4	217	CD	NUMBER	217	num	7	SENT_264	[p16l399t3252r441b3271],
5	First	NNP	ORDINAL	First	nn	7	SENT_264	[p16l1177t3249r1233b3272],
6	Line	NNP	O	Line	nn	7	SENT_264	[p16l1243t3249r1295b3272],
7	No.	NN	O	no.	prep_at	1	SENT_264	[p16l194t3286r237b3307],
8	of	IN	O	of	_	0	SENT_264	[p16l247t3283r276b3307],
9	Events	NNS	O	event	nn	11	SENT_264	[p16l282t3286r365b3307],
10	o	NN	O	o	nn	11	SENT_264	[p16l428t3286r441b3307],
11	No.	NN	O	no.	prep_of	1	SENT_264	[p16l1207t3285r1247b3305],
12	at	IN	O	at	_	0	SENT_264	[p16l1257t3287r1279b3305],
13	risk	NN	O	risk	nn	16	SENT_264	[p16l1289t3283r1329b3305],
14	113	CD	NUMBER	113	num	16	SENT_264	[p16l1390t3285r1428b3305],
15	No.	NN	O	no.	nn	16	SENT_264	[p16l1207t3318r1247b3338],
16	ofevents	NNS	O	ofevent	prep_at	1	SENT_264	[p16l1257t3316r1364b3338],
17	o	NN	O	o	nn	19	SENT_264	[p16l1417t3318r1430b3338],
18	Second	NNP	DURATION	Second	nn	19	SENT_264	[p16l1175t3350r1268b3374],
19	Line	NNP	O	Line	dep	20	SENT_264	[p16l1280t3351r1332b3374],
20	No.	NN	O	no.	_	0	SENT_264	[p16l1207t3387r1247b3407],
21	at	IN	O	at	_	0	SENT_264	[p16l1257t3389r1279b3407],
22	risk	NN	O	risk	nn	26	SENT_264	[p16l1289t3385r1329b3407],
23	104	CD	NUMBER	104	num	26	SENT_264	[p16l1390t3384r1430b3405],
24	No.	NN	O	no.	nn	26	SENT_264	[p16l1207t3420r1247b3440],
25	ofevents	NNS	O	ofevent	nn	26	SENT_264	[p16l1257t3418r1364b3440],
26	o	NN	O	o	prep_at	20	SENT_264	[p16l1417t3418r1430b3438],

1	Figure	NN	O	figure	_	0	SENT_265	[p16l122t3503r206b3535],
2	2	CD	NUMBER	2	dep	1	SENT_265	[p16l216t3504r240b3527],
3	.	.	O	.	_	0	SENT_265	[p16l216t3504r240b3527],

1	Kap	NN	O	kap	_	0	SENT_266	[p16l253t3502r447b3535],
2	|	CD	NUMBER	|	num	1	SENT_266	[p16l253t3502r447b3535],
3	an	DT	O	a	dep	1	SENT_266	[p16l253t3502r447b3535],
4	.	.	O	.	_	0	SENT_266	[p16l253t3502r447b3535],

1	—	NN	O	—	_	0	SENT_267	[p16l253t3502r447b3535],
2	.	.	O	.	_	0	SENT_267	[p16l253t3502r447b3535],

1	Meier	NNP	O	Meier	nn	2	SENT_268	[p16l253t3502r447b3535],
2	Curves	NNP	O	Curves	_	0	SENT_268	[p16l457t3504r551b3527],
3	of	IN	O	of	_	0	SENT_268	[p16l562t3502r594b3527],
4	Progression-free	JJ	O	progression-free	amod	7	SENT_268	[p16l601t3502r827b3535],
5	and	CC	O	and	_	0	SENT_268	[p16l838t3502r887b3527],
6	Overall	JJ	O	overall	amod	7	SENT_268	[p16l899t3502r997b3527],
7	Survival	NN	O	survival	prep_of	2	SENT_268	[p16l1009t3502r1127b3527],
8	.	.	O	.	_	0	SENT_268	[p16l1009t3502r1127b3527],

1	Survival	NN	O	survival	nn	2	SENT_269	[p16l120t3552r228b3577],
2	curves	NNS	O	curve	nsubj	13	SENT_269	[p16l241t3561r329b3577],
3	for	IN	O	for	_	0	SENT_269	[p16l341t3552r380b3577],
4	217	CD	NUMBER	217	num	5	SENT_269	[p16l390t3554r436b3577],
5	patients	NNS	O	patient	prep_for	2	SENT_269	[p16l449t3554r559b3585],
6	with	IN	O	with	_	0	SENT_269	[p16l570t3552r627b3577],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_269	[p16l642t3554r716b3577],
8	mutations	NNS	O	mutation	prep_with	5	SENT_269	[p16l728t3554r868b3577],
9	who	WP	O	who	nsubj	10	SENT_269	[p16l879t3552r936b3577],
10	received	VBD	O	receive	rcmod	5	SENT_269	[p16l949t3552r1061b3577],
11	erlotinib	NN	O	erlotinib	nn	12	SENT_269	[p16l1074t3552r1188b3577],
12	therapy	NN	O	therapy	dobj	10	SENT_269	[p16l1199t3552r1303b3585],
13	indicate	VBP	O	indicate	_	0	SENT_269	[p16l1315t3552r1422b3577],
14	the	DT	O	the	det	15	SENT_269	[p16l1433t3552r1476b3577],
15	probability	NN	O	probability	dobj	13	SENT_269	[p16l1489t3552r1636b3585],
16	of	IN	O	of	_	0	SENT_269	[p16l1647t3552r1676b3577],
17	progression-free	JJ	O	progression-free	amod	20	SENT_269	[p16l1684t3552r1911b3585],
18	survival	NN	O	survival	nn	20	SENT_269	[p16l1923t3552r2027b3577],
19	(	CD	NUMBER	(	num	20	SENT_269	[p16l123t3594r206b3627],
20	Panel	NN	O	panel	prep_of	15	SENT_269	[p16l123t3594r206b3627],
21	A	DT	O	a	det	22	SENT_269	[p16l218t3595r246b3627],
22	)	NN	O	)	dep	15	SENT_269	[p16l218t3595r246b3627],
23	and	CC	O	and	_	0	SENT_269	[p16l260t3594r309b3619],
24	overall	JJ	O	overall	amod	25	SENT_269	[p16l321t3594r410b3619],
25	survival	NN	O	survival	conj_and	15	SENT_269	[p16l424t3594r528b3619],
26	(	CD	NUMBER	(	num	29	SENT_269	[p16l544t3594r627b3627],
27	Panel	NN	O	panel	nn	29	SENT_269	[p16l544t3594r627b3627],
28	C	NN	O	c	nn	29	SENT_269	[p16l640t3596r668b3627],
29	)	NN	O	)	dep	25	SENT_269	[p16l640t3596r668b3627],
30	among	IN	O	among	_	0	SENT_269	[p16l682t3602r779b3627],
31	all	PDT	O	all	predet	33	SENT_269	[p16l790t3594r818b3619],
32	the	DT	O	the	det	33	SENT_269	[p16l829t3594r873b3619],
33	patients	NNS	O	patient	prep_among	13	SENT_269	[p16l886t3596r995b3626],
34	and	CC	O	and	_	0	SENT_269	[p16l1008t3594r1056b3619],
35	among	IN	O	among	_	0	SENT_269	[p16l1070t3602r1166b3627],
36	those	DT	O	those	prep_among	13	SENT_269	[p16l1175t3594r1252b3619],
37	who	WP	O	who	nsubj	38	SENT_269	[p16l1262t3594r1319b3619],
38	received	VBD	O	receive	rcmod	36	SENT_269	[p16l1332t3594r1444b3619],
39	it	PRP	O	it	dobj	38	SENT_269	[p16l1458t3596r1474b3619],
40	as	IN	O	as	_	0	SENT_269	[p16l1485t3602r1513b3619],
41	either	DT	O	either	preconj	43	SENT_269	[p16l1525t3594r1605b3619],
42	first-line	JJ	O	first-line	amod	43	SENT_269	[p16l1614t3593r1730b3619],
43	therapy	NN	O	therapy	prep_as	38	SENT_269	[p16l1740t3594r1845b3626],
44	or	CC	O	or	_	0	SENT_269	[p16l1855t3602r1883b3619],
45	secondline	NN	O	secondline	nn	46	SENT_269	[p16l1894t3594r2002b3619, p16l121t3635r168b3661],
46	therapy	NN	O	therapy	prep_as	38	SENT_269	[p16l179t3635r283b3668],
47	(	CD	NUMBER	(	num	48	SENT_269	[p16l296t3635r395b3668],
48	Panels	NNS	O	panel	dep	43	SENT_269	[p16l296t3635r395b3668],
49	B	NN	O	b	nn	52	SENT_269	[p16l409t3638r424b3660],
50	and	CC	O	and	_	0	SENT_269	[p16l436t3635r485b3661],
51	D	NN	O	d	nn	52	SENT_269	[p16l500t3637r537b3668],
52	)	NN	O	)	dep	48	SENT_269	[p16l500t3637r537b3668],
53	.	.	O	.	_	0	SENT_269	[p16l500t3637r537b3668],

1	The	DT	O	the	det	4	SENT_270	[p16l549t3635r600b3661],
2	cumulative	JJ	O	cumulative	amod	4	SENT_270	[p16l611t3635r763b3661],
3	number	NN	O	number	nn	4	SENT_270	[p16l776t3635r884b3661],
4	ofevents	NNS	O	ofevent	nsubjpass	6	SENT_270	[p16l894t3635r1019b3661],
5	is	VBZ	O	be	auxpass	6	SENT_270	[p16l1032t3638r1051b3661],
6	listed	VBN	O	list	_	0	SENT_270	[p16l1065t3635r1136b3661],
7	for	IN	O	for	_	0	SENT_270	[p16l1148t3635r1187b3661],
8	each	DT	O	each	det	10	SENT_270	[p16l1197t3635r1259b3661],
9	time	NN	O	time	nn	10	SENT_270	[p16l1271t3638r1333b3661],
10	point	NN	O	point	prep_for	6	SENT_270	[p16l1345t3638r1424b3668],
11	.	.	O	.	_	0	SENT_270	[p16l1345t3638r1424b3668],

1	sociated	VBN	O	sociate	_	0	SENT_271	[p17l381t44r512b75],
2	with	IN	O	with	_	0	SENT_271	[p17l521t44r595b76],
3	del	DT	O	del	det	7	SENT_271	[p17l606t44r653b75],
4	19	CD	NUMBER	19	number	5	SENT_271	[p17l666t47r702b75],
5	(	CD	NUMBER	(	num	6	SENT_271	[p17l716t44r801b80],
6	odds	NNS	O	odds	nn	7	SENT_271	[p17l716t44r801b80],
7	ratio	NN	O	ratio	prep_with	1	SENT_271	[p17l813t45r894b82],
8	,	,	O	,	_	0	SENT_271	[p17l813t45r894b82],
9	3.08	CD	NUMBER	3.08	appos	7	SENT_271	[p17l909t47r983b82],
10	;	:	O	;	_	0	SENT_271	[p17l909t47r983b82],
11	95	CD	PERCENT	95	num	13	SENT_271	[p17l997t46r1066b75],
12	%	NN	PERCENT	%	nn	13	SENT_271	[p17l997t46r1066b75],
13	CI	NN	O	ci	dep	7	SENT_271	[p17l1078t47r1121b82],
14	,	,	O	,	_	0	SENT_271	[p17l1078t47r1121b82],
15	1.63	CD	NUMBER	1.63	number	17	SENT_271	[p17l1136t47r1202b75],
16	to	TO	O	to	dep	17	SENT_271	[p17l381t100r413b124],
17	5.81	CD	NUMBER	5.81	appos	13	SENT_271	[p17l433t96r512b131],
18	;	:	O	;	_	0	SENT_271	[p17l433t96r512b131],
19	P	NN	O	p	dep	7	SENT_271	[p17l532t96r689b129],
20	=	JJ	O	=	amod	22	SENT_271	[p17l532t96r689b129],
21	0.001	CD	NUMBER	0.001	tmod	20	SENT_271	[p17l532t96r689b129],
22	)	NN	O	)	dep	19	SENT_271	[p17l532t96r689b129],
23	and	CC	O	and	_	0	SENT_271	[p17l710t94r772b124],
24	an	DT	O	a	det	25	SENT_271	[p17l790t104r831b124],
25	age	NN	O	age	prep_with	1	SENT_271	[p17l849t104r906b133],
26	between	IN	O	between	_	0	SENT_271	[p17l925t94r1066b125],
27	61	CD	NUMBER	61	nn	30	SENT_271	[p17l1085t96r1123b124],
28	and	CC	O	and	_	0	SENT_271	[p17l1142t94r1204b124],
29	70	CD	DURATION	70	nn	30	SENT_271	[p17l381t145r419b173],
30	years	NNS	NUMBER	year	prep_between	25	SENT_271	[p17l432t153r519b182],
31	(	JJ	O	(	amod	33	SENT_271	[p17l536t143r626b178],
32	odds	NNS	O	odds	nn	33	SENT_271	[p17l536t143r626b178],
33	ratio	NN	O	ratio	dep	30	SENT_271	[p17l642t143r729b180],
34	,	,	O	,	_	0	SENT_271	[p17l642t143r729b180],
35	2.55	CD	NUMBER	2.55	appos	30	SENT_271	[p17l746t145r825b180],
36	;	:	O	;	_	0	SENT_271	[p17l746t145r825b180],
37	95	CD	PERCENT	95	number	38	SENT_271	[p17l841t145r913b174],
38	%	NN	PERCENT	%	amod	39	SENT_271	[p17l841t145r913b174],
39	CI	NN	O	ci	dep	25	SENT_271	[p17l928t145r973b180],
40	,	,	O	,	_	0	SENT_271	[p17l928t145r973b180],
41	1.32	CD	NUMBER	1.32	num	43	SENT_271	[p17l991t145r1059b174],
42	to	TO	O	to	dep	43	SENT_271	[p17l1075t149r1107b173],
43	4.96	CD	NUMBER	4.96	appos	39	SENT_271	[p17l1121t145r1202b180],
44	;	:	O	;	_	0	SENT_271	[p17l1121t145r1202b180],
45	P	NN	O	p	dep	25	SENT_271	[p17l380t195r532b228],
46	=	JJ	O	=	amod	48	SENT_271	[p17l380t195r532b228],
47	0.006	CD	NUMBER	0.006	tmod	46	SENT_271	[p17l380t195r532b228],
48	)	NN	O	)	dep	45	SENT_271	[p17l380t195r532b228],
49	but	CC	O	but	_	0	SENT_271	[p17l548t192r602b223],
50	not	RB	O	not	_	0	SENT_271	[p17l613t199r668b223],
51	with	IN	O	with	_	0	SENT_271	[p17l678t192r752b223],
52	other	JJ	O	other	amod	53	SENT_271	[p17l766t192r852b223],
53	factors	NNS	O	factor	conj_negcc	7	SENT_271	[p17l865t192r984b223],
54	.	.	O	.	_	0	SENT_271	[p17l865t192r984b223],

1	Overall	RB	O	overall	advmod	29	SENT_272	[p17l1000t192r1125b230],
2	,	,	O	,	_	0	SENT_272	[p17l1000t192r1125b230],
3	median	JJ	O	median	amod	4	SENT_272	[p17l1140t202r1203b223, p17l381t242r453b273],
4	progression	NN	O	progression	nsubj	29	SENT_272	[p17l464t242r733b282],
5	—	CD	NUMBER	—	num	7	SENT_272	[p17l464t242r733b282],
6	free	JJ	O	free	amod	7	SENT_272	[p17l464t242r733b282],
7	survival	NN	O	survival	nsubj	12	SENT_272	[p17l745t242r871b274],
8	for	IN	O	for	_	0	SENT_272	[p17l882t242r929b273],
9	the	DT	O	the	det	11	SENT_272	[p17l940t242r991b273],
10	217	CD	NUMBER	217	num	11	SENT_272	[p17l1003t245r1060b273],
11	patients	NNS	O	patient	prep_for	7	SENT_272	[p17l1071t243r1203b282],
12	treated	VBN	O	treat	rcmod	4	SENT_272	[p17l381t292r497b323],
13	with	IN	O	with	_	0	SENT_272	[p17l507t292r583b323],
14	erlotinib	JJ	O	erlotinib	amod	15	SENT_272	[p17l596t292r738b323],
15	(	NN	O	(	prep_with	12	SENT_272	[p17l753t295r796b328],
16	as	IN	O	as	_	0	SENT_272	[p17l753t295r796b328],
17	first	JJ	ORDINAL	first	amod	18	SENT_272	[p17l809t292r897b329],
18	—	NN	O	—	prep_as	12	SENT_272	[p17l809t292r897b329],
19	,	,	O	,	_	0	SENT_272	[p17l809t292r897b329],
20	second	JJ	ORDINAL	second	amod	21	SENT_272	[p17l913t292r1048b329],
21	—	NN	O	—	conj_or	18	SENT_272	[p17l913t292r1048b329],
22	,	,	O	,	_	0	SENT_272	[p17l913t292r1048b329],
23	or	CC	O	or	_	0	SENT_272	[p17l1063t302r1097b323],
24	thirdline	JJ	O	thirdline	amod	26	SENT_272	[p17l1109t292r1203b323, p17l380t341r442b372],
25	therapy	NN	O	therapy	nn	26	SENT_272	[p17l455t341r589b381],
26	)	NN	O	)	prep_as	12	SENT_272	[p17l455t341r589b381],
27	was	VBD	O	be	cop	29	SENT_272	[p17l602t352r665b373],
28	14	CD	DURATION	14	num	29	SENT_272	[p17l680t344r716b372],
29	months	NNS	NUMBER	month	_	0	SENT_272	[p17l729t341r865b379],
30	,	,	O	,	_	0	SENT_272	[p17l729t341r865b379],
31	and	CC	O	and	_	0	SENT_272	[p17l880t341r942b372],
32	median	JJ	O	median	amod	34	SENT_272	[p17l954t341r1080b372],
33	overall	JJ	O	overall	amod	34	SENT_272	[p17l1093t341r1204b372],
34	survival	NN	O	survival	nsubj	37	SENT_272	[p17l381t391r507b422],
35	was	VBD	O	be	cop	37	SENT_272	[p17l517t401r579b422],
36	27	CD	DURATION	27	num	37	SENT_272	[p17l591t394r629b422],
37	months	NNS	NUMBER	month	conj_and	29	SENT_272	[p17l641t391r775b428],
38	,	,	O	,	_	0	SENT_272	[p17l641t391r775b428],
39	which	WDT	O	which	nsubj	42	SENT_272	[p17l787t391r887b422],
40	is	VBZ	O	be	cop	42	SENT_272	[p17l898t392r923b422],
41	an	DT	O	a	det	42	SENT_272	[p17l935t401r975b422],
42	improvement	NN	O	improvement	rcmod	37	SENT_272	[p17l986t392r1206b430],
43	over	IN	O	over	_	0	SENT_272	[p17l1244t54r1314b75],
44	findings	NNS	O	finding	prep_over	42	SENT_272	[p17l1329t44r1473b84],
45	in	IN	O	in	_	0	SENT_272	[p17l1490t45r1523b75],
46	patients	NNS	O	patient	prep_in	44	SENT_272	[p17l1539t45r1674b84],
47	with	IN	O	with	_	0	SENT_272	[p17l1689t44r1766b76],
48	lung	NN	O	lung	nn	49	SENT_272	[p17l1782t44r1859b84],
49	cancer	NN	O	cancer	prep_with	46	SENT_272	[p17l1874t54r1985b75],
50	that	WDT	O	that	nsubjpass	53	SENT_272	[p17l2000t44r2068b75],
51	have	VBP	O	have	aux	53	SENT_272	[p17l1243t94r1316b124],
52	been	VBN	O	be	auxpass	53	SENT_272	[p17l1328t94r1405b124],
53	reported	VBN	O	report	rcmod	42	SENT_272	[p17l1416t94r1556b133],
54	previously	RB	DATE	previously	advmod	53	SENT_272	[p17l1567t94r1738b133],
55	.	.	O	.	_	0	SENT_272	[p17l1567t94r1738b133],

1	These	DT	O	these	det	2	SENT_273	[p17l1750t94r1846b124],
2	results	NNS	O	result	nsubj	3	SENT_273	[p17l1858t94r1965b125],
3	highlight	VBP	O	highlight	_	0	SENT_273	[p17l1978t94r2066b133, p17l1243t143r1323b182],
4	the	DT	O	the	det	5	SENT_273	[p17l1335t143r1388b173],
5	idea	NN	O	idea	dobj	3	SENT_273	[p17l1402t143r1471b173],
6	that	IN	O	that	complm	13	SENT_273	[p17l1485t143r1553b173],
7	EGFR-mutant	JJ	O	egfr-mutant	amod	9	SENT_273	[p17l1565t145r1783b174],
8	lung	NN	O	lung	nn	9	SENT_273	[p17l1795t143r1871b182],
9	cancer	NN	O	cancer	nsubj	13	SENT_273	[p17l1885t153r1996b173],
10	is	VBZ	O	be	cop	13	SENT_273	[p17l2009t143r2034b173],
11	a	DT	O	a	det	13	SENT_273	[p17l2049t153r2067b173],
12	distinct	JJ	O	distinct	amod	13	SENT_273	[p17l1244t192r1374b223],
13	class	NN	O	class	ccomp	3	SENT_273	[p17l1388t192r1469b223],
14	of	IN	O	of	_	0	SENT_273	[p17l1486t192r1526b223],
15	non	JJ	O	non	amod	19	SENT_273	[p17l1535t192r1789b223],
16	—	JJ	O	—	amod	19	SENT_273	[p17l1535t192r1789b223],
17	small-cell	NN	O	small-cell	nn	19	SENT_273	[p17l1535t192r1789b223],
18	lung	NN	O	lung	nn	19	SENT_273	[p17l1805t192r1881b232],
19	cancer	NN	O	cancer	prep_of	13	SENT_273	[p17l1896t202r2016b230],
20	;	:	O	;	_	0	SENT_273	[p17l1896t202r2016b230],
21	in	IN	O	in	_	0	SENT_273	[p17l2033t193r2066b223],
22	patients	NNS	O	patient	prep_in	32	SENT_273	[p17l1243t243r1375b282],
23	who	WP	O	who	nsubj	26	SENT_273	[p17l1389t242r1460b274],
24	do	VBP	O	do	aux	26	SENT_273	[p17l1475t242r1515b273],
25	not	RB	O	not	neg	26	SENT_273	[p17l1530t249r1586b273],
26	have	VB	O	have	rcmod	22	SENT_273	[p17l1598t242r1672b273],
27	this	DT	O	this	det	28	SENT_273	[p17l1687t242r1749b273],
28	mutation	NN	O	mutation	dobj	26	SENT_273	[p17l1764t243r1925b280],
29	,	,	O	,	_	0	SENT_273	[p17l1764t243r1925b280],
30	chemotherapy	NN	O	chemotherapy	nsubj	32	SENT_273	[p17l1942t242r2066b273, p17l1244t292r1363b331],
31	normally	RB	O	normally	advmod	32	SENT_273	[p17l1372t292r1518b331],
32	yields	VBZ	O	yield	parataxis	3	SENT_273	[p17l1524t292r1615b331],
33	a	DT	O	a	det	36	SENT_273	[p17l1625t302r1643b323],
34	30	CD	PERCENT	30	num	36	SENT_273	[p17l1653t294r1723b323],
35	%	NN	PERCENT	%	nn	36	SENT_273	[p17l1653t294r1723b323],
36	response	NN	O	response	dobj	32	SENT_273	[p17l1733t302r1883b331],
37	,	,	O	,	_	0	SENT_273	[p17l1733t302r1883b331],
38	a	DT	O	a	det	43	SENT_273	[p17l1895t302r1913b323],
39	5-month	JJ	DURATION	5-month	amod	43	SENT_273	[p17l1923t292r2066b323],
40	progression	NN	O	progression	nn	43	SENT_273	[p17l1243t341r1511b381],
41	—	CD	NUMBER	—	num	43	SENT_273	[p17l1243t341r1511b381],
42	free	JJ	O	free	amod	43	SENT_273	[p17l1243t341r1511b381],
43	survival	NN	O	survival	conj_and	36	SENT_273	[p17l1523t341r1657b379],
44	,	,	O	,	_	0	SENT_273	[p17l1523t341r1657b379],
45	and	CC	O	and	_	0	SENT_273	[p17l1671t341r1731b372],
46	a	DT	O	a	det	49	SENT_273	[p17l1742t352r1759b372],
47	12-month	JJ	DURATION	12-month	amod	49	SENT_273	[p17l1772t341r1930b372],
48	median	NN	O	median	nn	49	SENT_273	[p17l1942t341r2066b372],
49	survival	NN	O	survival	conj_and	36	SENT_273	[p17l1244t391r1412b422],
50	.	.	O	.	_	0	SENT_273	[p17l1244t391r1412b422],

1	”	NN	O	”	nn	2	SENT_274	[p17l1244t391r1412b422],
2	Outcomes	NNS	O	outcome	nsubj	8	SENT_274	[p17l1425t394r1592b422],
3	in	IN	O	in	_	0	SENT_274	[p17l1605t392r1637b421],
4	our	PRP$	O	we	poss	5	SENT_274	[p17l1650t401r1706b422],
5	study	NN	O	study	prep_in	2	SENT_274	[p17l1718t391r1807b430],
6	were	VBD	O	be	cop	8	SENT_274	[p17l1816t401r1894b422],
7	not	RB	O	not	neg	8	SENT_274	[p17l1907t398r1962b422],
8	inﬂuN	NN	O	inﬂun	_	0	SENT_274	[p17l1972t391r2065b422, p17l875t516r889b531],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_275	[p17l904t516r982b538],
2	MED	NNP	O	MED	_	0	SENT_275	[p17l996t516r1048b531],
3	36	CD	NUMBER	36	number	4	SENT_275	[p17l1059t510r1136b538],
4	‘	CD	NUMBER	‘	num	5	SENT_275	[p17l1059t510r1136b538],
5	|	NN	O	|	dep	2	SENT_275	[p17l1059t510r1136b538],
6	;	:	O	;	_	0	SENT_275	[p17l1059t510r1136b538],
7	‘	CD	NUMBER	‘	number	8	SENT_275	[p17l1059t510r1136b538],
8	|	CD	NUMBER	|	num	10	SENT_275	[p17l1059t510r1136b538],
9	O	NN	O	o	nn	10	SENT_275	[p17l1059t510r1136b538],
10	NEJM.ORG	NN	O	nejm.org	dep	2	SENT_275	[p17l1171t516r1295b538],
11	SEPTEMBER	NN	DATE	september	dep	10	SENT_275	[p17l1330t516r1469b531],
12	3	CD	DATE	3	num	11	SENT_275	[p17l1479t516r1497b538],
13	,	,	DATE	,	_	0	SENT_275	[p17l1479t516r1497b538],
14	2009	CD	DATE	2009	appos	10	SENT_275	[p17l1509t516r1573b537],
15	The	DT	O	the	det	18	SENT_275	[p17l881t573r932b597],
16	New	NNP	O	New	nn	18	SENT_275	[p17l941t574r1003b597],
17	England	NNP	O	England	nn	18	SENT_275	[p17l1012t573r1123b604],
18	Journal	NNP	O	Journal	dep	2	SENT_275	[p17l1131t573r1229b597],
19	of	IN	O	of	_	0	SENT_275	[p17l1238t573r1267b597],
20	Medicine	NNP	O	Medicine	prep_of	18	SENT_275	[p17l1274t573r1399b597],

1	SCREENING	NN	O	screening	_	0	SENT_276	[p17l502t698r698b717],
2	FOR	IN	O	for	dep	1	SENT_276	[p17l712t698r776b717],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_276	[p17l788t698r859b717],
4	MUTATIONS	NNS	O	mutation	pobj	2	SENT_276	[p17l872t698r1067b717],
5	IN	IN	O	in	dep	1	SENT_276	[p17l1082t698r1120b717],
6	LUNG	NN	O	lung	nn	7	SENT_276	[p17l1135t698r1227b717],
7	CANCER	NNP	O	CANCER	pobj	5	SENT_276	[p17l1241t698r1375b717],

1	Table	NNP	O	Table	_	0	SENT_277	[p17l120t818r194b844],
2	3	CD	NUMBER	3	dep	1	SENT_277	[p17l203t821r226b844],
3	.	.	O	.	_	0	SENT_277	[p17l203t821r226b844],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_278	[p17l238t818r401b844],
2	Analyses	NNS	O	analysis	_	0	SENT_278	[p17l409t818r530b851],
3	of	IN	O	of	_	0	SENT_278	[p17l539t818r570b844],
4	Progression-free	JJ	O	progression-free	prep_of	2	SENT_278	[p17l576t818r798b851],
5	and	CC	O	and	_	0	SENT_278	[p17l807t818r856b844],
6	Overall	JJ	O	overall	amod	8	SENT_278	[p17l866t818r963b844],
7	Surviva	NN	O	surviva	nn	8	SENT_278	[p17l974t818r1108b844],
8	|	NN	O	|	prep_of	2	SENT_278	[p17l974t818r1108b844],
9	.	.	O	.	_	0	SENT_278	[p17l974t818r1108b844],

1	*	NN	O	*	_	0	SENT_279	[p17l974t818r1108b844],
2	Variable	JJ	O	variable	dep	1	SENT_279	[p17l120t893r231b918],

1	Sex	NN	O	sex	_	0	SENT_280	[p17l122t1048r166b1071],

1	Female	JJ	O	female	amod	2	SENT_281	[p17l173t1103r270b1128],
2	Male	NN	O	male	_	0	SENT_281	[p17l173t1161r238b1186],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_282	[p17l122t1221r198b1244],
2	mutation	NN	O	mutation	_	0	SENT_282	[p17l209t1221r330b1244],
3	del	FW	O	del	dep	2	SENT_282	[p17l171t1276r209b1302],
4	19	CD	NUMBER	19	num	5	SENT_282	[p17l222t1279r251b1302],
5	L858R	NN	O	l858r	dep	2	SENT_282	[p17l173t1336r255b1359],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_283	[p17l123t1394r198b1417],
2	in	IN	O	in	dep	1	SENT_283	[p17l208t1394r230b1417],
3	serum	NN	O	serum	nn	5	SENT_283	[p17l242t1401r326b1417],
4	Wild	NNP	O	Wild	nn	5	SENT_283	[p17l170t1450r230b1475],
5	type	NN	O	type	pobj	2	SENT_283	[p17l241t1454r297b1483],
6	Mutated	VBN	O	mutate	partmod	5	SENT_283	[p17l173t1507r285b1532],

1	Progression-free	JJ	O	progression-free	amod	4	SENT_284	[p17l792t892r1015b926],
2	Survival	NNP	O	Survival	nn	4	SENT_284	[p17l1025t893r1133b918],
3	Hazard	NNP	O	Hazard	nn	4	SENT_284	[p17l754t950r851b976],
4	Ratio	NNP	O	Ratio	_	0	SENT_284	[p17l864t953r931b976],
5	(	CD	PERCENT	(	number	6	SENT_284	[p17l784t989r853b1021],
6	95	CD	PERCENT	95	num	7	SENT_284	[p17l784t989r853b1021],
7	%	NN	PERCENT	%	dep	4	SENT_284	[p17l784t989r853b1021],
8	CI	NN	O	ci	nn	11	SENT_284	[p17l863t990r900b1021],
9	)	CD	NUMBER	)	num	11	SENT_284	[p17l863t990r900b1021],
10	P	NN	O	p	nn	11	SENT_284	[p17l1069t990r1083b1013],
11	Value	NN	O	value	dep	7	SENT_284	[p17l1092t988r1168b1013],

1	ECOG	NN	ORGANIZATION	ecog	_	0	SENT_285	[p17l123t1567r204b1590],
2	performance	NN	O	performance	nn	3	SENT_285	[p17l217t1565r390b1598],
3	status	NN	O	status	dep	1	SENT_285	[p17l400t1570r481b1590],

1	<	JJR	O	<	_	0	SENT_286	[p17l171t1855r221b1878],
2	60	CD	DURATION	60	num	3	SENT_286	[p17l171t1855r221b1878],
3	yr	NN	DURATION	yr	dep	1	SENT_286	[p17l229t1862r254b1886],
4	60-70	CD	NUMBER	60-70	num	5	SENT_286	[p17l171t1912r252b1936],
5	yr	NN	DURATION	yr	npadvmod	6	SENT_286	[p17l261t1920r285b1944],
6	>	JJR	O	>	amod	3	SENT_286	[p17l171t1970r221b1994],
7	70	CD	DURATION	70	num	8	SENT_286	[p17l171t1970r221b1994],
8	yr	NN	DURATION	yr	dep	1	SENT_286	[p17l229t1977r254b2001],

1	Smoking	NN	O	smoking	nn	2	SENT_287	[p17l121t2026r242b2059],
2	history	NN	O	history	_	0	SENT_287	[p17l252t2026r343b2059],

1	1.48	CD	NUMBER	1.48	num	2	SENT_288	[p17l733t1682r787b1706],
2	(	CD	NUMBER	(	_	0	SENT_288	[p17l800t1682r950b1713],
3	O.	NNP	O	O.	dep	2	SENT_288	[p17l800t1682r950b1713],
4	85	CD	NUMBER	85	num	3	SENT_288	[p17l800t1682r950b1713],
5	—	CD	NUMBER	—	number	6	SENT_288	[p17l800t1682r950b1713],
6	2.58	CD	NUMBER	2.58	num	7	SENT_288	[p17l800t1682r950b1713],
7	)	NN	O	)	dep	3	SENT_288	[p17l800t1682r950b1713],
8	1.12	CD	NUMBER	1.12	number	9	SENT_288	[p17l733t1740r786b1763],
9	(	CD	NUMBER	(	dep	3	SENT_288	[p17l800t1739r950b1771],
10	0.52	CD	NUMBER	0.52	num	11	SENT_288	[p17l800t1739r950b1771],
11	—	NN	O	—	dep	9	SENT_288	[p17l800t1739r950b1771],
12	2.45	CD	NUMBER	2.45	num	13	SENT_288	[p17l800t1739r950b1771],
13	)	NN	O	)	dep	2	SENT_288	[p17l800t1739r950b1771],

1	0.80	CD	NUMBER	0.80	number	2	SENT_289	[p17l731t1912r788b1936],
2	(	CD	NUMBER	(	_	0	SENT_289	[p17l800t1912r950b1944],
3	043-147	CD	NUMBER	043-147	num	4	SENT_289	[p17l800t1912r950b1944],
4	)	NN	O	)	dep	2	SENT_289	[p17l800t1912r950b1944],
5	0.88	CD	NUMBER	0.88	num	7	SENT_289	[p17l731t1970r787b1994],
6	(	CD	NUMBER	(	num	7	SENT_289	[p17l800t1970r950b2001],
7	o.	NN	O	o.	dep	2	SENT_289	[p17l800t1970r950b2001],
8	47	CD	NUMBER	47	number	9	SENT_289	[p17l800t1970r950b2001],
9	—	CD	NUMBER	—	dep	7	SENT_289	[p17l800t1970r950b2001],
10	1.57	CD	NUMBER	1.57	num	11	SENT_289	[p17l800t1970r950b2001],
11	)	NN	O	)	dep	9	SENT_289	[p17l800t1970r950b2001],

1	Former	JJ	O	former	amod	4	SENT_290	[p17l173t2086r271b2109],
2	smoker	NN	O	smoker	nn	4	SENT_290	[p17l281t2084r382b2109],
3	Current	JJ	DATE	current	amod	4	SENT_290	[p17l171t2143r274b2167],
4	smoker	NN	O	smoker	nsubj	6	SENT_290	[p17l284t2141r385b2166],
5	Never	RB	O	never	advmod	4	SENT_290	[p17l173t2201r252b2224],
6	smoked	VBD	O	smoke	_	0	SENT_290	[p17l262t2199r367b2224],

1	Tumor	NN	O	tumor	nn	2	SENT_291	[p17l120t2259r213b2282],
2	type	NN	O	type	_	0	SENT_291	[p17l221t2261r277b2290],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_292	[p17l170t2314r402b2339],
2	Bronchioloalveolar	JJ	O	bronchioloalveolar	amod	3	SENT_292	[p17l173t2372r428b2397],
3	adenocarcinoma	NN	O	adenocarcinoma	dep	1	SENT_292	[p17l437t2372r665b2397],
4	Large-cell	JJ	MISC	large-cell	amod	5	SENT_292	[p17l173t2430r299b2463],
5	carcinoma	NN	O	carcinoma	dep	1	SENT_292	[p17l310t2432r452b2455],

1	Tumor	NN	O	tumor	nn	2	SENT_293	[p17l120t2489r213b2512],
2	stage	NN	O	stage	_	0	SENT_293	[p17l222t2492r293b2520],

1	IIIB	NN	O	iiib	_	0	SENT_294	[p17l173t2547r217b2570],
2	IV	CD	NUMBER	iv	num	1	SENT_294	[p17l173t2605r199b2628],

1	Erlotinib	NN	O	erlotinib	nn	2	SENT_295	[p17l123t2660r236b2685],
2	therapy	NN	O	therapy	_	0	SENT_295	[p17l245t2660r347b2693],

1	First	JJ	ORDINAL	first	amod	2	SENT_296	[p17l173t2720r231b2743],
2	line	NN	O	line	_	0	SENT_296	[p17l242t2718r288b2743],
3	Second	JJ	ORDINAL	second	amod	4	SENT_296	[p17l171t2775r269b2801],
4	line	NN	O	line	dep	2	SENT_296	[p17l282t2775r328b2801],
5	Third	JJ	ORDINAL	third	amod	8	SENT_296	[p17l169t2833r240b2858],
6	line	NN	O	line	nn	8	SENT_296	[p17l253t2833r299b2858],
7	Brain	NN	O	brain	nn	8	SENT_296	[p17l123t2893r190b2916],
8	metastases	NNS	O	metastase	dep	2	SENT_296	[p17l203t2895r355b2916],

1	No	DT	O	no	det	3	SENT_297	[p17l173t2951r211b2974],
2	Yes	NNP	O	Yes	nn	3	SENT_297	[p17l170t3008r216b3031],
3	Bone	NN	O	bone	_	0	SENT_297	[p17l123t3066r190b3089],
4	metastases	NNS	O	metastase	dep	3	SENT_297	[p17l201t3068r353b3089],

1	No	DT	O	no	det	2	SENT_298	[p17l173t3124r211b3147],
2	Yes	NNP	O	Yes	_	0	SENT_298	[p17l170t3181r216b3204],

1	0.80	CD	NUMBER	0.80	number	2	SENT_299	[p17l730t2777r787b2801],
2	(	CD	NUMBER	(	_	0	SENT_299	[p17l800t2777r949b2808],
3	050-128	CD	NUMBER	050-128	num	4	SENT_299	[p17l800t2777r949b2808],
4	)	NN	O	)	dep	2	SENT_299	[p17l800t2777r949b2808],
5	1.22	CD	NUMBER	1.22	number	6	SENT_299	[p17l733t2835r786b2858],
6	(	CD	NUMBER	(	dep	2	SENT_299	[p17l800t2835r949b2866],
7	O.	NNP	O	O.	dep	6	SENT_299	[p17l800t2835r949b2866],
8	51	CD	NUMBER	51	num	7	SENT_299	[p17l800t2835r949b2866],
9	—	CD	NUMBER	—	number	10	SENT_299	[p17l800t2835r949b2866],
10	2.87	CD	NUMBER	2.87	num	11	SENT_299	[p17l800t2835r949b2866],
11	)	NN	O	)	dep	6	SENT_299	[p17l800t2835r949b2866],

1	1.07	CD	NUMBER	1.07	num	2	SENT_300	[p17l733t3008r787b3031],
2	(	CD	NUMBER	(	_	0	SENT_300	[p17l800t3008r949b3039],
3	O.	NNP	O	O.	dep	2	SENT_300	[p17l800t3008r949b3039],
4	53	CD	NUMBER	53	num	3	SENT_300	[p17l800t3008r949b3039],
5	—	CD	NUMBER	—	number	6	SENT_300	[p17l800t3008r949b3039],
6	2.18	CD	NUMBER	2.18	num	7	SENT_300	[p17l800t3008r949b3039],
7	)	NN	O	)	dep	3	SENT_300	[p17l800t3008r949b3039],

1	1.37	CD	NUMBER	1.37	num	2	SENT_301	[p17l732t3181r787b3204],
2	(	CD	NUMBER	(	_	0	SENT_301	[p17l800t3181r949b3212],
3	O.	NNP	O	O.	dep	2	SENT_301	[p17l800t3181r949b3212],
4	84	CD	NUMBER	84	num	3	SENT_301	[p17l800t3181r949b3212],
5	—	CD	NUMBER	—	number	6	SENT_301	[p17l800t3181r949b3212],
6	2.24	CD	NUMBER	2.24	num	7	SENT_301	[p17l800t3181r949b3212],
7	)	NN	O	)	dep	3	SENT_301	[p17l800t3181r949b3212],

1	*	NN	O	*	nn	2	SENT_302	[p17l94t3266r109b3281],
2	ECOG	NN	O	ecog	nsubj	3	SENT_302	[p17l122t3266r203b3289],
3	denotes	VBZ	O	denote	_	0	SENT_302	[p17l216t3264r323b3289],
4	Eastern	NNP	ORGANIZATION	Eastern	nn	7	SENT_302	[p17l338t3266r436b3289],
5	Cooperative	NNP	ORGANIZATION	Cooperative	nn	7	SENT_302	[p17l449t3266r612b3297],
6	Oncology	NNP	ORGANIZATION	Oncology	nn	7	SENT_302	[p17l624t3264r754b3297],
7	Group	NNP	ORGANIZATION	Group	dobj	3	SENT_302	[p17l765t3266r859b3297],
8	.	.	O	.	_	0	SENT_302	[p17l765t3266r859b3297],

1	N	NN	O	n	nn	2	SENT_303	[p17l589t3410r603b3425],
2	ENGLJ	NN	O	englj	_	0	SENT_303	[p17l618t3410r696b3432],
3	MED	NN	O	med	dep	2	SENT_303	[p17l710t3410r762b3425],
4	361	CD	NUMBER	361	num	3	SENT_303	[p17l772t3404r850b3432],
5	;	:	O	;	_	0	SENT_303	[p17l772t3404r850b3432],
6	1o	CD	NUMBER	1o	num	7	SENT_303	[p17l772t3404r850b3432],
7	NEJM.ORG	NN	O	nejm.org	dep	3	SENT_303	[p17l885t3410r1009b3432],

1	Overall	JJ	O	overall	amod	2	SENT_304	[p17l1402t893r1499b918],
2	Survival	NN	O	survival	_	0	SENT_304	[p17l1511t893r1619b918],

1	Hazard	NN	O	hazard	nn	2	SENT_305	[p17l1322t950r1418b976],
2	Ratio	NN	O	ratio	_	0	SENT_305	[p17l1431t953r1498b976],
3	(	CD	PERCENT	(	number	4	SENT_305	[p17l1351t989r1420b1021],
4	95	CD	PERCENT	95	num	5	SENT_305	[p17l1351t989r1420b1021],
5	%	NN	PERCENT	%	dep	2	SENT_305	[p17l1351t989r1420b1021],
6	Cl	NN	O	cl	dep	5	SENT_305	[p17l1430t990r1467b1021],
7	)	CD	NUMBER	)	num	6	SENT_305	[p17l1430t990r1467b1021],

1	P	NN	O	p	nn	2	SENT_306	[p17l1623t990r1637b1013],
2	Value	NN	O	value	_	0	SENT_306	[p17l1646t988r1721b1013],

1	2.98	CD	NUMBER	2.98	num	3	SENT_307	[p17l1298t1336r1354b1359],
2	(	CD	NUMBER	(	num	3	SENT_307	[p17l1367t1336r1517b1367],
3	l.	NN	O	l.	_	0	SENT_307	[p17l1367t1336r1517b1367],
4	48	CD	NUMBER	48	number	5	SENT_307	[p17l1367t1336r1517b1367],
5	—	CD	NUMBER	—	dep	3	SENT_307	[p17l1367t1336r1517b1367],
6	6.04	CD	NUMBER	6.04	num	7	SENT_307	[p17l1367t1336r1517b1367],
7	)	NN	O	)	dep	5	SENT_307	[p17l1367t1336r1517b1367],

1	1.50	CD	NUMBER	1.50	_	0	SENT_308	[p17l1300t1509r1355b1532],
2	(	JJ	O	(	amod	3	SENT_308	[p17l1367t1509r1517b1540],
3	O.	NNP	O	O.	dep	1	SENT_308	[p17l1367t1509r1517b1540],
4	82	CD	NUMBER	82	num	3	SENT_308	[p17l1367t1509r1517b1540],
5	—	CD	NUMBER	—	number	6	SENT_308	[p17l1367t1509r1517b1540],
6	2.74	CD	NUMBER	2.74	num	7	SENT_308	[p17l1367t1509r1517b1540],
7	)	NN	O	)	dep	3	SENT_308	[p17l1367t1509r1517b1540],

1	0.70	CD	NUMBER	0.70	number	2	SENT_309	[p17l1298t2085r1355b2109],
2	(	CD	NUMBER	(	_	0	SENT_309	[p17l1367t2085r1517b2117],
3	0.32	CD	NUMBER	0.32	num	4	SENT_309	[p17l1367t2085r1517b2117],
4	—	NN	O	—	dep	2	SENT_309	[p17l1367t2085r1517b2117],
5	1.54	CD	NUMBER	1.54	number	6	SENT_309	[p17l1367t2085r1517b2117],
6	)	CD	NUMBER	)	num	8	SENT_309	[p17l1367t2085r1517b2117],
7	1.37	CD	NUMBER	1.37	number	8	SENT_309	[p17l1300t2143r1354b2166],
8	(	CD	NUMBER	(	dep	2	SENT_309	[p17l1367t2143r1517b2174],
9	o.	NN	O	o.	dep	8	SENT_309	[p17l1367t2143r1517b2174],
10	45	CD	NUMBER	45	num	9	SENT_309	[p17l1367t2143r1517b2174],
11	—	CD	NUMBER	—	number	12	SENT_309	[p17l1367t2143r1517b2174],
12	4.22	CD	NUMBER	4.22	num	13	SENT_309	[p17l1367t2143r1517b2174],
13	)	NN	O	)	dep	9	SENT_309	[p17l1367t2143r1517b2174],

1	SEPTEMBER	NNP	DATE	SEPTEMBER	_	0	SENT_310	[p17l1044t3410r1183b3425],
2	3,2009	CD	NUMBER	3,2009	num	3	SENT_310	[p17l1193t3410r1287b3432],
3	955	CD	NUMBER	955	dep	1	SENT_310	[p17l2011t3399r2066b3423],

1	The	DT	O	the	det	4	SENT_311	[p17l753t3443r804b3467],
2	New	NNP	O	New	nn	4	SENT_311	[p17l813t3444r875b3467],
3	England	NNP	O	England	nn	4	SENT_311	[p17l884t3443r995b3474],
4	Journal	NNP	O	Journal	_	0	SENT_311	[p17l1004t3443r1101b3467],
5	of	IN	O	of	_	0	SENT_311	[p17l1111t3443r1140b3467],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_311	[p17l1146t3443r1271b3467],

1	The	DT	O	the	det	4	SENT_312	[p17l673t3631r719b3652],
2	NEW	NNP	O	NEW	nn	4	SENT_312	[p17l737t3633r822b3652],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_312	[p17l841t3633r1030b3652],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_312	[p17l1049t3633r1228b3659],
5	of	IN	O	of	_	0	SENT_312	[p17l1248t3631r1276b3658],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_312	[p17l1288t3633r1487b3652],

1	enced	VBN	O	ence	_	0	SENT_313	[p18l11t114r249b194],
2	by	IN	O	by	_	0	SENT_313	[p18l278t114r373b215],
3	smoking	NN	O	smoking	nn	4	SENT_313	[p18l398t114r763b216],
4	status	NN	O	status	prep_by	1	SENT_313	[p18l789t131r1029b194],
5	or	CC	O	or	_	0	SENT_313	[p18l1060t140r1148b194],
6	previous	JJ	O	previous	amod	7	SENT_313	[p18l1171t115r1519b215],
7	chemotherapy	NN	O	chemotherapy	nsubj	33	SENT_313	[p18l1550t114r2148b215],
8	,	,	O	,	_	0	SENT_313	[p18l1550t114r2148b215],
9	which	WDT	O	which	nsubj	21	SENT_313	[p18l6t244r272b324],
10	is	VBZ	O	be	cop	21	SENT_313	[p18l306t245r372b323],
11	in	IN	O	in	_	0	SENT_313	[p18l409t245r493b323],
12	line	NN	O	line	prep_in	21	SENT_313	[p18l527t244r688b324],
13	with	IN	O	with	_	0	SENT_313	[p18l719t244r916b324],
14	the	DT	O	the	det	15	SENT_313	[p18l951t244r1085b323],
15	results	NNS	O	result	prep_with	12	SENT_313	[p18l1120t244r1406b324],
16	of	IN	O	of	_	0	SENT_313	[p18l1444t243r1545b324],
17	a	DT	O	a	det	19	SENT_313	[p18l1560t271r1606b323],
18	small	JJ	O	small	amod	19	SENT_313	[p18l1641t244r1877b323],
19	phase	NN	O	phase	prep_of	15	SENT_313	[p18l1910t244r2153b345],
20	2	CD	NUMBER	2	num	21	SENT_313	[p18l11t379r58b451],
21	trial	NN	O	trial	rcmod	7	SENT_313	[p18l102t373r277b452],
22	of	IN	O	of	_	0	SENT_313	[p18l320t372r419b453],
23	geﬁtinib	NN	O	geﬁtinib	nn	25	SENT_313	[p18l442t372r908b475],
24	.21	CD	NUMBER	.21	num	25	SENT_313	[p18l442t372r908b475],
25	(	NN	O	(	prep_of	21	SENT_313	[p18l955t380r1125b465],
26	For	IN	O	for	_	0	SENT_313	[p18l955t380r1125b465],
27	details	NNS	O	detail	prep_for	21	SENT_313	[p18l1165t373r1443b453],
28	on	IN	O	on	_	0	SENT_313	[p18l1488t399r1594b453],
29	planned	JJ	O	planned	amod	31	SENT_313	[p18l1635t373r1981b474],
30	genetic	JJ	O	genetic	amod	31	SENT_313	[p18l2023t400r2152b475, p18l11t503r212b580],
31	analyses	NNS	O	analysis	prep_on	27	SENT_313	[p18l246t502r615b602],
32	,	,	O	,	_	0	SENT_313	[p18l246t502r615b602],
33	see	VBP	O	see	conj_or	1	SENT_313	[p18l658t528r786b580],
34	the	DT	O	the	det	38	SENT_313	[p18l822t502r951b580],
35	Supplementary	NNP	O	Supplementary	nn	38	SENT_313	[p18l989t502r1615b602],
36	Appendix	NNP	O	Appendix	nn	38	SENT_313	[p18l1643t502r2108b602],
37	.	.	O	.	_	0	SENT_313	[p18l1643t502r2108b602],
38	)	NN	O	)	dobj	33	SENT_313	[p18l1643t502r2108b602],

1	In	IN	O	in	_	0	SENT_314	[p18l140t639r229b709],
2	conclusion	NN	O	conclusion	prep_in	9	SENT_314	[p18l264t631r742b728],
3	,	,	O	,	_	0	SENT_314	[p18l264t631r742b728],
4	screening	VBG	O	screen	csubjpass	9	SENT_314	[p18l783t632r1196b733],
5	for	IN	O	for	_	0	SENT_314	[p18l1227t630r1349b711],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_314	[p18l1379t638r1590b712],
7	mutations	NNS	O	mutation	prep_for	4	SENT_314	[p18l1619t632r2048b711],
8	is	VBZ	O	be	auxpass	9	SENT_314	[p18l2085t632r2151b710],
9	warranted	VBN	O	warrant	_	0	SENT_314	[p18l6t761r454b841],
10	in	IN	O	in	_	0	SENT_314	[p18l494t762r579b839],
11	women	NNS	O	woman	prep_in	9	SENT_314	[p18l616t787r935b841],
12	With	IN	O	with	_	0	SENT_314	[p18l972t761r1170b841],
13	lung	NN	O	lung	nn	14	SENT_314	[p18l1210t761r1405b863],
14	cancer	NN	O	cancer	prep_with	11	SENT_314	[p18l1444t787r1745b858],
15	,	,	O	,	_	0	SENT_314	[p18l1444t787r1745b858],
16	in	IN	O	in	_	0	SENT_314	[p18l1792t762r1877b839],
17	those	DT	O	those	prep_in	9	SENT_314	[p18l1919t761r2153b841],
18	Who	WP	O	who	nsubj	21	SENT_314	[p18l6t890r191b969],
19	have	VBP	O	have	aux	21	SENT_314	[p18l231t890r423b969],
20	never	RB	O	never	neg	21	SENT_314	[p18l461t916r692b969],
21	smoked	VBN	O	smoke	rcmod	17	SENT_314	[p18l730t890r1088b986],
22	,	,	O	,	_	0	SENT_314	[p18l730t890r1088b986],
23	and	CC	O	and	_	0	SENT_314	[p18l1132t890r1291b969],
24	in	IN	O	in	_	0	SENT_314	[p18l1329t891r1412b968],
25	those	DT	O	those	prep_in	9	SENT_314	[p18l1452t890r1685b969],
26	with	IN	O	with	_	0	SENT_314	[p18l1719t890r1916b969],
27	nonsquamous	JJ	O	nonsquamous	amod	28	SENT_314	[p18l1955t916r2152b969, p18l12t1045r453b1120],
28	tumors	NNS	O	tumor	prep_with	25	SENT_314	[p18l502t1036r837b1099],
29	.	.	O	.	_	0	SENT_314	[p18l502t1036r837b1099],

1	Large	JJ	O	large	amod	4	SENT_315	[p18l887t1019r1381b1121],
2	—	NN	O	—	nn	4	SENT_315	[p18l887t1019r1381b1121],
3	scale	NN	O	scale	nn	4	SENT_315	[p18l887t1019r1381b1121],
4	screening	NN	O	screening	nsubj	18	SENT_315	[p18l1428t1020r1849b1121],
5	of	IN	O	of	_	0	SENT_315	[p18l1892t1018r1993b1099],
6	patients	NNS	O	patient	prep_of	4	SENT_315	[p18l2019t1045r2152b1120, p18l11t1150r250b1229],
7	for	IN	O	for	_	0	SENT_315	[p18l294t1148r418b1229],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_315	[p18l455t1156r669b1230],
9	mutations	NNS	O	mutation	prep_for	6	SENT_315	[p18l705t1150r1167b1246],
10	,	,	O	,	_	0	SENT_315	[p18l705t1150r1167b1246],
11	with	IN	O	with	_	0	SENT_315	[p18l1210t1149r1408b1229],
12	subsequent	JJ	O	subsequent	amod	13	SENT_315	[p18l1451t1149r1941b1250],
13	customization	NN	O	customization	prep_with	4	SENT_315	[p18l1978t1176r2152b1229, p18l11t1280r489b1359],
14	of	IN	O	of	_	0	SENT_315	[p18l529t1278r630b1359],
15	erlotinib	NN	O	erlotinib	prep_of	13	SENT_315	[p18l650t1279r1044b1376],
16	,	,	O	,	_	0	SENT_315	[p18l650t1279r1044b1376],
17	is	VBZ	O	be	cop	18	SENT_315	[p18l1088t1280r1153b1358],
18	feasible	JJ	O	feasible	_	0	SENT_315	[p18l1195t1278r1521b1359],
19	and	CC	O	and	_	0	SENT_315	[p18l1560t1279r1719b1359],
20	improves	VBZ	O	improve	conj_and	18	SENT_315	[p18l1757t1280r2151b1380],
21	the	DT	O	the	det	22	SENT_315	[p18l11t1409r145b1487],
22	outcome	NN	O	outcome	dobj	20	SENT_315	[p18l187t1426r582b1488],
23	.	.	O	.	_	0	SENT_315	[p18l187t1426r582b1488],

1	Supported	VBN	O	support	_	0	SENT_316	[p18l98t1593r445b1669],
2	by	IN	O	by	_	0	SENT_316	[p18l477t1593r553b1669],
3	a	DT	O	a	det	4	SENT_316	[p18l581t1613r614b1652],
4	grant	NN	O	grant	prep_by	1	SENT_316	[p18l645t1606r829b1669],
5	from	IN	O	from	_	0	SENT_316	[p18l857t1592r1021b1652],
6	the	DT	O	the	det	8	SENT_316	[p18l1054t1593r1157b1652],
7	Spanish	NNP	ORGANIZATION	Spanish	nn	8	SENT_316	[p18l1191t1593r1457b1669],
8	Ministry	NNP	ORGANIZATION	Ministry	prep_from	4	SENT_316	[p18l1487t1594r1781b1669],
9	of	IN	ORGANIZATION	of	_	0	SENT_316	[p18l1810t1592r1887b1652],
10	Science	NNP	ORGANIZATION	Science	prep_of	4	SENT_316	[p18l1907t1594r2154b1652],
11	and	CC	ORGANIZATION	and	_	0	SENT_316	[p18l9t1691r132b1751],
12	Innovation	NNP	ORGANIZATION	Innovation	prep_of	4	SENT_316	[p18l159t1692r527b1751],
13	(	CD	NUMBER	(	num	15	SENT_316	[p18l558t1695r1191b1764],
14	RD06/0020/0056	NN	O	rd06/0020/0056	nn	15	SENT_316	[p18l558t1695r1191b1764],
15	)	NN	O	)	dep	4	SENT_316	[p18l558t1695r1191b1764],
16	,	,	O	,	_	0	SENT_316	[p18l558t1695r1191b1764],
17	by	IN	O	by	_	0	SENT_316	[p18l1224t1691r1299b1767],
18	the	DT	O	the	det	23	SENT_316	[p18l1325t1691r1428b1750],
19	Fundacién	NNP	ORGANIZATION	Fundacién	nn	23	SENT_316	[p18l1455t1690r1810b1751],
20	Badalona	NNP	ORGANIZATION	Badalona	nn	23	SENT_316	[p18l1836t1691r2152b1751],
21	Contra	NNP	ORGANIZATION	Contra	nn	23	SENT_316	[p18l10t1794r240b1849],
22	el	NNP	O	el	nn	23	SENT_316	[p18l275t1789r329b1848],
23	Cancer	NNP	O	Cancer	prep_by	15	SENT_316	[p18l364t1788r614b1862],
24	,	,	O	,	_	0	SENT_316	[p18l364t1788r614b1862],
25	and	CC	O	and	_	0	SENT_316	[p18l654t1789r777b1849],
26	by	IN	O	by	conj_and	15	SENT_316	[p18l813t1789r888b1865],
27	the	DT	O	the	det	33	SENT_316	[p18l921t1789r1024b1848],
28	Bonnie	NNP	PERSON	Bonnie	nn	33	SENT_316	[p18l1059t1790r1297b1849],
29	J.	NNP	PERSON	J.	nn	33	SENT_316	[p18l1325t1795r1370b1858],
30	Addario	NNP	PERSON	Addario	nn	33	SENT_316	[p18l1407t1789r1678b1849],
31	Lung	NN	O	lung	nn	33	SENT_316	[p18l1714t1795r1885b1866],
32	Cancer	NN	O	cancer	nn	33	SENT_316	[p18l1918t1794r2152b1849],
33	Foundaﬁon	NN	O	foundaﬁon	pobj	26	SENT_316	[p18l8t1888r417b1948],
34	.	.	O	.	_	0	SENT_316	[p18l8t1888r417b1948],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_317	[p18l95t1986r484b2062],
2	data	NNS	O	datum	nsubjpass	4	SENT_317	[p18l503t1986r641b2046],
3	were	VBD	O	be	auxpass	4	SENT_317	[p18l658t2006r811b2046],
4	presented	VBN	O	present	_	0	SENT_317	[p18l831t1986r1148b2062],
5	in	IN	O	in	_	0	SENT_317	[p18l1169t1987r1233b2045],
6	part	NN	O	part	prep_in	4	SENT_317	[p18l1253t1999r1389b2062],
7	at	IN	O	at	_	0	SENT_317	[p18l1405t1999r1466b2046],
8	the	DT	O	the	det	10	SENT_317	[p18l1483t1986r1584b2046],
9	annual	JJ	SET	annual	amod	10	SENT_317	[p18l1605t1986r1829b2046],
10	meetings	NNS	O	meeting	prep_at	4	SENT_317	[p18l1850t1987r2148b2063],
11	of	IN	O	of	_	0	SENT_317	[p18l11t2084r86b2144],
12	the	DT	O	the	det	14	SENT_317	[p18l94t2085r194b2144],
13	American	NNP	ORGANIZATION	American	nn	14	SENT_317	[p18l212t2085r530b2144],
14	Society	NNP	ORGANIZATION	Society	prep_of	10	SENT_317	[p18l553t2085r783b2161],
15	of	IN	ORGANIZATION	of	_	0	SENT_317	[p18l801t2084r877b2144],
16	Clinical	JJ	ORGANIZATION	clinical	amod	17	SENT_317	[p18l884t2085r1135b2144],
17	Oncology	NN	ORGANIZATION	oncology	prep_of	14	SENT_317	[p18l1156t2085r1469b2161],
18	in	IN	O	in	_	0	SENT_317	[p18l1486t2085r1549b2143],
19	Atlanta	NNP	LOCATION	Atlanta	prep_in	17	SENT_317	[p18l1568t2085r1826b2157],
20	,	,	O	,	_	0	SENT_317	[p18l1568t2085r1826b2157],
21	June	NNP	DATE	June	appos	17	SENT_317	[p18l1843t2090r1989b2154],
22	2-6	CD	DATE	2-6	num	21	SENT_317	[p18l2010t2089r2145b2157],
23	,	,	DATE	,	_	0	SENT_317	[p18l2010t2089r2145b2157],
24	2006	CD	DATE	2006	num	21	SENT_317	[p18l10t2185r167b2240],
25	(	CD	NUMBER	(	num	28	SENT_317	[p18l200t2181r480b2249],
26	abstract	JJ	O	abstract	amod	28	SENT_317	[p18l200t2181r480b2249],
27	7020	CD	NUMBER	7020	tmod	26	SENT_317	[p18l506t2185r696b2252],
28	)	NN	O	)	dep	21	SENT_317	[p18l506t2185r696b2252],
29	;	:	O	;	_	0	SENT_317	[p18l506t2185r696b2252],
30	in	IN	O	in	_	0	SENT_317	[p18l727t2182r791b2239],
31	Chicago	NNP	LOCATION	Chicago	nn	33	SENT_317	[p18l819t2181r1099b2256],
32	,	,	O	,	_	0	SENT_317	[p18l819t2181r1099b2256],
33	June	NNP	DATE	June	prep_in	14	SENT_317	[p18l1125t2186r1271b2249],
34	1-5	CD	DATE	1-5	num	33	SENT_317	[p18l1303t2185r1427b2252],
35	,	,	DATE	,	_	0	SENT_317	[p18l1303t2185r1427b2252],
36	2007	CD	DATE	2007	num	33	SENT_317	[p18l1460t2185r1615b2240],
37	(	CD	NUMBER	(	num	40	SENT_317	[p18l1648t2181r1927b2249],
38	abstract	JJ	O	abstract	amod	40	SENT_317	[p18l1648t2181r1927b2249],
39	7505	CD	NUMBER	7505	tmod	38	SENT_317	[p18l1953t2185r2148b2252],
40	)	NN	O	)	dep	33	SENT_317	[p18l1953t2185r2148b2252],
41	;	:	O	;	_	0	SENT_317	[p18l1953t2185r2148b2252],
42	and	CC	O	and	_	0	SENT_317	[p18l9t2279r129b2339],
43	in	IN	O	in	_	0	SENT_317	[p18l152t2280r215b2338],
44	Chicago	NNP	LOCATION	Chicago	prep_in	14	SENT_317	[p18l239t2279r519b2356],
45	,	,	O	,	_	0	SENT_317	[p18l239t2279r519b2356],
46	May	NNP	DATE	May	prep_at	4	SENT_317	[p18l545t2284r682b2355],
47	30	CD	DATE	30	num	46	SENT_317	[p18l703t2283r964b2348],
48	.	.	O	.	_	0	SENT_317	[p18l703t2283r964b2348],

1	—	NN	O	—	_	0	SENT_318	[p18l703t2283r964b2348],
2	.	.	O	.	_	0	SENT_318	[p18l703t2283r964b2348],

1	June	NNP	DATE	June	_	0	SENT_319	[p18l703t2283r964b2348],
2	3	CD	DATE	3	num	1	SENT_319	[p18l988t2283r1041b2351],
3	,	,	DATE	,	_	0	SENT_319	[p18l988t2283r1041b2351],
4	2008	CD	DATE	2008	num	5	SENT_319	[p18l1069t2283r1225b2339],
5	(	CD	NUMBER	(	dep	1	SENT_319	[p18l1255t2279r1534b2348],
6	abstract	JJ	O	abstract	amod	8	SENT_319	[p18l1255t2279r1534b2348],
7	8038	CD	NUMBER	8038	number	8	SENT_319	[p18l1555t2283r1748b2348],
8	)	CD	NUMBER	)	dep	5	SENT_319	[p18l1555t2283r1748b2348],
9	.	.	O	.	_	0	SENT_319	[p18l1555t2283r1748b2348],

1	No	DT	O	no	det	3	SENT_320	[p18l95t2382r189b2436],
2	potential	JJ	O	potential	amod	3	SENT_320	[p18l225t2376r524b2451],
3	conflict	NN	O	conflict	nsubjpass	11	SENT_320	[p18l559t2376r820b2436],
4	of	IN	O	of	_	0	SENT_320	[p18l851t2376r927b2436],
5	interest	NN	O	interest	prep_of	3	SENT_320	[p18l948t2377r1201b2435],
6	relevant	JJ	O	relevant	amod	5	SENT_320	[p18l1232t2376r1495b2436],
7	to	TO	O	to	_	0	SENT_320	[p18l1526t2389r1589b2436],
8	this	DT	O	this	det	9	SENT_320	[p18l1625t2376r1749b2435],
9	article	NN	O	article	prep_to	6	SENT_320	[p18l1785t2376r1992b2435],
10	was	VBD	O	be	auxpass	11	SENT_320	[p18l2023t2396r2148b2436],
11	reported	VBN	O	report	_	0	SENT_320	[p18l9t2474r311b2549],
12	.	.	O	.	_	0	SENT_320	[p18l9t2474r311b2549],

1	We	PRP	O	we	nsubj	2	SENT_321	[p18l94t2575r194b2629],
2	thank	VBP	O	thank	_	0	SENT_321	[p18l219t2570r412b2630],
3	Maria	NNP	PERSON	Maria	nn	4	SENT_321	[p18l429t2571r621b2629],
4	Sanchez-Ronco	NNP	PERSON	Sanchez-Ronco	dobj	2	SENT_321	[p18l645t2570r1142b2633],
5	for	IN	O	for	_	0	SENT_321	[p18l1166t2569r1259b2629],
6	her	PRP$	O	she	poss	7	SENT_321	[p18l1280t2570r1385b2629],
7	assistance	NN	O	assistance	prep_for	4	SENT_321	[p18l1406t2571r1736b2629],
8	in	IN	O	in	_	0	SENT_321	[p18l1759t2571r1822b2629],
9	interpreting	VBG	O	interpret	prepc_in	7	SENT_321	[p18l1845t2571r2149b2646, p18l9t2670r115b2746],
10	the	DT	O	the	det	12	SENT_321	[p18l137t2669r237b2728],
11	statistical	JJ	O	statistical	amod	12	SENT_321	[p18l262t2669r575b2728],
12	analyses	NNS	O	analysis	dobj	9	SENT_321	[p18l598t2669r888b2745],
13	;	:	O	;	_	0	SENT_321	[p18l598t2669r888b2745],
14	Maria	NNP	PERSON	Maria	nn	15	SENT_321	[p18l913t2670r1104b2728],
15	Fernandez	NNP	PERSON	Fernandez	conj_and	4	SENT_321	[p18l1126t2669r1466b2729],
16	for	IN	O	for	_	0	SENT_321	[p18l1490t2669r1583b2729],
17	coordinating	VBG	O	coordinate	prepc_for	15	SENT_321	[p18l1605t2669r2028b2746],
18	the	DT	O	the	det	19	SENT_321	[p18l2050t2669r2150b2728],
19	study	NN	O	study	dobj	17	SENT_321	[p18l11t2767r185b2843],
20	in	IN	O	in	_	0	SENT_321	[p18l205t2768r267b2826],
21	the	DT	O	the	det	25	SENT_321	[p18l292t2767r392b2827],
22	Spanish	JJ	MISC	spanish	amod	25	SENT_321	[p18l418t2767r674b2843],
23	Lung	NN	MISC	lung	nn	25	SENT_321	[p18l696t2773r863b2844],
24	Cancer	NNP	MISC	Cancer	nn	25	SENT_321	[p18l884t2772r1110b2827],
25	Group	NNP	MISC	Group	prep_in	19	SENT_321	[p18l1131t2772r1354b2843],
26	;	:	O	;	_	0	SENT_321	[p18l1131t2772r1354b2843],
27	Esther	NNP	PERSON	Esther	nn	28	SENT_321	[p18l1380t2767r1589b2827],
28	Carrasco	NNP	PERSON	Carrasco	conj_and	19	SENT_321	[p18l1610t2772r1914b2840],
29	,	,	O	,	_	0	SENT_321	[p18l1610t2772r1914b2840],
30	Mireia	NNP	PERSON	Mireia	nn	31	SENT_321	[p18l1940t2768r2151b2827],
31	Tomas	NNP	PERSON	Tomas	appos	28	SENT_321	[p18l7t2870r241b2938],
32	,	,	O	,	_	0	SENT_321	[p18l7t2870r241b2938],
33	and	CC	O	and	_	0	SENT_321	[p18l273t2866r392b2925],
34	Emma	NNP	PERSON	Emma	nn	35	SENT_321	[p18l419t2871r631b2925],
35	Costas	NNP	PERSON	Costas	conj_and	19	SENT_321	[p18l657t2870r872b2925],
36	for	IN	O	for	_	0	SENT_321	[p18l901t2865r994b2925],
37	data	NNS	O	datum	nn	38	SENT_321	[p18l1021t2866r1159b2925],
38	management	NN	O	management	prep_for	35	SENT_321	[p18l1185t2878r1630b2942],
39	;	:	O	;	_	0	SENT_321	[p18l1185t2878r1630b2942],
40	Ana	NNP	O	Ana	nn	41	SENT_321	[p18l1658t2871r1789b2925],
41	Pradas	NNP	O	Pradas	dep	35	SENT_321	[p18l1815t2866r2030b2925],
42	for	IN	O	for	_	0	SENT_321	[p18l2059t2865r2152b2925],
43	laboratory	NN	O	laboratory	nn	44	SENT_321	[p18l9t2962r347b3038],
44	analyses	NNS	O	analysis	prep_for	41	SENT_321	[p18l367t2962r658b3038],
45	;	:	O	;	_	0	SENT_321	[p18l367t2962r658b3038],
46	Maria	NNP	PERSON	Maria	nn	47	SENT_321	[p18l683t2963r875b3021],
47	Perez	NNP	PERSON	Perez	dep	35	SENT_321	[p18l897t2967r1071b3021],
48	and	CC	O	and	_	0	SENT_321	[p18l1095t2962r1214b3021],
49	Monica	NNP	PERSON	Monica	nn	50	SENT_321	[p18l1237t2963r1480b3021],
50	Botia	NNP	PERSON	Botia	dep	35	SENT_321	[p18l1502t2963r1673b3021],
51	for	IN	O	for	_	0	SENT_321	[p18l1697t2961r1789b3021],
52	their	PRP$	O	they	poss	53	SENT_321	[p18l1812t2962r1966b3021],
53	work	NN	O	work	prep_for	17	SENT_321	[p18l1985t2962r2153b3023],
54	on	IN	O	on	_	0	SENT_321	[p18l11t3079r90b3119],
55	laser	NN	O	laser	nn	56	SENT_321	[p18l112t3060r267b3119],
56	microdissection	NN	O	microdissection	prep_on	53	SENT_321	[p18l286t3060r827b3131],
57	;	:	O	;	_	0	SENT_321	[p18l286t3060r827b3131],
58	and	CC	O	and	_	0	SENT_321	[p18l852t3060r972b3119],
59	Maria	NNP	PERSON	Maria	nn	61	SENT_321	[p18l991t3061r1183b3118],
60	Luz	NNP	PERSON	Luz	nn	61	SENT_321	[p18l1203t3065r1320b3120],
61	Amador	NNP	PERSON	Amador	conj_and	4	SENT_321	[p18l1339t3060r1605b3119],
62	and	CC	O	and	_	0	SENT_321	[p18l1624t3060r1743b3119],
63	Juan	NNP	PERSON	Juan	nn	64	SENT_321	[p18l1758t3065r1907b3129],
64	Lobera	NNP	PERSON	Lobera	conj_and	4	SENT_321	[p18l1928t3060r2151b3119],
65	for	IN	O	for	_	0	SENT_321	[p18l10t3158r103b3218],
66	their	PRP$	O	they	poss	67	SENT_321	[p18l126t3158r280b3218],
67	support	NN	O	support	prep_for	61	SENT_321	[p18l303t3171r555b3234],
68	throughout	IN	O	throughout	_	0	SENT_321	[p18l576t3158r948b3235],
69	the	DT	O	the	det	70	SENT_321	[p18l970t3158r1070b3218],
70	study	NN	O	study	prep_throughout	67	SENT_321	[p18l1096t3158r1280b3234],
71	.	.	O	.	_	0	SENT_321	[p18l1096t3158r1280b3234],

1	APPENDIX	NN	O	appendix	_	0	SENT_322	[p19l1017t24r1145b40],

1	The	DT	O	the	det	2	SENT_323	[p19l237t56r284b80],
2	authors	NNS	O	author	nsubj	3	SENT_323	[p19l297t56r397b80],
3	’	VBP	O	’	_	0	SENT_323	[p19l297t56r397b80],
4	afﬁliations	NNS	O	afﬁliations	nsubj	5	SENT_323	[p19l412t56r543b80],
5	are	VBP	O	be	ccomp	3	SENT_323	[p19l556t64r593b80],
6	as	IN	O	as	mark	7	SENT_323	[p19l606t64r631b80],
7	follows	VBZ	O	follow	advcl	5	SENT_323	[p19l644t56r742b80],
8	:	:	O	:	_	0	SENT_323	[p19l644t56r742b80],
9	Catalan	NNP	ORGANIZATION	Catalan	nn	10	SENT_323	[p19l756t56r848b80],
10	Institute	NNP	ORGANIZATION	Institute	dobj	7	SENT_323	[p19l861t57r964b80],
11	of	IN	O	of	_	0	SENT_323	[p19l977t56r1006b80],
12	Oncology	NNP	O	Oncology	prep_of	10	SENT_323	[p19l1014t56r1133b86],
13	and	CC	O	and	_	0	SENT_323	[p19l1145t56r1190b80],
14	Autonomous	NNP	ORGANIZATION	Autonomous	nn	15	SENT_323	[p19l1202t58r1363b80],
15	University	NNP	ORGANIZATION	University	conj_and	10	SENT_323	[p19l1376t57r1501b86],
16	of	IN	ORGANIZATION	of	_	0	SENT_323	[p19l1513t56r1542b80],
17	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	15	SENT_323	[p19l1549t56r1679b85],
18	,	,	O	,	_	0	SENT_323	[p19l1549t56r1679b85],
19	Hospital	NNP	O	Hospital	nn	20	SENT_323	[p19l1693t56r1798b86],
20	Germans	NNPS	O	Germans	appos	10	SENT_323	[p19l1811t58r1924b80],
21	Trias	NNP	O	Trias	nn	23	SENT_323	[p19l237t94r299b117],
22	i	FW	O	i	nn	23	SENT_323	[p19l308t94r315b116],
23	Pujol	NNP	PERSON	Pujol	dep	20	SENT_323	[p19l323t94r391b123],
24	,	,	O	,	_	0	SENT_323	[p19l323t94r391b123],
25	Barcelona	NNP	ORGANIZATION	Barcelona	nn	27	SENT_323	[p19l401t94r524b117],
26	(	CD	NUMBER	(	num	27	SENT_323	[p19l533t96r603b122],
27	R	NN	O	r	appos	10	SENT_323	[p19l533t96r603b122],
28	,	,	O	,	_	0	SENT_323	[p19l533t96r603b122],
29	R.	NNP	O	R.	nn	36	SENT_323	[p19l533t96r603b122],
30	,	,	O	,	_	0	SENT_323	[p19l533t96r603b122],
31	T.M.	NNP	LOCATION	T.M.	appos	36	SENT_323	[p19l612t96r678b122],
32	,	,	O	,	_	0	SENT_323	[p19l612t96r678b122],
33	C.Q.	NNP	LOCATION	C.Q.	appos	36	SENT_323	[p19l688t96r751b122],
34	,	,	O	,	_	0	SENT_323	[p19l688t96r751b122],
35	M.T.	NNP	LOCATION	M.T.	appos	36	SENT_323	[p19l760t96r837b122],
36	)	NNP	O	)	appos	27	SENT_323	[p19l760t96r837b122],
37	;	:	O	;	_	0	SENT_323	[p19l760t96r837b122],
38	Pangaea	NNP	ORGANIZATION	Pangaea	nn	39	SENT_323	[p19l846t96r948b123],
39	Biotech	NNP	ORGANIZATION	Biotech	dep	10	SENT_323	[p19l956t94r1056b122],
40	,	,	O	,	_	0	SENT_323	[p19l956t94r1056b122],
41	USP	NNP	ORGANIZATION	USP	nn	48	SENT_323	[p19l1066t96r1117b117],
42	Institut	NNP	ORGANIZATION	Institut	nn	48	SENT_323	[p19l1125t94r1216b117],
43	Universitari	NNP	ORGANIZATION	Universitari	nn	48	SENT_323	[p19l1222t94r1366b117],
44	Dexeus	NNP	ORGANIZATION	Dexeus	nn	48	SENT_323	[p19l1374t96r1470b121],
45	,	,	O	,	_	0	SENT_323	[p19l1374t96r1470b121],
46	Barcelona	NNP	ORGANIZATION	Barcelona	appos	48	SENT_323	[p19l1480t94r1603b117],
47	(	CD	NUMBER	(	num	48	SENT_323	[p19l1612t96r1682b122],
48	R.R.	NNP	LOCATION	R.R.	appos	39	SENT_323	[p19l1612t96r1682b122],
49	,	,	O	,	_	0	SENT_323	[p19l1612t96r1682b122],
50	C.M.	NNP	LOCATION	C.M.	appos	39	SENT_323	[p19l1692t96r1758b122],
51	,	,	O	,	_	0	SENT_323	[p19l1692t96r1758b122],
52	J.B.	NNP	PERSON	J.B.	appos	39	SENT_323	[p19l1766t96r1855b122],
53	.	.	O	.	_	0	SENT_323	[p19l1766t96r1855b122],

1	—	NN	O	—	_	0	SENT_324	[p19l1766t96r1855b122],
2	.	.	O	.	_	0	SENT_324	[p19l1766t96r1855b122],

1	A.	NN	O	a.	_	0	SENT_325	[p19l1766t96r1855b122],
2	,	,	O	,	_	0	SENT_325	[p19l1766t96r1855b122],
3	M.A.	NNP	PERSON	M.A.	nn	4	SENT_325	[p19l1864t96r1923b117],
4	Molina	NNP	PERSON	Molina	appos	1	SENT_325	[p19l237t130r331b159],
5	,	,	O	,	_	0	SENT_325	[p19l237t130r331b159],
6	M.T.	NNP	O	M.T.	nn	7	SENT_325	[p19l342t132r418b159],
7	)	NNP	O	)	appos	1	SENT_325	[p19l342t132r418b159],
8	;	:	O	;	_	0	SENT_325	[p19l342t132r418b159],
9	Catalan	NNP	ORGANIZATION	Catalan	nn	10	SENT_325	[p19l429t130r521b154],
10	Institute	NNP	ORGANIZATION	Institute	dep	1	SENT_325	[p19l531t131r633b154],
11	of	IN	ORGANIZATION	of	_	0	SENT_325	[p19l643t130r672b154],
12	Oncology	NNP	ORGANIZATION	Oncology	prep_of	10	SENT_325	[p19l677t130r801b160],
13	,	,	O	,	_	0	SENT_325	[p19l677t130r801b160],
14	Hospital	NNP	O	Hospital	nn	16	SENT_325	[p19l812t130r918b160],
15	Josep	NNP	PERSON	Josep	nn	16	SENT_325	[p19l924t132r992b160],
16	Trueta	NNP	PERSON	Trueta	appos	1	SENT_325	[p19l1001t132r1088b159],
17	,	,	O	,	_	0	SENT_325	[p19l1001t132r1088b159],
18	Girona	NNP	LOCATION	Girona	nn	22	SENT_325	[p19l1099t131r1186b154],
19	(	NNP	O	(	nn	22	SENT_325	[p19l1196t132r1230b157],
20	R.	NNP	PERSON	R.	nn	22	SENT_325	[p19l1196t132r1230b157],
21	Porta	NNP	PERSON	Porta	nn	22	SENT_325	[p19l1240t132r1322b158],
22	)	NN	O	)	appos	1	SENT_325	[p19l1240t132r1322b158],
23	;	:	O	;	_	0	SENT_325	[p19l1240t132r1322b158],
24	Catalan	NNP	ORGANIZATION	Catalan	nn	25	SENT_325	[p19l1333t130r1425b154],
25	Institute	NNP	ORGANIZATION	Institute	dep	1	SENT_325	[p19l1434t131r1537b154],
26	of	IN	ORGANIZATION	of	_	0	SENT_325	[p19l1547t130r1576b154],
27	Oncology	NNP	ORGANIZATION	Oncology	prep_of	25	SENT_325	[p19l1580t130r1705b160],
28	,	,	O	,	_	0	SENT_325	[p19l1580t130r1705b160],
29	Hospital	NNP	PERSON	Hospital	nn	32	SENT_325	[p19l1716t130r1821b160],
30	Duran	NNP	PERSON	Duran	nn	32	SENT_325	[p19l1830t132r1908b154],
31	i	FW	O	i	nn	32	SENT_325	[p19l1917t131r1924b153],
32	Reynals	NNP	O	Reynals	appos	1	SENT_325	[p19l238t168r340b197],
33	,	,	O	,	_	0	SENT_325	[p19l238t168r340b197],
34	Bellvitge	NNP	PERSON	Bellvitge	nn	38	SENT_325	[p19l354t168r466b197],
35	,	,	O	,	_	0	SENT_325	[p19l354t168r466b197],
36	Barcelona	NNP	ORGANIZATION	Barcelona	appos	38	SENT_325	[p19l481t168r603b191],
37	(	CD	NUMBER	(	num	38	SENT_325	[p19l618t170r682b196],
38	F.C.	NNP	LOCATION	F.C.	appos	1	SENT_325	[p19l618t170r682b196],
39	,	,	O	,	_	0	SENT_325	[p19l618t170r682b196],
40	R	NNP	PERSON	R	nn	41	SENT_325	[p19l695t170r719b192],
41	Palmero	NNP	PERSON	Palmero	appos	1	SENT_325	[p19l733t168r852b196],
42	)	NN	O	)	dep	41	SENT_325	[p19l733t168r852b196],
43	;	:	O	;	_	0	SENT_325	[p19l733t168r852b196],
44	Hospital	NNP	ORGANIZATION	Hospital	nn	48	SENT_325	[p19l866t168r972b197],
45	General	NNP	ORGANIZATION	General	nn	48	SENT_325	[p19l985t168r1082b191],
46	Universitario	NNP	ORGANIZATION	Universitario	nn	48	SENT_325	[p19l1095t168r1254b191],
47	de	IN	ORGANIZATION	de	amod	48	SENT_325	[p19l1268t168r1296b191],
48	Valencia	NNP	ORGANIZATION	Valencia	dep	41	SENT_325	[p19l1308t168r1419b196],
49	,	,	O	,	_	0	SENT_325	[p19l1308t168r1419b196],
50	Valencia	NNP	LOCATION	Valencia	nn	53	SENT_325	[p19l1433t168r1537b191],
51	(	NNP	O	(	nn	53	SENT_325	[p19l1552t170r1631b196],
52	C.C.	NNP	LOCATION	C.C.	nn	53	SENT_325	[p19l1552t170r1631b196],
53	)	NNP	O	)	appos	48	SENT_325	[p19l1552t170r1631b196],
54	;	:	O	;	_	0	SENT_325	[p19l1552t170r1631b196],
55	Hospital	NNP	PERSON	Hospital	nn	58	SENT_325	[p19l1645t168r1751b197],
56	de	NNP	PERSON	de	nn	58	SENT_325	[p19l1764t168r1792b191],
57	Sant	NNP	PERSON	Sant	nn	58	SENT_325	[p19l1806t170r1860b191],
58	Pau	NNP	PERSON	Pau	dep	41	SENT_325	[p19l1872t170r1923b196],
59	,	,	O	,	_	0	SENT_325	[p19l1872t170r1923b196],
60	Barcelona	NNP	LOCATION	Barcelona	nn	63	SENT_325	[p19l238t205r360b228],
61	(	NNP	O	(	nn	63	SENT_325	[p19l372t207r464b232],
62	M.M.	NNP	LOCATION	M.M.	nn	63	SENT_325	[p19l372t207r464b232],
63	)	NNP	O	)	appos	58	SENT_325	[p19l372t207r464b232],
64	;	:	O	;	_	0	SENT_325	[p19l372t207r464b232],
65	Hospital	NNP	ORGANIZATION	Hospital	nn	67	SENT_325	[p19l476t205r581b234],
66	de	NNP	ORGANIZATION	de	nn	67	SENT_325	[p19l592t205r620b228],
67	Cruces	NNP	ORGANIZATION	Cruces	dep	41	SENT_325	[p19l631t207r721b233],
68	,	,	O	,	_	0	SENT_325	[p19l631t207r721b233],
69	Baracaldo	NNP	O	Baracaldo	nn	73	SENT_325	[p19l733t205r862b233],
70	,	,	O	,	_	0	SENT_325	[p19l733t205r862b233],
71	Vizcaya	NNP	LOCATION	Vizcaya	appos	73	SENT_325	[p19l873t205r965b234],
72	(	NNP	O	(	nn	73	SENT_325	[p19l977t207r1092b232],
73	G.L.	NNP	O	G.L.	appos	67	SENT_325	[p19l977t207r1092b232],
74	.	.	O	.	_	0	SENT_325	[p19l977t207r1092b232],

1	—	NN	O	—	_	0	SENT_326	[p19l977t207r1092b232],
2	.	.	O	.	_	0	SENT_326	[p19l977t207r1092b232],

1	V.	NNP	O	V.	nn	2	SENT_327	[p19l977t207r1092b232],
2	)	NNP	O	)	_	0	SENT_327	[p19l977t207r1092b232],
3	;	:	O	;	_	0	SENT_327	[p19l977t207r1092b232],
4	Hospital	NNP	PERSON	Hospital	nn	6	SENT_327	[p19l1104t205r1209b234],
5	Lozano	NNP	PERSON	Lozano	nn	6	SENT_327	[p19l1219t207r1309b228],
6	Blesa	NNP	PERSON	Blesa	dep	2	SENT_327	[p19l1320t205r1392b233],
7	,	,	O	,	_	0	SENT_327	[p19l1320t205r1392b233],
8	Zaragoza	NNP	LOCATION	Zaragoza	appos	6	SENT_327	[p19l1403t207r1517b234],
9	(	CD	NUMBER	(	num	8	SENT_327	[p19l1529t207r1601b233],
10	D.I.	NNP	ORGANIZATION	D.I.	dep	8	SENT_327	[p19l1529t207r1601b233],
11	)	CD	NUMBER	)	num	10	SENT_327	[p19l1529t207r1601b233],
12	;	:	O	;	_	0	SENT_327	[p19l1529t207r1601b233],
13	Clinica	NNP	PERSON	Clinica	nn	16	SENT_327	[p19l1613t205r1699b228],
14	Puerta	NNP	PERSON	Puerta	nn	16	SENT_327	[p19l1709t207r1787b228],
15	de	IN	PERSON	de	amod	16	SENT_327	[p19l1797t205r1825b228],
16	Hierro	NNP	PERSON	Hierro	dep	2	SENT_327	[p19l1836t205r1923b233],
17	,	,	O	,	_	0	SENT_327	[p19l1836t205r1923b233],
18	Madrid	NNP	LOCATION	Madrid	nn	21	SENT_327	[p19l237t242r327b265],
19	(	NNP	O	(	nn	21	SENT_327	[p19l339t244r422b269],
20	M.P.	NNP	LOCATION	M.P.	nn	21	SENT_327	[p19l339t244r422b269],
21	)	NNP	O	)	appos	16	SENT_327	[p19l339t244r422b269],
22	;	:	O	;	_	0	SENT_327	[p19l339t244r422b269],
23	Hospital	NNP	ORGANIZATION	Hospital	nn	27	SENT_327	[p19l433t242r539b271],
24	Clinico	NNP	ORGANIZATION	Clinico	nn	27	SENT_327	[p19l549t241r636b265],
25	Universitario	NNP	ORGANIZATION	Universitario	nn	27	SENT_327	[p19l647t242r806b265],
26	de	IN	ORGANIZATION	de	amod	27	SENT_327	[p19l818t242r846b265],
27	Valencia	NNP	ORGANIZATION	Valencia	dep	2	SENT_327	[p19l855t242r966b270],
28	,	,	O	,	_	0	SENT_327	[p19l855t242r966b270],
29	Valencia	NNP	LOCATION	Valencia	appos	27	SENT_327	[p19l978t242r1082b265],
30	(	CD	NUMBER	(	num	32	SENT_327	[p19l1094t244r1164b269],
31	A.I.	NNP	O	A.I.	nn	32	SENT_327	[p19l1094t244r1164b269],
32	)	NN	O	)	dep	29	SENT_327	[p19l1094t244r1164b269],
33	;	:	O	;	_	0	SENT_327	[p19l1094t244r1164b269],
34	Hospital	NNP	ORGANIZATION	Hospital	nn	38	SENT_327	[p19l1175t242r1281b271],
35	General	NNP	ORGANIZATION	General	nn	38	SENT_327	[p19l1291t242r1388b265],
36	Universitario	NNP	ORGANIZATION	Universitario	nn	38	SENT_327	[p19l1399t242r1558b265],
37	de	IN	ORGANIZATION	de	amod	38	SENT_327	[p19l1569t242r1597b265],
38	Alicante	NNP	ORGANIZATION	Alicante	dep	2	SENT_327	[p19l1607t242r1714b270],
39	,	,	O	,	_	0	SENT_327	[p19l1607t242r1714b270],
40	Alicante	NNP	LOCATION	Alicante	appos	38	SENT_327	[p19l1726t242r1826b265],
41	(	CD	NUMBER	(	num	40	SENT_327	[p19l1838t244r1923b270],
42	B.M.	NNP	LOCATION	B.M.	dep	40	SENT_327	[p19l1838t244r1923b270],
43	)	CD	NUMBER	)	num	42	SENT_327	[p19l1838t244r1923b270],
44	;	:	O	;	_	0	SENT_327	[p19l1838t244r1923b270],
45	Hospital	NNP	LOCATION	Hospital	nn	47	SENT_327	[p19l238t279r343b308],
46	Clinico	NNP	LOCATION	Clinico	nn	47	SENT_327	[p19l354t278r441b302],
47	San	NNP	LOCATION	San	dep	2	SENT_327	[p19l453t281r496b302],
48	Carlos	NNP	LOCATION	Carlos	nn	52	SENT_327	[p19l507t279r593b307],
49	,	,	O	,	_	0	SENT_327	[p19l507t279r593b307],
50	Madrid	NNP	LOCATION	Madrid	appos	52	SENT_327	[p19l604t279r694b302],
51	(	CD	NUMBER	(	num	52	SENT_327	[p19l706t281r723b305],
52	J	NNP	O	J	dep	47	SENT_327	[p19l706t281r723b305],
53	.	.	O	.	_	0	SENT_327	[p19l725t281r836b306],

1	L.G.	NNP	PERSON	L.G.	_	0	SENT_328	[p19l725t281r836b306],
2	.	.	O	.	_	0	SENT_328	[p19l725t281r836b306],

1	—	NN	O	—	_	0	SENT_329	[p19l725t281r836b306],
2	.	.	O	.	_	0	SENT_329	[p19l725t281r836b306],

1	L.	NNP	O	L.	nn	2	SENT_330	[p19l725t281r836b306],
2	)	NNP	O	)	_	0	SENT_330	[p19l725t281r836b306],
3	;	:	O	;	_	0	SENT_330	[p19l725t281r836b306],
4	Hospital	NNP	ORGANIZATION	Hospital	nn	7	SENT_330	[p19l848t279r953b308],
5	Universitario	NNP	ORGANIZATION	Universitario	nn	7	SENT_330	[p19l964t279r1123b302],
6	Virgen	NNP	ORGANIZATION	Virgen	nn	7	SENT_330	[p19l1133t279r1215b308],
7	del	NNP	O	del	dep	2	SENT_330	[p19l1226t279r1262b302],
8	Roc1	NN	O	roc1	nn	10	SENT_330	[p19l1272t278r1350b306],
9	’	NN	O	’	nn	10	SENT_330	[p19l1272t278r1350b306],
10	o	NN	O	o	dep	2	SENT_330	[p19l1272t278r1350b306],
11	,	,	O	,	_	0	SENT_330	[p19l1272t278r1350b306],
12	Seville	NNP	LOCATION	Seville	appos	2	SENT_330	[p19l1363t279r1440b302],
13	(	CD	NUMBER	(	num	12	SENT_330	[p19l1452t281r1562b307],
14	L.P.	NNP	O	L.P.	dep	12	SENT_330	[p19l1452t281r1562b307],
15	.	.	O	.	_	0	SENT_330	[p19l1452t281r1562b307],

1	—	NN	O	—	_	0	SENT_331	[p19l1452t281r1562b307],
2	.	.	O	.	_	0	SENT_331	[p19l1452t281r1562b307],

1	A.	NN	O	a.	nn	2	SENT_332	[p19l1452t281r1562b307],
2	)	NN	O	)	_	0	SENT_332	[p19l1452t281r1562b307],
3	;	:	O	;	_	0	SENT_332	[p19l1452t281r1562b307],
4	Hospital	NNP	LOCATION	Hospital	nn	10	SENT_332	[p19l1574t279r1679b308],
5	Son	NNP	LOCATION	Son	nn	10	SENT_332	[p19l1690t281r1736b302],
6	Llatzer	NNP	LOCATION	Llatzer	nn	10	SENT_332	[p19l1747t279r1837b307],
7	,	,	O	,	_	0	SENT_332	[p19l1747t279r1837b307],
8	Palma	NNP	LOCATION	Palma	appos	10	SENT_332	[p19l1849t279r1925b302],
9	de	IN	LOCATION	de	amod	10	SENT_332	[p19l238t316r266b339],
10	Mallorca	NNP	LOCATION	Mallorca	dep	2	SENT_332	[p19l275t316r384b339],
11	(	CD	NUMBER	(	num	13	SENT_332	[p19l395t318r464b343],
12	I.B.	NNP	LOCATION	I.B.	nn	13	SENT_332	[p19l395t318r464b343],
13	)	NNP	O	)	dep	10	SENT_332	[p19l395t318r464b343],
14	;	:	O	;	_	0	SENT_332	[p19l395t318r464b343],
15	Hospital	NNP	O	Hospital	nn	17	SENT_332	[p19l474t316r580b345],
16	Juan	NNP	PERSON	Juan	nn	17	SENT_332	[p19l587t318r643b342],
17	Canalejo	NNP	PERSON	Canalejo	dep	2	SENT_332	[p19l653t316r766b345],
18	,	,	O	,	_	0	SENT_332	[p19l653t316r766b345],
19	La	NNP	LOCATION	La	nn	22	SENT_332	[p19l777t318r806b339],
20	Coruﬁa	NNP	LOCATION	Coruﬁa	nn	22	SENT_332	[p19l815t317r906b339],
21	(	NNP	O	(	nn	22	SENT_332	[p19l917t318r1037b343],
22	R.G.	NNP	PERSON	R.G.	appos	17	SENT_332	[p19l917t318r1037b343],
23	.	.	O	.	_	0	SENT_332	[p19l917t318r1037b343],

1	—	NN	O	—	_	0	SENT_333	[p19l917t318r1037b343],
2	.	.	O	.	_	0	SENT_333	[p19l917t318r1037b343],

1	C.	NNP	O	C.	nn	2	SENT_334	[p19l917t318r1037b343],
2	)	NNP	O	)	_	0	SENT_334	[p19l917t318r1037b343],
3	;	:	O	;	_	0	SENT_334	[p19l917t318r1037b343],
4	Complejo	NNP	PERSON	Complejo	nn	8	SENT_334	[p19l1048t316r1167b345],
5	Hospitalario	NNP	PERSON	Hospitalario	nn	8	SENT_334	[p19l1178t316r1331b345],
6	de	IN	PERSON	de	amod	8	SENT_334	[p19l1341t316r1369b339],
7	Jae	NNP	PERSON	Jae	nn	8	SENT_334	[p19l1376t315r1437b344],
8	’n	NNP	O	’n	dep	2	SENT_334	[p19l1376t315r1437b344],
9	,	,	O	,	_	0	SENT_334	[p19l1376t315r1437b344],
10	Jaén	NNP	O	Jaén	nn	14	SENT_334	[p19l1446t315r1500b342],
11	(	NNP	O	(	nn	14	SENT_334	[p19l1511t318r1578b342],
12	M.A.	NNP	PERSON	M.A.	nn	14	SENT_334	[p19l1511t318r1578b342],
13	Moreno	NNP	PERSON	Moreno	nn	14	SENT_334	[p19l1588t318r1703b343],
14	)	NN	O	)	appos	8	SENT_334	[p19l1588t318r1703b343],
15	;	:	O	;	_	0	SENT_334	[p19l1588t318r1703b343],
16	Hospital	NNP	LOCATION	Hospital	nn	21	SENT_334	[p19l1714t316r1819b345],
17	Althaia	NNP	LOCATION	Althaia	nn	21	SENT_334	[p19l1828t316r1923b344],
18	,	,	O	,	_	0	SENT_334	[p19l1828t316r1923b344],
19	Manresa	NNP	ORGANIZATION	Manresa	appos	21	SENT_334	[p19l237t355r343b376],
20	(	CD	NUMBER	(	num	21	SENT_334	[p19l355t355r431b381],
21	S.C.	NNP	LOCATION	S.C.	dep	8	SENT_334	[p19l355t355r431b381],
22	)	CD	NUMBER	)	dep	21	SENT_334	[p19l355t355r431b381],
23	;	:	O	;	_	0	SENT_334	[p19l355t355r431b381],
24	Clinica	NNP	PERSON	Clinica	nn	29	SENT_334	[p19l443t352r528b376],
25	Rotger	NNP	PERSON	Rotger	nn	29	SENT_334	[p19l538t355r628b382],
26	,	,	O	,	_	0	SENT_334	[p19l538t355r628b382],
27	Palma	NNP	O	Palma	appos	29	SENT_334	[p19l640t353r716b376],
28	de	IN	O	de	amod	29	SENT_334	[p19l726t353r754b376],
29	Mallorca	NNP	LOCATION	Mallorca	dep	8	SENT_334	[p19l764t353r873b376],
30	(	NNP	O	(	nn	32	SENT_334	[p19l884t355r964b381],
31	C.R.	NNP	LOCATION	C.R.	nn	32	SENT_334	[p19l884t355r964b381],
32	)	NNP	O	)	dep	29	SENT_334	[p19l884t355r964b381],
33	;	:	O	;	_	0	SENT_334	[p19l884t355r964b381],
34	Hospital	NNP	ORGANIZATION	Hospital	nn	35	SENT_334	[p19l976t353r1081b382],
35	Clinic	NNP	ORGANIZATION	Clinic	dep	8	SENT_334	[p19l1091t352r1170b381],
36	,	,	O	,	_	0	SENT_334	[p19l1091t352r1170b381],
37	Barcelona	NNP	ORGANIZATION	Barcelona	nn	40	SENT_334	[p19l1182t353r1305b376],
38	(	NNP	O	(	nn	40	SENT_334	[p19l1316t355r1399b381],
39	N.R.	NNP	LOCATION	N.R.	nn	40	SENT_334	[p19l1316t355r1399b381],
40	)	NNP	O	)	appos	35	SENT_334	[p19l1316t355r1399b381],
41	;	:	O	;	_	0	SENT_334	[p19l1316t355r1399b381],
42	Hospital	NNP	O	Hospital	dep	8	SENT_334	[p19l1411t353r1516b382],
43	12	CD	NUMBER	12	num	42	SENT_334	[p19l1527t355r1556b375],
44	de	IN	O	de	_	0	SENT_334	[p19l1567t353r1595b376],
45	Octubre	NNP	O	Octubre	nn	47	SENT_334	[p19l1605t353r1711b381],
46	,	,	O	,	_	0	SENT_334	[p19l1605t353r1711b381],
47	Madrid	NNP	LOCATION	Madrid	prep_de	42	SENT_334	[p19l1722t353r1812b376],
48	(	CD	NUMBER	(	num	47	SENT_334	[p19l1824t355r1923b381],
49	J.M.S.	NNP	O	J.M.S.	dep	47	SENT_334	[p19l1824t355r1923b381],
50	)	CD	NUMBER	)	dep	49	SENT_334	[p19l1824t355r1923b381],
51	;	:	O	;	_	0	SENT_334	[p19l1824t355r1923b381],
52	Hospital	NNP	PERSON	Hospital	nn	55	SENT_334	[p19l238t389r343b419],
53	Mutua	NNP	PERSON	Mutua	nn	55	SENT_334	[p19l352t391r432b413],
54	de	IN	PERSON	de	amod	55	SENT_334	[p19l442t389r470b413],
55	Terrassa	NNP	PERSON	Terrassa	dep	49	SENT_334	[p19l479t391r590b418],
56	,	,	O	,	_	0	SENT_334	[p19l479t391r590b418],
57	Barcelona	NNP	ORGANIZATION	Barcelona	nn	59	SENT_334	[p19l602t389r724b413],
58	(	CD	NUMBER	(	num	59	SENT_334	[p19l735t391r813b417],
59	RB	NN	O	rb	appos	55	SENT_334	[p19l735t391r813b417],
60	.	.	O	.	_	0	SENT_334	[p19l735t391r813b417],
61	)	SYM	O	)	dep	2	SENT_334	[p19l735t391r813b417],

1	;	:	O	;	_	0	SENT_335	[p19l735t391r813b417],
2	and	CC	O	and	advmod	4	SENT_335	[p19l824t389r870b413],
3	Autonomous	NNP	ORGANIZATION	Autonomous	nn	4	SENT_335	[p19l879t391r1040b413],
4	University	NNP	ORGANIZATION	University	_	0	SENT_335	[p19l1050t390r1175b419],
5	of	IN	ORGANIZATION	of	_	0	SENT_335	[p19l1184t389r1213b413],
6	Madrid	NNP	ORGANIZATION	Madrid	nn	10	SENT_335	[p19l1217t389r1313b418],
7	,	,	O	,	_	0	SENT_335	[p19l1217t389r1313b418],
8	Madrid	NNP	LOCATION	Madrid	appos	10	SENT_335	[p19l1324t389r1414b413],
9	(	CD	NUMBER	(	num	10	SENT_335	[p19l1425t391r1499b416],
10	J.J.S.	NNP	O	J.J.S.	prep_of	4	SENT_335	[p19l1425t391r1499b416],
11	)	CD	NUMBER	)	number	12	SENT_335	[p19l1425t391r1499b416],
12	—	CD	NUMBER	—	dep	10	SENT_335	[p19l1509t403r1541b405],
13	all	DT	O	all	dep	12	SENT_335	[p19l1549t389r1578b413],
14	in	IN	O	in	_	0	SENT_335	[p19l1588t390r1612b412],
15	Spain	NNP	LOCATION	Spain	prep_in	4	SENT_335	[p19l1622t390r1697b419],
16	.	.	O	.	_	0	SENT_335	[p19l1622t390r1697b419],

1	The	DT	O	the	det	3	SENT_336	[p19l268t426r315b450],
2	following	VBG	O	follow	amod	3	SENT_336	[p19l326t426r442b456],
3	investigators	NNS	O	investigator	nsubj	4	SENT_336	[p19l452t427r605b456],
4	participated	VBD	O	participate	_	0	SENT_336	[p19l616t426r759b456],
5	in	IN	O	in	_	0	SENT_336	[p19l770t427r794b449],
6	the	DT	O	the	det	7	SENT_336	[p19l805t426r842b450],
7	study	NN	O	study	prep_in	4	SENT_336	[p19l853t426r923b456],
8	:	:	O	:	_	0	SENT_336	[p19l853t426r923b456],
9	M.	NNP	PERSON	M.	nn	10	SENT_336	[p19l934t428r966b450],
10	Cuello	NNP	PERSON	Cuello	dep	7	SENT_336	[p19l978t426r1062b454],
11	,	,	O	,	_	0	SENT_336	[p19l978t426r1062b454],
12	C.	NNP	PERSON	C.	nn	13	SENT_336	[p19l1075t428r1099b450],
13	Pallares	NNP	PERSON	Pallares	appos	10	SENT_336	[p19l1111t426r1211b455],
14	,	,	O	,	_	0	SENT_336	[p19l1111t426r1211b455],
15	P.	NNP	PERSON	P.	nn	16	SENT_336	[p19l1223t428r1244b450],
16	Lianes	NNP	PERSON	Lianes	appos	10	SENT_336	[p19l1256t427r1340b455],
17	,	,	O	,	_	0	SENT_336	[p19l1256t427r1340b455],
18	J.	NNP	PERSON	J.	nn	19	SENT_336	[p19l1350t428r1367b453],
19	Remon	NNP	PERSON	Remon	appos	10	SENT_336	[p19l1379t428r1474b455],
20	,	,	O	,	_	0	SENT_336	[p19l1379t428r1474b455],
21	R.	NNP	PERSON	R.	nn	22	SENT_336	[p19l1486t428r1511b451],
22	Ibeas	NNP	PERSON	Ibeas	appos	10	SENT_336	[p19l1523t426r1592b455],
23	,	,	O	,	_	0	SENT_336	[p19l1523t426r1592b455],
24	P.	NNP	PERSON	P.	nn	27	SENT_336	[p19l1605t428r1626b450],
25	Martinez	NNP	PERSON	Martinez	nn	27	SENT_336	[p19l1638t427r1746b450],
26	del	NNP	PERSON	del	nn	27	SENT_336	[p19l1757t426r1793b450],
27	Prado	NNP	PERSON	Prado	appos	10	SENT_336	[p19l1803t426r1880b455],
28	,	,	O	,	_	0	SENT_336	[p19l1803t426r1880b455],
29	M.	NNP	PERSON	M.	nn	31	SENT_336	[p19l1891t428r1923b450],
30	Angeles	NNP	PERSON	Angeles	nn	31	SENT_336	[p19l237t464r333b493],
31	Sala	NNP	PERSON	Sala	appos	10	SENT_336	[p19l343t464r397b492],
32	,	,	O	,	_	0	SENT_336	[p19l343t464r397b492],
33	C.	NNP	PERSON	C.	nn	34	SENT_336	[p19l408t466r432b487],
34	Santander	NNP	PERSON	Santander	appos	10	SENT_336	[p19l443t464r664b492],
35	.	.	O	.	_	0	SENT_336	[p19l443t464r664b492],

1	—	NN	O	—	_	0	SENT_337	[p19l443t464r664b492],
2	.	.	O	.	_	0	SENT_337	[p19l443t464r664b492],

1	Lobera	NNP	PERSON	Lobera	_	0	SENT_338	[p19l443t464r664b492],
2	,	,	O	,	_	0	SENT_338	[p19l443t464r664b492],
3	E.	NNP	PERSON	E.	nn	6	SENT_338	[p19l674t466r696b487],
4	Velez	NNP	PERSON	Velez	nn	6	SENT_338	[p19l706t464r771b487],
5	de	IN	PERSON	de	amod	6	SENT_338	[p19l780t464r807b487],
6	Mendizabal	NNP	PERSON	Mendizabal	appos	1	SENT_338	[p19l816t464r964b492],
7	,	,	O	,	_	0	SENT_338	[p19l816t464r964b492],
8	N.	NNP	PERSON	N.	nn	9	SENT_338	[p19l974t466r1002b487],
9	Viﬁolas	NNP	PERSON	Viﬁolas	appos	6	SENT_338	[p19l1011t464r1108b492],
10	,	,	O	,	_	0	SENT_338	[p19l1011t464r1108b492],
11	J.	NNP	PERSON	J.	nn	12	SENT_338	[p19l1116t466r1133b490],
12	Terrasa	NNP	PERSON	Terrasa	appos	6	SENT_338	[p19l1143t466r1239b491],
13	,	,	O	,	_	0	SENT_338	[p19l1143t466r1239b491],
14	J.	NNP	PERSON	J.	nn	15	SENT_338	[p19l1247t466r1264b490],
15	Valdivia	NNP	PERSON	Valdivia	appos	6	SENT_338	[p19l1273t464r1375b492],
16	,	,	O	,	_	0	SENT_338	[p19l1273t464r1375b492],
17	P.	NNP	PERSON	P.	nn	18	SENT_338	[p19l1385t466r1407b487],
18	Diz	NNP	PERSON	Diz	appos	6	SENT_338	[p19l1417t464r1465b492],
19	,	,	O	,	_	0	SENT_338	[p19l1417t464r1465b492],
20	U.	NNP	PERSON	U.	nn	21	SENT_338	[p19l1475t466r1502b487],
21	Jimenez	NNP	PERSON	Jimenez	appos	6	SENT_338	[p19l1509t464r1717b492],
22	.	.	O	.	_	0	SENT_338	[p19l1509t464r1717b492],

1	—	NN	O	—	_	0	SENT_339	[p19l1509t464r1717b492],
2	.	.	O	.	_	0	SENT_339	[p19l1509t464r1717b492],

1	Berlana	NNP	PERSON	Berlana	_	0	SENT_340	[p19l1509t464r1717b492],
2	,	,	O	,	_	0	SENT_340	[p19l1509t464r1717b492],
3	A.	NNP	PERSON	A.	nn	4	SENT_340	[p19l1726t466r1751b487],
4	Velasco	NNP	PERSON	Velasco	appos	1	SENT_340	[p19l1761t464r1924b487],
5	.	.	O	.	_	0	SENT_340	[p19l1761t464r1924b487],

1	—	NN	O	—	_	0	SENT_341	[p19l1761t464r1924b487],
2	.	.	O	.	_	0	SENT_341	[p19l1761t464r1924b487],

1	Ortiz	NNP	PERSON	Ortiz	nn	3	SENT_342	[p19l1761t464r1924b487],
2	de	NNP	PERSON	de	nn	3	SENT_342	[p19l238t501r266b524],
3	Taranco	NNP	PERSON	Taranco	_	0	SENT_342	[p19l274t503r379b529],
4	,	,	O	,	_	0	SENT_342	[p19l274t503r379b529],
5	E.	NNP	PERSON	E.	nn	7	SENT_342	[p19l389t503r411b524],
6	Ales	NNP	PERSON	Ales	nn	7	SENT_342	[p19l421t501r471b524],
7	Martinez	NNP	PERSON	Martinez	appos	3	SENT_342	[p19l480t501r595b529],
8	,	,	O	,	_	0	SENT_342	[p19l480t501r595b529],
9	R	NNP	O	R	nn	11	SENT_342	[p19l605t503r629b525],
10	,	,	O	,	_	0	SENT_342	[p19l605t503r629b525],
11	Sanchez	NNP	PERSON	Sanchez	appos	7	SENT_342	[p19l640t501r876b529],
12	.	.	O	.	_	0	SENT_342	[p19l640t501r876b529],

1	—	NN	O	—	_	0	SENT_343	[p19l640t501r876b529],
2	.	.	O	.	_	0	SENT_343	[p19l640t501r876b529],

1	Escribano	NNP	PERSON	Escribano	_	0	SENT_344	[p19l640t501r876b529],
2	,	,	O	,	_	0	SENT_344	[p19l640t501r876b529],
3	A.	NNP	PERSON	A.	nn	4	SENT_344	[p19l885t503r910b524],
4	Carrato	NNP	PERSON	Carrato	appos	1	SENT_344	[p19l921t503r1017b529],
5	,	,	O	,	_	0	SENT_344	[p19l921t503r1017b529],
6	C.	NNP	PERSON	C.	nn	7	SENT_344	[p19l1027t503r1051b524],
7	Guillen	NNP	PERSON	Guillen	appos	4	SENT_344	[p19l1061t501r1240b529],
8	.	.	O	.	_	0	SENT_344	[p19l1061t501r1240b529],

1	—	NN	O	—	_	0	SENT_345	[p19l1061t501r1240b529],
2	.	.	O	.	_	0	SENT_345	[p19l1061t501r1240b529],

1	Ponce	NNP	LOCATION	Ponce	_	0	SENT_346	[p19l1061t501r1240b529],
2	,	,	O	,	_	0	SENT_346	[p19l1061t501r1240b529],
3	C.	NNP	PERSON	C.	nn	4	SENT_346	[p19l1250t503r1274b524],
4	Mesia	NNP	PERSON	Mesia	appos	1	SENT_346	[p19l1284t501r1362b529],
5	,	,	O	,	_	0	SENT_346	[p19l1284t501r1362b529],
6	J.	NNP	PERSON	J.	nn	8	SENT_346	[p19l1369t503r1386b527],
7	Antonio	NNP	PERSON	Antonio	nn	8	SENT_346	[p19l1395t501r1494b524],
8	Macias	NNP	PERSON	Macias	appos	1	SENT_346	[p19l1502t501r1593b529],
9	,	,	O	,	_	0	SENT_346	[p19l1502t501r1593b529],
10	M.	NNP	PERSON	M.	nn	11	SENT_346	[p19l1602t503r1634b524],
11	Lopez	NNP	PERSON	Lopez	appos	1	SENT_346	[p19l1644t503r1787b530],
12	.	.	O	.	_	0	SENT_346	[p19l1644t503r1787b530],

1	—	NN	O	—	_	0	SENT_347	[p19l1644t503r1787b530],
2	.	.	O	.	_	0	SENT_347	[p19l1644t503r1787b530],

1	Brea	NNP	PERSON	Brea	dep	52	SENT_348	[p19l1644t503r1787b530],
2	,	,	O	,	_	0	SENT_348	[p19l1644t503r1787b530],
3	J.	NNP	PERSON	J.	nn	4	SENT_348	[p19l1794t503r1811b527],
4	Oramas	NNP	PERSON	Oramas	appos	1	SENT_348	[p19l1821t503r1923b529],
5	,	,	O	,	_	0	SENT_348	[p19l1821t503r1923b529],
6	I.	NNP	PERSON	I.	nn	7	SENT_348	[p19l238t540r253b561],
7	Barneto	NNP	PERSON	Barneto	appos	1	SENT_348	[p19l263t540r364b566],
8	,	,	O	,	_	0	SENT_348	[p19l263t540r364b566],
9	P.	NNP	PERSON	P.	nn	10	SENT_348	[p19l375t540r396b561],
10	Garrido	NNP	PERSON	Garrido	appos	1	SENT_348	[p19l407t538r508b566],
11	,	,	O	,	_	0	SENT_348	[p19l407t538r508b566],
12	M.J.	NNP	PERSON	M.J.	nn	13	SENT_348	[p19l518t540r566b564],
13	Mayol	NNP	PERSON	Mayol	appos	1	SENT_348	[p19l576t538r656b567],
14	,	,	O	,	_	0	SENT_348	[p19l576t538r656b567],
15	A.	NNP	PERSON	A.	nn	16	SENT_348	[p19l666t540r691b561],
16	Lopez	NNP	PERSON	Lopez	appos	1	SENT_348	[p19l702t540r781b567],
17	,	,	O	,	_	0	SENT_348	[p19l702t540r781b567],
18	A.	NNP	PERSON	A.	nn	19	SENT_348	[p19l791t540r816b561],
19	Artal	NNP	PERSON	Artal	appos	1	SENT_348	[p19l825t538r891b566],
20	,	,	O	,	_	0	SENT_348	[p19l825t538r891b566],
21	A.	NNP	PERSON	A.	nn	22	SENT_348	[p19l901t540r926b561],
22	Saenz	NNP	PERSON	Saenz	appos	1	SENT_348	[p19l937t540r1013b566],
23	,	,	O	,	_	0	SENT_348	[p19l937t540r1013b566],
24	S.	NNP	PERSON	S.	nn	25	SENT_348	[p19l1025t540r1045b561],
25	Hernando	NNP	PERSON	Hernando	appos	1	SENT_348	[p19l1055t538r1184b566],
26	,	,	O	,	_	0	SENT_348	[p19l1055t538r1184b566],
27	M.	NNP	PERSON	M.	nn	28	SENT_348	[p19l1195t540r1226b561],
28	Cobo	NNP	PERSON	Cobo	appos	1	SENT_348	[p19l1237t538r1308b566],
29	,	,	O	,	_	0	SENT_348	[p19l1237t538r1308b566],
30	R.	NNP	PERSON	R.	nn	31	SENT_348	[p19l1318t540r1343b562],
31	Blanco	NNP	PERSON	Blanco	appos	1	SENT_348	[p19l1354t538r1443b566],
32	,	,	O	,	_	0	SENT_348	[p19l1354t538r1443b566],
33	R.	NNP	PERSON	R.	nn	34	SENT_348	[p19l1453t540r1478b562],
34	Bernabe	NNP	PERSON	Bernabe	appos	1	SENT_348	[p19l1488t538r1594b566],
35	,	,	O	,	_	0	SENT_348	[p19l1488t538r1594b566],
36	V.	NNP	PERSON	V.	nn	37	SENT_348	[p19l1604t540r1628b561],
37	Guillem	NNP	PERSON	Guillem	appos	1	SENT_348	[p19l1639t538r1743b566],
38	,	,	O	,	_	0	SENT_348	[p19l1639t538r1743b566],
39	M.	NNP	PERSON	M.	nn	41	SENT_348	[p19l1753t540r1785b561],
40	Angel	NNP	PERSON	Angel	nn	41	SENT_348	[p19l1794t538r1866b567],
41	Muﬁoz	NNP	PERSON	Muﬁoz	appos	1	SENT_348	[p19l1874t540r1924b561, p19l238t576r289b603],
42	,	,	O	,	_	0	SENT_348	[p19l1874t540r1924b561, p19l238t576r289b603],
43	I.	NNP	PERSON	I.	nn	44	SENT_348	[p19l301t577r316b598],
44	Maestu	NNP	PERSON	Maestu	appos	1	SENT_348	[p19l327t577r422b603],
45	,	,	O	,	_	0	SENT_348	[p19l327t577r422b603],
46	A.	NNP	PERSON	A.	nn	47	SENT_348	[p19l433t577r458b598],
47	Salvatierra	NNP	PERSON	Salvatierra	appos	1	SENT_348	[p19l471t575r601b603],
48	,	,	O	,	_	0	SENT_348	[p19l471t575r601b603],
49	R.	NNP	PERSON	R.	nn	50	SENT_348	[p19l613t577r638b599],
50	De	NNP	PERSON	De	appos	1	SENT_348	[p19l649t577r682b598],
51	Las	NNP	PERSON	Las	nn	52	SENT_348	[p19l693t577r732b598],
52	Peﬁas	NNP	PERSON	Peﬁas	_	0	SENT_348	[p19l743t576r819b603],
53	,	,	O	,	_	0	SENT_348	[p19l743t576r819b603],
54	J.	NNP	PERSON	J.	nn	55	SENT_348	[p19l829t577r846b601],
55	Alfaro	NNP	PERSON	Alfaro	appos	52	SENT_348	[p19l857t575r938b603],
56	,	,	O	,	_	0	SENT_348	[p19l857t575r938b603],
57	V.	NNP	PERSON	V.	nn	58	SENT_348	[p19l949t577r973b598],
58	Alberola	NNP	PERSON	Alberola	appos	52	SENT_348	[p19l984t575r1093b603],
59	,	,	O	,	_	0	SENT_348	[p19l984t575r1093b603],
60	o.	NNP	O	o.	nn	61	SENT_348	[p19l1105t577r1132b598],
61	Juan	NNP	PERSON	Juan	appos	52	SENT_348	[p19l1141t577r1203b603],
62	,	,	O	,	_	0	SENT_348	[p19l1141t577r1203b603],
63	C.	NNP	PERSON	C.	nn	64	SENT_348	[p19l1215t577r1239b598],
64	Martin	NNP	PERSON	Martin	appos	52	SENT_348	[p19l1251t575r1339b603],
65	,	,	O	,	_	0	SENT_348	[p19l1251t575r1339b603],
66	J.	NNP	PERSON	J.	nn	67	SENT_348	[p19l1348t577r1365b601],
67	Puertas	NNP	PERSON	Puertas	appos	52	SENT_348	[p19l1377t577r1472b603],
68	,	,	O	,	_	0	SENT_348	[p19l1377t577r1472b603],
69	E.	NNP	PERSON	E.	nn	70	SENT_348	[p19l1483t577r1506b598],
70	Felip	NNP	PERSON	Felip	appos	52	SENT_348	[p19l1517t575r1583b604],
71	,	,	O	,	_	0	SENT_348	[p19l1517t575r1583b604],
72	J.F.	NNP	PERSON	J.F.	nn	73	SENT_348	[p19l1592t577r1632b601],
73	Gonzalez	NNP	PERSON	Gonzalez	appos	52	SENT_348	[p19l1645t574r1890b603],
74	.	.	O	.	_	0	SENT_348	[p19l1645t574r1890b603],

1	—	NN	O	—	_	0	SENT_349	[p19l1645t574r1890b603],
2	.	.	O	.	_	0	SENT_349	[p19l1645t574r1890b603],

1	Gonzalez	NNP	PERSON	Gonzalez	_	0	SENT_350	[p19l1645t574r1890b603],
2	,	,	O	,	_	0	SENT_350	[p19l1645t574r1890b603],
3	L.	NNP	PERSON	L.	nn	4	SENT_350	[p19l1902t577r1923b598],
4	Iglesias	NNP	PERSON	Iglesias	appos	1	SENT_350	[p19l238t612r464b641],
5	.	.	O	.	_	0	SENT_350	[p19l238t612r464b641],

1	—	NN	O	—	_	0	SENT_351	[p19l238t612r464b641],
2	.	.	O	.	_	0	SENT_351	[p19l238t612r464b641],

1	Docampo	NNP	O	Docampo	_	0	SENT_352	[p19l238t612r464b641],
2	,	,	O	,	_	0	SENT_352	[p19l238t612r464b641],
3	F.J.	NNP	PERSON	F.J.	nn	4	SENT_352	[p19l475t614r512b638],
4	Dorta	NNP	PERSON	Dorta	appos	1	SENT_352	[p19l523t614r598b640],
5	,	,	O	,	_	0	SENT_352	[p19l523t614r598b640],
6	M.	NNP	PERSON	M.	nn	7	SENT_352	[p19l609t614r640b635],
7	Martinez-Aguillo	NNP	PERSON	Martinez-Aguillo	appos	4	SENT_352	[p19l651t612r864b641],
8	,	,	O	,	_	0	SENT_352	[p19l651t612r864b641],
9	E.	NNP	PERSON	E.	nn	10	SENT_352	[p19l875t614r897b635],
10	Salgado	NNP	PERSON	Salgado	appos	4	SENT_352	[p19l909t612r1010b641],
11	,	,	O	,	_	0	SENT_352	[p19l909t612r1010b641],
12	R.	NNP	PERSON	R.	nn	13	SENT_352	[p19l1021t614r1046b636],
13	Mesia	NNP	PERSON	Mesia	appos	4	SENT_352	[p19l1057t612r1135b640],
14	,	,	O	,	_	0	SENT_352	[p19l1057t612r1135b640],
15	E.	NNP	PERSON	E.	nn	16	SENT_352	[p19l1146t614r1168b635],
16	Lastra	NNP	PERSON	Lastra	appos	4	SENT_352	[p19l1179t614r1323b640],
17	.	.	O	.	_	0	SENT_352	[p19l1179t614r1323b640],

1	—	NN	O	—	_	0	SENT_353	[p19l1179t614r1323b640],
2	.	.	O	.	_	0	SENT_353	[p19l1179t614r1323b640],

1	Aras	NNP	O	Aras	_	0	SENT_354	[p19l1179t614r1323b640],
2	,	,	O	,	_	0	SENT_354	[p19l1179t614r1323b640],
3	J.P.	NNP	PERSON	J.P.	nn	4	SENT_354	[p19l1331t614r1372b638],
4	Garcia	NNP	PERSON	Garcia	appos	1	SENT_354	[p19l1383t612r1564b640],
5	.	.	O	.	_	0	SENT_354	[p19l1383t612r1564b640],

1	—	NN	O	—	_	0	SENT_355	[p19l1383t612r1564b640],
2	.	.	O	.	_	0	SENT_355	[p19l1383t612r1564b640],

1	Muﬁoz	NNP	PERSON	Muﬁoz	_	0	SENT_356	[p19l1383t612r1564b640],
2	,	,	O	,	_	0	SENT_356	[p19l1383t612r1564b640],
3	R.	NNP	PERSON	R.	nn	4	SENT_356	[p19l1575t614r1600b636],
4	Lastra	NNP	PERSON	Lastra	appos	1	SENT_356	[p19l1611t614r1691b640],
5	,	,	O	,	_	0	SENT_356	[p19l1611t614r1691b640],
6	I.	NNP	PERSON	I.	nn	7	SENT_356	[p19l1702t614r1717b635],
7	Alvarez	NNP	PERSON	Alvarez	appos	4	SENT_356	[p19l1727t612r1823b640],
8	,	,	O	,	_	0	SENT_356	[p19l1727t612r1823b640],
9	J.	NNP	PERSON	J.	nn	10	SENT_356	[p19l1831t614r1848b638],
10	Roig	NNP	PERSON	Roig	appos	4	SENT_356	[p19l1859t612r1923b641],
11	,	,	O	,	_	0	SENT_356	[p19l1859t612r1923b641],
12	J.	NNP	PERSON	J.	nn	13	SENT_356	[p19l235t651r252b675],
13	Oruezabal	NNP	PERSON	Oruezabal	appos	4	SENT_356	[p19l263t649r393b677],
14	,	,	O	,	_	0	SENT_356	[p19l263t649r393b677],
15	A.	NNP	PERSON	A.	nn	16	SENT_356	[p19l404t651r429b672],
16	Poveda	NNP	PERSON	Poveda	appos	4	SENT_356	[p19l440t649r531b677],
17	,	,	O	,	_	0	SENT_356	[p19l440t649r531b677],
18	J.	NNP	PERSON	J.	nn	19	SENT_356	[p19l540t651r557b675],
19	Lavernia	NNP	PERSON	Lavernia	appos	4	SENT_356	[p19l568t649r675b676],
20	,	,	O	,	_	0	SENT_356	[p19l568t649r675b676],
21	D.	NNP	PERSON	D.	nn	22	SENT_356	[p19l687t651r713b672],
22	Gutierrez	NNP	PERSON	Gutierrez	appos	4	SENT_356	[p19l725t649r845b677],
23	,	,	O	,	_	0	SENT_356	[p19l725t649r845b677],
24	E.	NNP	PERSON	E.	nn	25	SENT_356	[p19l856t651r879b672],
25	Filipovich	NNP	PERSON	Filipovich	appos	4	SENT_356	[p19l890t649r1015b678],
26	,	,	O	,	_	0	SENT_356	[p19l890t649r1015b678],
27	D.	NNP	PERSON	D.	nn	28	SENT_356	[p19l1026t651r1053b672],
28	Aguiar	NNP	PERSON	Aguiar	appos	4	SENT_356	[p19l1063t649r1151b678],
29	,	,	O	,	_	0	SENT_356	[p19l1063t649r1151b678],
30	D.	NNP	PERSON	D.	nn	31	SENT_356	[p19l1162t651r1189b672],
31	Rodriguez	NNP	PERSON	Rodriguez	appos	4	SENT_356	[p19l1200t649r1332b678],
32	,	,	O	,	_	0	SENT_356	[p19l1200t649r1332b678],
33	J.	NNP	PERSON	J.	nn	34	SENT_356	[p19l1341t651r1357b675],
34	Buxo	NNP	PERSON	Buxo	appos	4	SENT_356	[p19l1369t651r1437b677],
35	,	,	O	,	_	0	SENT_356	[p19l1369t651r1437b677],
36	A.F.	NNP	PERSON	A.F.	nn	37	SENT_356	[p19l1447t651r1495b672],
37	Cardona	NNP	PERSON	Cardona	appos	4	SENT_356	[p19l1507t649r1616b677],
38	,	,	O	,	_	0	SENT_356	[p19l1507t649r1616b677],
39	P.	NNP	PERSON	P.	nn	40	SENT_356	[p19l1627t651r1648b672],
40	Bes	NNP	PERSON	Bes	appos	4	SENT_356	[p19l1660t651r1708b677],
41	,	,	O	,	_	0	SENT_356	[p19l1660t651r1708b677],
42	A.	NNP	PERSON	A.	nn	43	SENT_356	[p19l1719t651r1744b672],
43	Paredes	NNP	PERSON	Paredes	appos	4	SENT_356	[p19l1755t649r1854b677],
44	,	,	O	,	_	0	SENT_356	[p19l1755t649r1854b677],
45	A.M.	NNP	O	A.M.	nn	46	SENT_356	[p19l1865t651r1923b672],
46	Tortorel1a	NNP	O	Tortorel1a	appos	4	SENT_356	[p19l237t686r414b714],
47	,	,	O	,	_	0	SENT_356	[p19l237t686r414b714],
48	J.A.	NNP	PERSON	J.A.	nn	49	SENT_356	[p19l237t686r414b714],
49	Moreno	NNP	PERSON	Moreno	appos	4	SENT_356	[p19l423t688r525b714],
50	,	,	O	,	_	0	SENT_356	[p19l423t688r525b714],
51	J.	NNP	PERSON	J.	nn	52	SENT_356	[p19l532t688r549b712],
52	Martinez	NNP	PERSON	Martinez	appos	4	SENT_356	[p19l558t686r762b714],
53	.	.	O	.	_	0	SENT_356	[p19l558t686r762b714],

1	—	NN	O	—	_	0	SENT_357	[p19l558t686r762b714],
2	.	.	O	.	_	0	SENT_357	[p19l558t686r762b714],

1	Garcia	NNP	PERSON	Garcia	_	0	SENT_358	[p19l558t686r762b714],
2	,	,	O	,	_	0	SENT_358	[p19l558t686r762b714],
3	J.L.	NNP	PERSON	J.L.	nn	4	SENT_358	[p19l770t688r810b712],
4	Alonso	NNP	PERSON	Alonso	appos	1	SENT_358	[p19l818t686r911b714],
5	,	,	O	,	_	0	SENT_358	[p19l818t686r911b714],
6	A.	NNP	PERSON	A.	nn	7	SENT_358	[p19l920t688r945b709],
7	Lopez	NNP	PERSON	Lopez	appos	4	SENT_358	[p19l954t686r1125b715],
8	.	.	O	.	_	0	SENT_358	[p19l954t686r1125b715],

1	—	NN	O	—	_	0	SENT_359	[p19l954t686r1125b715],
2	.	.	O	.	_	0	SENT_359	[p19l954t686r1125b715],

1	Martin	NNP	PERSON	Martin	_	0	SENT_360	[p19l954t686r1125b715],
2	,	,	O	,	_	0	SENT_360	[p19l954t686r1125b715],
3	M.J.	NNP	PERSON	M.J.	nn	4	SENT_360	[p19l1134t688r1182b712],
4	Echarri	NNP	PERSON	Echarri	appos	1	SENT_360	[p19l1191t686r1410b714],
5	.	.	O	.	_	0	SENT_360	[p19l1191t686r1410b714],

1	—	NN	O	—	_	0	SENT_361	[p19l1191t686r1410b714],
2	.	.	O	.	_	0	SENT_361	[p19l1191t686r1410b714],

1	Gonzalez	NNP	PERSON	Gonzalez	_	0	SENT_362	[p19l1191t686r1410b714],
2	,	,	O	,	_	0	SENT_362	[p19l1191t686r1410b714],
3	M.	NNP	PERSON	M.	nn	5	SENT_362	[p19l1419t688r1451b709],
4	Van	NNP	PERSON	Van	nn	5	SENT_362	[p19l1459t688r1506b709],
5	Kooten	NNP	PERSON	Kooten	appos	1	SENT_362	[p19l1514t688r1609b714],
6	,	,	O	,	_	0	SENT_362	[p19l1514t688r1609b714],
7	A.	NNP	PERSON	A.	nn	8	SENT_362	[p19l1618t688r1642b709],
8	Guerrero	NNP	PERSON	Guerrero	appos	5	SENT_362	[p19l1652t688r1769b714],
9	,	,	O	,	_	0	SENT_362	[p19l1652t688r1769b714],
10	M.	NNP	PERSON	M.	nn	11	SENT_362	[p19l1778t688r1809b709],
11	Domine	NNP	PERSON	Domine	appos	5	SENT_362	[p19l1819t686r1923b714],
12	,	,	O	,	_	0	SENT_362	[p19l1819t686r1923b714],
13	I.	NNP	PERSON	I.	nn	14	SENT_362	[p19l238t725r253b746],
14	Diaz	NNP	PERSON	Diaz	appos	5	SENT_362	[p19l264t723r325b751],
15	,	,	O	,	_	0	SENT_362	[p19l264t723r325b751],
16	L.	NNP	PERSON	L.	nn	17	SENT_362	[p19l336t725r357b746],
17	Heras	NNP	PERSON	Heras	appos	5	SENT_362	[p19l368t725r445b751],
18	,	,	O	,	_	0	SENT_362	[p19l368t725r445b751],
19	R.	NNP	PERSON	R.	nn	20	SENT_362	[p19l456t725r481b747],
20	Garcia	NNP	PERSON	Garcia	appos	5	SENT_362	[p19l492t723r577b751],
21	,	,	O	,	_	0	SENT_362	[p19l492t723r577b751],
22	1	CD	NUMBER	1	appos	5	SENT_362	[p19l588t725r603b746],
23	.	.	O	.	_	0	SENT_362	[p19l588t725r603b746],

1	Anton	NNP	PERSON	Anton	_	0	SENT_363	[p19l613t725r696b751],
2	,	,	O	,	_	0	SENT_363	[p19l613t725r696b751],
3	G.	NNP	PERSON	G.	nn	4	SENT_363	[p19l707t725r734b746],
4	Jarchum	NNP	PERSON	Jarchum	appos	1	SENT_363	[p19l742t723r853b751],
5	,	,	O	,	_	0	SENT_363	[p19l742t723r853b751],
6	R.	NNP	PERSON	R.	nn	8	SENT_363	[p19l864t725r889b747],
7	E.	NNP	PERSON	E.	nn	8	SENT_363	[p19l900t725r922b746],
8	Bartolucci	NNP	PERSON	Bartolucci	appos	4	SENT_363	[p19l933t723r1061b751],
9	,	,	O	,	_	0	SENT_363	[p19l933t723r1061b751],
10	M.	NNP	PERSON	M.	nn	11	SENT_363	[p19l1071t725r1103b746],
11	Lomas	NNP	PERSON	Lomas	appos	4	SENT_363	[p19l1114t725r1201b751],
12	,	,	O	,	_	0	SENT_363	[p19l1114t725r1201b751],
13	A.	NNP	PERSON	A.	nn	14	SENT_363	[p19l1211t725r1236b746],
14	Rubiales	NNP	PERSON	Rubiales	appos	4	SENT_363	[p19l1247t723r1357b751],
15	,	,	O	,	_	0	SENT_363	[p19l1247t723r1357b751],
16	J.L.	NNP	PERSON	J.L.	nn	17	SENT_363	[p19l1366t725r1406b749],
17	Duque	NNP	PERSON	Duque	appos	4	SENT_363	[p19l1417t725r1504b752],
18	,	,	O	,	_	0	SENT_363	[p19l1417t725r1504b752],
19	S.	NNP	PERSON	S.	nn	22	SENT_363	[p19l1515t725r1535b746],
20	Escriva	NNP	PERSON	Escriva	nn	22	SENT_363	[p19l1546t723r1631b746],
21	de	IN	PERSON	de	amod	22	SENT_363	[p19l1641t723r1668b746],
22	Romani	NNP	PERSON	Romani	appos	4	SENT_363	[p19l1678t723r1780b750],
23	,	,	O	,	_	0	SENT_363	[p19l1678t723r1780b750],
24	E.	NNP	LOCATION	E.	nn	25	SENT_363	[p19l1791t725r1814b746],
25	Barbeta	NNP	LOCATION	Barbeta	appos	4	SENT_363	[p19l1824t723r1923b751],
26	,	,	O	,	_	0	SENT_363	[p19l1824t723r1923b751],
27	J.J.	NNP	PERSON	J.J.	nn	28	SENT_363	[p19l235t762r269b786],
28	Reina	NNP	PERSON	Reina	appos	4	SENT_363	[p19l280t760r355b788],
29	,	,	O	,	_	0	SENT_363	[p19l280t760r355b788],
30	J.	NNP	PERSON	J.	nn	31	SENT_363	[p19l364t762r380b786],
31	Castro	NNP	PERSON	Castro	appos	4	SENT_363	[p19l392t762r476b788],
32	,	,	O	,	_	0	SENT_363	[p19l392t762r476b788],
33	C.	NNP	PERSON	C.	nn	34	SENT_363	[p19l488t762r512b783],
34	Belda	NNP	PERSON	Belda	appos	4	SENT_363	[p19l523t760r597b788],
35	,	,	O	,	_	0	SENT_363	[p19l523t760r597b788],
36	J.M.	NNP	PERSON	J.M.	nn	37	SENT_363	[p19l605t762r655b786],
37	Vidal	NNP	PERSON	Vidal	appos	4	SENT_363	[p19l665t760r734b788],
38	,	,	O	,	_	0	SENT_363	[p19l665t760r734b788],
39	J.M.	NNP	PERSON	J.M.	nn	40	SENT_363	[p19l743t762r793b786],
40	Trigo	NNP	PERSON	Trigo	appos	4	SENT_363	[p19l803t760r876b789],
41	,	,	O	,	_	0	SENT_363	[p19l803t760r876b789],
42	C.	NNP	PERSON	C.	nn	43	SENT_363	[p19l887t762r912b783],
43	Vadell	NNP	PERSON	Vadell	appos	4	SENT_363	[p19l922t760r1003b787],
44	,	,	O	,	_	0	SENT_363	[p19l922t760r1003b787],
45	J.J.	NNP	PERSON	J.J.	nn	46	SENT_363	[p19l1012t762r1045b786],
46	Zarba	NNP	PERSON	Zarba	appos	4	SENT_363	[p19l1056t760r1132b788],
47	,	,	O	,	_	0	SENT_363	[p19l1056t760r1132b788],
48	P.	NNP	PERSON	P.	nn	49	SENT_363	[p19l1143t762r1164b783],
49	Esunza	NNP	PERSON	Esunza	appos	4	SENT_363	[p19l1175t762r1269b788],
50	,	,	O	,	_	0	SENT_363	[p19l1175t762r1269b788],
51	I.	NNP	PERSON	I.	nn	52	SENT_363	[p19l1280t762r1295b783],
52	Garau	NNP	PERSON	Garau	appos	4	SENT_363	[p19l1307t762r1387b788],
53	,	,	O	,	_	0	SENT_363	[p19l1307t762r1387b788],
54	A.	NNP	PERSON	A.	nn	55	SENT_363	[p19l1397t762r1422b783],
55	Lopez	NNP	PERSON	Lopez	appos	4	SENT_363	[p19l1433t762r1594b789],
56	.	.	O	.	_	0	SENT_363	[p19l1433t762r1594b789],

1	—	NN	O	—	_	0	SENT_364	[p19l1433t762r1594b789],
2	.	.	O	.	_	0	SENT_364	[p19l1433t762r1594b789],

1	Pousa	NNP	PERSON	Pousa	_	0	SENT_365	[p19l1433t762r1594b789],
2	,	,	O	,	_	0	SENT_365	[p19l1433t762r1594b789],
3	I.	NNP	PERSON	I.	nn	5	SENT_365	[p19l1605t762r1621b783],
4	Dela	NNP	PERSON	Dela	nn	5	SENT_365	[p19l1632t760r1695b783],
5	Gandara	NNP	PERSON	Gandara	appos	1	SENT_365	[p19l1705t760r1815b788],
6	,	,	O	,	_	0	SENT_365	[p19l1705t760r1815b788],
7	J.	NNP	O	J.	nn	10	SENT_365	[p19l1824t762r1840b786],
8	Wida	NNP	O	Wida	nn	10	SENT_365	[p19l1851t760r1924b783],
9	—	NN	O	—	nn	10	SENT_365	[p19l1851t760r1924b783],
10	kovvich	NN	O	kovvich	appos	5	SENT_365	[p19l238t797r332b825],
11	,	,	O	,	_	0	SENT_365	[p19l238t797r332b825],
12	S.	NNP	PERSON	S.	nn	13	SENT_365	[p19l344t799r364b820],
13	Morales	NNP	PERSON	Morales	appos	5	SENT_365	[p19l374t797r478b825],
14	,	,	O	,	_	0	SENT_365	[p19l374t797r478b825],
15	M.	NNP	PERSON	M.	nn	16	SENT_365	[p19l488t799r519b820],
16	Martinez	NNP	PERSON	Martinez	appos	5	SENT_365	[p19l529t797r644b825],
17	,	,	O	,	_	0	SENT_365	[p19l529t797r644b825],
18	R	NNP	O	R	nn	19	SENT_365	[p19l655t799r679b821],
19	Luis	NNP	PERSON	Luis	appos	5	SENT_365	[p19l690t797r747b825],
20	,	,	O	,	_	0	SENT_365	[p19l690t797r747b825],
21	M.	NNP	PERSON	M.	nn	23	SENT_365	[p19l757t799r788b820],
22	Dela	NNP	PERSON	Dela	nn	23	SENT_365	[p19l799t797r862b820],
23	Colina	NNP	PERSON	Colina	appos	5	SENT_365	[p19l871t797r956b825],
24	,	,	O	,	_	0	SENT_365	[p19l871t797r956b825],
25	J.	NNP	PERSON	J.	nn	26	SENT_365	[p19l964t799r981b823],
26	Calzas	NNP	PERSON	Calzas	appos	5	SENT_365	[p19l992t797r1076b825],
27	,	,	O	,	_	0	SENT_365	[p19l992t797r1076b825],
28	I.	NNP	PERSON	I.	nn	29	SENT_365	[p19l1087t799r1102b820],
29	Garcia	NNP	PERSON	Garcia	appos	5	SENT_365	[p19l1113t797r1287b825],
30	.	.	O	.	_	0	SENT_365	[p19l1113t797r1287b825],

1	—	NN	O	—	_	0	SENT_366	[p19l1113t797r1287b825],
2	.	.	O	.	_	0	SENT_366	[p19l1113t797r1287b825],

1	Castro	NNP	PERSON	Castro	_	0	SENT_367	[p19l1113t797r1287b825],
2	,	,	O	,	_	0	SENT_367	[p19l1113t797r1287b825],
3	C.	NNP	PERSON	C.	nn	4	SENT_367	[p19l1298t799r1322b820],
4	Ruiz	NNP	PERSON	Ruiz	appos	1	SENT_367	[p19l1333t797r1394b825],
5	,	,	O	,	_	0	SENT_367	[p19l1333t797r1394b825],
6	P.	NNP	PERSON	P.	nn	7	SENT_367	[p19l1405t799r1426b820],
7	Lopez	NNP	PERSON	Lopez	appos	4	SENT_367	[p19l1437t797r1607b826],
8	.	.	O	.	_	0	SENT_367	[p19l1437t797r1607b826],

1	—	NN	O	—	_	0	SENT_368	[p19l1437t797r1607b826],
2	.	.	O	.	_	0	SENT_368	[p19l1437t797r1607b826],

1	Criado	NNP	PERSON	Criado	_	0	SENT_369	[p19l1437t797r1607b826],
2	.	.	O	.	_	0	SENT_369	[p19l1437t797r1607b826],

1	REFERENCES	NNS	O	reference	_	0	SENT_370	[p19l16t994r682b1057],

1	1	LS	NUMBER	1	_	0	SENT_371	[p19l14t1137r89b1216],
2	.	.	O	.	_	0	SENT_371	[p19l14t1137r89b1216],

1	Rikova	NN	PERSON	rikova	nn	2	SENT_372	[p19l206t1125r553b1222],
2	K	NN	PERSON	k	_	0	SENT_372	[p19l589t1133r690b1236],
3	,	,	O	,	_	0	SENT_372	[p19l589t1133r690b1236],
4	Guo	NNP	O	Guo	nn	5	SENT_372	[p19l736t1131r942b1216],
5	A	NNP	O	A	appos	2	SENT_372	[p19l978t1133r1081b1234],
6	,	,	O	,	_	0	SENT_372	[p19l978t1133r1081b1234],
7	Zeng	NNP	O	Zeng	nn	8	SENT_372	[p19l1123t1133r1377b1242],
8	Q	NNP	O	Q	appos	2	SENT_372	[p19l1410t1133r1523b1238],
9	,	,	O	,	_	0	SENT_372	[p19l1410t1133r1523b1238],
10	et	FW	O	et	nn	11	SENT_372	[p19l1569t1145r1658b1215],
11	al.	FW	O	al.	appos	2	SENT_372	[p19l1692t1125r1805b1216],
12	.	.	O	.	_	0	SENT_372	[p19l1692t1125r1805b1216],

1	Global	JJ	O	global	amod	2	SENT_373	[p19l1850t1125r2132b1216, p19l10t1274r97b1364],
2	survey	NN	O	survey	nsubj	6	SENT_373	[p19l172t1304r494b1389],
3	of	IN	O	of	_	0	SENT_373	[p19l565t1274r681b1365],
4	phosphotyrosine	NN	O	phosphotyrosine	nn	5	SENT_373	[p19l732t1274r1587b1389],
5	signaling	NN	O	signaling	prep_of	2	SENT_373	[p19l1662t1274r2138b1391],
6	identifies	VBZ	O	identify	_	0	SENT_373	[p19l10t1423r486b1514],
7	oncogenic	JJ	O	oncogenic	amod	8	SENT_373	[p19l532t1425r1049b1540],
8	kinases	NNS	O	kinase	dobj	6	SENT_373	[p19l1091t1423r1470b1514],
9	in	IN	O	in	_	0	SENT_373	[p19l1513t1425r1611b1512],
10	lung	NN	O	lung	nn	11	SENT_373	[p19l1654t1423r1880b1540],
11	cancer	NN	O	cancer	prep_in	8	SENT_373	[p19l1920t1453r2132b1513, p19l12t1602r182b1663],
12	.	.	O	.	_	0	SENT_373	[p19l1920t1453r2132b1513, p19l12t1602r182b1663],

1	Cell	NN	O	cell	_	0	SENT_374	[p19l228t1572r423b1663],
2	2007	CD	DATE	2007	num	1	SENT_374	[p19l462t1578r1430b1681],
3	;	:	O	;	_	0	SENT_374	[p19l462t1578r1430b1681],
4	131:1190	CD	NUMBER	131:1190	number	5	SENT_374	[p19l462t1578r1430b1681],
5	-203	CD	NUMBER	-203	dep	1	SENT_374	[p19l462t1578r1430b1681],
6	.	.	O	.	_	0	SENT_374	[p19l462t1578r1430b1681],

1	2	LS	NUMBER	2	_	0	SENT_375	[p19l8t1733r92b1812],
2	.	.	O	.	_	0	SENT_375	[p19l8t1733r92b1812],

1	Ding	VBG	PERSON	ding	_	0	SENT_376	[p19l206t1723r456b1838],
2	L	NN	PERSON	l	dobj	1	SENT_376	[p19l513t1729r601b1830],
3	,	,	O	,	_	0	SENT_376	[p19l513t1729r601b1830],
4	Getz	NNP	PERSON	Getz	nn	5	SENT_376	[p19l669t1727r905b1812],
5	G	NNP	O	G	appos	2	SENT_376	[p19l968t1729r1075b1832],
6	,	,	O	,	_	0	SENT_376	[p19l968t1729r1075b1832],
7	Wheeler	NNP	ORGANIZATION	Wheeler	nn	8	SENT_376	[p19l1140t1721r1559b1811],
8	DA	NNP	ORGANIZATION	DA	appos	2	SENT_376	[p19l1617t1729r1797b1832],
9	,	,	O	,	_	0	SENT_376	[p19l1617t1729r1797b1832],
10	et	FW	O	et	nn	11	SENT_376	[p19l1866t1741r1958b1811],
11	al.	FW	O	al.	appos	2	SENT_376	[p19l2013t1721r2127b1812],
12	.	.	O	.	_	0	SENT_376	[p19l2013t1721r2127b1812],

1	Somatic	JJ	MISC	somatic	amod	2	SENT_377	[p19l12t1872r417b1961],
2	mutations	NNS	O	mutation	nsubj	3	SENT_377	[p19l454t1872r966b1961],
3	affect	VBP	O	affect	_	0	SENT_377	[p19l1005t1870r1295b1961],
4	key	JJ	O	key	amod	5	SENT_377	[p19l1327t1870r1496b1985],
5	pathways	NNS	O	pathway	dobj	3	SENT_377	[p19l1527t1870r1997b1985],
6	in	IN	O	in	_	0	SENT_377	[p19l2037t1872r2134b1959],
7	lung	NN	O	lung	nn	8	SENT_377	[p19l10t2019r236b2136],
8	adenocarcinoma	NN	O	adenocarcinoma	prep_in	5	SENT_377	[p19l297t2019r1166b2110],
9	.	.	O	.	_	0	SENT_377	[p19l297t2019r1166b2110],

1	Nature	NNP	O	Nature	_	0	SENT_378	[p19l1236t2027r1581b2110],
2	2008	CD	DATE	2008	num	1	SENT_378	[p19l1648t2025r2129b2128],
3	;	:	O	;	_	0	SENT_378	[p19l1648t2025r2129b2128],
4	455	CD	NUMBER	455	num	6	SENT_378	[p19l1648t2025r2129b2128],
5	:	:	O	:	_	0	SENT_378	[p19l1648t2025r2129b2128],
6	1069-75	CD	NUMBER	1069-75	dep	1	SENT_378	[p19l14t2173r429b2258],
7	.	.	O	.	_	0	SENT_378	[p19l14t2173r429b2258],

1	3	LS	NUMBER	3	_	0	SENT_379	[p19l10t2328r87b2407],
2	.	.	O	.	_	0	SENT_379	[p19l10t2328r87b2407],

1	Lynch	NNP	PERSON	Lynch	nn	2	SENT_380	[p19l206t2316r500b2431],
2	TJ	NNP	PERSON	TJ	_	0	SENT_380	[p19l553t2324r684b2425],
3	,	,	O	,	_	0	SENT_380	[p19l553t2324r684b2425],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_380	[p19l746t2316r934b2406],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_380	[p19l990t2324r1190b2427],
6	,	,	O	,	_	0	SENT_380	[p19l990t2324r1190b2427],
7	Sordella	NNP	PERSON	Sordella	nn	8	SENT_380	[p19l1257t2316r1656b2407],
8	R	NNP	PERSON	R	appos	2	SENT_380	[p19l1711t2324r1811b2427],
9	,	,	O	,	_	0	SENT_380	[p19l1711t2324r1811b2427],
10	et	FW	O	et	nn	11	SENT_380	[p19l1876t2336r1966b2406],
11	al.	FW	O	al.	appos	2	SENT_380	[p19l2015t2316r2128b2407],
12	.	.	O	.	_	0	SENT_380	[p19l2015t2316r2128b2407],

1	Activating	VBG	O	activate	amod	2	SENT_381	[p19l6t2467r516b2582],
2	mutations	NNS	O	mutation	_	0	SENT_381	[p19l605t2467r1107b2556],
3	in	IN	O	in	_	0	SENT_381	[p19l1200t2467r1297b2554],
4	the	DT	O	the	det	7	SENT_381	[p19l1390t2465r1543b2555],
5	epidermal	JJ	O	epidermal	amod	7	SENT_381	[p19l1636t2465r2134b2580],
6	growth	NN	O	growth	nn	7	SENT_381	[p19l10t2614r373b2731],
7	factor	NN	O	factor	prep_in	2	SENT_381	[p19l412t2614r702b2705],
8	receptor	NN	O	receptor	nn	10	SENT_381	[p19l738t2634r1149b2729],
9	underlying	VBG	O	underlie	amod	10	SENT_381	[p19l1186t2614r1724b2731],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_381	[p19l1761t2644r2132b2729, p19l12t2765r409b2854],
11	of	IN	O	of	_	0	SENT_381	[p19l462t2763r577b2854],
12	non	JJ	O	non	amod	18	SENT_381	[p19l607t2763r1347b2854],
13	—	JJ	O	—	amod	18	SENT_381	[p19l607t2763r1347b2854],
14	small	JJ	O	small	amod	18	SENT_381	[p19l607t2763r1347b2854],
15	—	NN	O	—	nn	18	SENT_381	[p19l607t2763r1347b2854],
16	cell	NN	O	cell	nn	18	SENT_381	[p19l607t2763r1347b2854],
17	lung	NN	O	lung	nn	18	SENT_381	[p19l1396t2763r1620b2880],
18	cancer	NN	O	cancer	prep_of	10	SENT_381	[p19l1668t2793r1991b2853],
19	to	TO	O	to	_	0	SENT_381	[p19l2039t2783r2132b2854],
20	gefitinib	NN	O	gefitinib	prep_to	10	SENT_381	[p19l10t2912r466b3029],
21	.	.	O	.	_	0	SENT_381	[p19l10t2912r466b3029],

1	N	NN	O	n	nn	2	SENT_382	[p19l506t2920r593b3003],
2	EnglJ	NN	O	englj	nsubj	3	SENT_382	[p19l627t2912r919b3029],
3	Med	VBD	O	med	_	0	SENT_382	[p19l950t2912r1166b3003],
4	2004	CD	DATE	2004	dobj	3	SENT_382	[p19l1204t2918r2106b3021],
5	;	:	O	;	_	0	SENT_382	[p19l1204t2918r2106b3021],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_382	[p19l1204t2918r2106b3021],
7	—	CD	NUMBER	—	dep	4	SENT_382	[p19l1204t2918r2106b3021],
8	39	CD	NUMBER	39	dep	7	SENT_382	[p19l1204t2918r2106b3021],
9	.	.	O	.	_	0	SENT_382	[p19l1204t2918r2106b3021],

1	4	LS	NUMBER	4	_	0	SENT_383	[p19l8t3073r89b3152],
2	.	.	O	.	_	0	SENT_383	[p19l8t3073r89b3152],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_384	[p19l206t3069r433b3152],
2	JG	NNP	O	JG	_	0	SENT_384	[p19l462t3069r615b3172],
3	,	,	O	,	_	0	SENT_384	[p19l462t3069r615b3172],
4	Jéinne	NNP	ORGANIZATION	Jéinne	nn	5	SENT_384	[p19l650t3069r938b3166],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_384	[p19l978t3069r1133b3170],
6	,	,	O	,	_	0	SENT_384	[p19l978t3069r1133b3170],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_384	[p19l1178t3069r1347b3152],
8	JC	NNP	PERSON	JC	appos	2	SENT_384	[p19l1375t3067r1519b3170],
9	,	,	O	,	_	0	SENT_384	[p19l1375t3067r1519b3170],
10	et	FW	O	et	nn	11	SENT_384	[p19l1565t3081r1656b3152],
11	al.	FW	O	al.	appos	2	SENT_384	[p19l1688t3061r1803b3152],
12	.	.	O	.	_	0	SENT_384	[p19l1688t3061r1803b3152],

1	EGIFR	NN	O	egifr	_	0	SENT_385	[p19l1847t3067r2146b3157],

1	mutations	NNS	O	mutation	_	0	SENT_386	[p19l10t3212r522b3301],
2	in	IN	O	in	_	0	SENT_386	[p19l617t3212r714b3299],
3	lung	NN	O	lung	nn	4	SENT_386	[p19l807t3210r1034b3327],
4	cancer	NN	O	cancer	prep_in	1	SENT_386	[p19l1124t3240r1480b3301],
5	:	:	O	:	_	0	SENT_386	[p19l1124t3240r1480b3301],
6	correlation	NN	O	correlation	dep	1	SENT_386	[p19l1579t3210r2134b3301],
7	with	IN	O	with	_	0	SENT_386	[p19l6t3359r234b3450],
8	clinical	JJ	O	clinical	amod	9	SENT_386	[p19l284t3359r655b3449],
9	response	NN	O	response	prep_with	6	SENT_386	[p19l704t3389r1151b3474],
10	to	TO	O	to	_	0	SENT_386	[p19l1202t3379r1297b3450],
11	gefitinib	NN	O	gefitinib	nn	12	SENT_386	[p19l1347t3359r1785b3476],
12	therapy	NN	O	therapy	prep_to	9	SENT_386	[p19l1837t3359r2132b3449, p19l8t3538r141b3623],
13	.	.	O	.	_	0	SENT_386	[p19l1837t3359r2132b3449, p19l8t3538r141b3623],

1	Science	NNP	O	Science	_	0	SENT_387	[p19l190t3510r559b3599],
2	2004	CD	DATE	2004	num	1	SENT_387	[p19l599t3516r1575b3617],
3	;	:	O	;	_	0	SENT_387	[p19l599t3516r1575b3617],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_387	[p19l599t3516r1575b3617],
5	-500	CD	NUMBER	-500	dep	1	SENT_387	[p19l599t3516r1575b3617],
6	.	.	O	.	_	0	SENT_387	[p19l599t3516r1575b3617],

1	5	CD	NUMBER	5	_	0	SENT_388	[p19l12t3669r87b3748],
2	.	.	O	.	_	0	SENT_388	[p19l12t3669r87b3748],

1	Pao	NNP	O	Pao	nn	2	SENT_389	[p19l206t3665r385b3748],
2	W	NNP	O	W	_	0	SENT_389	[p19l440t3665r565b3766],
3	,	,	O	,	_	0	SENT_389	[p19l440t3665r565b3766],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_389	[p19l627t3657r934b3747],
5	V	NNP	O	V	appos	2	SENT_389	[p19l986t3665r1071b3766],
6	,	,	O	,	_	0	SENT_389	[p19l986t3665r1071b3766],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_389	[p19l1135t3657r1623b3748],
8	M	NNP	O	M	appos	2	SENT_389	[p19l1678t3665r1803b3766],
9	,	,	O	,	_	0	SENT_389	[p19l1678t3665r1803b3766],
10	et	FW	O	et	nn	11	SENT_389	[p19l1870t3677r1960b3748],
11	al.	FW	O	al.	appos	2	SENT_389	[p19l2013t3657r2127b3748],
12	.	.	O	.	_	0	SENT_389	[p19l2013t3657r2127b3748],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_390	[p20l8t31r217b116],
2	receptor	NN	O	receptor	nn	4	SENT_390	[p20l288t45r708b140],
3	gene	NN	O	gene	nn	4	SENT_390	[p20l774t55r1008b142],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_390	[p20l1079t27r1589b116],
5	are	VBP	O	be	cop	6	SENT_390	[p20l1660t55r1811b116],
6	common	JJ	O	common	_	0	SENT_390	[p20l1882t55r2132b116, p20l10t204r236b265],
7	in	IN	O	in	_	0	SENT_390	[p20l290t176r387b263],
8	lung	NN	O	lung	nn	9	SENT_390	[p20l440t174r668b291],
9	cancers	NNS	O	cancer	prep_in	6	SENT_390	[p20l720t204r1097b265],
10	from	IN	O	from	_	0	SENT_390	[p20l1154t174r1400b265],
11	“	CD	NUMBER	“	prep_from	9	SENT_390	[p20l1458t180r1777b265],
12	never	RB	O	never	advmod	9	SENT_390	[p20l1458t180r1777b265],
13	smokers	NNS	O	smoker	dep	9	SENT_390	[p20l1831t174r2132b265, p20l12t329r204b413],
14	”	CD	NUMBER	”	tmod	6	SENT_390	[p20l1831t174r2132b265, p20l12t329r204b413],
15	and	CC	O	and	_	0	SENT_390	[p20l248t323r433b414],
16	are	VBP	O	be	auxpass	17	SENT_390	[p20l472t353r623b413],
17	associated	VBN	O	associate	conj_and	6	SENT_390	[p20l662t323r1186b414],
18	with	IN	O	with	_	0	SENT_390	[p20l1220t323r1450b414],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_390	[p20l1491t325r2003b438],
20	of	IN	O	of	_	0	SENT_390	[p20l2039t323r2154b414],
21	tumors	NNS	O	tumor	prep_of	19	SENT_390	[p20l10t492r371b563],
22	to	TO	O	to	_	0	SENT_390	[p20l444t492r540b563],
23	gefitinib	NN	O	gefitinib	prep_to	17	SENT_390	[p20l611t472r1049b589],
24	and	CC	O	and	_	0	SENT_390	[p20l1121t472r1305b563],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_390	[p20l1376t472r1837b563],
26	.	.	O	.	_	0	SENT_390	[p20l1376t472r1837b563],

1	Proc	NNP	O	Proc	_	0	SENT_391	[p20l1912t480r2134b563],

1	Natl	NNP	O	Natl	nn	6	SENT_392	[p20l8t621r222b712],
2	Acad	NNP	O	Acad	nn	6	SENT_392	[p20l258t621r506b712],
3	Sci	NNP	O	Sci	nn	6	SENT_392	[p20l547t623r688b712],
4	U	NNP	O	U	nn	6	SENT_392	[p20l726t629r805b712],
5	S	NNP	O	S	nn	6	SENT_392	[p20l847t627r895b712],
6	A	NNP	O	A	_	0	SENT_392	[p20l934t629r1010b710],
7	2004	CD	DATE	2004	num	6	SENT_392	[p20l1047t627r2025b730],
8	;	:	O	;	_	0	SENT_392	[p20l1047t627r2025b730],
9	101:13306	CD	NUMBER	101:13306	number	10	SENT_392	[p20l1047t627r2025b730],
10	-11	CD	NUMBER	-11	dep	6	SENT_392	[p20l1047t627r2025b730],
11	.	.	O	.	_	0	SENT_392	[p20l1047t627r2025b730],

1	6	CD	NUMBER	6	_	0	SENT_393	[p20l10t780r91b861],
2	.	.	O	.	_	0	SENT_393	[p20l10t780r91b861],

1	Shigematsu	NN	PERSON	shigematsu	nn	2	SENT_394	[p20l212t770r798b887],
2	H	NN	PERSON	h	_	0	SENT_394	[p20l841t778r952b879],
3	,	,	O	,	_	0	SENT_394	[p20l841t778r952b879],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_394	[p20l1003t772r1165b859],
5	L	NNP	PERSON	L	appos	2	SENT_394	[p20l1208t778r1295b881],
6	,	,	O	,	_	0	SENT_394	[p20l1208t778r1295b881],
7	Takahashi	NNP	PERSON	Takahashi	nn	8	SENT_394	[p20l1343t770r1869b861],
8	T	NN	O	t	appos	2	SENT_394	[p20l1908t778r1997b881],
9	,	,	O	,	_	0	SENT_394	[p20l1908t778r1997b881],
10	et	FW	O	et	nn	11	SENT_394	[p20l2049t790r2140b861],
11	al.	FW	O	al.	appos	2	SENT_394	[p20l10t919r123b1010],
12	.	.	O	.	_	0	SENT_394	[p20l10t919r123b1010],

1	Clinical	JJ	O	clinical	amod	4	SENT_395	[p20l166t919r558b1010],
2	and	CC	O	and	_	0	SENT_395	[p20l593t919r778b1010],
3	biological	JJ	O	biological	conj_and	1	SENT_395	[p20l813t919r1313b1036],
4	features	NNS	O	feature	nsubj	5	SENT_395	[p20l1347t919r1751b1010],
5	associated	VBN	O	associate	_	0	SENT_395	[p20l1789t921r2132b1010, p20l10t1068r218b1159],
6	with	IN	O	with	_	0	SENT_395	[p20l256t1068r484b1159],
7	epidermal	JJ	O	epidermal	amod	10	SENT_395	[p20l528t1068r1037b1183],
8	growth	NN	O	growth	nn	10	SENT_395	[p20l1079t1068r1446b1185],
9	factor	NN	O	factor	nn	10	SENT_395	[p20l1489t1068r1785b1159],
10	receptor	NN	O	receptor	prep_with	5	SENT_395	[p20l1823t1098r2132b1183, p20l8t1338r78b1373],

1	gene	NN	O	gene	nn	2	SENT_396	[p20l94t1343r208b1386],
2	mutations	NNS	O	mutation	_	0	SENT_396	[p20l226t1330r475b1374],
3	in	IN	O	in	_	0	SENT_396	[p20l494t1330r541b1373],
4	lung	NN	O	lung	nn	5	SENT_396	[p20l559t1329r669b1386],
5	cancers	NNS	O	cancer	prep_in	2	SENT_396	[p20l686t1343r884b1373],
6	.	.	O	.	_	0	SENT_396	[p20l686t1343r884b1373],

1	J	NNP	O	J	nn	4	SENT_397	[p20l900t1333r921b1380],
2	Natl	NNP	O	Natl	nn	4	SENT_397	[p20l936t1329r1041b1374],
3	Cancer	NNP	O	Cancer	nn	4	SENT_397	[p20l7t1404r178b1445],
4	Inst	NNP	O	Inst	_	0	SENT_397	[p20l195t1405r292b1445],
5	2005	CD	DATE	2005	num	4	SENT_397	[p20l308t1404r696b1454],
6	;	:	O	;	_	0	SENT_397	[p20l308t1404r696b1454],
7	97:339	CD	NUMBER	97:339	number	8	SENT_397	[p20l308t1404r696b1454],
8	—	CD	NUMBER	—	dep	4	SENT_397	[p20l308t1404r696b1454],
9	46	CD	NUMBER	46	dep	8	SENT_397	[p20l308t1404r696b1454],
10	.	.	O	.	_	0	SENT_397	[p20l308t1404r696b1454],

1	7	CD	NUMBER	7	_	0	SENT_398	[p20l8t1479r41b1517],
2	.	.	O	.	_	0	SENT_398	[p20l8t1479r41b1517],

1	Kosaka	NNP	PERSON	Kosaka	nn	2	SENT_399	[p20l104t1473r283b1518],
2	T	NN	O	t	_	0	SENT_399	[p20l297t1477r340b1527],
3	,	,	O	,	_	0	SENT_399	[p20l297t1477r340b1527],
4	Yatabe	NNP	PERSON	Yatabe	nn	5	SENT_399	[p20l358t1473r519b1517],
5	Y	NN	PERSON	y	appos	2	SENT_399	[p20l533t1477r574b1526],
6	,	,	O	,	_	0	SENT_399	[p20l533t1477r574b1526],
7	Endoh	NN	PERSON	endoh	nn	8	SENT_399	[p20l593t1473r751b1517],
8	H	NN	PERSON	h	appos	2	SENT_399	[p20l766t1477r821b1526],
9	,	,	O	,	_	0	SENT_399	[p20l766t1477r821b1526],
10	Kuwano	NNP	PERSON	Kuwano	nn	11	SENT_399	[p20l840t1477r1040b1518],
11	H	NNP	O	H	appos	2	SENT_399	[p20l7t1548r61b1597],
12	,	,	O	,	_	0	SENT_399	[p20l7t1548r61b1597],
13	Takahashi	NNP	PERSON	Takahashi	nn	14	SENT_399	[p20l86t1544r342b1589],
14	T	NN	O	t	appos	2	SENT_399	[p20l362t1547r406b1597],
15	,	,	O	,	_	0	SENT_399	[p20l362t1547r406b1597],
16	Mitsudomi	NNP	O	Mitsudomi	nn	18	SENT_399	[p20l430t1544r701b1589],
17	T.	NNP	O	T.	nn	18	SENT_399	[p20l721t1547r765b1588],
18	Mutations	NNS	O	mutation	appos	2	SENT_399	[p20l789t1545r1039b1588],
19	of	IN	O	of	_	0	SENT_399	[p20l8t1615r65b1659],
20	the	DT	O	the	det	25	SENT_399	[p20l82t1615r158b1659],
21	epidermal	JJ	O	epidermal	amod	25	SENT_399	[p20l186t1615r434b1671],
22	growth	NN	O	growth	nn	25	SENT_399	[p20l461t1615r640b1672],
23	factor	NN	O	factor	nn	25	SENT_399	[p20l668t1615r812b1659],
24	receptor	NN	O	receptor	nn	25	SENT_399	[p20l838t1624r1042b1671],
25	gene	NN	O	gene	prep_of	18	SENT_399	[p20l7t1700r123b1743],
26	in	IN	O	in	_	0	SENT_399	[p20l141t1687r189b1730],
27	lung	NN	O	lung	nn	28	SENT_399	[p20l207t1686r320b1743],
28	cancer	NN	O	cancer	prep_in	25	SENT_399	[p20l337t1700r514b1730],
29	:	:	O	:	_	0	SENT_399	[p20l337t1700r514b1730],
30	biological	JJ	O	biological	dep	2	SENT_399	[p20l535t1686r783b1743],
31	and	CC	O	and	_	0	SENT_399	[p20l801t1686r892b1730],
32	clinical	JJ	O	clinical	amod	33	SENT_399	[p20l911t1686r1040b1730, p20l8t1757r78b1801],
33	implications	NNS	O	implication	conj_and	30	SENT_399	[p20l116t1757r445b1813],
34	.	.	O	.	_	0	SENT_399	[p20l116t1757r445b1813],

1	Cancer	NNP	O	Cancer	nn	2	SENT_400	[p20l486t1760r660b1801],
2	Res	NNP	O	Res	_	0	SENT_400	[p20l697t1761r784b1804],
3	2004	CD	DATE	2004	num	2	SENT_400	[p20l824t1760r1038b1810],
4	;	:	O	;	_	0	SENT_400	[p20l824t1760r1038b1810],
5	64	CD	NUMBER	64	num	7	SENT_400	[p20l824t1760r1038b1810],
6	:	:	O	:	_	0	SENT_400	[p20l824t1760r1038b1810],
7	8919-23	CD	NUMBER	8919-23	dep	2	SENT_400	[p20l8t1832r213b1873],
8	.	.	O	.	_	0	SENT_400	[p20l8t1832r213b1873],

1	8	CD	NUMBER	8	_	0	SENT_401	[p20l7t1904r46b1945],
2	.	.	O	.	_	0	SENT_401	[p20l7t1904r46b1945],

1	Yun	NNP	PERSON	Yun	nn	2	SENT_402	[p20l102t1904r194b1945],
2	CH	NN	O	ch	_	0	SENT_402	[p20l216t1903r305b1954],
3	,	,	O	,	_	0	SENT_402	[p20l216t1903r305b1954],
4	Boggon	NNP	PERSON	Boggon	nn	6	SENT_402	[p20l329t1904r517b1957],
5	T	NN	O	t	nn	6	SENT_402	[p20l537t1904r600b1953],
6	]	NN	O	]	appos	2	SENT_402	[p20l537t1904r600b1953],
7	,	,	O	,	_	0	SENT_402	[p20l537t1904r600b1953],
8	Li	NNP	PERSON	Li	nn	9	SENT_402	[p20l625t1901r669b1944],
9	Y	NN	PERSON	y	appos	2	SENT_402	[p20l689t1904r730b1954],
10	,	,	O	,	_	0	SENT_402	[p20l689t1904r730b1954],
11	et	FW	O	et	nn	12	SENT_402	[p20l755t1909r798b1944],
12	al.	FW	O	al.	appos	2	SENT_402	[p20l817t1900r872b1944],
13	.	.	O	.	_	0	SENT_402	[p20l817t1900r872b1944],

1	Structures	NNS	O	structure	_	0	SENT_403	[p20l898t1903r1040b1945, p20l8t1980r127b2016],
2	of	IN	O	of	_	0	SENT_403	[p20l143t1971r199b2015],
3	lung	NN	O	lung	prep_of	1	SENT_403	[p20l203t1971r311b2028],
4	cancer-derived	JJ	O	cancer-derived	amod	6	SENT_403	[p20l324t1971r676b2015],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_403	[p20l689t1974r833b2018],
6	mutants	NNS	O	mutant	dep	1	SENT_403	[p20l841t1980r1040b2016],
7	and	CC	O	and	_	0	SENT_403	[p20l7t2043r98b2087],
8	inhibitor	NN	O	inhibitor	nn	9	SENT_403	[p20l124t2043r348b2087],
9	complexes	NNS	O	complex	dep	1	SENT_403	[p20l373t2043r647b2099],
10	:	:	O	:	_	0	SENT_403	[p20l373t2043r647b2099],
11	mechanism	NN	O	mechanism	dep	1	SENT_403	[p20l676t2043r967b2087],
12	of	IN	O	of	_	0	SENT_403	[p20l993t2043r1051b2087],
13	activation	NN	O	activation	prep_of	11	SENT_403	[p20l7t2114r247b2158],
14	and	CC	O	and	_	0	SENT_403	[p20l279t2113r369b2157],
15	insights	NNS	O	insight	prep_of	11	SENT_403	[p20l402t2113r598b2170],
16	into	IN	O	into	_	0	SENT_403	[p20l632t2114r728b2157],
17	differential	JJ	O	differential	amod	19	SENT_403	[p20l762t2113r1041b2157],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_403	[p20l7t2184r223b2228],
19	sensitivity	NN	O	sensitivity	prep_into	11	SENT_403	[p20l248t2185r499b2240],
20	.	.	O	.	_	0	SENT_403	[p20l248t2185r499b2240],

1	Cancer	NN	O	cancer	nn	2	SENT_404	[p20l529t2187r696b2228],
2	Cell	NN	O	cell	_	0	SENT_404	[p20l721t2184r815b2228],
3	2007	CD	DATE	2007	dep	2	SENT_404	[p20l841t2187r1038b2237],
4	;	:	O	;	_	0	SENT_404	[p20l841t2187r1038b2237],
5	11	CD	NUMBER	11	num	7	SENT_404	[p20l841t2187r1038b2237],
6	:	:	O	:	_	0	SENT_404	[p20l841t2187r1038b2237],
7	217-27	CD	NUMBER	217-27	dep	2	SENT_404	[p20l7t2259r168b2300],
8	.	.	O	.	_	0	SENT_404	[p20l7t2259r168b2300],

1	9	CD	NUMBER	9	_	0	SENT_405	[p20l7t2332r45b2371],
2	.	.	O	.	_	0	SENT_405	[p20l7t2332r45b2371],

1	Politi	NNP	PERSON	Politi	nn	2	SENT_406	[p20l103t2327r233b2371],
2	K	NNP	PERSON	K	_	0	SENT_406	[p20l247t2331r297b2380],
3	,	,	O	,	_	0	SENT_406	[p20l247t2331r297b2380],
4	Zakowski	NNP	O	Zakowski	nn	5	SENT_406	[p20l314t2327r551b2372],
5	MF	NN	O	mf	appos	2	SENT_406	[p20l564t2331r653b2380],
6	,	,	O	,	_	0	SENT_406	[p20l564t2331r653b2380],
7	Fan	NN	O	fan	nn	8	SENT_406	[p20l671t2331r759b2371],
8	PD	NN	O	pd	appos	2	SENT_406	[p20l774t2331r854b2380],
9	,	,	O	,	_	0	SENT_406	[p20l774t2331r854b2380],
10	Schonfeld	NNP	ORGANIZATION	Schonfeld	nn	11	SENT_406	[p20l874t2327r1040b2371, p20l7t2397r98b2441],
11	EA	NN	ORGANIZATION	ea	appos	2	SENT_406	[p20l118t2401r199b2450],
12	,	,	O	,	_	0	SENT_406	[p20l118t2401r199b2450],
13	Pao	NNP	O	Pao	nn	14	SENT_406	[p20l223t2401r309b2441],
14	W	NNP	O	W	appos	2	SENT_406	[p20l328t2401r389b2451],
15	,	,	O	,	_	0	SENT_406	[p20l328t2401r389b2451],
16	Varmus	NNP	PERSON	Varmus	appos	2	SENT_406	[p20l411t2401r597b2442],
17	HE	PRP	O	he	dep	16	SENT_406	[p20l619t2401r707b2441],
18	.	.	O	.	_	0	SENT_406	[p20l619t2401r707b2441],

1	Lung	NN	O	lung	nn	2	SENT_407	[p20l730t2401r856b2454],
2	adenocarcinomas	NNS	O	adenocarcinoma	nsubj	15	SENT_407	[p20l874t2397r1040b2441, p20l8t2470r291b2513],
3	induced	VBN	O	induce	partmod	2	SENT_407	[p20l324t2469r518b2514],
4	in	IN	O	in	_	0	SENT_407	[p20l550t2470r598b2513],
5	mice	NNS	O	mouse	prep_in	3	SENT_407	[p20l630t2470r746b2513],
6	by	IN	O	by	_	0	SENT_407	[p20l779t2469r834b2525],
7	mutant	JJ	O	mutant	amod	9	SENT_407	[p20l864t2478r1043b2514],
8	EGF	NN	ORGANIZATION	egf	nn	9	SENT_407	[p20l7t2542r108b2583],
9	receptors	NNS	O	receptor	agent	3	SENT_407	[p20l130t2548r357b2595],
10	found	VBN	O	find	partmod	9	SENT_407	[p20l379t2539r523b2584],
11	in	IN	O	in	_	0	SENT_407	[p20l544t2540r591b2583],
12	human	JJ	O	human	amod	14	SENT_407	[p20l613t2539r786b2584],
13	lung	NN	O	lung	nn	14	SENT_407	[p20l806t2539r917b2596],
14	cancers	NNS	O	cancer	prep_in	10	SENT_407	[p20l936t2553r1040b2583, p20l8t2626r103b2655],
15	respond	VBP	O	respond	_	0	SENT_407	[p20l128t2611r326b2667],
16	to	TO	O	to	_	0	SENT_407	[p20l350t2620r397b2655],
17	a	DT	O	a	det	20	SENT_407	[p20l421t2626r446b2655],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_407	[p20l469t2612r668b2667],
19	kinase	NN	O	kinase	nn	20	SENT_407	[p20l692t2611r851b2656],
20	inhibitor	NN	O	inhibitor	prep_to	15	SENT_407	[p20l875t2611r1040b2655, p20l8t2691r78b2726],
21	or	CC	O	or	_	0	SENT_407	[p20l107t2696r157b2726],
22	to	TO	O	to	_	0	SENT_407	[p20l186t2691r232b2726],
23	down-regulation	NN	O	down-regulation	prep_to	15	SENT_407	[p20l263t2682r676b2739],
24	of	IN	O	of	_	0	SENT_407	[p20l706t2682r764b2726],
25	the	DT	O	the	det	26	SENT_407	[p20l784t2682r859b2726],
26	receptors	NNS	O	receptor	prep_of	23	SENT_407	[p20l890t2696r1040b2738, p20l8t2763r115b2798],
27	.	.	O	.	_	0	SENT_407	[p20l890t2696r1040b2738, p20l8t2763r115b2798],

1	Genes	NNS	O	gene	_	0	SENT_408	[p20l137t2757r288b2798],
2	Dev	JJ	O	dev	amod	1	SENT_408	[p20l308t2758r401b2799],
3	2006	CD	DATE	2006	tmod	2	SENT_408	[p20l419t2757r865b2807],
4	;	:	O	;	_	0	SENT_408	[p20l419t2757r865b2807],
5	20:1496	CD	NUMBER	20:1496	num	6	SENT_408	[p20l419t2757r865b2807],
6	—	NN	O	—	dep	1	SENT_408	[p20l419t2757r865b2807],
7	510	CD	NUMBER	510	dep	6	SENT_408	[p20l419t2757r865b2807],
8	.	.	O	.	_	0	SENT_408	[p20l419t2757r865b2807],

1	10	CD	NUMBER	10	_	0	SENT_409	[p20l9t2831r72b2870],
2	.	.	O	.	_	0	SENT_409	[p20l9t2831r72b2870],

1	Ji	NN	O	jus	nn	2	SENT_410	[p20l98t2827r135b2877],
2	H	NN	O	h	_	0	SENT_410	[p20l152t2830r206b2880],
3	,	,	O	,	_	0	SENT_410	[p20l152t2830r206b2880],
4	Li	NNP	PERSON	Li	nn	5	SENT_410	[p20l226t2827r272b2870],
5	D	NNP	PERSON	D	appos	2	SENT_410	[p20l288t2830r339b2880],
6	,	,	O	,	_	0	SENT_410	[p20l288t2830r339b2880],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_410	[p20l360t2826r485b2870],
8	L	NNP	PERSON	L	appos	2	SENT_410	[p20l502t2830r545b2880],
9	,	,	O	,	_	0	SENT_410	[p20l502t2830r545b2880],
10	et	FW	O	et	nn	11	SENT_410	[p20l566t2835r610b2870],
11	al.	FW	O	al.	appos	2	SENT_410	[p20l625t2826r681b2870],
12	.	.	O	.	_	0	SENT_410	[p20l625t2826r681b2870],

1	The	DT	O	the	det	2	SENT_411	[p20l700t2826r791b2870],
2	impact	NN	O	impact	_	0	SENT_411	[p20l809t2827r979b2882],
3	of	IN	O	of	_	0	SENT_411	[p20l994t2826r1051b2870],
4	human	JJ	O	human	amod	8	SENT_411	[p20l7t2897r181b2942],
5	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_411	[p20l211t2900r356b2944],
6	kinase	NN	O	kinase	nn	8	SENT_411	[p20l381t2897r540b2942],
7	domain	NN	O	domain	nn	8	SENT_411	[p20l571t2897r760b2941],
8	mutations	NNS	O	mutation	prep_of	2	SENT_411	[p20l790t2898r1040b2942],
9	on	IN	O	on	_	0	SENT_411	[p20l8t2982r68b3012],
10	lung	NN	O	lung	nn	11	SENT_411	[p20l91t2968r201b3025],
11	tumorigenesis	NN	O	tumorigenesis	prep_on	8	SENT_411	[p20l223t2969r573b3025],
12	and	CC	O	and	_	0	SENT_411	[p20l597t2968r687b3012],
13	in	IN	O	in	_	0	SENT_411	[p20l710t2969r758b3012],
14	Vivo	NNP	LOCATION	Vivo	nn	15	SENT_411	[p20l778t2969r875b3013],
15	sensitivity	NN	O	sensitivity	prep_in	8	SENT_411	[p20l900t2969r1040b3012, p20l8t3040r132b3095],
16	to	TO	O	to	_	0	SENT_411	[p20l152t3048r199b3083],
17	EGFR-targeted	JJ	O	egfr-targeted	amod	18	SENT_411	[p20l222t3039r584b3096],
18	therapies	NNS	O	therapy	prep_to	2	SENT_411	[p20l607t3039r845b3095],
19	.	.	O	.	_	0	SENT_411	[p20l607t3039r845b3095],

1	Cancer	NN	O	cancer	nn	2	SENT_412	[p20l871t3042r1042b3083],
2	Cell	NN	O	cell	_	0	SENT_412	[p20l7t3111r102b3155],
3	2006	CD	DATE	2006	dep	2	SENT_412	[p20l121t3114r482b3164],
4	;	:	O	;	_	0	SENT_412	[p20l121t3114r482b3164],
5	9:485	CD	NUMBER	9:485	num	6	SENT_412	[p20l121t3114r482b3164],
6	-95	CD	NUMBER	-95	dep	2	SENT_412	[p20l121t3114r482b3164],
7	.	.	O	.	_	0	SENT_412	[p20l121t3114r482b3164],

1	11	CD	NUMBER	11	_	0	SENT_413	[p20l1118t1335r1181b1373],
2	.	.	O	.	_	0	SENT_413	[p20l1118t1335r1181b1373],

1	Greulich	NN	PERSON	greulich	nn	2	SENT_414	[p20l1213t1329r1426b1374],
2	H	NN	PERSON	h	_	0	SENT_414	[p20l1450t1333r1505b1383],
3	,	,	O	,	_	0	SENT_414	[p20l1450t1333r1505b1383],
4	Chen	NNP	PERSON	Chen	nn	5	SENT_414	[p20l1532t1329r1657b1373],
5	TH	NN	O	th	appos	2	SENT_414	[p20l1680t1332r1770b1383],
6	,	,	O	,	_	0	SENT_414	[p20l1680t1332r1770b1383],
7	Feng	NNP	O	Feng	nn	8	SENT_414	[p20l1797t1333r1916b1386],
8	W	NNP	O	W	appos	2	SENT_414	[p20l1936t1333r1998b1383],
9	,	,	O	,	_	0	SENT_414	[p20l1936t1333r1998b1383],
10	et	FW	O	et	nn	11	SENT_414	[p20l2025t1338r2069b1373],
11	al.	FW	O	al.	appos	2	SENT_414	[p20l2091t1329r2146b1373],
12	.	.	O	.	_	0	SENT_414	[p20l2091t1329r2146b1373],

1	Oncogenic	JJ	O	oncogenic	amod	2	SENT_415	[p20l1116t1402r1379b1458],
2	transformation	NN	O	transformation	_	0	SENT_415	[p20l1414t1401r1791b1445],
3	by	IN	O	by	_	0	SENT_415	[p20l1826t1401r1881b1457],
4	inhibitorsensitive	JJ	O	inhibitorsensitive	prep_by	2	SENT_415	[p20l1913t1401r2149b1445, p20l1117t1474r1326b1517],
5	and	CC	O	and	cc	2	SENT_415	[p20l1362t1473r1452b1517],
6	-	:	O	-	_	0	SENT_415	[p20l1489t1474r1721b1517],
7	resistant	JJ	O	resistant	amod	9	SENT_415	[p20l1489t1474r1721b1517],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_415	[p20l1754t1476r1899b1520],
9	mutants	NNS	O	mutant	dep	2	SENT_415	[p20l1930t1482r2146b1517],
10	.	.	O	.	_	0	SENT_415	[p20l1930t1482r2146b1517],

1	PLoS	NNP	O	PLoS	nn	2	SENT_416	[p20l1115t1547r1233b1588],
2	Med	NNP	O	Med	_	0	SENT_416	[p20l1253t1544r1359b1588],
3	2005	CD	DATE	2005	num	2	SENT_416	[p20l1378t1547r1779b1597],
4	;	:	O	;	_	0	SENT_416	[p20l1378t1547r1779b1597],
5	2	CD	NUMBER	2	number	6	SENT_416	[p20l1378t1547r1779b1597],
6	(	CD	NUMBER	(	dep	2	SENT_416	[p20l1378t1547r1779b1597],
7	11	CD	NUMBER	11	num	8	SENT_416	[p20l1378t1547r1779b1597],
8	)	NN	O	)	dep	6	SENT_416	[p20l1378t1547r1779b1597],
9	:	:	O	:	_	0	SENT_416	[p20l1378t1547r1779b1597],
10	e313	NN	O	e313	dep	6	SENT_416	[p20l1378t1547r1779b1597],
11	.	.	O	.	_	0	SENT_416	[p20l1378t1547r1779b1597],

1	12	CD	NUMBER	12	_	0	SENT_417	[p20l1118t1621r1183b1659],
2	.	.	O	.	_	0	SENT_417	[p20l1118t1621r1183b1659],

1	Jiang	NNP	PERSON	Jiang	nn	2	SENT_418	[p20l1207t1616r1338b1672],
2	J	NNP	PERSON	J	_	0	SENT_418	[p20l1353t1619r1386b1669],
3	,	,	O	,	_	0	SENT_418	[p20l1353t1619r1386b1669],
4	Greulich	NNP	PERSON	Greulich	nn	5	SENT_418	[p20l1412t1615r1625b1660],
5	H	NNP	PERSON	H	appos	2	SENT_418	[p20l1648t1619r1702b1668],
6	,	,	O	,	_	0	SENT_418	[p20l1648t1619r1702b1668],
7	Jéinne	NNP	ORGANIZATION	Jéinne	nn	8	SENT_418	[p20l1723t1619r1864b1666],
8	PA	NN	ORGANIZATION	pa	appos	5	SENT_418	[p20l1886t1619r1962b1669],
9	,	,	O	,	_	0	SENT_418	[p20l1886t1619r1962b1669],
10	Sellers	NNPS	O	Sellers	nn	11	SENT_418	[p20l1990t1615r2148b1659],
11	WR	NNP	O	WR	appos	5	SENT_418	[p20l1114t1690r1220b1740],
12	,	,	O	,	_	0	SENT_418	[p20l1114t1690r1220b1740],
13	Meyerson	NNP	PERSON	Meyerson	nn	14	SENT_418	[p20l1247t1690r1484b1742],
14	M	NNP	O	M	appos	5	SENT_418	[p20l1508t1690r1570b1739],
15	,	,	O	,	_	0	SENT_418	[p20l1508t1690r1570b1739],
16	Griffin	NNP	PERSON	Griffin	nn	17	SENT_418	[p20l1599t1686r1774b1730],
17	JD	NNP	O	JD	appos	5	SENT_418	[p20l1794t1690r1868b1737],
18	.	.	O	.	_	0	SENT_418	[p20l1794t1690r1868b1737],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_419	[p20l1896t1686r2150b1742],
2	growth	NN	O	growth	nn	4	SENT_419	[p20l1116t1757r1293b1814],
3	factor-independent	JJ	O	factor-independent	amod	4	SENT_419	[p20l1306t1757r1767b1813],
4	transformation	NN	O	transformation	nsubj	15	SENT_419	[p20l1779t1757r2150b1801],
5	of	IN	O	of	_	0	SENT_419	[p20l1116t1829r1174b1873],
6	BalF3	NN	O	balf3	nn	7	SENT_419	[p20l1183t1832r1318b1879],
7	cells	NNS	O	cell	prep_of	4	SENT_419	[p20l1341t1829r1449b1873],
8	with	IN	O	with	_	0	SENT_419	[p20l1468t1829r1579b1874],
9	cancer-derived	JJ	O	cancer-derived	amod	14	SENT_419	[p20l1600t1829r1959b1873],
10	epidermal	JJ	O	epidermal	amod	14	SENT_419	[p20l1980t1829r2149b1885, p20l1116t1900r1209b1944],
11	growth	NN	O	growth	nn	14	SENT_419	[p20l1238t1900r1418b1957],
12	factor	NN	O	factor	nn	14	SENT_419	[p20l1447t1900r1591b1944],
13	receptor	NN	O	receptor	nn	14	SENT_419	[p20l1619t1909r1823b1956],
14	mutants	NNS	O	mutant	prep_with	7	SENT_419	[p20l1851t1909r2053b1945],
15	induces	VBZ	O	induce	_	0	SENT_419	[p20l2083t1901r2149b1944, p20l1116t1971r1250b2016],
16	gefitinib-sensitive	JJ	O	gefitinib-sensitive	amod	19	SENT_419	[p20l1266t1971r1703b2028],
17	cell	NN	O	cell	nn	19	SENT_419	[p20l1718t1971r1800b2015],
18	cycle	NN	O	cycle	nn	19	SENT_419	[p20l1815t1971r1929b2027],
19	progression	NN	O	progression	dobj	15	SENT_419	[p20l1943t1985r2149b2028, p20l1117t2044r1231b2087],
20	.	.	O	.	_	0	SENT_419	[p20l1943t1985r2149b2028, p20l1117t2044r1231b2087],

1	Cancer	NNP	O	Cancer	nn	2	SENT_420	[p20l1253t2046r1424b2087],
2	Res	NNP	O	Res	_	0	SENT_420	[p20l1441t2047r1527b2090],
3	2005	CD	DATE	2005	num	2	SENT_420	[p20l1548t2046r1961b2096],
4	;	:	O	;	_	0	SENT_420	[p20l1548t2046r1961b2096],
5	65:8968	CD	NUMBER	65:8968	number	6	SENT_420	[p20l1548t2046r1961b2096],
6	-74	CD	NUMBER	-74	dep	2	SENT_420	[p20l1548t2046r1961b2096],
7	.	.	O	.	_	0	SENT_420	[p20l1548t2046r1961b2096],

1	13	CD	NUMBER	13	_	0	SENT_421	[p20l1118t2118r1181b2157],
2	.	.	O	.	_	0	SENT_421	[p20l1118t2118r1181b2157],

1	Carey	NNP	PERSON	Carey	nn	2	SENT_422	[p20l1213t2116r1351b2169],
2	KD	NN	O	kd	_	0	SENT_422	[p20l1372t2117r1462b2167],
3	,	,	O	,	_	0	SENT_422	[p20l1372t2117r1462b2167],
4	Garton	NNP	PERSON	Garton	nn	6	SENT_422	[p20l1488t2116r1663b2157],
5	A	NNP	O	A	nn	6	SENT_422	[p20l1684t2117r1750b2167],
6	]	NN	O	]	appos	2	SENT_422	[p20l1684t2117r1750b2167],
7	,	,	O	,	_	0	SENT_422	[p20l1684t2117r1750b2167],
8	Romero	NNP	PERSON	Romero	nn	9	SENT_422	[p20l1775t2117r1970b2160],
9	MS	NN	O	m	appos	2	SENT_422	[p20l1992t2116r2082b2167],
10	,	,	O	,	_	0	SENT_422	[p20l1992t2116r2082b2167],
11	et	FW	O	et	nn	12	SENT_422	[p20l2108t2122r2152b2157],
12	al.	FW	O	al.	appos	2	SENT_422	[p20l1116t2184r1172b2228],
13	.	.	O	.	_	0	SENT_422	[p20l1116t2184r1172b2228],

1	Kinetic	JJ	O	kinetic	amod	2	SENT_423	[p20l1200t2185r1377b2229],
2	analysis	NN	O	analysis	nsubj	11	SENT_423	[p20l1402t2184r1597b2240],
3	of	IN	O	of	_	0	SENT_423	[p20l1624t2184r1681b2228],
4	epidermal	JJ	O	epidermal	amod	7	SENT_423	[p20l1697t2184r1945b2240],
5	growth	NN	O	growth	nn	7	SENT_423	[p20l1970t2184r2149b2241],
6	factor	NN	O	factor	nn	7	SENT_423	[p20l1116t2256r1260b2300],
7	receptor	NN	O	receptor	prep_of	2	SENT_423	[p20l1287t2265r1491b2312],
8	somatic	JJ	O	somatic	amod	10	SENT_423	[p20l1520t2257r1712b2300],
9	mutant	JJ	O	mutant	amod	10	SENT_423	[p20l1741t2265r1920b2301],
10	proteins	NNS	O	protein	dep	7	SENT_423	[p20l1945t2257r2148b2312],
11	shows	VBZ	O	show	_	0	SENT_423	[p20l1117t2327r1268b2372],
12	increased	VBN	O	increase	amod	13	SENT_423	[p20l1290t2327r1524b2371],
13	sensitivity	NN	O	sensitivity	dobj	11	SENT_423	[p20l1546t2328r1795b2383],
14	to	TO	O	to	_	0	SENT_423	[p20l1814t2336r1861b2371],
15	the	DT	O	the	det	22	SENT_423	[p20l1883t2327r1958b2371],
16	epidermal	JJ	O	epidermal	amod	22	SENT_423	[p20l1980t2327r2149b2383, p20l1116t2397r1208b2441],
17	growth	NN	O	growth	nn	22	SENT_423	[p20l1222t2397r1399b2454],
18	factor	NN	O	factor	nn	22	SENT_423	[p20l1414t2397r1555b2441],
19	receptor	NN	O	receptor	nn	22	SENT_423	[p20l1568t2406r1768b2453],
20	tyrosine	NN	O	tyrosine	nn	22	SENT_423	[p20l1781t2398r1976b2453],
21	kinase	NN	O	kinase	nn	22	SENT_423	[p20l1991t2397r2149b2442],
22	inhibitor	NN	O	inhibitor	prep_to	11	SENT_423	[p20l1116t2469r1346b2522],
23	,	,	O	,	_	0	SENT_423	[p20l1116t2469r1346b2522],
24	erlotinib	NN	O	erlotinib	appos	22	SENT_423	[p20l1376t2469r1600b2513],
25	.	.	O	.	_	0	SENT_423	[p20l1376t2469r1600b2513],

1	Cancer	NN	O	cancer	_	0	SENT_424	[p20l1629t2472r1800b2513],
2	Res	NNP	O	Res	dep	1	SENT_424	[p20l1824t2473r1910b2516],
3	2006	CD	DATE	2006	num	2	SENT_424	[p20l1937t2472r2147b2522],
4	;	:	O	;	_	0	SENT_424	[p20l1937t2472r2147b2522],
5	66	CD	NUMBER	66	num	7	SENT_424	[p20l1937t2472r2147b2522],
6	:	:	O	:	_	0	SENT_424	[p20l1937t2472r2147b2522],
7	8163-71	CD	NUMBER	8163-71	dep	1	SENT_424	[p20l1116t2542r1318b2583],
8	.	.	O	.	_	0	SENT_424	[p20l1116t2542r1318b2583],

1	14	CD	NUMBER	14	_	0	SENT_425	[p20l1118t2617r1182b2655],
2	.	.	O	.	_	0	SENT_425	[p20l1118t2617r1182b2655],

1	Mitsudomi	JJ	ORGANIZATION	mitsudomi	amod	2	SENT_426	[p20l1211t2611r1481b2656],
2	T	NN	ORGANIZATION	t	_	0	SENT_426	[p20l1503t2615r1546b2664],
3	,	,	O	,	_	0	SENT_426	[p20l1503t2615r1546b2664],
4	Kosaka	NNP	PERSON	Kosaka	nn	5	SENT_426	[p20l1573t2611r1753b2656],
5	T	NN	PERSON	t	appos	2	SENT_426	[p20l1775t2614r1818b2665],
6	,	,	O	,	_	0	SENT_426	[p20l1775t2614r1818b2665],
7	Endoh	NN	PERSON	endoh	nn	8	SENT_426	[p20l1845t2611r2003b2655],
8	H	NN	O	h	appos	2	SENT_426	[p20l2026t2615r2081b2665],
9	,	,	O	,	_	0	SENT_426	[p20l2026t2615r2081b2665],
10	et	FW	O	et	nn	11	SENT_426	[p20l2108t2620r2152b2655],
11	al.	FW	O	al.	appos	2	SENT_426	[p20l1116t2682r1172b2726],
12	.	.	O	.	_	0	SENT_426	[p20l1116t2682r1172b2726],

1	Mutations	NNS	O	mutation	nsubj	9	SENT_427	[p20l1208t2683r1458b2727],
2	of	IN	O	of	_	0	SENT_427	[p20l1495t2682r1552b2726],
3	the	DT	O	the	det	8	SENT_427	[p20l1577t2682r1652b2726],
4	epidermal	JJ	O	epidermal	amod	8	SENT_427	[p20l1688t2682r1935b2738],
5	growth	NN	O	growth	nn	8	SENT_427	[p20l1970t2682r2149b2739],
6	factor	NN	O	factor	nn	8	SENT_427	[p20l1116t2754r1260b2798],
7	receptor	NN	O	receptor	nn	8	SENT_427	[p20l1297t2763r1501b2810],
8	gene	NN	O	gene	prep_of	1	SENT_427	[p20l1538t2768r1651b2811],
9	predict	VBP	O	predict	_	0	SENT_427	[p20l1689t2754r1864b2810],
10	prolonged	JJ	O	prolonged	amod	11	SENT_427	[p20l1898t2754r2150b2811],
11	survival	NN	O	survival	dobj	9	SENT_427	[p20l1117t2826r1308b2871],
12	after	IN	O	after	_	0	SENT_427	[p20l1337t2826r1453b2870],
13	gefitinib	NN	O	gefitinib	nn	14	SENT_427	[p20l1482t2826r1695b2883],
14	treatment	NN	O	treatment	prep_after	9	SENT_427	[p20l1726t2835r1969b2870],
15	in	IN	O	in	_	0	SENT_427	[p20l1997t2827r2044b2870],
16	patients	NNS	O	patient	prep_in	14	SENT_427	[p20l2074t2840r2149b2882, p20l1116t2898r1252b2941],
17	with	IN	O	with	_	0	SENT_427	[p20l1292t2897r1403b2942],
18	non-small-cell	JJ	O	non-small-cell	amod	20	SENT_427	[p20l1444t2897r1800b2941],
19	lung	NN	O	lung	nn	20	SENT_427	[p20l1840t2897r1951b2954],
20	cancer	NN	O	cancer	prep_with	16	SENT_427	[p20l1990t2911r2151b2941],
21	with	IN	O	with	_	0	SENT_427	[p20l1114t2968r1225b3013],
22	postoperative	JJ	O	postoperative	amod	23	SENT_427	[p20l1246t2969r1579b3024],
23	recurrence	NN	O	recurrence	prep_with	20	SENT_427	[p20l1600t2982r1875b3013],
24	.	.	O	.	_	0	SENT_427	[p20l1600t2982r1875b3013],

1	J	NNP	O	J	nn	3	SENT_428	[p20l1894t2972r1916b3019],
2	Clin	NNP	O	Clin	nn	3	SENT_428	[p20l1936t2968r2037b3012],
3	Oncol	NNP	O	Oncol	_	0	SENT_428	[p20l2058t2971r2149b3012, p20l1116t3039r1187b3083],
4	2005	CD	DATE	2005	num	3	SENT_428	[p20l1206t3042r1622b3092],
5	;	:	O	;	_	0	SENT_428	[p20l1206t3042r1622b3092],
6	23:2513	CD	NUMBER	23:2513	number	7	SENT_428	[p20l1206t3042r1622b3092],
7	-20	CD	NUMBER	-20	dep	3	SENT_428	[p20l1206t3042r1622b3092],
8	.	.	O	.	_	0	SENT_428	[p20l1206t3042r1622b3092],

1	15	CD	NUMBER	15	_	0	SENT_429	[p20l1118t3117r1181b3155],
2	.	.	O	.	_	0	SENT_429	[p20l1118t3117r1181b3155],

1	Riely	NNP	O	Riely	nn	2	SENT_430	[p20l1212t3111r1335b3167],
2	GJ	NNP	O	GJ	_	0	SENT_430	[p20l1353t3114r1422b3165],
3	,	,	O	,	_	0	SENT_430	[p20l1353t3114r1422b3165],
4	Pao	NNP	O	Pao	nn	5	SENT_430	[p20l1445t3115r1531b3155],
5	W	NNP	O	W	appos	2	SENT_430	[p20l1551t3115r1612b3165],
6	,	,	O	,	_	0	SENT_430	[p20l1551t3115r1612b3165],
7	Pham	NNP	PERSON	Pham	nn	8	SENT_430	[p20l1635t3111r1775b3155],
8	D	NNP	PERSON	D	appos	2	SENT_430	[p20l1795t3115r1845b3164],
9	,	,	O	,	_	0	SENT_430	[p20l1795t3115r1845b3164],
10	et	FW	O	et	nn	11	SENT_430	[p20l1870t3120r1914b3155],
11	al.	FW	O	al.	appos	2	SENT_430	[p20l1932t3111r1987b3155],
12	.	.	O	.	_	0	SENT_430	[p20l1932t3111r1987b3155],

1	Clini966	NN	O	clini966	_	0	SENT_431	[p20l2012t3111r2149b3155, p20l149t3242r206b3266],

1	NENGLjMED361	NN	O	nengljmed361	_	0	SENT_432	[p20l931t3247r1192b3275],
2	;	:	O	;	_	0	SENT_432	[p20l931t3247r1192b3275],
3	1O	NN	O	1o	nn	5	SENT_432	[p20l931t3247r1192b3275],
4	NEjM.ORG	NN	O	nejm.org	nn	5	SENT_432	[p20l1227t3253r1351b3275],
5	SEPTEMBER3	NN	O	september3	dep	1	SENT_432	[p20l1386t3253r1628b3275],
6	,2009	CD	NUMBER	,2009	dep	5	SENT_432	[p20l1386t3253r1628b3275],

1	The	DT	O	the	det	4	SENT_433	[p20l936t3286r987b3310],
2	New	NNP	O	New	nn	4	SENT_433	[p20l996t3287r1058b3310],
3	England	NNP	O	England	nn	4	SENT_433	[p20l1067t3286r1178b3317],
4	Joumal	NNP	O	Joumal	_	0	SENT_433	[p20l1187t3286r1284b3310],
5	of	IN	O	of	_	0	SENT_433	[p20l1294t3286r1323b3310],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_433	[p20l1330t3286r1455b3310],

1	SCREENING	NN	O	screening	_	0	SENT_434	[p20l643t3474r839b3493],
2	FOR	IN	O	for	dep	1	SENT_434	[p20l853t3474r917b3493],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_434	[p20l929t3474r1000b3493],
4	MUTATIONS	NNS	O	mutation	pobj	2	SENT_434	[p20l1013t3474r1208b3493],
5	IN	IN	O	in	dep	1	SENT_434	[p20l1223t3474r1261b3493],
6	LUNG	NN	O	lung	nn	7	SENT_434	[p20l1277t3474r1368b3493],
7	CANCER	NNP	O	CANCER	pobj	5	SENT_434	[p20l1382t3474r1516b3493],

1	cal	JJ	O	cal	amod	2	SENT_435	[p21l9t78r76b121],
2	course	NN	O	course	nsubj	21	SENT_435	[p21l96t92r253b122],
3	of	IN	O	of	_	0	SENT_435	[p21l273t78r329b121],
4	patients	NNS	O	patient	prep_of	2	SENT_435	[p21l338t79r530b133],
5	with	IN	O	with	_	0	SENT_435	[p21l548t78r658b122],
6	non-small	JJ	O	non-small	amod	9	SENT_435	[p21l677t78r923b121],
7	cell	NN	O	cell	nn	9	SENT_435	[p21l943t78r1025b121],
8	lung	NN	O	lung	nn	9	SENT_435	[p21l8t148r116b204],
9	cancer	NN	O	cancer	prep_with	4	SENT_435	[p21l136t162r294b191],
10	and	CC	O	and	_	0	SENT_435	[p21l313t148r402b191],
11	epidermal	JJ	O	epidermal	amod	14	SENT_435	[p21l423t148r666b203],
12	growth	NN	O	growth	nn	14	SENT_435	[p21l687t148r864b204],
13	factor	NN	O	factor	nn	14	SENT_435	[p21l885t148r1026b191],
14	receptor	NN	O	receptor	conj_and	4	SENT_435	[p21l8t227r209b273],
15	exon	NN	O	exon	num	20	SENT_435	[p21l232t232r345b262],
16	19	CD	NUMBER	19	num	15	SENT_435	[p21l371t221r424b261],
17	and	CC	O	and	_	0	SENT_435	[p21l449t218r537b261],
18	exon	NN	O	exon	num	20	SENT_435	[p21l562t232r674b262],
19	21	CD	NUMBER	21	num	18	SENT_435	[p21l699t221r754b261],
20	mutations	NNS	O	mutation	dep	14	SENT_435	[p21l779t219r1023b262],
21	treated	VBN	O	treat	_	0	SENT_435	[p21l9t288r177b331],
22	with	IN	O	with	_	0	SENT_435	[p21l206t288r315b332],
23	gefitinib	NN	O	gefitinib	prep_with	21	SENT_435	[p21l347t288r557b344],
24	or	CC	O	or	_	0	SENT_435	[p21l590t302r640b331],
25	erlotinib	NN	O	erlotinib	prep_with	21	SENT_435	[p21l670t288r890b331],
26	.	.	O	.	_	0	SENT_435	[p21l670t288r890b331],

1	Clin	NNP	O	Clin	nn	3	SENT_436	[p21l925t288r1025b332],
2	Cancer	NNP	O	Cancer	nn	3	SENT_436	[p21l8t361r176b401],
3	Res	NNP	O	Res	_	0	SENT_436	[p21l193t362r277b404],
4	2006	CD	DATE	2006	num	3	SENT_436	[p21l297t361r686b410],
5	;	:	O	;	_	0	SENT_436	[p21l297t361r686b410],
6	12:839	CD	NUMBER	12:839	number	7	SENT_436	[p21l297t361r686b410],
7	—	CD	NUMBER	—	dep	3	SENT_436	[p21l297t361r686b410],
8	44	CD	NUMBER	44	dep	7	SENT_436	[p21l297t361r686b410],
9	.	.	O	.	_	0	SENT_436	[p21l297t361r686b410],

1	16	CD	NUMBER	16	_	0	SENT_437	[p21l10t433r73b471],
2	.	.	O	.	_	0	SENT_437	[p21l10t433r73b471],

1	Jackman	NNP	PERSON	Jackman	nn	2	SENT_438	[p21l98t428r311b478],
2	DM	NN	O	dm	_	0	SENT_438	[p21l334t432r433b481],
3	,	,	O	,	_	0	SENT_438	[p21l334t432r433b481],
4	Yeap	NNP	PERSON	Yeap	nn	5	SENT_438	[p21l458t432r569b483],
5	BY	NNP	O	BY	appos	2	SENT_438	[p21l593t432r665b481],
6	,	,	O	,	_	0	SENT_438	[p21l593t432r665b481],
7	Sequist	NNP	O	Sequist	nn	8	SENT_438	[p21l693t429r869b483],
8	LV	NNP	O	LV	appos	2	SENT_438	[p21l890t432r956b481],
9	,	,	O	,	_	0	SENT_438	[p21l890t432r956b481],
10	et	FW	O	et	nn	11	SENT_438	[p21l984t437r1027b471],
11	al.	FW	O	al.	appos	2	SENT_438	[p21l8t498r63b541],
12	.	.	O	.	_	0	SENT_438	[p21l8t498r63b541],

1	Exon	NN	O	exon	nsubjpass	11	SENT_439	[p21l87t502r206b541],
2	19	CD	NUMBER	19	num	4	SENT_439	[p21l230t501r283b541],
3	deletion	NN	O	deletion	nn	4	SENT_439	[p21l306t498r501b541],
4	mutations	NNS	O	mutation	dep	1	SENT_439	[p21l522t499r767b542],
5	of	IN	O	of	_	0	SENT_439	[p21l790t498r846b541],
6	epidermal	JJ	O	epidermal	amod	9	SENT_439	[p21l858t498r1024b553, p21l8t568r99b611],
7	growth	NN	O	growth	nn	9	SENT_439	[p21l117t568r293b624],
8	factor	NN	O	factor	nn	9	SENT_439	[p21l310t568r452b611],
9	receptor	NN	O	receptor	prep_of	1	SENT_439	[p21l468t577r668b623],
10	are	VBP	O	be	auxpass	11	SENT_439	[p21l684t582r756b611],
11	associated	VBN	O	associate	_	0	SENT_439	[p21l774t568r1025b611],
12	with	IN	O	with	_	0	SENT_439	[p21l6t638r115b682],
13	prolonged	JJ	O	prolonged	amod	14	SENT_439	[p21l135t638r382b694],
14	survival	NN	O	survival	prep_with	11	SENT_439	[p21l403t638r590b682],
15	in	IN	O	in	_	0	SENT_439	[p21l610t639r656b681],
16	non-small	JJ	O	non-small	amod	20	SENT_439	[p21l676t638r922b682],
17	cell	NN	O	cell	nn	20	SENT_439	[p21l943t638r1025b681],
18	lung	NN	O	lung	nn	20	SENT_439	[p21l8t708r116b764],
19	cancer	NN	O	cancer	nn	20	SENT_439	[p21l149t722r308b751],
20	patients	NNS	O	patient	prep_in	11	SENT_439	[p21l340t709r532b763],
21	treated	VBN	O	treat	partmod	20	SENT_439	[p21l568t708r737b751],
22	with	IN	O	with	_	0	SENT_439	[p21l769t708r878b752],
23	gefitinib	NN	O	gefitinib	prep_with	21	SENT_439	[p21l913t708r1024b764, p21l9t778r122b821],
24	or	CC	O	or	_	0	SENT_439	[p21l147t792r197b821],
25	erlotinib	NN	O	erlotinib	prep_with	21	SENT_439	[p21l220t778r441b821],
26	.	.	O	.	_	0	SENT_439	[p21l220t778r441b821],

1	Clin	NNP	O	Clin	nn	3	SENT_440	[p21l468t778r568b821],
2	Cancer	NNP	O	Cancer	nn	3	SENT_440	[p21l592t781r760b821],
3	Res	NNP	O	Res	_	0	SENT_440	[p21l781t782r866b824],
4	2006	CD	DATE	2006	num	3	SENT_440	[p21l891t781r1022b830],
5	;	:	O	;	_	0	SENT_440	[p21l891t781r1022b830],
6	12:3908	CD	NUMBER	12:3908	number	7	SENT_440	[p21l10t851r283b892],
7	-14	CD	NUMBER	-14	dep	3	SENT_440	[p21l10t851r283b892],
8	.	.	O	.	_	0	SENT_440	[p21l10t851r283b892],

1	17	CD	NUMBER	17	_	0	SENT_441	[p21l10t923r68b961],
2	.	.	O	.	_	0	SENT_441	[p21l10t923r68b961],

1	Taron	NNP	PERSON	Taron	nn	2	SENT_442	[p21l101t921r244b961],
2	M	NNP	PERSON	M	_	0	SENT_442	[p21l267t922r328b971],
3	,	,	O	,	_	0	SENT_442	[p21l267t922r328b971],
4	Ichinose	NNP	PERSON	Ichinose	nn	5	SENT_442	[p21l355t918r560b961],
5	Y	NN	PERSON	y	appos	2	SENT_442	[p21l583t922r624b971],
6	,	,	O	,	_	0	SENT_442	[p21l583t922r624b971],
7	Rosell	NNP	PERSON	Rosell	nn	8	SENT_442	[p21l651t918r801b964],
8	R	NNP	PERSON	R	appos	2	SENT_442	[p21l825t922r873b971],
9	,	,	O	,	_	0	SENT_442	[p21l825t922r873b971],
10	et	FW	O	et	nn	11	SENT_442	[p21l902t927r945b961],
11	al.	FW	O	al.	appos	2	SENT_442	[p21l967t918r1022b961],
12	.	.	O	.	_	0	SENT_442	[p21l967t918r1022b961],

1	Activating	VBG	O	activate	amod	2	SENT_443	[p21l6t989r256b1044],
2	mutations	NNS	O	mutation	nsubjpass	15	SENT_443	[p21l283t989r527b1032],
3	in	IN	O	in	_	0	SENT_443	[p21l557t989r604b1031],
4	the	DT	O	the	det	7	SENT_443	[p21l633t988r708b1031],
5	tyrosine	NN	O	tyrosine	nn	7	SENT_443	[p21l737t989r932b1043],
6	kinase	NN	O	kinase	nn	7	SENT_443	[p21l961t988r1024b1032, p21l8t1072r116b1101],
7	domain	NN	O	domain	prep_in	2	SENT_443	[p21l133t1058r318b1101],
8	of	IN	O	of	_	0	SENT_443	[p21l334t1058r390b1101],
9	the	DT	O	the	det	13	SENT_443	[p21l396t1058r470b1101],
10	epidermal	JJ	O	epidermal	amod	13	SENT_443	[p21l486t1058r730b1113],
11	growth	NN	O	growth	nn	13	SENT_443	[p21l745t1058r921b1114],
12	factor	NN	O	factor	nn	13	SENT_443	[p21l937t1058r1024b1101, p21l9t1137r77b1171],
13	receptor	NN	O	receptor	prep_of	7	SENT_443	[p21l94t1137r295b1183],
14	are	VBP	O	be	auxpass	15	SENT_443	[p21l312t1142r384b1171],
15	associated	VBN	O	associate	_	0	SENT_443	[p21l402t1128r654b1171],
16	with	IN	O	with	_	0	SENT_443	[p21l670t1128r779b1172],
17	improved	JJ	O	improved	amod	18	SENT_443	[p21l797t1128r1025b1183],
18	survival	NN	O	survival	prep_with	15	SENT_443	[p21l9t1198r196b1242],
19	in	IN	O	in	_	0	SENT_443	[p21l215t1199r262b1241],
20	gefitinib-treated	JJ	O	gefitinib-treated	amod	23	SENT_443	[p21l282t1198r684b1254],
21	chemorefractory	JJ	O	chemorefractory	amod	23	SENT_443	[p21l704t1198r1024b1241, p21l9t1277r105b1323],
22	lung	NN	O	lung	nn	23	SENT_443	[p21l129t1268r238b1324],
23	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	18	SENT_443	[p21l262t1268r702b1312],
24	.	.	O	.	_	0	SENT_443	[p21l262t1268r702b1312],

1	Clin	NNP	O	Clin	nn	3	SENT_444	[p21l732t1268r831b1312],
2	Cancer	NNP	O	Cancer	nn	3	SENT_444	[p21l858t1271r1026b1311],
3	Res	NNP	O	Res	_	0	SENT_444	[p21l8t1342r92b1384],
4	2005	CD	DATE	2005	num	3	SENT_444	[p21l112t1341r521b1390],
5	;	:	O	;	_	0	SENT_444	[p21l112t1341r521b1390],
6	11:5878	CD	NUMBER	11:5878	number	7	SENT_444	[p21l112t1341r521b1390],
7	-85	CD	NUMBER	-85	dep	3	SENT_444	[p21l112t1341r521b1390],
8	.	.	O	.	_	0	SENT_444	[p21l112t1341r521b1390],

1	18	CD	NUMBER	18	_	0	SENT_445	[p21l10t1412r74b1452],
2	.	.	O	.	_	0	SENT_445	[p21l10t1412r74b1452],

1	Cortes-Funes	JJ	O	cortes-funes	amod	2	SENT_446	[p21l103t1411r421b1452],
2	H	NN	O	h	_	0	SENT_446	[p21l447t1412r500b1461],
3	,	,	O	,	_	0	SENT_446	[p21l447t1412r500b1461],
4	Gomez	NNP	PERSON	Gomez	nn	5	SENT_446	[p21l528t1411r700b1451],
5	C	NNP	O	C	appos	2	SENT_446	[p21l725t1411r772b1461],
6	,	,	O	,	_	0	SENT_446	[p21l725t1411r772b1461],
7	Rosell	NNP	PERSON	Rosell	nn	8	SENT_446	[p21l799t1408r949b1454],
8	R	NNP	O	R	appos	2	SENT_446	[p21l973t1412r1022b1461],
9	,	,	O	,	_	0	SENT_446	[p21l973t1412r1022b1461],
10	et	FW	O	et	nn	11	SENT_446	[p21l9t1487r52b1521],
11	al.	FW	O	al.	appos	2	SENT_446	[p21l80t1478r134b1521],
12	.	.	O	.	_	0	SENT_446	[p21l80t1478r134b1521],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_447	[p21l168t1478r418b1533],
2	growth	NN	O	growth	nn	4	SENT_447	[p21l448t1478r624b1534],
3	factor	NN	O	factor	nn	4	SENT_447	[p21l655t1478r796b1522],
4	receptor	NN	O	receptor	_	0	SENT_447	[p21l825t1487r1026b1533],
5	activating	VBG	O	activate	partmod	4	SENT_447	[p21l8t1549r246b1604],
6	mutations	NNS	O	mutation	dobj	5	SENT_447	[p21l261t1549r505b1592],
7	in	IN	O	in	_	0	SENT_447	[p21l523t1549r570b1591],
8	Spanish	JJ	MISC	spanish	prep_in	5	SENT_447	[p21l587t1548r777b1603],
9	gefitinibtreated	VBN	O	gefitinibtreat	partmod	8	SENT_447	[p21l794t1548r1024b1604, p21l9t1618r170b1662],
10	non-small-cell	JJ	O	non-small-cell	amod	13	SENT_447	[p21l184t1618r519b1662],
11	lung	NN	O	lung	nn	13	SENT_447	[p21l533t1618r639b1674],
12	cancer	NN	O	cancer	nn	13	SENT_447	[p21l652t1632r804b1661],
13	patients	NNS	O	patient	dobj	9	SENT_447	[p21l817t1619r1021b1673],
14	.	.	O	.	_	0	SENT_447	[p21l817t1619r1021b1673],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_448	[p21l6t1692r109b1731],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_448	[p21l127t1688r270b1731],
3	2005	CD	DATE	2005	num	2	SENT_448	[p21l289t1691r667b1740],
4	;	:	O	;	_	0	SENT_448	[p21l289t1691r667b1740],
5	16:1081	CD	NUMBER	16:1081	number	6	SENT_448	[p21l289t1691r667b1740],
6	-6	CD	NUMBER	-6	dep	2	SENT_448	[p21l289t1691r667b1740],
7	.	.	O	.	_	0	SENT_448	[p21l289t1691r667b1740],

1	19	CD	NUMBER	19	_	0	SENT_449	[p21l10t1763r70b1801],
2	.	.	O	.	_	0	SENT_449	[p21l10t1763r70b1801],

1	Han	NNP	O	Han	nn	2	SENT_450	[p21l103t1762r203b1801],
2	SW	NNP	O	SW	_	0	SENT_450	[p21l234t1761r318b1811],
3	,	,	O	,	_	0	SENT_450	[p21l234t1761r318b1811],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_450	[p21l351t1759r452b1803],
5	TY	NNP	PERSON	TY	appos	2	SENT_450	[p21l480t1761r554b1811],
6	,	,	O	,	_	0	SENT_450	[p21l480t1761r554b1811],
7	Hwang	NNP	PERSON	Hwang	nn	8	SENT_450	[p21l586t1762r757b1814],
8	PG	NNP	O	PG	appos	2	SENT_450	[p21l783t1761r866b1811],
9	,	,	O	,	_	0	SENT_450	[p21l783t1761r866b1811],
10	et	FW	O	et	nn	11	SENT_450	[p21l899t1767r941b1801],
11	al.	FW	O	al.	appos	2	SENT_450	[p21l968t1758r1021b1801],
12	.	.	O	.	_	0	SENT_450	[p21l968t1758r1021b1801],

1	Predictive	JJ	O	predictive	amod	4	SENT_451	[p21l8t1828r239b1872],
2	and	CC	O	and	_	0	SENT_451	[p21l269t1828r356b1871],
3	prognostic	JJ	O	prognostic	conj_and	1	SENT_451	[p21l385t1829r642b1884],
4	impact	NN	O	impact	nsubj	16	SENT_451	[p21l671t1829r835b1883],
5	of	IN	O	of	_	0	SENT_451	[p21l863t1828r918b1871],
6	epidermal	JJ	O	epidermal	amod	10	SENT_451	[p21l938t1829r1024b1883, p21l1099t78r1267b121],
7	growth	NN	O	growth	nn	10	SENT_451	[p21l1282t78r1456b134],
8	factor	NN	O	factor	nn	10	SENT_451	[p21l1472t78r1611b121],
9	receptor	NN	O	receptor	nn	10	SENT_451	[p21l1625t87r1822b133],
10	mutation	NN	O	mutation	prep_of	4	SENT_451	[p21l1836t79r2053b122],
11	in	IN	O	in	_	0	SENT_451	[p21l2069t79r2115b121],
12	non-small-cell	JJ	O	non-small-cell	amod	15	SENT_451	[p21l1099t148r1441b192],
13	lung	NN	O	lung	nn	15	SENT_451	[p21l1456t148r1563b204],
14	cancer	NN	O	cancer	nn	15	SENT_451	[p21l1577t162r1732b191],
15	patients	NNS	O	patient	prep_in	10	SENT_451	[p21l1745t149r1933b203],
16	treated	VBN	O	treat	_	0	SENT_451	[p21l1951t148r2115b192],
17	with	IN	O	with	_	0	SENT_451	[p21l1096t218r1204b262],
18	gefitinib	NN	O	gefitinib	prep_with	16	SENT_451	[p21l1225t218r1443b274],
19	.	.	O	.	_	0	SENT_451	[p21l1225t218r1443b274],

1	J	NNP	O	J	nn	3	SENT_452	[p21l1462t222r1483b268],
2	Clin	NNP	O	Clin	nn	3	SENT_452	[p21l1502t218r1600b261],
3	Oncol	NNP	O	Oncol	_	0	SENT_452	[p21l1622t218r1762b261],
4	2005	CD	DATE	2005	num	3	SENT_452	[p21l1783t221r2114b270, p21l1100t291r1194b332],
5	;	:	O	;	_	0	SENT_452	[p21l1783t221r2114b270, p21l1100t291r1194b332],
6	23:2493501	CD	NUMBER	23:2493501	dep	3	SENT_452	[p21l1783t221r2114b270, p21l1100t291r1194b332],
7	.	.	O	.	_	0	SENT_452	[p21l1783t221r2114b270, p21l1100t291r1194b332],

1	20	CD	NUMBER	20	_	0	SENT_453	[p21l1098t362r1166b401],
2	.	.	O	.	_	0	SENT_453	[p21l1098t362r1166b401],

1	Takano	NNP	PERSON	Takano	nn	2	SENT_454	[p21l1192t358r1374b402],
2	T	NN	O	t	_	0	SENT_454	[p21l1395t362r1438b410],
3	,	,	O	,	_	0	SENT_454	[p21l1395t362r1438b410],
4	Ohe	NN	O	ohe	nn	5	SENT_454	[p21l1463t358r1560b401],
5	Y	NN	O	y	appos	2	SENT_454	[p21l1580t362r1621b410],
6	,	,	O	,	_	0	SENT_454	[p21l1580t362r1621b410],
7	Sakamoto	NNP	PERSON	Sakamoto	nn	8	SENT_454	[p21l1647t358r1891b402],
8	H	NNP	O	H	appos	2	SENT_454	[p21l1914t362r1968b410],
9	,	,	O	,	_	0	SENT_454	[p21l1914t362r1968b410],
10	et	FW	O	et	nn	11	SENT_454	[p21l1993t367r2037b401],
11	al.	FW	O	al.	appos	2	SENT_454	[p21l2056t358r2112b401],
12	.	.	O	.	_	0	SENT_454	[p21l2056t358r2112b401],

1	Epidermal	JJ	O	epidermal	amod	6	SENT_455	[p21l1098t428r1353b483],
2	growth	NN	O	growth	nn	6	SENT_455	[p21l1383t428r1562b484],
3	factor	NN	O	factor	nn	6	SENT_455	[p21l1594t428r1738b471],
4	receptor	NN	O	receptor	nn	6	SENT_455	[p21l1768t437r1972b483],
5	gene	NN	O	gene	nn	6	SENT_455	[p21l2001t442r2115b484],
6	mutations	NNS	O	mutation	nsubj	11	SENT_455	[p21l1099t499r1348b542],
7	and	CC	O	and	_	0	SENT_455	[p21l1378t498r1467b541],
8	increased	VBD	O	increase	amod	9	SENT_455	[p21l1496t498r1731b541],
9	copy	NN	O	copy	nsubj	11	SENT_455	[p21l1760t512r1872b553],
10	numbers	NNS	O	number	dep	6	SENT_455	[p21l1899t498r2114b542],
11	predict	VBP	O	predict	_	0	SENT_455	[p21l1098t568r1273b623],
12	gefitinib	NN	O	gefitinib	nn	13	SENT_455	[p21l1304t568r1519b624],
13	sensitivity	NN	O	sensitivity	dobj	11	SENT_455	[p21l1555t569r1805b623],
14	in	IN	O	in	_	0	SENT_455	[p21l1837t569r1884b611],
15	patients	NNS	O	patient	prep_in	11	SENT_455	[p21l1917t569r2114b623],
16	with	IN	O	with	_	0	SENT_455	[p21l1096t638r1208b682],
17	recurrent	JJ	O	recurrent	amod	20	SENT_455	[p21l1235t647r1465b682],
18	non-small-cell	JJ	O	non-small-cell	amod	20	SENT_455	[p21l1490t638r1848b682],
19	lung	NN	O	lung	nn	20	SENT_455	[p21l1875t638r1985b694],
20	cancer	NN	O	cancer	prep_with	15	SENT_455	[p21l2011t652r2114b681, p21l1099t722r1183b751],
21	.	.	O	.	_	0	SENT_455	[p21l2011t652r2114b681, p21l1099t722r1183b751],

1	J	NNP	O	J	nn	3	SENT_456	[p21l1201t712r1221b758],
2	Clin	NNP	O	Clin	nn	3	SENT_456	[p21l1240t708r1341b751],
3	Oncol	NNP	O	Oncol	_	0	SENT_456	[p21l1362t708r1507b752],
4	2005	CD	DATE	2005	num	3	SENT_456	[p21l1527t711r1942b760],
5	;	:	O	;	_	0	SENT_456	[p21l1527t711r1942b760],
6	23:6829	CD	NUMBER	23:6829	number	7	SENT_456	[p21l1527t711r1942b760],
7	-37	CD	NUMBER	-37	dep	3	SENT_456	[p21l1527t711r1942b760],
8	.	.	O	.	_	0	SENT_456	[p21l1527t711r1942b760],

1	21	CD	NUMBER	21	_	0	SENT_457	[p21l1098t783r1164b821],
2	.	.	O	.	_	0	SENT_457	[p21l1098t783r1164b821],

1	Tamura	NNP	PERSON	Tamura	nn	2	SENT_458	[p21l1192t781r1379b822],
2	K	NNP	PERSON	K	_	0	SENT_458	[p21l1397t782r1446b831],
3	,	,	O	,	_	0	SENT_458	[p21l1397t782r1446b831],
4	Okamoto	NNP	PERSON	Okamoto	nn	5	SENT_458	[p21l1467t778r1692b822],
5	I	NNP	O	I	appos	2	SENT_458	[p21l1711t782r1741b831],
6	,	,	O	,	_	0	SENT_458	[p21l1711t782r1741b831],
7	Kashii	NNP	PERSON	Kashii	nn	8	SENT_458	[p21l1762t778r1916b823],
8	T	NN	O	t	appos	2	SENT_458	[p21l1933t781r1976b831],
9	,	,	O	,	_	0	SENT_458	[p21l1933t781r1976b831],
10	et	FW	O	et	nn	11	SENT_458	[p21l1998t787r2041b821],
11	al.	FW	O	al.	appos	2	SENT_458	[p21l2057t778r2112b821],
12	.	.	O	.	_	0	SENT_458	[p21l2057t778r2112b821],

1	Multicentre	JJ	O	multicentre	amod	3	SENT_459	[p21l1097t848r1384b892],
2	prospective	JJ	O	prospective	amod	3	SENT_459	[p21l1408t849r1690b903],
3	phase	NN	O	phase	_	0	SENT_459	[p21l1714t848r1856b903],
4	II	CD	NUMBER	ii	num	5	SENT_459	[p21l1880t852r1917b891],
5	trial	NN	O	trial	dep	3	SENT_459	[p21l1941t848r2044b891],
6	of	IN	O	of	_	0	SENT_459	[p21l2069t848r2126b891],
7	gefitinib	NN	O	gefitinib	prep_of	5	SENT_459	[p21l1099t918r1313b974],
8	for	IN	O	for	_	0	SENT_459	[p21l1357t918r1427b961],
9	advanced	JJ	O	advanced	amod	13	SENT_459	[p21l1468t918r1695b962],
10	non-small	JJ	O	non-small	amod	13	SENT_459	[p21l1738t918r1988b962],
11	cell	NN	O	cell	nn	13	SENT_459	[p21l2031t918r2115b961],
12	lung	NN	O	lung	nn	13	SENT_459	[p21l1098t988r1209b1044],
13	cancer	NN	O	cancer	prep_for	7	SENT_459	[p21l1232t1002r1393b1031],
14	with	IN	O	with	_	0	SENT_459	[p21l1413t988r1524b1032],
15	epidermal	JJ	O	epidermal	amod	19	SENT_459	[p21l1549t988r1798b1043],
16	growth	NN	O	growth	nn	19	SENT_459	[p21l1822t988r2001b1044],
17	factor	NN	O	factor	nn	19	SENT_459	[p21l2026t988r2114b1031, p21l1099t1067r1169b1102],
18	receptor	NN	O	receptor	nn	19	SENT_459	[p21l1205t1067r1411b1113],
19	mutations	NNS	O	mutation	prep_with	5	SENT_459	[p21l1447t1059r1711b1102],
20	:	:	O	:	_	0	SENT_459	[p21l1447t1059r1711b1102],
21	results	NNS	O	result	dep	3	SENT_459	[p21l1752t1058r1915b1102],
22	of	IN	O	of	_	0	SENT_459	[p21l1955t1058r2011b1102],
23	the	DT	O	the	det	27	SENT_459	[p21l2039t1058r2115b1101],
24	Westlapan	NNP	ORGANIZATION	Westlapan	nn	27	SENT_459	[p21l1097t1132r1361b1183],
25	Thoracic	NNP	ORGANIZATION	Thoracic	nn	27	SENT_459	[p21l1375t1128r1585b1172],
26	Oncology	NNP	ORGANIZATION	Oncology	nn	27	SENT_459	[p21l1601t1128r1834b1184],
27	Group	NNP	ORGANIZATION	Group	prep_of	21	SENT_459	[p21l1847t1131r1998b1183],
28	trial	NN	O	trial	nn	31	SENT_459	[p21l2015t1128r2115b1171],
29	(	CD	NUMBER	(	num	31	SENT_459	[p21l1101t1201r1457b1248],
30	WJTOG0403	NN	O	wjtog0403	nn	31	SENT_459	[p21l1101t1201r1457b1248],
31	)	NN	O	)	dep	21	SENT_459	[p21l1101t1201r1457b1248],
32	.	.	O	.	_	0	SENT_459	[p21l1101t1201r1457b1248],

1	Br	NN	O	br	nn	3	SENT_460	[p21l1488t1202r1542b1241],
2	J	NN	O	j	nn	3	SENT_460	[p21l1563t1202r1584b1248],
3	Cancer	NN	O	cancer	_	0	SENT_460	[p21l1611t1201r1779b1241],
4	2008	CD	DATE	2008	num	6	SENT_460	[p21l1805t1201r2114b1250, p21l1101t1271r1165b1311],
5	;	:	O	;	_	0	SENT_460	[p21l1805t1201r2114b1250, p21l1101t1271r1165b1311],
6	98:90714	CD	NUMBER	98:90714	dep	3	SENT_460	[p21l1805t1201r2114b1250, p21l1101t1271r1165b1311],
7	.	.	O	.	_	0	SENT_460	[p21l1805t1201r2114b1250, p21l1101t1271r1165b1311],

1	22	CD	NUMBER	22	_	0	SENT_461	[p21l1098t1343r1166b1381],
2	.	.	O	.	_	0	SENT_461	[p21l1098t1343r1166b1381],

1	Sequist	NNP	O	Sequist	nn	2	SENT_462	[p21l1195t1339r1371b1393],
2	LV	NNP	O	LV	_	0	SENT_462	[p21l1394t1342r1460b1391],
3	,	,	O	,	_	0	SENT_462	[p21l1394t1342r1460b1391],
4	Martins	NNP	PERSON	Martins	nn	5	SENT_462	[p21l1488t1339r1680b1381],
5	RG	NNP	O	RG	appos	2	SENT_462	[p21l1707t1341r1794b1391],
6	,	,	O	,	_	0	SENT_462	[p21l1707t1341r1794b1391],
7	Spigel	NNP	PERSON	Spigel	nn	8	SENT_462	[p21l1825t1338r1969b1394],
8	D	NNP	O	D	appos	2	SENT_462	[p21l1995t1342r2044b1391],
9	,	,	O	,	_	0	SENT_462	[p21l1995t1342r2044b1391],
10	et	FW	O	et	nn	11	SENT_462	[p21l2074t1347r2118b1381],
11	al.	FW	O	al.	appos	2	SENT_462	[p21l1098t1408r1153b1451],
12	.	.	O	.	_	0	SENT_462	[p21l1098t1408r1153b1451],

1	First-line	JJ	O	first-line	amod	2	SENT_463	[p21l1174t1408r1391b1451],
2	gefitinib	NN	O	gefitinib	_	0	SENT_463	[p21l1409t1408r1619b1464],
3	in	IN	O	in	_	0	SENT_463	[p21l1639t1409r1685b1451],
4	patients	NNS	O	patient	prep_in	2	SENT_463	[p21l1703t1409r1896b1463],
5	with	IN	O	with	_	0	SENT_463	[p21l1914t1408r2023b1452],
6	advanced	JJ	O	advanced	amod	9	SENT_463	[p21l2042t1408r2114b1451, p21l1096t1478r1261b1522],
7	non-small-cell	JJ	O	non-small-cell	amod	9	SENT_463	[p21l1279t1478r1622b1522],
8	lung	NN	O	lung	nn	9	SENT_463	[p21l1639t1478r1746b1534],
9	cancer	NN	O	cancer	prep_with	4	SENT_463	[p21l1763t1492r1919b1521],
10	harboring	VBG	O	harbor	partmod	9	SENT_463	[p21l1936t1478r2114b1521, p21l1098t1549r1177b1604],
11	somatic	JJ	O	somatic	amod	13	SENT_463	[p21l1192t1549r1381b1591],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_463	[p21l1396t1551r1539b1594],
13	mutations	NNS	O	mutation	dobj	10	SENT_463	[p21l1549t1549r1808b1592],
14	.	.	O	.	_	0	SENT_463	[p21l1549t1549r1808b1592],

1	J	NNP	O	J	nn	3	SENT_464	[p21l1822t1552r1842b1598],
2	Clin	NNP	O	Clin	nn	3	SENT_464	[p21l1857t1548r1957b1592],
3	Oncol	NNP	O	Oncol	_	0	SENT_464	[p21l1973t1548r2115b1591],
4	2008	CD	DATE	2008	num	3	SENT_464	[p21l1099t1621r1488b1670],
5	;	:	O	;	_	0	SENT_464	[p21l1099t1621r1488b1670],
6	26:2442	CD	NUMBER	26:2442	number	7	SENT_464	[p21l1099t1621r1488b1670],
7	-9	CD	NUMBER	-9	dep	3	SENT_464	[p21l1099t1621r1488b1670],
8	.	.	O	.	_	0	SENT_464	[p21l1099t1621r1488b1670],

1	[	NNP	O	[	_	0	SENT_465	[p21l1526t1622r1762b1671],
2	Erratum	NNP	O	Erratum	nn	6	SENT_465	[p21l1526t1622r1762b1671],
3	,	,	O	,	_	0	SENT_465	[p21l1526t1622r1762b1671],
4	J	NNP	O	J	appos	6	SENT_465	[p21l1789t1622r1810b1668],
5	Clin	NNP	O	Clin	nn	6	SENT_465	[p21l1839t1618r1940b1662],
6	Oncol	NNP	O	Oncol	dep	1	SENT_465	[p21l1970t1618r2115b1661],
7	2008	CD	DATE	2008	rcmod	6	SENT_465	[p21l1099t1691r1450b1740],
8	;	:	O	;	_	0	SENT_465	[p21l1099t1691r1450b1740],
9	26:3472	CD	NUMBER	26:3472	dep	7	SENT_465	[p21l1099t1691r1450b1740],
10	.	.	O	.	_	0	SENT_465	[p21l1099t1691r1450b1740],
11	]	SYM	O	]	dep	7	SENT_465	[p21l1099t1691r1450b1740],

1	23	CD	NUMBER	23	_	0	SENT_466	[p21l1098t1763r1164b1801],
2	.	.	O	.	_	0	SENT_466	[p21l1098t1763r1164b1801],

1	Costa	NNP	O	Costa	nn	2	SENT_467	[p21l1194t1761r1330b1802],
2	DB	NNP	O	DB	_	0	SENT_467	[p21l1363t1762r1447b1811],
3	,	,	O	,	_	0	SENT_467	[p21l1363t1762r1447b1811],
4	Kobayashi	NNP	LOCATION	Kobayashi	nn	5	SENT_467	[p21l1484t1758r1732b1813],
5	S	NNP	LOCATION	S	appos	2	SENT_467	[p21l1767t1761r1805b1811],
6	,	,	O	,	_	0	SENT_467	[p21l1767t1761r1805b1811],
7	Tenen	NNP	PERSON	Tenen	nn	8	SENT_467	[p21l1840t1761r1985b1801],
8	DG	NNS	O	dg	appos	2	SENT_467	[p21l2019t1761r2112b1811],
9	,	,	O	,	_	0	SENT_467	[p21l2019t1761r2112b1811],
10	Huberman	NNP	PERSON	Huberman	nn	12	SENT_467	[p21l1098t1828r1359b1872],
11	MS.	NNP	O	MS.	nn	12	SENT_467	[p21l1395t1831r1485b1872],
12	Pooled	NNP	O	Pooled	appos	2	SENT_467	[p21l1525t1828r1687b1871],
13	analysis	NN	O	analysis	dep	2	SENT_467	[p21l1725t1828r1917b1883],
14	of	IN	O	of	_	0	SENT_467	[p21l1956t1828r2012b1871],
15	the	DT	O	the	det	17	SENT_467	[p21l2041t1828r2115b1871],
16	prospective	JJ	O	prospective	amod	17	SENT_467	[p21l79t2317r637b2426],
17	trials	NNS	O	trial	prep_of	13	SENT_467	[p21l675t2315r926b2402],
18	of	IN	O	of	_	0	SENT_467	[p21l966t2315r1080b2403],
19	gefitinib	NN	O	gefitinib	nn	20	SENT_467	[p21l1097t2315r1521b2428],
20	monotherapy	NN	O	monotherapy	prep_of	17	SENT_467	[p21l1561t2315r2132b2403, p21l79t2488r190b2570],

1	for	IN	O	for	_	0	SENT_468	[p21l240t2459r380b2547],
2	EGFR	NN	ORGANIZATION	egfr	pobj	1	SENT_468	[p21l429t2465r1099b2551],
3	—	CD	NUMBER	—	num	8	SENT_468	[p21l429t2465r1099b2551],
4	mutant	JJ	O	mutant	amod	8	SENT_468	[p21l429t2465r1099b2551],
5	non-small	JJ	O	non-small	amod	8	SENT_468	[p21l1148t2459r1645b2547],
6	cell	NN	O	cell	nn	8	SENT_468	[p21l1699t2459r1865b2546],
7	lung	NN	O	lung	nn	8	SENT_468	[p21l1917t2459r2136b2572],
8	cancers	NNS	O	cancer	dep	2	SENT_468	[p21l81t2631r474b2690],
9	.	.	O	.	_	0	SENT_468	[p21l81t2631r474b2690],

1	Lung	NN	O	lung	nn	2	SENT_469	[p21l518t2610r767b2715],
2	Cancer	NN	O	cancer	_	0	SENT_469	[p21l801t2608r1141b2690],
3	2007	CD	DATE	2007	dep	2	SENT_469	[p21l1175t2608r1929b2708],
4	;	:	O	;	_	0	SENT_469	[p21l1175t2608r1929b2708],
5	58:95	CD	NUMBER	58:95	num	6	SENT_469	[p21l1175t2608r1929b2708],
6	-103	CD	NUMBER	-103	dep	2	SENT_469	[p21l1175t2608r1929b2708],
7	.	.	O	.	_	0	SENT_469	[p21l1175t2608r1929b2708],

1	24	CD	NUMBER	24	_	0	SENT_470	[p21l79t2756r213b2831],
2	.	.	O	.	_	0	SENT_470	[p21l79t2756r213b2831],

1	Molina-Vila	NNP	O	Molina-Vila	nn	2	SENT_471	[p21l268t2745r838b2833],
2	MA	NNP	O	MA	_	0	SENT_471	[p21l901t2753r1101b2850],
3	,	,	O	,	_	0	SENT_471	[p21l901t2753r1101b2850],
4	Bertran-Alamillo	NNP	O	Bertran-Alamillo	nn	5	SENT_471	[p21l1171t2745r2006b2833],
5	J	NNP	O	J	appos	2	SENT_471	[p21l2063t2753r2128b2852],
6	,	,	O	,	_	0	SENT_471	[p21l2063t2753r2128b2852],

1	Reguart	NN	O	reguart	nn	2	SENT_472	[p21l79t2896r476b3002],
2	N	NN	O	n	_	0	SENT_472	[p21l519t2897r625b2995],
3	,	,	O	,	_	0	SENT_472	[p21l519t2897r625b2995],
4	et	FW	O	et	nn	5	SENT_472	[p21l683t2908r771b2976],
5	al.	FW	O	al.	appos	2	SENT_472	[p21l815t2889r926b2977],
6	.	.	O	.	_	0	SENT_472	[p21l815t2889r926b2977],

1	A	DT	O	a	det	3	SENT_473	[p21l980t2897r1053b2975],
2	sensitive	JJ	O	sensitive	amod	3	SENT_473	[p21l1103t2891r1519b2977],
3	method	NN	O	method	_	0	SENT_473	[p21l1570t2889r1946b2977],
4	for	IN	O	for	_	0	SENT_473	[p21l1998t2889r2138b2977],
5	detecting	VBG	O	detect	prepc_for	3	SENT_473	[p21l81t3033r537b3146],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_473	[p21l592t3039r880b3125],
7	mutations	NNS	O	mutation	dobj	5	SENT_473	[p21l930t3035r1423b3121],
8	in	IN	O	in	_	0	SENT_473	[p21l1484t3035r1578b3119],
9	non-small	JJ	O	non-small	amod	13	SENT_473	[p21l1637t3033r2134b3121],
10	cell	NN	O	cell	nn	13	SENT_473	[p21l81t3177r246b3264],
11	lung	NN	O	lung	nn	13	SENT_473	[p21l290t3177r510b3290],
12	cancer	NN	O	cancer	nn	13	SENT_473	[p21l552t3206r871b3264],
13	samples	NNS	O	sample	prep_in	5	SENT_473	[p21l916t3177r1308b3288],
14	with	IN	O	with	_	0	SENT_473	[p21l1350t3177r1572b3265],
15	few	JJ	O	few	amod	17	SENT_473	[p21l1616t3177r1792b3265],
16	tumor	NN	O	tumor	nn	17	SENT_473	[p21l1834t3196r2138b3265],
17	cells	NNS	O	cell	prep_with	13	SENT_473	[p21l81t3320r323b3408],
18	.	.	O	.	_	0	SENT_473	[p21l81t3320r323b3408],

1	J	NN	O	j	nn	3	SENT_474	[p21l357t3328r399b3421],
2	T	NN	O	t	nn	3	SENT_474	[p21l430t3327r499b3406],
3	horac	NN	O	horac	_	0	SENT_474	[p21l501t3320r771b3408],
4	Oncol	NN	O	oncol	dep	3	SENT_474	[p21l809t3320r1097b3408],
5	2008	CD	DATE	2008	num	4	SENT_474	[p21l1135t3326r1906b3425],
6	;	:	O	;	_	0	SENT_474	[p21l1135t3326r1906b3425],
7	3:1224	CD	NUMBER	3:1224	num	8	SENT_474	[p21l1135t3326r1906b3425],
8	-35	CD	NUMBER	-35	dep	3	SENT_474	[p21l1135t3326r1906b3425],
9	.	.	O	.	_	0	SENT_474	[p21l1135t3326r1906b3425],

1	25	CD	NUMBER	25	_	0	SENT_475	[p21l79t3475r211b3552],
2	.	.	O	.	_	0	SENT_475	[p21l79t3475r211b3552],

1	Lopez-Abente	NNP	O	Lopez-Abente	nn	2	SENT_476	[p21l270t3462r942b3575],
2	G	NNP	O	G	_	0	SENT_476	[p21l989t3470r1093b3571],
3	,	,	O	,	_	0	SENT_476	[p21l989t3470r1093b3571],
4	Pollrjin	NNP	O	Pollrjin	nn	7	SENT_476	[p21l1146t3462r1455b3552],
5	M	NNP	O	M	nn	7	SENT_476	[p21l1499t3472r1620b3571],
6	,	,	O	,	_	0	SENT_476	[p21l1499t3472r1620b3571],
7	Aragonés	NNP	PERSON	Aragonés	appos	2	SENT_476	[p21l1670t3462r2132b3577],

1	N	NN	O	n	_	0	SENT_477	[p21l77t3616r183b3715],
2	,	,	O	,	_	0	SENT_477	[p21l77t3616r183b3715],
3	et	FW	O	et	nn	4	SENT_477	[p21l240t3627r326b3694],
4	al.	FW	O	al.	appos	1	SENT_477	[p21l370t3608r480b3696],
5	.	.	O	.	_	0	SENT_477	[p21l370t3608r480b3696],

1	Situacién	NNP	O	Situacién	nn	3	SENT_478	[p21l537t3606r986b3696],
2	del	NNP	O	del	nn	3	SENT_478	[p21l1037t3608r1177b3696],
3	cancer	NN	O	cancer	_	0	SENT_478	[p21l1227t3606r1546b3694],
4	en	IN	O	en	_	0	SENT_478	[p21l1593t3636r1703b3694],
5	Espaﬁa	NNP	O	Espaﬁa	prep_en	3	SENT_478	[p21l1750t3613r2130b3719],
6	:	:	O	:	_	0	SENT_478	[p21l1750t3613r2130b3719],

1	incidencia	NN	O	incidencium	_	0	SENT_479	[p22l79t23r604b111],
2	.	.	O	.	_	0	SENT_479	[p22l79t23r604b111],

1	An	DT	O	a	det	4	SENT_480	[p22l663t31r802b109],
2	Sist	NNP	O	Sist	nn	4	SENT_480	[p22l861t25r1034b111],
3	Sanit	NNP	O	Sanit	nn	4	SENT_480	[p22l1087t25r1335b111],
4	Navar	NNP	O	Navar	_	0	SENT_480	[p22l1384t31r1670b111],
5	2004	CD	DATE	2004	num	4	SENT_480	[p22l1723t29r2130b128],
6	;	:	O	;	_	0	SENT_480	[p22l1723t29r2130b128],
7	27	CD	NUMBER	27	dep	4	SENT_480	[p22l1723t29r2130b128],
8	:	:	O	:	_	0	SENT_480	[p22l1723t29r2130b128],

1	26	CD	NUMBER	26	_	0	SENT_481	[p22l79t320r213b397],
2	.	.	O	.	_	0	SENT_481	[p22l79t320r213b397],

1	Marchetti	NNP	PERSON	Marchetti	nn	2	SENT_482	[p22l268t309r748b395],
2	A	NNP	O	A	_	0	SENT_482	[p22l796t317r896b416],
3	,	,	O	,	_	0	SENT_482	[p22l796t317r896b416],
4	Martella	NNP	PERSON	Martella	nn	5	SENT_482	[p22l953t309r1367b395],
5	C	NNP	O	C	dep	2	SENT_482	[p22l1419t315r1513b416],
6	,	,	O	,	_	0	SENT_482	[p22l1419t315r1513b416],
7	Felicioni	NNP	O	Felicioni	nn	8	SENT_482	[p22l1572t309r1992b397],
8	L	NNP	O	L	appos	5	SENT_482	[p22l2043t317r2128b414],
9	,	,	O	,	_	0	SENT_482	[p22l2043t317r2128b414],

1	et	FW	O	et	_	0	SENT_483	[p22l81t472r169b540],
2	al.	FW	O	al.	dep	1	SENT_483	[p22l219t453r328b541],
3	.	.	O	.	_	0	SENT_483	[p22l219t453r328b541],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_484	[p22l389t459r679b545],
2	mutations	NNS	O	mutation	_	0	SENT_484	[p22l723t455r1218b541],
3	in	IN	O	in	_	0	SENT_484	[p22l1277t455r1369b539],
4	non	JJ	O	non	amod	10	SENT_484	[p22l1426t453r2134b541],
5	—	JJ	O	—	amod	10	SENT_484	[p22l1426t453r2134b541],
6	small	JJ	O	small	amod	10	SENT_484	[p22l1426t453r2134b541],
7	—	NN	O	—	nn	10	SENT_484	[p22l1426t453r2134b541],
8	cell	NN	O	cell	nn	10	SENT_484	[p22l1426t453r2134b541],
9	lung	NN	O	lung	nn	10	SENT_484	[p22l79t597r298b710],
10	cancer	NN	O	cancer	prep_in	2	SENT_484	[p22l345t626r689b685],
11	:	:	O	:	_	0	SENT_484	[p22l345t626r689b685],
12	analysis	NN	O	analysis	dep	2	SENT_484	[p22l742t597r1130b708],
13	of	IN	O	of	_	0	SENT_484	[p22l1183t597r1295b685],
14	a	DT	O	a	det	16	SENT_484	[p22l1325t626r1373b683],
15	large	JJ	O	large	amod	16	SENT_484	[p22l1420t597r1664b710],
16	series	NN	O	series	prep_of	12	SENT_484	[p22l1716t599r1988b685],
17	of	IN	O	of	_	0	SENT_484	[p22l2042t597r2153b685],
18	cases	NNS	O	case	prep_of	16	SENT_484	[p22l81t770r334b827],
19	and	CC	O	and	_	0	SENT_484	[p22l368t741r547b829],
20	development	NN	O	development	conj_and	18	SENT_484	[p22l581t741r1206b852],
21	of	IN	O	of	_	0	SENT_484	[p22l1235t741r1348b829],
22	a	DT	O	a	det	26	SENT_484	[p22l1359t770r1409b827],
23	rapid	JJ	O	rapid	amod	26	SENT_484	[p22l1442t741r1689b852],
24	and	CC	O	and	_	0	SENT_484	[p22l1723t741r1900b829],
25	sensitive	JJ	O	sensitive	conj_and	23	SENT_484	[p22l1936t770r2132b827, p22l81t887r328b973],
26	method	NN	O	method	prep_of	12	SENT_484	[p22l405t885r781b973],
27	for	IN	O	for	_	0	SENT_484	[p22l857t885r997b973],
28	diagnostic	JJ	O	diagnostic	amod	29	SENT_484	[p22l1072t885r1584b998],
29	screening	NN	O	screening	prep_for	26	SENT_484	[p22l1662t887r2138b998],
30	with	IN	O	with	_	0	SENT_484	[p22l75t1029r296b1117],
31	potential	JJ	O	potential	amod	32	SENT_484	[p22l326t1029r769b1140],
32	implications	NNS	O	implication	prep_with	29	SENT_484	[p22l801t1029r1411b1140],
33	on	IN	O	on	_	0	SENT_484	[p22l1447t1058r1567b1117],
34	pharmacologic	JJ	O	pharmacologic	amod	35	SENT_484	[p22l1597t1029r2132b1140, p22l79t1173r315b1286],
35	treatment	NN	O	treatment	prep_on	32	SENT_484	[p22l349t1192r855b1261],
36	.	.	O	.	_	0	SENT_484	[p22l349t1192r855b1261],

1	J	NNP	O	J	nn	3	SENT_485	[p22l884t1181r924b1275],
2	Clin	NNP	O	Clin	nn	3	SENT_485	[p22l955t1173r1156b1261],
3	Oncol	NNP	O	Oncol	_	0	SENT_485	[p22l1190t1173r1478b1261],
4	2005	CD	DATE	2005	num	3	SENT_485	[p22l1511t1179r2132b1279, p22l79t1471r202b1548],
5	;	:	O	;	_	0	SENT_485	[p22l1511t1179r2132b1279, p22l79t1471r202b1548],
6	23:85727	CD	NUMBER	23:85727	dep	3	SENT_485	[p22l1511t1179r2132b1279, p22l79t1471r202b1548],
7	.	.	O	.	_	0	SENT_485	[p22l1511t1179r2132b1279, p22l79t1471r202b1548],

1	Schiller	NNP	PERSON	Schiller	nn	2	SENT_486	[p22l274t1460r644b1548],
2	JH	NNP	O	JH	_	0	SENT_486	[p22l673t1468r828b1567],
3	,	,	O	,	_	0	SENT_486	[p22l673t1468r828b1567],
4	Harrington	NNP	PERSON	Harrington	nn	5	SENT_486	[p22l878t1462r1438b1573],
5	D	NNP	O	D	appos	2	SENT_486	[p22l1480t1467r1580b1567],
6	,	,	O	,	_	0	SENT_486	[p22l1480t1467r1580b1567],
7	Belani	NNP	PERSON	Belani	nn	8	SENT_486	[p22l1629t1460r1939b1548],
8	CP	NNP	O	CP	appos	2	SENT_486	[p22l1982t1466r2128b1567],
9	,	,	O	,	_	0	SENT_486	[p22l1982t1466r2128b1567],
10	et	FW	O	et	nn	11	SENT_486	[p22l81t1623r169b1690],
11	al.	FW	O	al.	appos	2	SENT_486	[p22l215t1604r326b1692],
12	.	.	O	.	_	0	SENT_486	[p22l215t1604r326b1692],

1	Comparison	NN	O	comparison	_	0	SENT_487	[p22l386t1606r988b1715],
2	of	IN	O	of	_	0	SENT_487	[p22l1043t1604r1155b1692],
3	four	CD	NUMBER	four	num	5	SENT_487	[p22l1189t1604r1392b1692],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_487	[p22l1444t1604r2140b1715],
5	regimens	NNS	O	regimen	prep_of	1	SENT_487	[p22l79t1750r539b1861],
6	for	IN	O	for	_	0	SENT_487	[p22l623t1748r767b1836],
7	advanced	JJ	O	advanced	amod	9	SENT_487	[p22l845t1748r1304b1836],
8	non	JJ	O	non	amod	9	SENT_487	[p22l1386t1748r2134b1836],
9	—	NN	O	—	prep_for	1	SENT_487	[p22l1386t1748r2134b1836],
10	small	JJ	O	small	amod	14	SENT_487	[p22l1386t1748r2134b1836],
11	—	NN	O	—	nn	14	SENT_487	[p22l1386t1748r2134b1836],
12	cell	NN	O	cell	nn	14	SENT_487	[p22l1386t1748r2134b1836],
13	lung	NN	O	lung	nn	14	SENT_487	[p22l79t1892r301b2005],
14	cancer	NN	O	cancer	dep	9	SENT_487	[p22l374t1921r723b1980],
15	.	.	O	.	_	0	SENT_487	[p22l374t1921r723b1980],

1	N	NN	O	n	nn	3	SENT_488	[p22l803t1900r886b1980],
2	Engl	NNP	O	Engl	nn	3	SENT_488	[p22l959t1892r1183b2005],
3	J	NNP	O	J	nsubj	4	SENT_488	[p22l1246t1900r1289b1994],
4	Med	VBD	O	med	_	0	SENT_488	[p22l1359t1892r1572b1980],
5	2002	CD	DATE	2002	dobj	4	SENT_488	[p22l1647t1898r2130b1998],
6	;	:	O	;	_	0	SENT_488	[p22l1647t1898r2130b1998],
7	346	CD	NUMBER	346	dep	5	SENT_488	[p22l1647t1898r2130b1998],
8	:	:	O	:	_	0	SENT_488	[p22l1647t1898r2130b1998],

1	Copyright	NN	O	copyright	_	0	SENT_489	[p22l83t2167r439b2263],
2	©	CD	NUMBER	©	num	6	SENT_489	[p22l475t2174r555b2254],
3	2009	CD	DATE	2009	num	6	SENT_489	[p22l594t2171r784b2240],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_489	[p22l817t2167r1354b2238],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_489	[p22l1388t2167r1683b2240],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_489	[p22l1712t2169r1990b2261],
7	.	.	O	.	_	0	SENT_489	[p22l1712t2169r1990b2261],

1	ICMJE	NNP	O	ICMJE	_	0	SENT_490	[p22l538t2599r634b2630],
2	SEEKING	VBG	O	seek	dep	1	SENT_490	[p22l650t2599r799b2621],
3	TWO	CD	NUMBER	two	num	6	SENT_490	[p22l815t2599r891b2621],
4	NEW	JJ	O	new	amod	6	SENT_490	[p22l910t2600r985b2621],
5	MEMBER	NN	O	member	nn	6	SENT_490	[p22l1003t2600r1146b2621],
6	JOURNALS	NNS	O	journal	dobj	2	SENT_490	[p22l1159t2599r1338b2630],

1	The	DT	O	the	det	3	SENT_491	[p22l113t2640r161b2663],
2	International	NNP	ORGANIZATION	International	nn	3	SENT_491	[p22l169t2640r334b2663],
3	Committee	NNP	ORGANIZATION	Committee	nsubj	12	SENT_491	[p22l342t2640r482b2663],
4	of	IN	ORGANIZATION	of	_	0	SENT_491	[p22l490t2639r520b2663],
5	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_491	[p22l522t2640r622b2663],
6	Journal	NNP	ORGANIZATION	Journal	nn	7	SENT_491	[p22l627t2640r721b2666],
7	Editors	NNP	ORGANIZATION	Editors	prep_of	3	SENT_491	[p22l729t2640r819b2663],
8	(	CD	NUMBER	(	num	10	SENT_491	[p22l829t2641r926b2666],
9	ICMJE	NN	O	icmje	nn	10	SENT_491	[p22l829t2641r926b2666],
10	)	NN	O	)	dep	7	SENT_491	[p22l829t2641r926b2666],
11	is	VBZ	O	be	aux	12	SENT_491	[p22l936t2640r956b2663],
12	seeking	VBG	O	seek	_	0	SENT_491	[p22l965t2640r1062b2669],
13	two	CD	NUMBER	two	num	16	SENT_491	[p22l1070t2644r1115b2663],
14	new	JJ	O	new	amod	16	SENT_491	[p22l1124t2647r1176b2663],
15	member	NN	O	member	nn	16	SENT_491	[p22l1183t2640r1289b2663],
16	journals	NNS	O	journal	dobj	12	SENT_491	[p22l1292t2640r1398b2669],
17	to	TO	O	to	aux	19	SENT_491	[p22l1407t2644r1430b2663],
18	be	VB	O	be	auxpass	19	SENT_491	[p22l1440t2640r1468b2663],
19	represented	VBN	O	represent	xcomp	12	SENT_491	[p22l1476t2640r1624b2669],
20	by	IN	O	by	_	0	SENT_491	[p22l1633t2640r1662b2669],
21	their	PRP$	O	they	poss	22	SENT_491	[p22l1669t2640r1728b2663],
22	editors-in-chief	NN	O	editors-in-chief	agent	19	SENT_491	[p22l114t2677r316b2700],
23	.	.	O	.	_	0	SENT_491	[p22l114t2677r316b2700],

1	Information	NN	O	information	nsubj	6	SENT_492	[p22l326t2677r479b2700],
2	about	IN	O	about	_	0	SENT_492	[p22l488t2677r560b2700],
3	the	DT	O	the	det	4	SENT_492	[p22l568t2677r606b2700],
4	ICMJE	NN	O	icmje	prep_about	1	SENT_492	[p22l614t2679r693b2704],
5	is	VBZ	O	be	cop	6	SENT_492	[p22l702t2677r722b2700],
6	available	JJ	O	available	_	0	SENT_492	[p22l731t2677r839b2700],
7	at	IN	O	at	_	0	SENT_492	[p22l848t2682r871b2700],
8	wWw.icmje.org	NN	O	www.icmje.org	prep_at	6	SENT_492	[p22l877t2677r1078b2707],
9	.	.	O	.	_	0	SENT_492	[p22l877t2677r1078b2707],

1	The	DT	O	the	det	2	SENT_493	[p22l1087t2677r1135b2700],
2	ICMJE	NN	O	icmje	nsubj	3	SENT_493	[p22l1143t2679r1222b2704],
3	anticipates	VBZ	O	anticipate	_	0	SENT_493	[p22l1231t2677r1367b2706],
4	selection	NN	O	selection	dobj	3	SENT_493	[p22l1376t2677r1487b2700],
5	of	IN	O	of	_	0	SENT_493	[p22l1496t2677r1526b2700],
6	new	JJ	O	new	amod	7	SENT_493	[p22l1529t2685r1581b2700],
7	members	NNS	O	member	prep_of	4	SENT_493	[p22l1588t2677r1705b2700],
8	by	IN	O	by	_	0	SENT_493	[p22l1715t2677r1743b2706],
9	November	NNP	DATE	November	prep_by	3	SENT_493	[p22l113t2715r245b2738],
10	1	CD	DATE	1	num	9	SENT_493	[p22l254t2716r274b2742],
11	,	,	DATE	,	_	0	SENT_493	[p22l254t2716r274b2742],
12	2009	CD	DATE	2009	num	9	SENT_493	[p22l284t2716r353b2738],
13	.	.	O	.	_	0	SENT_493	[p22l284t2716r353b2738],

1	Candidate	NN	O	candidate	nn	2	SENT_494	[p22l363t2715r490b2738],
2	journals	NNS	O	journal	nsubj	4	SENT_494	[p22l495t2715r600b2744],
3	should	MD	O	should	aux	4	SENT_494	[p22l609t2715r694b2738],
4	meet	VB	O	meet	_	0	SENT_494	[p22l703t2720r765b2738],
5	the	DT	O	the	dobj	4	SENT_494	[p22l773t2715r811b2738],
6	following	VBG	O	follow	_	0	SENT_494	[p22l820t2714r941b2744],
7	criteria	NNS	O	criterion	prep_following	5	SENT_494	[p22l949t2715r1044b2738],
8	:	:	O	:	_	0	SENT_494	[p22l949t2715r1044b2738],
9	-	:	O	-	_	0	SENT_494	[p22l158t2761r165b2768],
10	peer	VB	O	peer	dep	4	SENT_494	[p22l180t2760r235b2781],
11	reviewed	VBN	O	review	dep	10	SENT_494	[p22l243t2752r360b2780],
12	,	,	O	,	_	0	SENT_494	[p22l243t2752r360b2780],
13	general	JJ	O	general	amod	15	SENT_494	[p22l370t2752r462b2782],
14	medical	JJ	O	medical	amod	15	SENT_494	[p22l471t2752r569b2775],
15	journal	NN	O	journal	dobj	11	SENT_494	[p22l574t2752r667b2781],
16	-	:	O	-	_	0	SENT_494	[p22l158t2799r165b2806],
17	represent	VB	O	represent	dep	15	SENT_494	[p22l180t2794r300b2819],
18	geographic	JJ	O	geographic	amod	19	SENT_494	[p22l307t2790r448b2819],
19	areas	NNS	O	area	nsubj	20	SENT_494	[p22l456t2797r520b2813],
20	(	VBP	O	(	ccomp	17	SENT_494	[p22l531t2790r603b2816],
21	Latin	NNP	LOCATION	Latin	nn	22	SENT_494	[p22l531t2790r603b2816],
22	America	NNP	LOCATION	America	dobj	20	SENT_494	[p22l610t2790r722b2818],
23	,	,	O	,	_	0	SENT_494	[p22l610t2790r722b2818],
24	Asia	NNP	LOCATION	Asia	conj_or	22	SENT_494	[p22l731t2790r792b2817],
25	,	,	O	,	_	0	SENT_494	[p22l731t2790r792b2817],
26	Africa	NNP	LOCATION	Africa	conj_or	22	SENT_494	[p22l801t2789r886b2816],
27	)	CD	NUMBER	)	num	26	SENT_494	[p22l801t2789r886b2816],
28	or	CC	O	or	_	0	SENT_494	[p22l896t2797r922b2813],
29	publication	NN	O	publication	nn	30	SENT_494	[p22l930t2790r1073b2819],
30	models	NNS	O	model	conj_or	22	SENT_494	[p22l1081t2790r1173b2813],
31	(	RB	O	(	advmod	32	SENT_494	[p22l1183t2792r1254b2819],
32	open	JJ	O	open	amod	34	SENT_494	[p22l1183t2792r1254b2819],
33	access	NN	O	access	nn	34	SENT_494	[p22l1262t2792r1350b2816],
34	)	NN	O	)	dep	30	SENT_494	[p22l1262t2792r1350b2816],
35	not	RB	O	not	_	0	SENT_494	[p22l1360t2794r1403b2813],
36	well	RB	O	well	_	0	SENT_494	[p22l1409t2790r1461b2813],
37	represented	VBN	O	represent	dep	10	SENT_494	[p22l1469t2790r1617b2819],
38	by	IN	O	by	_	0	SENT_494	[p22l1626t2790r1654b2819],
39	current	JJ	DATE	current	amod	41	SENT_494	[p22l1662t2795r1754b2813],
40	ICMJE	NN	O	icmje	nn	41	SENT_494	[p22l180t2829r259b2854],
41	members	NNS	O	member	prep_by	37	SENT_494	[p22l268t2827r385b2850],
42	-	:	O	-	_	0	SENT_494	[p22l158t2874r165b2881],
43	editor	NN	O	editor	dep	41	SENT_494	[p22l180t2865r255b2888],
44	who	WP	O	who	nsubj	46	SENT_494	[p22l261t2865r315b2888],
45	is	VBZ	O	be	cop	46	SENT_494	[p22l324t2865r343b2888],
46	knowledgeable	JJ	O	knowledgeable	rcmod	43	SENT_494	[p22l353t2865r542b2894],
47	about	IN	O	about	_	0	SENT_494	[p22l551t2865r623b2888],
48	publication	NN	O	publication	nn	49	SENT_494	[p22l630t2865r773b2894],
49	ethics	NNS	O	ethic	prep_about	46	SENT_494	[p22l782t2865r854b2888],
50	-	:	O	-	_	0	SENT_494	[p22l158t2911r165b2918],
51	editor	NN	O	editor	dep	49	SENT_494	[p22l180t2902r255b2925],
52	who	WP	O	who	nsubj	53	SENT_494	[p22l261t2902r315b2925],
53	expects	VBZ	O	expect	rcmod	51	SENT_494	[p22l324t2907r416b2931],
54	to	TO	O	to	aux	55	SENT_494	[p22l425t2907r448b2925],
55	be	VB	O	be	xcomp	53	SENT_494	[p22l458t2902r486b2925],
56	in	IN	O	in	_	0	SENT_494	[p22l495t2902r518b2925],
57	the	DT	O	the	det	58	SENT_494	[p22l527t2902r566b2925],
58	position	NN	O	position	prep_in	55	SENT_494	[p22l574t2902r678b2931],
59	for	IN	O	for	_	0	SENT_494	[p22l687t2902r723b2925],
60	at	IN	DURATION	at	quantmod	62	SENT_494	[p22l731t2907r754b2925],
61	least	JJS	DURATION	least	mwe	60	SENT_494	[p22l761t2902r819b2925],
62	3	CD	DURATION	3	num	63	SENT_494	[p22l827t2904r840b2925],
63	years	NNS	NUMBER	year	prep_for	11	SENT_494	[p22l848t2910r912b2931],

1	To	TO	O	to	dep	129	SENT_495	[p22l112t2979r145b3000],
2	apply	VB	O	apply	dep	129	SENT_495	[p22l154t2977r228b3006],
3	,	,	O	,	_	0	SENT_495	[p22l154t2977r228b3006],
4	editors-in-chief	NN	O	editors-in-chief	dep	129	SENT_495	[p22l239t2977r439b3000],
5	of	IN	O	of	dep	129	SENT_495	[p22l442t2977r472b3000],
6	interested	JJ	O	interested	dep	129	SENT_495	[p22l475t2977r599b3000],
7	journals	NNS	O	journal	dep	129	SENT_495	[p22l604t2977r709b3006],
8	should	MD	O	should	dep	129	SENT_495	[p22l719t2977r804b3000],
9	send	VB	O	send	dep	129	SENT_495	[p22l813t2977r871b3000],
10	electronic	JJ	O	electronic	dep	129	SENT_495	[p22l880t2977r1003b3000],
11	copies	NNS	O	copy	dep	129	SENT_495	[p22l1012t2977r1090b3006],
12	of	IN	O	of	dep	129	SENT_495	[p22l1100t2977r1129b3000],
13	the	DT	O	the	dep	129	SENT_495	[p22l1133t2977r1171b3000],
14	following	VBG	O	follow	dep	129	SENT_495	[p22l1180t2977r1301b3007],
15	to	TO	O	to	dep	129	SENT_495	[p22l1309t2982r1333b3000],
16	the	DT	O	the	dep	129	SENT_495	[p22l1342t2977r1380b3000],
17	ICMJE	NN	O	icmje	dep	129	SENT_495	[p22l1388t2979r1467b3004],
18	secretariat	NN	O	secretariat	dep	129	SENT_495	[p22l1477t2977r1608b3000],
19	(	CD	NUMBER	(	dep	129	SENT_495	[p22l1616t2977r1741b3004],
20	Christine	NNP	PERSON	Christine	dep	129	SENT_495	[p22l1616t2977r1741b3004],
21	Laine	NNP	PERSON	Laine	dep	129	SENT_495	[p22l113t3015r181b3038],
22	at	IN	O	at	dep	129	SENT_495	[p22l189t3020r213b3038],
23	claine@acponline.org	JJ	O	claine@acponline.org	dep	129	SENT_495	[p22l220t3015r504b3044],
24	)	NN	O	)	dep	129	SENT_495	[p22l220t3015r504b3044],
25	by	IN	O	by	dep	129	SENT_495	[p22l514t3015r542b3044],
26	September	NNP	DATE	September	dep	129	SENT_495	[p22l551t3015r685b3044],
27	1	CD	DATE	1	dep	129	SENT_495	[p22l694t3016r714b3038],
28	:	:	O	:	_	0	SENT_495	[p22l694t3016r714b3038],
29	-	:	O	-	_	0	SENT_495	[p22l158t3061r164b3068],
30	brief	JJ	O	brief	dep	129	SENT_495	[p22l180t3052r243b3075],
31	curriculum	NN	O	curriculum	dep	129	SENT_495	[p22l247t3052r385b3075],
32	vitae	NN	O	vita	dep	129	SENT_495	[p22l393t3052r451b3075],
33	-	:	O	-	_	0	SENT_495	[p22l158t3099r164b3106],
34	description	NN	O	description	dep	129	SENT_495	[p22l180t3090r322b3119],
35	of	IN	O	of	dep	129	SENT_495	[p22l331t3089r360b3113],
36	journal	NN	O	journal	dep	129	SENT_495	[p22l360t3090r460b3119],
37	,	,	O	,	_	0	SENT_495	[p22l360t3090r460b3119],
38	including	VBG	O	include	dep	129	SENT_495	[p22l470t3090r591b3119],
39	age	NN	O	age	dep	129	SENT_495	[p22l598t3097r648b3119],
40	,	,	O	,	_	0	SENT_495	[p22l598t3097r648b3119],
41	sponsorlpublisher	NN	O	sponsorlpublisher	dep	129	SENT_495	[p22l658t3090r896b3119],
42	,	,	O	,	_	0	SENT_495	[p22l658t3090r896b3119],
43	publishing	VBG	O	publish	dep	129	SENT_495	[p22l906t3090r1044b3119],
44	model	NN	O	model	dep	129	SENT_495	[p22l1051t3090r1130b3113],
45	(	CD	NUMBER	(	dep	129	SENT_495	[p22l1140t3090r1306b3119],
46	subscription	NN	O	subscription	dep	129	SENT_495	[p22l1140t3090r1306b3119],
47	model	NN	O	model	dep	129	SENT_495	[p22l1315t3090r1401b3118],
48	,	,	O	,	_	0	SENT_495	[p22l1315t3090r1401b3118],
49	author	NN	O	author	dep	129	SENT_495	[p22l1411t3090r1494b3113],
50	pays	VBZ	O	pay	dep	129	SENT_495	[p22l1502t3097r1564b3119],
51	,	,	O	,	_	0	SENT_495	[p22l1502t3097r1564b3119],
52	open	JJ	O	open	dep	129	SENT_495	[p22l1574t3097r1636b3119],
53	access	NN	O	access	dep	129	SENT_495	[p22l1644t3097r1731b3117],
54	,	,	O	,	_	0	SENT_495	[p22l1644t3097r1731b3117],
55	etc.	FW	O	etc.	dep	129	SENT_495	[p22l180t3129r241b3155],
56	)	FW	O	)	dep	129	SENT_495	[p22l180t3129r241b3155],
57	,	,	O	,	_	0	SENT_495	[p22l180t3129r241b3155],
58	target	NN	O	target	dep	129	SENT_495	[p22l251t3132r325b3157],
59	audience	NN	O	audience	dep	129	SENT_495	[p22l332t3127r450b3155],
60	,	,	O	,	_	0	SENT_495	[p22l332t3127r450b3155],
61	circulation	NN	O	circulation	dep	129	SENT_495	[p22l461t3127r602b3155],
62	,	,	O	,	_	0	SENT_495	[p22l461t3127r602b3155],
63	number	NN	O	number	dep	129	SENT_495	[p22l612t3127r712b3150],
64	of	IN	O	of	dep	129	SENT_495	[p22l720t3127r749b3150],
65	manuscript	NN	O	manuscript	dep	129	SENT_495	[p22l753t3127r897b3156],
66	submissions	NNS	O	submission	dep	129	SENT_495	[p22l905t3127r1062b3150],
67	per	IN	O	per	dep	129	SENT_495	[p22l1071t3135r1112b3156],
68	year	NN	DURATION	year	dep	129	SENT_495	[p22l1119t3135r1177b3156],
69	,	,	O	,	_	0	SENT_495	[p22l1119t3135r1177b3156],
70	description	NN	O	description	dep	129	SENT_495	[p22l1188t3127r1329b3156],
71	of	IN	O	of	dep	129	SENT_495	[p22l1338t3127r1368b3150],
72	peer	VB	O	peer	dep	129	SENT_495	[p22l1371t3135r1426b3156],
73	review	NN	O	review	dep	129	SENT_495	[p22l1434t3127r1514b3150],
74	process	NN	O	process	dep	129	SENT_495	[p22l1521t3135r1616b3156],
75	used	VBN	O	use	dep	129	SENT_495	[p22l1626t3127r1683b3150],
76	to	TO	O	to	dep	129	SENT_495	[p22l1692t3132r1716b3150],
77	select	VB	O	select	dep	129	SENT_495	[p22l180t3165r251b3188],
78	material	NN	O	material	dep	129	SENT_495	[p22l258t3165r362b3188],
79	for	IN	O	for	dep	129	SENT_495	[p22l370t3164r407b3188],
80	publication	NN	O	publication	dep	129	SENT_495	[p22l414t3165r564b3194],
81	,	,	O	,	_	0	SENT_495	[p22l414t3165r564b3194],
82	acceptance	NN	O	acceptance	dep	129	SENT_495	[p22l574t3169r711b3194],
83	rate	NN	O	rate	dep	129	SENT_495	[p22l720t3170r774b3193],
84	,	,	O	,	_	0	SENT_495	[p22l720t3170r774b3193],
85	bibliographical	JJ	O	bibliographical	dep	129	SENT_495	[p22l784t3165r976b3194],
86	databases	NNS	O	database	dep	129	SENT_495	[p22l985t3165r1106b3188],
87	where	WRB	O	where	dep	129	SENT_495	[p22l1114t3165r1191b3188],
88	indexed	VBN	O	index	dep	129	SENT_495	[p22l1199t3165r1304b3192],
89	,	,	O	,	_	0	SENT_495	[p22l1199t3165r1304b3192],
90	Web	NN	O	web	dep	129	SENT_495	[p22l1314t3165r1370b3188],
91	site	NN	O	site	dep	129	SENT_495	[p22l1380t3165r1422b3188],
92	address	NN	O	address	dep	129	SENT_495	[p22l1431t3165r1526b3188],
93	if	IN	O	if	dep	129	SENT_495	[p22l1535t3164r1558b3187],
94	applicable	JJ	O	applicable	dep	129	SENT_495	[p22l1561t3165r1696b3194],
95	,	,	O	,	_	0	SENT_495	[p22l1561t3165r1696b3194],
96	and	CC	O	and	dep	129	SENT_495	[p22l1706t3165r1752b3188],
97	copy	NN	O	copy	dep	129	SENT_495	[p22l180t3210r238b3231],
98	of	IN	O	of	dep	129	SENT_495	[p22l246t3202r276b3225],
99	guidelines	NNS	O	guideline	dep	129	SENT_495	[p22l279t3202r408b3232],
100	for	IN	O	for	dep	129	SENT_495	[p22l417t3202r454b3225],
101	authors	NNS	O	author	dep	129	SENT_495	[p22l461t3202r556b3225],
102	-	:	O	-	_	0	SENT_495	[p22l157t3249r164b3256],
103	statement	NN	O	statement	dep	129	SENT_495	[p22l180t3244r305b3263],
104	on	IN	O	on	dep	129	SENT_495	[p22l312t3247r344b3263],
105	why	WRB	O	why	dep	129	SENT_495	[p22l351t3240r403b3269],
106	the	DT	O	the	dep	129	SENT_495	[p22l411t3240r449b3263],
107	journal/editor	NN	O	journal/editor	dep	129	SENT_495	[p22l454t3239r745b3269],
108	—	NN	O	—	dep	129	SENT_495	[p22l454t3239r745b3269],
109	in	IN	O	in	dep	129	SENT_495	[p22l454t3239r745b3269],
110	—	NN	O	—	dep	129	SENT_495	[p22l454t3239r745b3269],
111	chief	NN	O	chief	dep	129	SENT_495	[p22l454t3239r745b3269],
112	wants	VBZ	O	want	dep	129	SENT_495	[p22l747t3244r821b3263],
113	to	TO	O	to	dep	129	SENT_495	[p22l830t3244r853b3263],
114	be	VB	O	be	dep	129	SENT_495	[p22l863t3240r891b3263],
115	an	DT	O	a	dep	129	SENT_495	[p22l899t3247r929b3263],
116	ICMJE	NN	O	icmje	dep	129	SENT_495	[p22l937t3241r1016b3266],
117	member	NN	O	member	dep	129	SENT_495	[p22l1025t3240r1131b3263],
118	(	NN	O	(	dep	129	SENT_495	[p22l1140t3240r1235b3266],
119	should	MD	O	should	dep	129	SENT_495	[p22l1140t3240r1235b3266],
120	not	RB	O	not	dep	129	SENT_495	[p22l1243t3244r1286b3263],
121	exceed	VB	O	exceed	dep	129	SENT_495	[p22l1293t3240r1376b3263],
122	1000	CD	NUMBER	1000	dep	129	SENT_495	[p22l1386t3241r1446b3263],
123	words	NNS	O	word	dep	129	SENT_495	[p22l1454t3240r1531b3263],
124	in	IN	O	in	dep	129	SENT_495	[p22l1540t3240r1564b3262],
125	length	NN	O	length	dep	129	SENT_495	[p22l1572t3240r1661b3269],
126	)	SYM	O	)	dep	129	SENT_495	[p22l1572t3240r1661b3269],
127	-	:	O	-	_	0	SENT_495	[p22l157t3286r164b3293],
128	contact	NN	O	contact	dep	129	SENT_495	[p22l180t3282r272b3300],
129	information	NN	O	information	_	0	SENT_495	[p22l279t3277r431b3300],

1	N	NN	O	n	nn	3	SENT_496	[p22l589t3446r603b3461],
2	ENGLJ	NN	O	englj	nn	3	SENT_496	[p22l617t3446r695b3468],
3	MED	NN	O	med	_	0	SENT_496	[p22l710t3446r762b3461],
4	361	CD	NUMBER	361	dep	3	SENT_496	[p22l772t3440r850b3468],
5	;	:	O	;	_	0	SENT_496	[p22l772t3440r850b3468],
6	1o	CD	NUMBER	1o	num	8	SENT_496	[p22l772t3440r850b3468],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_496	[p22l885t3446r1009b3468],
8	SEPTEMBER	NN	DATE	september	dep	4	SENT_496	[p22l1044t3446r1183b3461],
9	3	CD	DATE	3	dep	8	SENT_496	[p22l1193t3446r1211b3468],
10	,	,	DATE	,	_	0	SENT_496	[p22l1193t3446r1211b3468],
11	2009	CD	DATE	2009	num	12	SENT_496	[p22l1223t3446r1287b3467],
12	967	CD	NUMBER	967	appos	8	SENT_496	[p22l2010t3435r2067b3459],

1	The	DT	O	the	det	4	SENT_497	[p22l753t3479r804b3503],
2	New	NNP	O	New	nn	4	SENT_497	[p22l813t3480r875b3503],
3	England	NNP	O	England	nn	4	SENT_497	[p22l884t3479r995b3510],
4	Journal	NNP	O	Journal	_	0	SENT_497	[p22l1003t3479r1101b3503],
5	of	IN	O	of	_	0	SENT_497	[p22l1110t3479r1139b3503],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_497	[p22l1146t3479r1271b3503],

